0001193125-12-458748.txt : 20121108 0001193125-12-458748.hdr.sgml : 20121108 20121108060733 ACCESSION NUMBER: 0001193125-12-458748 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120930 FILED AS OF DATE: 20121108 DATE AS OF CHANGE: 20121108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNIVERSAL HEALTH REALTY INCOME TRUST CENTRAL INDEX KEY: 0000798783 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 236858580 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-09321 FILM NUMBER: 121188332 BUSINESS ADDRESS: STREET 1: UNIVERSAL CORPORATE CTR STREET 2: 367 S GULPH RD CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 BUSINESS PHONE: 610-265-0688 MAIL ADDRESS: STREET 1: UNIVERSAL CORPORATE CTR STREET 2: 367 S GULPH ROAD CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 10-Q 1 d404019d10q.htm FORM 10-Q Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(MARK ONE)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2012

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 1-9321

 

 

UNIVERSAL HEALTH REALTY INCOME TRUST

(Exact name of registrant as specified in its charter)

 

 

 

MARYLAND   23-6858580

(State or other jurisdiction of

incorporation or organization)

 

(I. R. S. Employer

Identification No.)

UNIVERSAL CORPORATE CENTER

367 SOUTH GULPH ROAD

KING OF PRUSSIA, PENNSYLVANIA

  19406
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (610) 265-0688

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated Filer   x
Non-accelerated filer   ¨    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Number of common shares of beneficial interest outstanding at October 31, 2012 - 12,685,646

 

 

 


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

INDEX

 

         

PAGE NO.

 

PART I. FINANCIAL INFORMATION

  

Item 1.

  

Financial Statements

  
  

Condensed Consolidated Statements of Income – Three and Nine Months Ended September  30, 2012 and 2011

     3   
  

Condensed Consolidated Balance Sheets - September 30, 2012 and December 31, 2011

     4   
  

Condensed Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2012 and 2011

     5   
  

Notes to Condensed Consolidated Financial Statements

     6 through 14   

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     15 through 28   

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

     28   

Item 4.

  

Controls and Procedures

     28   

PART II. Other Information

     29   

Item 6.

  

Exhibits

     29   

Signatures

     30   

EXHIBIT INDEX

     31   

 

2


Table of Contents

Part I. Financial Information

Item I. Financial Statements

Universal Health Realty Income Trust

Condensed Consolidated Statements of Income

For the Three and Nine Months Ended September 30, 2012 and 2011

(amounts in thousands, except per share amounts)

(unaudited)

 

     Three Months
Ended September 30,
    Nine Months
Ended September 30,
 
     2012     2011     2012     2011  

Revenues:

        

Base rental - UHS facilities

   $ 4,068      $ 3,266      $ 11,556      $ 9,788   

Base rental - Non-related parties

     6,623        2,676        20,265        6,727   

Bonus rental - UHS facilities

     955        1,013        3,109        3,217   

Tenant reimbursements and other - Non-related parties

     1,816        421        5,341        1,059   

Tenant reimbursements and other - UHS facilities

     148        18        356        45   
  

 

 

   

 

 

   

 

 

   

 

 

 
     13,610        7,394        40,627        20,836   
  

 

 

   

 

 

   

 

 

   

 

 

 

Expenses:

        

Depreciation and amortization

     5,263        1,799        15,484        4,841   

Advisory fees to UHS

     540        525        1,594        1,476   

Other operating expenses

     3,578        1,424        11,244        3,674   

Transaction costs

     14        455        663        590   
  

 

 

   

 

 

   

 

 

   

 

 

 
     9,395        4,203        28,985        10,581   
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated limited liability companies (“LLCs”), interest expense and gain, net

     4,215        3,191        11,642        10,255   

Equity in income of unconsolidated LLCs

     645        875        1,803        2,377   

Gain on divestiture of property owned by an unconsolidated LLC, net

     0        0        7,375        0   

Interest expense, net

     (1,874     (718     (5,853     (1,464
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 2,986      $ 3,348      $ 14,967      $ 11,168   
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic earnings per share

   $ 0.24      $ 0.26      $ 1.18      $ 0.88   
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted earnings per share

   $ 0.24      $ 0.26      $ 1.18      $ 0.88   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding - Basic

     12,666        12,648        12,658        12,643   

Weighted average number of share equivalents

     10        3        7        5   
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares and equivalents outstanding - Diluted

     12,676        12,651        12,665        12,648   
  

 

 

   

 

 

   

 

 

   

 

 

 

See accompanying notes to these condensed consolidated financial statements.

 

3


Table of Contents

Universal Health Realty Income Trust

Condensed Consolidated Balance Sheets

(dollar amounts in thousands)

(unaudited)

 

     September 30,
2012
    December 31,
2011
 

Assets:

    

Real Estate Investments:

    

Buildings and improvements

   $ 366,321      $ 338,648   

Accumulated depreciation

     (84,186     (74,865
  

 

 

   

 

 

 
     282,135        263,783   

Land

     27,058        24,850   
  

 

 

   

 

 

 

Net Real Estate Investments

     309,193        288,633   
  

 

 

   

 

 

 

Investments in and advances to limited liability companies (“LLCs”)

     38,895        33,057   

Other Assets:

    

Cash and cash equivalents

     3,151        11,649   

Base and bonus rent receivable from UHS

     1,963        1,982   

Rent receivable - other

     3,016        2,056   

Intangible assets (net of accumulated amortization of $6.6 million and $1.2 million at September 30, 2012 and December 31, 2011, respectively)

     25,645        28,081   

Deferred charges, goodwill and other assets, net

     6,143        5,471   
  

 

 

   

 

 

 

Total Assets

   $ 388,006      $ 370,929   
  

 

 

   

 

 

 

Liabilities:

    

Line of credit borrowings

   $ 83,000      $ 77,150   

Mortgage and other notes payable, non-recourse to us (including net debt premium of $1.4 million and $1.1 million at September 30, 2012 and December 31, 2011, respectively)

     116,175        97,686   

Accrued interest

     541        473   

Accrued expenses and other liabilities

     4,954        4,984   

Tenant reserves, escrows, deposits and prepaid rents

     2,234        1,691   
  

 

 

   

 

 

 

Total Liabilities

     206,904        181,984   
  

 

 

   

 

 

 

Equity:

    

Preferred shares of beneficial interest, $.01 par value; 5,000,000 shares authorized; none issued and outstanding

     0        0   

Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2012 - 12,685,403 2011 -12,666,824

     127        127   

Capital in excess of par value

     214,092        213,566   

Cumulative net income

     462,365        447,398   

Cumulative dividends

     (495,558     (472,230
  

 

 

   

 

 

 

Total Universal Health Realty Income Trust Shareholders’ Equity

     181,026        188,861   

Non-controlling equity interest

     76        84   
  

 

 

   

 

 

 

Total Equity

     181,102        188,945   
  

 

 

   

 

 

 

Total Liabilities and Equity

   $ 388,006      $ 370,929   
  

 

 

   

 

 

 

See the accompanying notes to these condensed consolidated financial statements.

 

4


Table of Contents

Universal Health Realty Income Trust

Condensed Consolidated Statements of Cash Flows

(amounts in thousands)

(unaudited)

 

     Nine months ended September 30,  
     2012     2011  

Cash flows from operating activities:

    

Net income

   $ 14,967      $ 11,168   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     15,484        4,841   

Amortization on debt premium

     (509     0   

Restricted/stock-based compensation expense

     238        210   

Gain on divestiture of property owned by an unconsolidated LLC

     (7,375     0   

Changes in assets and liabilities:

    

Rent receivable

     (1,017     (371

Accrued expenses and other liabilities

     (152     (114

Tenant reserves, escrows, deposits and prepaid rents

     543        (1

Accrued interest

     68        (23

Other, net

     196        87   
  

 

 

   

 

 

 

Net cash provided by operating activities

     22,443        15,797   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Investments in LLCs

     (1,677     (3,475

Repayments of advances made to LLCs

     499        6,664   

Advances made to LLCs

     (8,000     (11,541

Cash distributions in excess of income from LLCs

     2,622        4,066   

Cash distributions of refinancing proceeds from LLCs

     0        2,111   

Additions to real estate investments

     (2,733     (172

Deposit on real estate assets

     100        (834

Net cash paid for acquisition of medical office building

     (7,324     (26,505

Payment of assumed liabilities on acquired properties

     (553     0   

Cash proceeds received from divestiture of property owned by an unconsolidated LLC, net

     8,077        0   
  

 

 

   

 

 

 

Net cash used in investing activities

     (8,989     (29,686
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Net borrowings on line of credit

     5,850        37,800   

Proceeds from mortgage notes payable

     7,000        0   

Repayments of mortgage and other notes payable

     (11,242     (214

Financing costs paid on mortgage and other notes payable

     (524     (1,104

Dividends paid

     (23,328     (22,977

Issuance of shares of beneficial interest, net

     292        184   
  

 

 

   

 

 

 

Net cash (used in)/ provided by financing activities

     (21,952     13,689   
  

 

 

   

 

 

 

Decrease in cash and cash equivalents

     (8,498     (200

Cash and cash equivalents, beginning of period

     11,649        987   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 3,151      $ 787   
  

 

 

   

 

 

 

Supplemental disclosures of cash flow information:

    

Interest paid

   $ 6,033      $ 1,297   
  

 

 

   

 

 

 

See accompanying notes to these condensed consolidated financial statements.

 

5


Table of Contents

UNIVERSAL HEALTH REALTY INCOME TRUST

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2012

(unaudited)

(1) General

This Quarterly Report on Form 10-Q is for the Quarterly Period ended September 30, 2012. In this Quarterly Report, “we,” “us,” “our” and the “Trust” refer to Universal Health Realty Income Trust.

You should carefully review all of the information contained in this Quarterly Report, and should particularly consider any risk factors that we set forth in this Quarterly Report and in other reports or documents that we file from time to time with the Securities and Exchange Commission (the “SEC”). In this Quarterly Report, we state our beliefs of future events and of our future financial performance. In some cases, you can identify those so-called “forward-looking statements” by words such as “may,” “will,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “appears,” “projects” and similar expressions, as well as statements in future tense. You should be aware that those statements are only our predictions. Actual events or results may differ materially. In evaluating those statements, you should specifically consider various factors, including the risks outlined herein and in our Annual Report on Form 10-K for the year ended December 31, 2011 in Item 1A Risk Factors and in Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations - Forward Looking Statements. Those factors may cause our actual results to differ materially from any of our forward-looking statements.

Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

In this Quarterly Report on Form 10-Q, the term “revenues” does not include the revenues of the unconsolidated limited liability companies (“LLCs”) in which we have various non-controlling equity interests ranging from 33% to 95%. We currently account for our share of the income/loss from these investments by the equity method (see Note 5). As of September 30, 2012, we had investments or commitments in fourteen LLCs, thirteen of which are accounted for by the equity method and one that is currently consolidated in our financial statements. Additionally, as previously disclosed, during the fourth quarter of 2011, we purchased the third-party minority ownership interests in eleven LLCs of which we previously held non-controlling, majority ownership interests ranging from 85% to 99%. As a result, we now own 100% of each of these entities and began recording their financial results in our financial statements on a consolidated basis during the fourth quarter of 2011.

The financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the SEC and reflect all normal and recurring adjustments which, in our opinion, are necessary to fairly present results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. It is suggested that these financial statements be read in conjunction with the financial statements, the notes thereto and accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2011.

(2) Relationship with Universal Health Services, Inc. (“UHS”) and Related Party Transactions

Leases: We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

The combined revenues generated from the leases on the UHS hospital facilities comprised approximately 29% and 30% of our consolidated revenues during the three and nine months ended September 30, 2012, respectively, and 55% and 59% of our

 

6


Table of Contents

consolidated revenues during the three and nine months ended September 30, 2011, respectively. The decreases during the third quarter and the first nine months of 2012, as compared to the comparable quarter and nine months of the prior year, were due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of these entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (“MOBs”) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 21% and 18% of the combined consolidated and unconsolidated revenue for the three month periods ended September 30, 2012 and 2011, respectively, and 21% and 19% of the combined consolidated and unconsolidated revenue for the nine months ended September 30, 2012 and 2011, respectively. In addition, fourteen MOBs, twelve of which are owned by LLCs in which we hold either 100% of the ownership interest or various non-controlling, majority ownership interests, include or will include tenants which are subsidiaries of UHS. The leases to the hospital facilities of UHS are guaranteed by UHS and cross-defaulted with one another.

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties listed below at their appraised fair market value.

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:

 

Hospital Name

   Type of Facility    Annual
Minimum
Rent
     End of Lease Term    Renewal
Term
(years)
 

McAllen Medical Center

   Acute Care    $ 5,485,000       December, 2016      15 (a) 

Wellington Regional Medical Center

   Acute Care    $ 3,030,000       December, 2016      15 (b) 

Southwest Healthcare System, Inland Valley Campus

   Acute Care    $ 2,648,000       December, 2016      15 (b) 

The Bridgeway

   Behavioral Health    $ 930,000       December, 2014      10 (c) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
(c) UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).

We are committed to invest up to a total of $8.9 million in equity and debt financing, of which $5.0 million has been funded as of September 30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Palmdale Medical Properties) that constructed, owns, and operates the Palmdale Medical Plaza, located in Palmdale, California, on the campus of a UHS hospital. This MOB has a triple net, 75% master lease commitment by UHS of Palmdale, Inc., a wholly-owned subsidiary of UHS, pursuant to the terms of which the master lease for each suite will be cancelled at such time that the suite is leased to another tenant acceptable to the LLC and UHS of Palmdale, Inc. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. As of September 30, 2012, the master lease threshold of 75% has not been met. The LLC has a third-party term loan of $6.3 million, which is non-recourse to us, outstanding as of September 30, 2012. This LLC, which is deemed to be a variable interest entity, is consolidated in our financial statements since we are the primary beneficiary.

We are committed to invest up to $6.4 million in equity and debt financing, of which $5.7 million has been funded as of September 30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Sparks Medical Properties) that owns and operates the Vista Medical Terrace and The Sparks Medical Building, located in Sparks, Nevada, on the campus of a UHS hospital. This LLC has a third-party term loan of $5.2 million, which is non-recourse to us, outstanding as of September 30, 2012. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

We are committed to invest up to a total of $4.4 million in equity and debt financing, of which $1.7 million has been funded as of September 30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the

 

7


Table of Contents

first quarter of 2010. This MOB is located on the campus of a newly constructed and recently opened replacement UHS acute care hospital owned and operated by Texoma Medical Center (“Texoma Hospital”), a wholly-owned subsidiary of UHS. Texoma Hospital has committed to lease 75% of this building, pursuant to which the master lease for each suite will be cancelled at such time that the suite is leased to another tenant acceptable to the LLC and Texoma Hospital. It is anticipated that the master lease threshold on this MOB will be met in the near future. This MOB will have tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $12.9 million, which is non-recourse to us, outstanding as of September 30, 2012. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

Advisory Agreement: UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. The Advisory Agreement was renewed for 2012 at the same terms and conditions as 2011.

The Advisory Agreement provides that the Advisor is entitled to receive an annual advisory fee equal to 0.65% of our average invested real estate assets, as derived from our consolidated balance sheet. The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during the first nine months of 2012 or 2011 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $540,000 and $525,000 for the three months ended September 30, 2012 and 2011, respectively, and were based upon average invested real estate assets of $332 million and $323 million for the three-month periods ended September 30, 2012 and 2011, respectively. Advisory fees incurred and paid (or payable) to UHS amounted to $1.6 million and $1.5 million for the nine months ended September 30, 2012 and 2011, respectively, and were based upon average invested real estate assets of $327 million and $303 million for the nine-month periods ended September 30, 2012 and 2011, respectively.

Officers and Employees: Our officers are all employees of UHS and although as of September 30, 2012 we had no salaried employees, our officers do receive stock-based compensation from time-to-time. As previously disclosed on our Current Report on Form 8-K as filed on June 11, 2012, in recognition of the efforts and contributions of our executive officers in connection with the various previously disclosed acquisitions, divestitures and purchases of third-party minority ownership interests in certain majority-owned limited liability companies, as completed at various times during 2011 and the first quarter of 2012, the Compensation Committee of the Board of Trustees of the Trust recommended, and the Board of Trustees of the Trust approved, one-time, special compensation awards to our executive officers in the form of a cash bonus and/or shares of restricted stock. The cash bonuses were paid and the restricted shares were granted during the second quarter of 2012. The restricted shares are scheduled to vest on the second anniversary of the date of grant. For additional disclosure, please refer to our Current Report on Form 8-K as filed on June 11, 2012.

Share Ownership: As of September 30, 2012 and December 31, 2011, UHS owned 6.2% of our outstanding shares of beneficial interest.

SEC reporting requirements of UHS: UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 29% and 30% of our consolidated revenues during the three and nine months ended September 30, 2012, respectively, and 55% and 59% of our consolidated revenues during the three and nine months ended September 30, 2011, respectively, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

 

8


Table of Contents

(3) Dividends

We declared and paid dividends of $7.8 million, or $.615 per share, during the third quarter of 2012 and $7.7 million, or $.605 per share, during the third quarter of 2011. We declared and paid dividends of $23.3 million, or $1.84 per share, during the nine-month period ended September 30, 2012 and $23.0 million, or $1.815 per share, during the nine-month period ended September 30, 2011.

(4) Acquisitions and Dispositions

Nine Months Ended September 30, 2012:

New Construction and Acquisition:

During the third quarter of 2012, we entered into an agreement whereby we will own a 95% non-controlling ownership interest in FTX MOB Phase II LP, which will develop, construct, own and operate the Forney Medical Plaza II, a newly constructed MOB, consisting of approximately 30,000 rentable square feet, located in Forney, Texas. We have committed to invest up to $2.5 million in this newly formed LLC. This MOB is expected to be completed and opened during the first quarter of 2013.

In January, 2012, we purchased, as part of a planned, like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code, the PeaceHealth Medical Clinic, a single-tenant medical office building consisting of approximately 99,000 rentable square feet, located in Bellingham, Washington. The property was purchased for approximately $30.4 million, including the assumption of approximately $22.4 million of third-party financing. The aggregate purchase price of this MOB was allocated to the assets and liabilities acquired consisting of tangible property ($26.8 million) and identified intangible assets ($3.6 million), based on the respective fair values at acquisition, as determined by an appraisal. Intangible assets include the value of the in-place lease at the time of acquisition and will be amortized over the average remaining lease term of approximately ten years (amounts in thousands).

 

Land, buildings and improvements

   $ 26,810   

Other assets

     4,399   

Debt

     (23.240

Other liabilities, net

     (111

Deposits funded in 2011

     (534
  

 

 

 

Net cash paid in 2012

   $ 7,324   
  

 

 

 

In connection with this MOB, during the three months ended September 30, 2012, we recorded revenue of $698,000 and net income of approximately $106,000 (excluding transaction expenses of $14,000 and including the $108,000 favorable interest expense adjustment resulting from the amortization of the fair value of debt). During the nine months ended September 30, 2012, we recorded revenue of $1.9 million and net income of approximately $158,000 (excluding transaction expenses of $663,000 and including the $108,000 favorable interest expense adjustment resulting from the amortization of the fair value of debt).

Divestitures:

In February, 2012, Canyon Healthcare Properties, a limited liability company (“LLC”) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer has assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing costs and the minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the nine months ended September 30, 2012 (recorded during the first quarter of 2012).

Subsequent to September 30, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.1 million of cash proceeds to us, net of closing costs and minority members’ share of the proceeds. This divestiture is expected to result in a gain, which will be recorded during the fourth quarter of 2012 and is not expected to have a material impact on our financial statements.

Nine Months Ended September 30, 2011:

Acquisitions:

In June and July, 2011, utilizing a qualified third-party intermediary in connection with planned like-kind exchange transactions pursuant to Section 1031 of the Internal Revenue Code, we purchased the:

 

   

Lake Pointe Medical Arts Building—a 50,974 square foot, multi-tenant, medical office building located in Rowlett, Texas, which was acquired in June, 2011, for $12.2 million; the weighted average remaining lease term at the date of acquisition was 6.5 years, and;

 

9


Table of Contents
   

Forney Medical Plaza—a 50,946 square foot, multi-tenant medical office building located in Forney, Texas, which was acquired in July, 2011, for $15.0 million; the weighted average remaining lease term at the date of acquisition was 6.2 years.

The aggregate purchase price for these MOBs was allocated to the assets acquired consisting of tangible property ($23.0 million) and identified intangible assets ($4.2 million), based on their respective fair values at acquisition, as determined by third-party appraisals. Intangible assets include the value of the in-place leases at the time of acquisition. The intangible assets at each MOB will be amortized over the remaining lease terms.

There were no divestitures during the first nine months of 2011.

Assuming the 2012 acquisition and divestiture, as well as the 2011 acquisitions and divestitures as previously disclosed, occurred on January 1, 2011, our 2011 pro forma net revenues for the three and nine months ended September 30, 2011 would have been approximately $13.4 million and $39.8 million, respectively, and our 2011 pro forma net income for the three and nine months ended September 30, 2011 would have been approximately $2.2 million, or $0.18 per diluted share, and $8.1 million, or $0.64 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2011. Assuming the 2012 acquisition and divestiture occurred on January 1, 2012, our net revenues and net income for the three month period ended September 30, 2012 would have remained unchanged from the actual net revenues and net income as reported, and our pro forma net revenues and net income for the nine months ended September 30, 2012 would have been approximately $40.8 million and $8.3 million, or $.65 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.

(5) Summarized Financial Information of Equity Affiliates

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the Financial Accounting Standards Board’s (“FASB”) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

In December, 2011, as previously disclosed on our Annual Report on Form 10-K for the year ended December 31, 2011, we purchased the third-party minority ownership interests in eleven LLCs of which we previously held non-controlling, majority ownership interests ranging from 85% to 99%. As a result, we now own 100% of each of these entities and began recording their financial results in our financial statements on a consolidated basis. Prior to December, 2011, the financial results of these LLCs were included in our financial statements on an unconsolidated basis under the equity method of accounting. With the exception of no longer providing for the third-party’s share of the operating results of these entities, there was no material impact on our net income as a result of the consolidation of these entities.

At September 30, 2012, we have non-controlling equity investments or commitments in fourteen LLCs which own MOBs. As of September 30, 2012, we accounted for: (i) thirteen of these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities, and; (ii) one of these LLCs (Palmdale Medical Properties) on a consolidated basis, as discussed below, since it is considered to be a variable interest entity where we are the primary beneficiary by virtue of its master lease with a subsidiary of Universal Health Services, Inc. (“UHS”), a related party to us. Additionally, as discussed above, subsequent to September 30, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex, reducing the number of non-controlling equity investments or commitments in LLCs to thirteen. The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or short to intermediate term loans.

Palmdale Medical Properties has a master lease with a subsidiary of UHS. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS. As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we account for this LLC on a consolidated basis, since the fourth quarter of 2007, since it is a variable interest entity and we are deemed to be the primary beneficiary. The master lease threshold on this MOB has not yet been met.

 

10


Table of Contents

The other LLCs in which we hold various non-controlling ownership interests are not variable interest entities and therefore are not subject to consolidation. As a result of master lease arrangements between UHS and various LLCs in which we hold majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB’s standards and guidance.

Rental income is recorded by our consolidated and unconsolidated MOBs relating to leases in excess of one year in length using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors, including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisition and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period.

The following property table represents the thirteen LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of September 30, 2012:

 

Name of LLC

   Ownership    

Property Owned by LLC

DVMC Properties

     90   Desert Valley Medical Center

Suburban Properties

     33   Suburban Medical Plaza II

Santa Fe Scottsdale

     90   Santa Fe Professional Plaza

575 Hardy Investors(a.)

     90   Centinela Medical Building Complex

Brunswick Associates

     74   Mid Coast Hospital MOB

PCH Medical Properties

     85   Rosenberg Children’s Medical Plaza

Arlington Medical Properties

     75   Saint Mary’s Professional Office Building

Sierra Medical Properties

     95   Sierra San Antonio Medical Plaza

PCH Southern Properties

     95   Phoenix Children’s East Valley Care Center

Sparks Medical Properties(b.)

     95   Vista Medical Terrace & The Sparks Medical Building

Grayson Properties(b.)

     95   Texoma Medical Plaza

3811 Bell Medical Properties

     95   North Valley Medical Plaza

FTX MOB Phase II (c.)

     95   Forney Medical Plaza II

 

(a.) Subsequent to September 30, 2012, this LLC divested the Centinela Medical Building Complex.
(b.) Tenants of this medical office building include or will include subsidiaries of UHS.
(c.) During the third quarter of 2012, this LP entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which is scheduled to be completed during the first quarter of 2013.

Below are the combined statements of income (unaudited) for the LLCs accounted for under the equity method at September 30, 2012 and 2011:

 

     Three Months  Ended
September 30,
     Nine Months  Ended
September 30,
 
     2012(b.)      2011      2012(b.)      2011  
     (amounts in thousands)  

Revenues

   $ 5,514       $ 15,222       $ 16,499       $ 44,803   

Operating expenses

     2,327         6,882         6,992         19,986   

Depreciation and amortization

     1,062         3,284         3,120         10,009   

Interest, net

     1,545         4,599         4,716         13,619   
  

 

 

    

 

 

    

 

 

    

 

 

 

Net income

   $ 580       $ 457       $ 1,671       $ 1,189   
  

 

 

    

 

 

    

 

 

    

 

 

 

Our share of net income (a.)

   $ 645       $ 875       $ 1,803       $ 2,377   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

(a.) Our share of net income includes interest income earned by us on various advances made to LLCs of approximately $438,000 and $715,000 for the three months ended September 30, 2012 and 2011, respectively, and $1.3 million and $2.0 million for the nine months ended September 30, 2012 and 2011, respectively.
(b.) As previously disclosed, during the fourth quarter of 2011, eleven of our previously unconsolidated investments in LLCs are now owned 100% by us and are therefore included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011 and the first quarter of 2012, nine LLCs, in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.

 

11


Table of Contents

Below are the combined balance sheets (unaudited) for the LLCs accounted for under the equity method (including the balance sheet for the MOB that was divested subsequent to September 30, 2012, as discussed above):

 

     September 30,
2012
     December 31,
2011
 
     (amounts in thousands)  

Net property, including CIP

   $ 111,206       $ 127,755   

Other assets

     10,360         12,719   
  

 

 

    

 

 

 

Total assets

   $ 121,566       $ 140,474   
  

 

 

    

 

 

 

Liabilities

   $ 6,149       $ 4,949   

Mortgage notes payable, non-recourse to us

     76,025         101,839   

Advances payable to us

     20,637         12,692   

Equity

     18,755         20,994   
  

 

 

    

 

 

 

Total liabilities and equity

   $ 121,566       $ 140,474   
  

 

 

    

 

 

 

Our share of equity and advances to LLCs

   $ 38,895       $ 33,057   
  

 

 

    

 

 

 

As of September 30, 2012, aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

2012

   $ 4,210   

2013

     6,766   

2014

     13,854   

2015

     35,231   

2016

     316   

Later

     15,648   
  

 

 

 

Total

   $ 76,025   
  

 

 

 

 

Name of LLC

   Mortgage/
Construction  Loan

Balance
(b)
     Maturity Date  

Sierra Medical Properties(a.)

   $ 3,808         12/31/2012   

Sparks Medical Properties(a.)

     5,245         02/12/2013   

Grayson Properties

     12,914         07/01/2014   

Brunswick Associates

     8,124         01/01/2015   

Arlington Medical Properties

     24,954         10/10/2015   

DVMC Properties

     4,098         11/01/2015   

FTX MOB Phase II(c.)

     1,299         8/01/2017   

PCH Southern Properties

     6,766         12/01/2017   

PCH Medical Properties

     8,817         05/01/2018   
  

 

 

    
   $ 76,025      
  

 

 

    

 

(a.) We believe the terms of these loans are within current market underwriting criteria. At this time, we expect to refinance these loans on or before the 2012 and 2013 maturity dates for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance these loans on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.
(b.) All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(c.) Construction loan.

Pursuant to the operating agreements of the LLCs, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member.

 

12


Table of Contents

The LLCs in which we have invested maintain property insurance on all properties. Although we believe that generally our properties are adequately insured, three of the LLCs in which we own various non-controlling equity interests, own properties in California that are located in earthquake zones. These properties are not covered by earthquake insurance since earthquake insurance is no longer available at rates which are economical in relation to the risks covered.

(6) Recent Accounting Pronouncements

There were no new accounting pronouncements during the first nine months of 2012 that impacted, or are expected to impact, us.

In May 2011, the FASB issued an update to the accounting standard for measuring and disclosing fair value. The update modifies the wording used to describe the requirements for fair value measuring and for disclosing information about fair value measurements to improve consistency between U.S. GAAP and International Financial Reporting Standards (“IFRS”). This update is effective for the annual and interim periods beginning after December 15, 2011. The adoption of this guidance in 2012 did not have a material impact on our consolidated financial position or results of operations as its impact was limited to disclosure requirements.

(7) Long-term debt

Our previous unsecured $100 million revolving credit agreement (the “Agreement”) was terminated by us on July 25, 2011 and replaced with a new revolving credit facility. The Agreement provided for interest at our option, at the Eurodollar rate plus 0.75% to 1.125%, or the prime rate plus zero to 0.125%. A fee of 0.15% to 0.225% was payable on the unused portion of the commitment. The margins over the Eurodollar, prime rate and the commitment fee were based upon our debt to total capital ratio as defined by the Agreement.

On July 25, 2011, we entered into a new $150 million revolving credit agreement (“Credit Agreement”). The Credit Agreement, which is scheduled to expire on July 24, 2015, replaced our previous revolving credit facility which was scheduled to mature in January, 2012 and increased our borrowing capacity from $100 million to $150 million. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate, (b) the federal funds effective rate plus 1/2 of 1%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At September 30, 2012, the applicable margin over the LIBOR rate was 1.75%, the margin over the Base Rate was 0.75%, and the commitment fee was 0.30%.

At September 30, 2012, we had $83.0 million of outstanding borrowings and $13.6 million of letters of credit outstanding against our revolving credit agreement. We had $53.4 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of September 30, 2012. There are no compensating balance requirements.

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at September 30, 2012. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

The following table includes a summary of the required compliance ratios, giving effect to the new covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     September 30,
2012
 

Tangible net worth

   $ 125,000      $ 155,381   

Debt to total capital

     < 55     31.4

Debt service coverage ratio

     > 5.00     29.24

Debt to cash flow ratio

     < 3.50     1.30

We have thirteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of September 30, 2012, with a combined outstanding balance of $114.8 million (excluding net debt premium, resulting from fair value recognition of

 

13


Table of Contents

third-party debt related to majority-owned LLCs in which we purchased the minority ownership interests, as well as the purchase of the PeaceHealth Medical Clinic in January, 2012, of $1.4 million at September 30, 2012). The following table summarizes our outstanding mortgages at September 30, 2012 (amounts in thousands):

 

Facility Name

  Outstanding
Balance
(in thousands)
    Interest
Rate
    Maturity
Date
 

BRB Medical Office Building mortgage loan(b)

  $ 6,180        6.25     2012   

Centennial Hills Medical Office Building I mortgage loan(a)(e)

    11,691        6.00     2013   

Palmdale Medical Plaza fixed rate mortgage loan(a)(f)

    6,327        5.10     2013   

Summerlin Hospital Medical Office Building I mortgage loan(a)

    9,442        6.55     2014   

Spring Valley Medical Office Building mortgage loan(a)

    5,360        5.50     2015   

Summerlin III Medical Office Building III mortgage loan(a) (c)

    11,728        Floating        2016   

PeaceHealth Medical Clinic fixed rate mortgage loan(a)

    22,188        5.64     2017   

Summerlin Hospital Medical Office Building II mortgage loan(a)

    12,366        5.50     2017   

Auburn Medical II mortgage loan (a)(d)

    7,674        Floating        2017   

Medical Center of Western Connecticut fixed rate mortgage loan(a)

    5,033        6.00     2017   

Kindred Hospital-Corpus Christi fixed rate mortgage loan(a)

    3,077        6.50     2019   

700 Shadow Lane and Goldring MOB mortgage loan (a)

    6,962        4.54     2022   

Tuscan Professional Building fixed rate mortgage loan(a)

    6,732        5.56     2025   
 

 

 

     

Total

  $ 114,760       
 

 

 

     

 

(a) Amortized principal payments made on a monthly basis.
(b) Subsequent to September 30, 2012, this loan was refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December 1, 2022.
(c) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower’s option.
(d) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower’s option.
(e) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan on or before the January 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.
(f) We believe the terms of this loan are within current market underwriting criteria. We expect to refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $117.6 million as of September 30, 2012. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

(8) Segment Reporting

Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.

Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.

 

14


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Overview

We are a real estate investment trust (“REIT”) that commenced operations in 1986. We invest in healthcare and human service related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute facilities, surgery centers, childcare centers and medical office buildings (“MOBs”). As of September 30, 2012, we have fifty-five real estate investments or commitments located in fifteen states consisting of:

 

   

seven hospital facilities consisting of three acute care, one behavioral healthcare, one rehabilitation and two sub-acute;

 

   

forty-four medical office buildings, including fourteen owned by various jointly-owned LLCs, the majority of which are unconsolidated, and;

 

   

four pre-school and childcare centers.

Forward Looking Statements and Certain Risk Factors

This report contains “forward-looking statements” that reflect our current estimates, expectations and projections about our future results, performance, prospects and opportunities. Forward-looking statements include, among other things, the information concerning our possible future results of operations, business and growth strategies, financing plans, expectations that regulatory developments or other matters will not have a material adverse effect on our business or financial condition, our competitive position and the effects of competition, the projected growth of the industry in which we operate, and the benefits and synergies to be obtained from our completed and any future acquisitions, and statements of our goals and objectives, and other similar expressions concerning matters that are not historical facts. Words such as “may,” “will,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “appears,” “projects” and similar expressions, as well as statements in future tense, identify forward-looking statements.

Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by which, such performance or results will be achieved. Forward-looking information is based on information available at the time and/or our good faith belief with respect to future events, and is subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Such factors include, among other things, the following:

 

   

a substantial portion of our revenues are dependent upon one operator, Universal Health Services, Inc. (“UHS”);

 

   

a number of legislative initiatives have recently been passed into law that may result in major changes in the health care delivery system on a national or state level to the operators of our facilities, including UHS. No assurances can be given that the implementation of these new laws will not have a material adverse effect on the business, financial condition or results of operations of our operators;

 

   

a subsidiary of UHS is our Advisor and our officers are all employees of UHS, which may create the potential for conflicts of interest;

 

   

lost revenues from purchase option exercises and lease expirations and renewals, loan repayments and other restructuring;

 

   

the availability and terms of capital to fund the growth of our business;

 

   

the outcome of known and unknown litigation, government investigations, and liabilities and other claims asserted against us or the operators of our facilities;

 

   

failure of the operators of our hospital facilities to comply with governmental regulations related to the Medicare and Medicaid licensing and certification requirements could have a material adverse impact on our future revenues and the underlying value of the property;

 

   

the potential unfavorable impact on our business of deterioration in national, regional and local economic and business conditions, including a continuation or worsening of unfavorable credit and/or capital market conditions, which may adversely affect, on acceptable terms, our access to sources of capital which may be required to fund the future growth of our business and refinance existing debt with near term maturities;

 

   

further deterioration in general economic conditions which could result in increases in the number of people unemployed and/or insured and likely increase the number of individuals without health insurance; as a result, the operators of our facilities may experience decreases in patient volumes which could result in decreased occupancy rates at our medical office buildings;

 

15


Table of Contents
   

a worsening of the economic and employment conditions in the United States could materially affect the business of our operators, including UHS, which may unfavorably impact our future bonus rentals (on the UHS hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties;

 

   

real estate market factors, including without limitation, the supply and demand of office space and market rental rates, changes in interest rates as well as an increase in the development of medical office condominiums in certain markets;

 

   

government regulations, including changes in the reimbursement levels under the Medicare and Medicaid program resulting from, among other things, the various health care reform initiatives being implemented;

 

   

the issues facing the health care industry that affect the operators of our facilities, including UHS, such as: changes in, or the ability to comply with, existing laws and government regulations; unfavorable changes in the levels and terms of reimbursement by third party payors or government programs, including Medicare (including, but not limited to, the potential unfavorable impact of future reductions to Medicare reimbursements resulting from the Budget Control Act of 2011, as discussed below) and Medicaid (most states have reported significant budget deficits that have resulted in the reduction of Medicaid funding to the operators of our facilities, including UHS, during each of the last several years, and many states may effectuate further reductions in the level of Medicaid funding due to continued projected state budget deficits); demographic changes; the ability to enter into managed care provider agreements on acceptable terms; an increase in uninsured and self-pay patients which unfavorably impacts the collectability of patient accounts; decreasing in-patient admission trends; technological and pharmaceutical improvements that may increase the cost of providing, or reduce the demand for, health care, and; the ability to attract and retain qualified medical personnel, including physicians;

 

   

in August, 2011, the Budget Control Act of 2011 (the “2011 Act”) was enacted into law. The 2011 Act imposed annual spending limits for most federal agencies and programs aimed at reducing budget deficits by $917 billion between 2012 and 2021, according to a report released by the Congressional Budget Office. The 2011 Act provides for new spending on program integrity initiatives intended to reduce fraud and abuse under the Medicare program. Among its other provisions, the law established a bipartisan Congressional committee, known as the Joint Select Committee on Deficit Reduction (the “Joint Committee”), which was tasked with making recommendations aimed at reducing future federal budget deficits by an additional $1.5 trillion over 10 years. The Joint Committee was unable to reach an agreement by the November 23, 2011 deadline and, as a result, across-the-board cuts to discretionary, national defense and Medicare spending were implemented which, if triggered, would result in Medicare payment reductions of up to 2% per fiscal year with a uniform percentage reduction across all Medicare programs starting in 2013. We cannot predict whether Congress will attempt to suspend or restructure the automatic budget cuts or what other deficit reduction initiatives may be proposed by Congress. We also cannot predict the effect this enactment will have on operators (including UHS), and, thus, our business;

 

   

three LLCs that own properties in California (one of which was divested subsequent to the third quarter of 2012), in which we have various non-controlling equity interests, could not obtain earthquake insurance at rates which are economically beneficial in relation to the risks covered;

 

   

competition for our operators from other REITs;

 

   

the operators of our facilities face competition from other health care providers, including physician owned facilities and other competing facilities, including certain facilities operated by UHS but the real property of which is not owned by us. Such competition is experienced in markets including, but not limited to, McAllen, Texas, the site of our McAllen Medical Center, a 428-bed acute care hospital, and Riverside County, California, the site of our Southwest Healthcare System-Inland Valley Campus, a 130-bed acute care hospital;

 

   

changes in, or inadvertent violations of, tax laws and regulations and other factors than can affect REITs and our status as a REIT;

 

   

should we be unable to comply with the strict income distribution requirements applicable to REITs, utilizing only cash generated by operating activities, we would be required to generate cash from other sources which could adversely affect our financial condition;

 

   

our majority ownership interests in various LLCs in which we hold non-controlling equity interests. In addition, pursuant to the operating agreements of most of the LLCs (consisting of substantially all of the LLCs that own MOBs in Arizona, Reno, Nevada and California), the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to

 

16


Table of Contents
 

Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member;

 

   

UHS’s 2010 acquisition of Psychiatric Solutions, Inc. has required UHS to substantially increase its level of indebtedness, which will be further increased by UHS’s planned acquisition of Ascend Health Corporation later in 2012, which could, among other things, adversely affect its ability to raise additional capital to fund operations, limit its ability to react to changes in the economy or its industry and could potentially prevent it from meeting its obligations under the agreements related to its indebtedness. If UHS experiences financial difficulties and, as a result, operations of its existing facilities suffer, or UHS otherwise fails to make payments to us, our revenues will significantly decline;

 

   

fluctuations in the value of our common stock, and;

 

   

other factors referenced herein or in our other filings with the Securities and Exchange Commission.

Given these uncertainties, risks and assumptions, you are cautioned not to place undue reliance on such forward-looking statements. Our actual results and financial condition, including the operating results of our lessees and the facilities leased to subsidiaries of UHS, could differ materially from those expressed in, or implied by, the forward-looking statements.

Forward-looking statements speak only as of the date the statements are made. We assume no obligation to publicly update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information, except as may be required by law. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and accompanying notes. We consider our critical accounting policies to be those that require us to make significant judgments and estimates when we prepare our financial statements, including the following:

Revenue Recognition: Our revenues consist primarily of rentals received from tenants, which are comprised of minimum rent (base rentals), bonus rentals and reimbursements from tenants for their pro-rata share of expenses such as common area maintenance costs, real estate taxes and utilities.

The minimum rent for all hospital facilities is fixed over the initial term or renewal term of the respective leases. Rental income recorded by our consolidated and unconsolidated medical office buildings (“MOBs”) relating to leases in excess of one year in length is recognized using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisitions and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. Bonus rents are recognized when earned based upon increases in each facility’s net revenue in excess of stipulated amounts. Bonus rentals are determined and paid each quarter based upon a computation that compares the respective facility’s current quarter’s net revenue to the corresponding quarter in the base year. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred.

Real Estate Investments: On the date of acquisition, the purchase price of a property is allocated to the property’s land, buildings and intangible assets based upon our estimates of their fair values. Depreciation is computed using the straight-line method over the useful lives of the buildings and capital improvements. The value of intangible assets is amortized over the remaining lease term.

Asset Impairment: Real estate investments and related intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the property might not be recoverable. A property to be held and used is considered impaired only if management’s estimate of the aggregate future cash flows, less estimated capital expenditures, to be generated by the property, undiscounted and without interest charges, are less than the carrying value of the property. This estimate takes into consideration factors such as expected future operating income, trends and prospects, as well as the effects of demand, competition, local market conditions and other factors.

The determination of undiscounted cash flows requires significant estimates by management, including the expected course of action at the balance sheet date that would lead to such cash flows. Subsequent changes in estimated undiscounted cash flows arising from changes in anticipated action to be taken with respect to the property could impact the determination of whether an impairment exists and whether the effects could materially impact our net income. To the extent estimated undiscounted cash flows are less than the

carrying value of the property, the loss will be measured as the excess of the carrying amount of the property over the fair value of the property.

 

17


Table of Contents

Assessment of the recoverability by us of certain lease related costs must be made when we have reason to believe that a tenant might not be able to perform under the terms of the lease as originally expected. This requires us to make estimates as to the recoverability of such costs.

An other than temporary impairment of an investment/advance in an LLC is recognized when the carrying value of the investment is not considered recoverable based on evaluation of the severity and duration of the decline in value, including projected declines in cash flow. To the extent impairment has occurred, the excess carrying value of the asset over its estimated fair value is charged to income.

Investments in Limited Liability Companies (“LLCs”): Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the FASB’s standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

At September 30, 2012, we have non-controlling equity investments or commitments in fourteen LLCs which own medical office buildings (“MOBs”), one of which was divested subsequent to September 30, 2012. As of September 30, 2012, we accounted for: (i) thirteen of these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities, and; (ii) one of these LLCs (Palmdale Medical Properties) on a consolidated basis, as discussed below, since it is considered to be a variable interest entity where we are the primary beneficiary by virtue of its master lease with a subsidiary of Universal Health Services, Inc. (“UHS”), a related party to us.

The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures and/or leasehold improvements. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or short to intermediate term loans.

In addition, at December 31, 2011 and September 30, 2012, as a result of our purchases of third-party minority ownership interests in eleven LLCs in which we formerly held non-controlling majority ownership interests, we now hold 100% of the ownership interest in these LLCs which own MOBs and are accounted for on a consolidated basis, as previously disclosed.

Palmdale Medical Properties has a master lease with a subsidiary of UHS. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS. As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we account for this LLC on a consolidated basis, since the fourth quarter of 2007, since it is a variable interest entity and we are deemed to be the primary beneficiary. The master lease threshold on this MOB has not yet been met and is not expected to be met in the near future.

The other LLCs in which we hold various non-controlling ownership interests are not variable interest entities and therefore are not subject to consolidation.

Federal Income Taxes: No provision has been made for federal income tax purposes since we qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986, and intend to continue to remain so qualified. As such, we are exempt from federal income taxes and we are required to distribute at least 90% of our real estate investment taxable income to our shareholders.

We are subject to a federal excise tax computed on a calendar year basis. The excise tax equals 4% of the amount by which 85% of our ordinary income plus 95% of any capital gain income for the calendar year exceeds cash distributions during the calendar year, as defined. No provision for excise tax has been reflected in the financial statements as no tax is expected to be due.

 

18


Table of Contents

Earnings and profits, which determine the taxability of dividends to shareholders, will differ from net income reported for financial reporting purposes due to the differences for federal tax purposes in the cost basis of assets and in the estimated useful lives used to compute depreciation and the recording of provision for investment losses.

Relationship with Universal Health Services, Inc. (“UHS”) and Related Party Transactions — UHS is our principal tenant and through UHS of Delaware, Inc., a wholly owned subsidiary of UHS, serves as our advisor (the “Advisor”) under an Advisory Agreement dated December 24, 1986 between the Advisor and us (the “Advisory Agreement”). Our officers are all employees of UHS and although as of September 30, 2012 we had no salaried employees, our officers do receive stock-based compensation from time-to-time. As previously disclosed on our Current Report on Form 8-K as filed on June 11, 2012, in recognition of the efforts and contributions of our executive officers in connection with the various previously disclosed acquisitions, divestitures and purchases of third-party minority ownership interests in certain majority-owned limited liability companies, as completed at various times during 2011 and the first quarter of 2012, the Compensation Committee of the Board of Trustees of the Trust recommended, and the Board of Trustees of the Trust approved, one-time, special compensation awards to our executive officers in the form of a cash bonus and/or shares of restricted stock. The cash bonuses were paid and the restricted shares were granted during the second quarter of 2012. The restricted shares are scheduled to vest on the second anniversary of the date of grant. Please see additional details and disclosure included on our Current Report on Form 8-K as filed on June 11, 2012.

Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. The Advisor is entitled to certain advisory fees for its services. See “Relationship with Universal Health Services, Inc. (“UHS”) and Related Party Transactions” in Note 2 to the condensed consolidated financial statements for additional information on the Advisory Agreement and related fees. In December of 2011, based upon a review of our advisory fee and other general and administrative expenses, as compared to an industry peer group, the Advisory Agreement was renewed for 2012 at the same terms and conditions as 2011.

The combined revenues generated from the leases on the UHS hospital facilities comprised approximately 29% and 30% of our consolidated revenues during the three and nine months ended September 30, 2012, respectively, and 55% and 59% of our consolidated revenues during the three and nine months ended September 30, 2011, respectively. The decreases during the third quarter and the first nine months of 2012, as compared to the comparable quarter and nine months of the prior year, were due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of these entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (“MOBs”) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 21% and 18% of the combined consolidated and unconsolidated revenue for the three month periods ended September 30, 2012 and 2011, respectively, and 21% and 19% of the combined consolidated and unconsolidated revenue for the nine months ended September 30, 2012 and 2011, respectively. In addition, fourteen MOBs, twelve of which are owned by LLCs in which we hold either 100% of the ownership interest or various non-controlling, majority ownership interests, include or will include tenants which are subsidiaries of UHS. The leases to the hospital facilities of UHS are guaranteed by UHS and cross-defaulted with one another. For additional disclosure related to our relationship with UHS, please refer to Note 2 to the condensed consolidated financial statements — Relationship with Universal Health Services, Inc. (“UHS”) and Related Party Transactions.

Results of Operations

Our Consolidated Statement of Income for the three and nine months ended September 30, 2012 includes the revenue and expenses associated with the previously disclosed LLCs in which we purchased the third-party minority ownership interests during the fourth quarter of 2011. As a result of the purchases of the minority ownership interests, we now own 100% of these entities and therefore began consolidating the financial data of each effective December 12, 2011. Prior to these minority ownership interest purchases, we previously held noncontrolling majority ownership interests in these LLCs and they were therefore accounted for on an unconsolidated basis.

The tables below reflect the “As Adjusted” Statement of Income for the three and nine months ended September 30, 2011, reflecting the revenue and expense impact of the consolidation of these various LLCs as if they had been consolidated for the three and nine-month periods ended September 30, 2011. The “As Adjusted” amounts are used for comparison discussions in the Results of Operations, as they present both periods on a comparable basis. There was no material impact on our net income as a result of the consolidation of these LLCs.

 

19


Table of Contents

Three Months Ended September 30, 2011:

 

     As reported
in
Consolidated
Statements
of Income for
the Three
Months
Ended

September 30,
2012
    As reported
in
Consolidated
Statements
of Income for
the Three
Months
Ended

September 30,
2011
    Three
months
ended
September 30,
2011

Statements
of  Income
for LLCs
in which
we
purchased
third-party
minority
interests
    “As
Adjusted”
Three
Months
Ended
September 30,
2011
    “As
Adjusted”
Variance
 

Revenues

   $ 13,610      $ 7,394      $ 4,603      $ 11,997      $ 1,613   

Expenses:

          

Depreciation and amortization

     5,263        1,799        976        2,775        (2,488

Advisory fees to UHS

     540        525        —          525        (15

Other operating expenses

     3,578        1,424        1,973        3,397        (181

Transaction costs

     14        455       —          455       441   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     9,395        4,203        2,949        7,152        (2,243
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated LLCs, interest expense and gain, net

     4,215        3,191        1,654        4,845        (630

Equity in income of unconsolidated LLCs

     645        875        (575     300        345   

Interest expense, net

     (1,874     (718     (1,079     (1,797     (77
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 2,986      $ 3,348      $ —        $ 3,348      ($ 362
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nine Months Ended September 30, 2011:

 

     As reported
in
Consolidated
Statements
of Income for
the Nine
Months Ended
September 30,
2012
    As reported
in
Consolidated
Statements
of Income for
the Nine
Months Ended
September 30,
2011
    Nine
months
ended
September 30,
2011

Statements
of  Income
for LLCs
in which
we
purchased
third-party
minority
interests
    “As
Adjusted”
Nine
Months
Ended
September 30,
2011
    “As
Adjusted”
Variance
 

Revenues

   $ 40,627      $ 20,836      $ 13,423      $ 34,259      $ 6,368   

Expenses:

          

Depreciation and amortization

     15,484        4,841        2,871        7,712        (7,772

Advisory fees to UHS

     1,594        1,476        —          1,476        (118

Other operating expenses

     11,244        3,674        5,704        9,378        (1,866

Transaction costs

     663        590       —          590       (73
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
     28,985        10,581        8,575        19,156        (9,829
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before equity in income of unconsolidated LLCs, interest expense and gain, net

     11,642        10,255        4,848        15,103        (3,461

Equity in income of unconsolidated LLCs

     1,803        2,377        (1,513     864        939   

Gain on divestiture of property owned by an unconsolidated LLC

     7,375        —          —          —          7,375   

Interest expense, net

     (5,853     (1,464     (3,335     (4,799     (1,054
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 14,967      $ 11,168      $ —        $ 11,168      $ 3,799   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

20


Table of Contents

For the three months ended September 30, 2012, net income was $3.0 million as compared to $3.3 million during the comparable prior year quarter. For the nine-month period ended September 30, 2012, net income was $15.0 million as compared to $11.2 million during the comparable nine-month period of the prior year.

The decrease in net income of $362,000 during the third quarter of 2012, as compared to the comparable prior year quarter, was primarily attributable to:

 

   

an unfavorable change of $2.5 million (As Adjusted) in depreciation and amortization expense primarily due to a $1.9 million increase incurred during the third quarter of 2012 resulting from the increased basis recorded in connection with the fair value recognition of the assets and liabilities related to the eleven LLCs of which we purchased the third-party minority ownership interests during the fourth quarter of 2011, as well as a $700,000 increase during the third quarter of 2012 at five MOBs and clinics acquired during 2011 and the first quarter of 2012;

 

   

a favorable change of approximately $1.3 million from the net operating income (before depreciation and amortization and interest expenses) generated during the third quarter of 2012 at five MOBs and clinics acquired during 2011 and the first quarter of 2012;

 

   

a favorable change of $441,000 resulting from transaction costs recorded during the third quarter of 2011;

 

   

a favorable change of $345,000 (As Adjusted) resulting from an increase in equity in income of unconsolidated LLCs resulting primarily from increased income generated at a number of our LLCs;

 

   

an unfavorable change of $77,000 (As Adjusted) in interest expense, as discussed below, and;

 

   

other combined net favorable changes of approximately $130,000.

The increase in net income of $3.8 million during the first nine months of 2012, as compared to the first nine months in 2011, was primarily attributable to:

 

   

a favorable change of $7.4 million resulting from the net gain recorded during the first quarter of 2012 on the divestiture of property owned by an unconsolidated LLC, as discussed above and herein;

 

   

an unfavorable change of $7.8 million (As Adjusted) in depreciation and amortization expense primarily due to a $5.3 million increase incurred during the first nine months of 2012 resulting from the increased basis recorded in connection with the fair value recognition of the assets and liabilities related to the eleven LLCs of which we purchased the third-party minority ownership interests during the fourth quarter of 2011, as well as a $2.5 million increase during the first nine months of 2012 at five MOBs and clinics acquired during 2011 and the first quarter of 2012;

 

   

a favorable change of approximately $4.4 million from the net operating income (before depreciation and amortization and interest expenses) generated during the first nine months of 2012 at five MOBs and clinics acquired during 2011 and the first quarter of 2012;

 

   

an unfavorable change of $1.1 million (As Adjusted) in interest expense, as discussed below;

 

   

a favorable change of $939,000 (As Adjusted) resulting from an increase in equity in income of unconsolidated LLCs resulting primarily from increased income generated at a number of our LLCs.

During the first quarter of 2012, we recorded a net gain of $7.4 million in connection with the sale of a medical office building by an LLC in which the Trust formerly held a noncontrolling majority ownership interest, as discussed above and herein. See Note 4 to the consolidated financial statements for additional disclosure related to this divestiture.

 

21


Table of Contents

Interest expense, net of interest income, increased $77,000 and $1.1 million (As Adjusted) during the three and nine month periods of 2012 as compared to the same periods in 2011, respectively. The $77,000 increase (As Adjusted) in interest expense during the third quarter of 2012, as compared to the third quarter of 2011 was due primarily to: (i) interest expense incurred on the combined $29.4 million of third-party debt assumed as part of the acquisitions of PeaceHealth Medical Clinic in January, 2012 ($22.4 million of assumed third-party financing) and the Tuscan Professional Building in December, 2011 ($7.0 million of assumed third-party financing) partially offset by; (ii) a decrease in interest expense related to the previously unconsolidated LLCs which are now consolidated in our financial statements, as discussed above. The $1.1 million increase (As Adjusted) in interest expense during the nine month period of 2012, as compared to the nine month period of 2011, was due primarily to: (i) an increase in our average outstanding borrowings as well as an increase in the average effective interest rate pursuant to the terms of our new $150 million revolving credit agreement that commenced in July, 2011; (ii) interest expense incurred on the combined $29.4 million of third-party debt assumed as part of the acquisitions, as mentioned above, partially offset by; (iii) a decrease in interest expense related to the previously unconsolidated LLCs which are now consolidated in our financial statements, as discussed above. The increased borrowings during the nine month period of 2012 as compared to the same period during 2011 were used primarily to: (i) fund the purchases of the five newly acquired MOBs during 2011 and the first quarter of 2012; (ii) fund the fourth quarter of 2011 purchases of the third-party minority ownership interests in various LLCs in which we formerly held noncontrolling majority ownership interests; (iii) fund investments in, and advances to, various LLCs, partially offset by; (iv) our share of the cash proceeds generated during the fourth quarter of 2011 and the first quarter of 2012 in connection with the sale of MOBs by various LLCs in which we formerly held noncontrolling majority ownership interests, as previously disclosed.

During the three month period ended September 30, 2012, total revenue increased by $1.6 million (As Adjusted). The net increase during the three months ended September 30, 2012, as compared to the comparable prior year period, resulted primarily from a $1.6 million increase in revenue generated during the third quarter of 2012 as compared to the third quarter of 2011 at the five newly acquired MOBs as discussed above (acquired during 2011 and the first quarter of 2012). During the nine month period ended September 30, 2012, total revenue increased by $6.4 million (As Adjusted). The net increase during the nine months ended September 30, 2012, as compared to the comparable prior year period, resulted primarily from: (i) a $5.9 million increase of revenue generated during the nine month period of 2012 as compared to the same nine month period of 2011 at the five newly acquired MOBs as discussed above, and; (ii) approximately $300,000 increase in revenues generated at the eleven LLCs which, effective December, 2011 when we purchased the third-party minority ownership interests, we began recording on a consolidated basis in our financial statements, and; (iii) approximately $200,000 increase in revenue generated at a number of our properties.

Included in our other operating expenses are expenses related to the consolidated medical office buildings, which totaled $3.2 million and $3.1 million (As Adjusted basis), for the three-month periods ended September 30, 2012 and 2011, respectively, and $10.0 million and $8.5 million (As Adjusted basis) for the nine month periods ended September 30, 2012 and 2011, respectively. The increase in other operating expenses for the nine-month period ended September 30, 2012 as compared to the same period during 2011 is primarily attributable to: (i) the expenses related to the five recently acquired MOBs, as previously discussed; (ii) reserves established in connection with certain tenant receivables at various consolidated properties, offset by; (iii) a decrease in other operating expenses related to the previously unconsolidated LLCs which are now consolidated in our financial statements, as discussed above. A portion of the expenses associated with our consolidated medical office buildings is passed on directly to the tenants. Tenant reimbursements for operating expenses are accrued as revenue in the same period the related expenses are incurred and are included as tenant reimbursement revenue in our condensed consolidated statements of income.

Funds from operations (“FFO”) is a widely recognized measure of performance for Real Estate Investment Trusts (“REITs”). We believe that FFO and FFO per diluted share, and adjusted funds from operations (“AFFO”) and AFFO per diluted share, which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. We compute FFO, as reflected below, in accordance with standards established by the National Association of Real Estate Investment Trusts (“NAREIT”), which may not be comparable to FFO reported by other REITs that do not compute FFO in accordance with the NAREIT definition, or that interpret the NAREIT definition differently than we interpret the definition. AFFO was also computed for the three and nine-month period ended September 30, 2012, as reflected below, since we believe it is helpful to our investors since it adjusts for the effect of a gain on divestiture of property owned by an unconsolidated LLC and transaction costs related to an acquisition. FFO/AFFO do not represent cash generated from operating activities in accordance with GAAP and should not be considered to be an alternative to net income determined in accordance with GAAP. In addition, FFO/AFFO should not be used as: (i) an indication of our financial performance determined in accordance with GAAP; (ii) an alternative to cash flow from operating activities determined in accordance with GAAP; (iii) a measure of our liquidity, or; (iv) an indicator of funds available for our cash needs, including our ability to make cash distributions to shareholders. A reconciliation of our reported net income to FFO/AFFO is reflected on the Supplemental Schedules included below.

 

22


Table of Contents

Below is a reconciliation of our reported net income to FFO and AFFO for the three and nine-month periods ended September 30, 2012 and 2011 (in thousands):

 

     Three Months  Ended
September 30,
     Nine Months  Ended
September 30,
 
     2012      2011      2012     2011  

Net income

   $ 2,986       $ 3,348       $ 14,967      $ 11,168   

Depreciation and amortization expense on consolidated investments

     5,216         1,770         15,354        4,739   

Depreciation and amortization expense on unconsolidated affiliates

     827         2,734         2,507        8,139   

Gain on divestiture of property owned by an unconsolidated LLC

     —           —           (7,375     —     
  

 

 

    

 

 

    

 

 

   

 

 

 

Funds From Operations

   $ 9,029       $ 7,852       $ 25,453      $ 24,046   

Transaction costs

     14         455         663        590   
  

 

 

    

 

 

    

 

 

   

 

 

 

Adjusted Funds From Operations

   $ 9,043       $ 8,307       $ 26,116      $ 24,636   
  

 

 

    

 

 

    

 

 

   

 

 

 

 

23


Table of Contents

Our FFO increased approximately $1.2 million to $9.0 million during the third quarter of 2012 as compared to $7.9 million during the third quarter of 2011. The increase was primarily due to: (i) an unfavorable change of $362,000 resulting from the decrease in net income, as discussed above; (ii) plus a $1.5 million increase in the add-back of depreciation and amortization expense (including consolidated investments and unconsolidated affiliates).

Our FFO increased $1.4 million to $25.5 million during the first nine months of 2012 as compared to $24.0 million during the first nine months of 2011. The increase was primarily due to: (i) a favorable change of $3.8 million resulting from the increase in net income, as discussed above; (ii) plus a $5.0 million increase in the add-back of depreciation and amortization expense (including consolidated investments and unconsolidated affiliates), and; (iii) less the $7.4 million gain recorded during the first quarter of 2012 on divestiture of property owned by an unconsolidated LLC.

Our AFFO increased $736,000 to $9.0 million during the third quarter of 2012 as compared to $8.3 million during the comparable quarter of 2011. The increase in AFFO during the third quarter of 2012, as compared to the comparable quarter of 2011, was attributable to: (i) the above-mentioned $1.2 million increase in FFO, less; (ii) the unfavorable change of $441,000 resulting from a decrease in the add-back of the transaction costs incurred during each period.

Our AFFO increased $1.5 million to $26.1 million during the first nine months of 2012 as compared to $24.6 million during the comparable period of 2011. The increase in AFFO during the first nine months of 2012, as compared to the comparable period in 2011, was attributable to: (i) the above-mentioned $1.4 million increase in FFO, plus; (ii) the $73,000 increase in the add-back of the transaction costs incurred during each period.

Liquidity and Capital Resources

Net cash provided by operating activities

Net cash provided by operating activities was $22.4 million and $15.8 million during the nine-month periods ended September 30, 2012 and 2011, respectively.

The $6.6 million net increase was attributable to:

 

   

a favorable change of $6.6 million due to an increase in net income net of the adjustments to reconcile net income to net cash provided by operating activities (depreciation and amortization, amortization on debt premium, restricted/stock-based compensation and gain on divestiture of property owned by an unconsolidated LLC), as discussed above in Results of Operations;

 

   

an unfavorable change of $646,000 in rent receivable, primarily resulting from an increase in receivables at various MOBs;

 

   

a favorable change of $544,000 in tenant reserves, escrows, deposits and prepaid rents resulting primarily from increased prepaid rents collected from various MOBs, including the medical clinic acquired during the first quarter of 2012, and;

 

   

other net favorable change of $162,000.

Net cash used in investing activities

Net cash used in investing activities was $9.0 million during the nine months ended September 30, 2012 as compared to $29.7 million during the nine months ended September 30, 2011.

During the nine-month period ended September 30, 2012, we funded: (i) an $8.0 million advance in the form of a member loan to an unconsolidated LLC to retire its third-party debt (this entity divested its property in October, 2012 and the member loan was repaid to us); (ii) $7.3 million (net of certain acquired liabilities, third-party debt and prepaid deposit) to acquire the real estate assets of the PeaceHealth Medical Clinic, as discussed above; (iii) $2.7 million on additions to real estate investments primarily for tenant improvements at various MOBs; (iv) $553,000 for settlement of assumed liabilities related to newly acquired MOBs, and; (v) $1.7 million in equity investments in various unconsolidated LLCs. In addition, during the nine-month period ended September 30, 2012, we received: (i) $499,000 in repayments of advances previously made to unconsolidated LLCs;

 

24


Table of Contents

(ii) $2.6 million of cash distributions in excess of income from our unconsolidated LLCs; (iii) $100,000 of refunded real estate deposits, and; (iv) $8.1 million, net, of cash in connection with our share of the proceeds received from the divestiture of an MOB owned by an unconsolidated LLC, as discussed above.

During the nine-month period ended September 30, 2011, we funded $26.5 million (net of certain acquired liabilities) consisting of: (i) $11.9 million (net of certain acquired liabilities) to acquire the real estate assets of the Lake Pointe Medical Arts MOB, and; (ii) $14.6 million (net of certain acquired liabilities) to acquire the real estate assets of the Forney Medical Plaza. In addition, during the nine-month period ended September 30, 2011, we also funded: (i) $11.5 million of advances to LLCs; (ii) $3.5 million of equity investments in LLCs; (iii) $172,000 in capital additions, and; (iv) $834,000 of deposits on real estate assets related to the acquisition of the Tuscan Professional Building, which was acquired during the fourth quarter of 2011 and the PeaceHealth Medical Clinic, which was acquired during the first quarter of 2012. Also during the nine-month period ended September 30, 2011, we received: (i) $6.7 million in repayments of advances to LLCs; (ii) $4.1 million of cash distributions in excess of income from our unconsolidated LLCs, and; (iii) $2.1 million of cash distributions of refinancing proceeds from our unconsolidated LLCs.

Net cash (used in)/provided by financing activities

Net cash used in financing activities was $22.0 million during the nine months ended September 30, 2012 as compared to $13.7 million of net cash provided by financing activities during the nine months ended September 30, 2011.

During the nine-month period ended September 30, 2012, we: (i) received $5.9 million of additional net borrowings on our revolving line of credit; (ii) received $7.0 million of proceeds related to a new mortgage note payable that is non-recourse to us, and; (iii) generated $292,000 of net cash from the issuance of shares of beneficial interest. Additionally, during the nine months ended September 30, 2012, we paid: (i) $11.2 million on mortgage and other notes payable that are non-recourse to us (including the pay-off of a mortgage note payable that was refinanced during the second quarter of 2012, resulting in the $7.0 million of proceeds, as mentioned above, as well as a $600,000 mortgage principal pay-down); (ii) $524,000 of financing costs on mortgage and other notes payable, and; (iii) $23.3 million of dividends.

During the nine-month period ended September 30, 2011, we: (i) received $37.8 million of additional net borrowings on our revolving line of credit, and; (ii) generated $184,000 of net cash from the issuance of shares of beneficial interest. Additionally, during the nine months ended September 30, 2011, we paid: (i) $214,000 on mortgage and other notes payable that are non-recourse to us; (ii) $1.1 million of financing costs related to our new $150 million revolving credit agreement, executed on July 25, 2011, as discussed above, and; (iii) $23.0 million of dividends.

Additional cash flow and dividends paid information for the nine-month periods ended September 30, 2012 and 2011:

As indicated on our consolidated statement of cash flows, we generated net cash provided by operating activities of $22.4 million and $15.8 million during the nine-month periods ended September 30, 2012 and 2011, respectively. As also indicated on our statement of cash flows, noncash expenses such as depreciation and amortization expense, restricted/stock-based compensation expense as well as the gain recorded during the first nine months of 2012, are the primary differences between our net income and net cash provided by operating activities during each period. In addition, as reflected in the cash flows from investing activities section, we received $2.6 million and $4.1 million during the nine months ended September 30, 2012 and 2011, respectively, of cash distributions in excess of income from various unconsolidated LLCs which represents our share of the net cash flow distributions from these entities. These cash distributions in excess of income represent operating cash flows net of capital expenditures and debt repayments made by the LLCs.

We generated $25.1 million and $19.9 million of net cash during the nine months ended September 30, 2012 and 2011, respectively, related to the operating activities of our properties recorded on a consolidated and an unconsolidated basis. We paid dividends of $23.3 million and $23.0 million during the nine months ended September 30, 2012 and 2011, respectively. During the first nine months of 2012, the cash generated from the operating activities of our properties ($25.1 million) exceeded the dividends paid ($23.3 million) by approximately $1.7 million. During the first nine months of 2011, the $19.9 million of net cash generated related to operating activities was approximately $3.1 million less than the $23.0 million of dividends paid during the prior year nine month period. The shortfall experienced during the first nine months of 2011 was attributable to certain operating factors being experienced at that time.

 

25


Table of Contents

As indicated in the cash flows from investing activities and cash flows from financing activities sections of the statements of cash flows, there were various other sources and uses of cash during the nine months ended September 30, 2012 and 2011. Therefore, the funding source for our dividend payments is not wholly dependent on the operating cash flow generated by our properties in any given period. Rather, our dividends, as well as our capital reinvestments into our existing properties, acquisitions of real property and other investments are funded based upon the aggregate net cash inflows or outflows from all sources and uses of cash from the properties we own either in whole or through LLCs, as outlined above.

In determining and monitoring our dividend level on a quarterly basis, our management and Board of Trustees consider many factors in determining the amount of dividends to be paid each period. These considerations primarily include: (i) the minimum required amount of dividends to be paid in order to maintain our REIT status; (ii) the current and projected operating results of our properties, including those owned in LLCs, and; (iii) our future capital commitments and debt repayments, including those of our LLCs. Based upon the information discussed above, as well as consideration of projections and forecasts of our future operating cash flows, management and the Board of Trustees have determined that our operating cash flows have been sufficient to fund our dividend payments. Future dividend levels will be determined based upon the factors outlined above with consideration given to our projected future results of operations.

Included in the various sources of cash were: (i) funds generated from the repayments of advances made from us to LLCs ($499,000 and $6.7 million for the nine months ended September 30, 2012 and 2011, respectively); (ii) cash distributions of refinancing proceeds from LLCs ($2.1 million for the nine months ended September 30, 2011); (iii) refunds/(deposits) on real estate assets ($100,000 and ($834,000) for the nine months ended September 30, 2012 and 2011, respectively); (iv) net borrowings on our revolving credit agreement ($5.9 million and $37.8 million for the nine months ended September 30, 2012 and 2011, respectively); (v) proceeds from mortgage notes payable ($7.0 million for the nine months ended September 30, 2012), and; (vi) net cash generated in connection with the issuance of shares of beneficial interest ($292,000 and $184,000 for the nine months ended September 30, 2012 and 2011, respectively). In addition, during the first nine months of 2012, we generated $8.1 million from the divestiture of an MOB owned by an unconsolidated LLC.

In addition to the dividends paid, the following were also included in the various uses of cash: (i) investments in LLCs ($1.7 million and $3.5 million for the nine months ended September 30, 2012 and 2011, respectively); (ii) advances made to LLCs ($8.0 million and $11.5 million for the nine months ended September 30, 2012 and 2011, respectively); (iii) net real estate additions ($2.7 million and $172,000 for the nine months ended September 30, 2012 and 2011, respectively); (iv) repayments of mortgage and other notes payable ($11.2 million and $214,000 for the nine months ended September 30, 2012 and 2011, respectively); (v) financing costs paid on mortgage and other notes payable ($524,000 and $1.1 million for the nine months ended September 30, 2012 and 2011, respectively), and; (vi) acquisitions of medical office buildings ($7.3 million and $26.5 million for the nine months ended September 30, 2012 and 2011, respectively). Additionally, during the first nine months of 2012, we had additional uses of cash consisting of a $553,000 payment of assumed liabilities on acquired properties.

We expect to finance all capital expenditures and acquisitions and pay dividends utilizing internally generated and additional funds. Additional funds may be obtained through: (i) borrowings under our existing $150 million revolving credit facility agreement (which has $53.4 million of available borrowing capacity, net of outstanding borrowings and letters of credit, as of September 30, 2012); (ii) borrowings under or refinancing of existing third-party debt pursuant to mortgage and construction loan agreements entered into by our LLCs, and/or; (iii) the issuance of other long-term debt.

We believe that our operating cash flows, cash and cash equivalents, available borrowing capacity under our revolving credit facility and access to the capital markets provide us with sufficient capital resources to fund our operating, investing and financing requirements for the next twelve months, including providing sufficient capital to allow us to make distributions necessary to enable us to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986. In the event we need to access the capital markets or other sources of financing, there can be no assurance that we will be able to obtain financing on acceptable terms or within an acceptable time. Our inability to obtain financing on terms acceptable to us could have a material unfavorable impact on our results of operations, financial condition and liquidity.

Credit facilities and mortgage debt

Our previous unsecured $100 million revolving credit agreement (the “Agreement”) was terminated by us on July 25, 2011 and replaced with a new revolving credit facility. The Agreement provided for interest at our option, at the Eurodollar rate plus 0.75% to 1.125%, or the prime rate plus zero to 0.125%. A fee of 0.15% to 0.225% was payable on the unused portion of the commitment. The margins over the Eurodollar, prime rate and the commitment fee were based upon our debt to total capital ratio as defined by the Agreement.

On July 25, 2011, we entered into a new $150 million revolving credit agreement (“Credit Agreement”). The Credit Agreement, which is scheduled to expire on July 24, 2015, replaced our previous revolving credit facility which was scheduled to mature in January, 2012 and increased our borrowing capacity from $100 million to $150 million. The Credit Agreement includes a $50 million

 

26


Table of Contents

sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate, (b) the federal funds effective rate plus 1/2 of 1%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At September 30, 2012, the applicable margin over the LIBOR rate was 1.75%, the margin over the Base Rate was 0.75%, and the commitment fee was 0.30%.

At September 30, 2012, we had $83.0 million of outstanding borrowings and $13.6 million of letters of credit outstanding against our revolving credit agreement. We had $53.4 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of September 30, 2012. There are no compensating balance requirements.

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at September 30, 2012. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

The following table includes a summary of the required compliance ratios, giving effect to the new covenants contained in the Credit Agreement (dollar amounts in thousands):

 

     Covenant     September 30,
2012
 

Tangible net worth

   $ 125,000      $ 155,381   

Debt to total capital

     < 55     31.4

Debt service coverage ratio

     > 5.00     29.24

Debt to cash flow ratio

     < 3.50     1.30

We have thirteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of September 30, 2012, with a combined outstanding balance of $114.8 million (excluding net debt premium, of $1.4 million at September 30, 2012). The following table summarizes our outstanding mortgages at September 30, 2012 (amounts in thousands):

 

Facility Name

  Outstanding
Balance
(in thousands)
    Interest
Rate
    Maturity
Date
 

BRB Medical Office Building mortgage loan(b)

  $ 6,180        6.25     2012   

Centennial Hills Medical Office Building I mortgage loan(a)(e)

    11,691        6.00     2013   

Palmdale Medical Plaza fixed rate mortgage loan(a)(f)

    6,327        5.10     2013   

Summerlin Hospital Medical Office Building I mortgage loan(a)

    9,442        6.55     2014   

Spring Valley Medical Office Building mortgage loan(a)

    5,360        5.50     2015   

Summerlin III Medical Office Building III mortgage loan(a) (c)

    11,728        Floating        2016   

PeaceHealth Medical Clinic fixed rate mortgage loan(a)

    22,188        5.64     2017   

Summerlin Hospital Medical Office Building II mortgage loan(a)

    12,366        5.50     2017   

Auburn Medical II mortgage loan (a)(d)

    7,674        Floating        2017   

Medical Center of Western Connecticut fixed rate mortgage loan(a)

    5,033        6.00     2017   

Kindred Hospital-Corpus Christi fixed rate mortgage loan(a)

    3,077        6.50     2019   

700 Shadow Lane and Goldring MOB mortgage loan (a)

    6,962        4.54     2022   

Tuscan Professional Building fixed rate mortgage loan(a)

    6,732        5.56     2025   
 

 

 

     

Total

  $ 114,760       
 

 

 

     

 

(a) Amortized principal payments made on a monthly basis.
(b) Subsequent to September 30, 2012, this loan was refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December 1, 2022.

 

27


Table of Contents
(c) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower’s option.
(d) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower’s option.
(e) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan on or before the January 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.
(f) We believe the terms of this loan are within current market underwriting criteria. We expect to refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $117.6 million as of September 30, 2012. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

Off Balance Sheet Arrangements

As of September 30, 2012, we are party to certain off balance sheet arrangements consisting of standby letters of credit and equity and debt financing commitments. Our outstanding letters of credit at September 30, 2012 totaled $13.6 million consisting of: (i) $2.7 million related to Grayson Properties; (ii) $2.5 million related to Centennial Hills Medical Properties; (iii) $2.4 million related to FTX MOB Phase II, LP; (iv) $2.0 million related to Palmdale Medical Properties; (v) $1.8 million related to Banburry Medical Properties; (vi) $1.0 million related to Sierra Medical Properties; (vii) $519,000 related to Sparks Medical Properties; (viii) $478,000 related to Arlington Medical Properties, and; (ix) $240,000 related to BRB/E Building One.

Acquisition and Divestiture Activity

Please see Note 4 to the condensed consolidated financial statements for completed transactions.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in the quantitative and qualitative disclosures during the first nine months of 2012. Reference is made to Item 7A in our Annual Report on Form 10-K for the year ended December 31, 2011.

 

Item 4. Controls and Procedures

As of September 30, 2012, under the supervision and with the participation of our management, including the Trust’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), we performed an evaluation of the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) or Rule 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “1934 Act”). Based on this evaluation, the CEO and CFO have concluded that our disclosure controls and procedures are effective to ensure that material information is recorded, processed, summarized and reported by management on a timely basis in order to comply with our disclosure obligations under the 1934 Act and the SEC rules thereunder.

There have been no changes in our internal control over financial reporting or in other factors during the third quarter of 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

28


Table of Contents

PART II. OTHER INFORMATION

UNIVERSAL HEALTH REALTY INCOME TRUST

 

Item 6. Exhibits

 

  (a.) Exhibits:

 

  31.1  

Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15(d)-14(a) under the Securities Exchange

Act of 1934, as amended.

  31.2  

Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15(d)-14(a) under the Securities Exchange

Act of 1934, as amended.

  32.1   Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2   Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**   XBRL Instance Document
101.SCH **   XBRL Taxonomy Extension Schema Document
101.CAL **   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF**   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB **   XBRL Taxonomy Extension Label Linkbase Document
101.PRE **   XBRL Taxonomy Extension Presentation Linkbase Document

 

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 

29


Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 8, 2012      

UNIVERSAL HEALTH REALTY INCOME TRUST

(Registrant)

              

/s/ Alan B. Miller

      Alan B. Miller, Chairman of the Board,
     

President and Chief Executive Officer

(Principal Executive Officer)

     

/s/ Charles F. Boyle

     

Charles F. Boyle,

Vice President and Chief Financial Officer

      (Principal Financial Officer)

 

30


Table of Contents

EXHIBIT INDEX

 

Exhibit

No.

 

Description

  31.1   Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15(d)-14(a) under the Securities Exchange Act of 1934, as amended.
  31.2   Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15(d)-14(a) under the Securities Exchange Act of 1934, as amended.
  32.1   Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32.2   Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**   XBRL Instance Document
101.SCH**   XBRL Taxonomy Extension Schema Document
101.CAL**   XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF**   XBRL Taxonomy Extension Definition Linkbase Document
101.LAB**   XBRL Taxonomy Extension Label Linkbase Document
101.PRE**   XBRL Taxonomy Extension Presentation Linkbase Document

 

** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 

31

EX-31.1 2 d404019dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION—Chief Executive Officer

I, Alan B. Miller, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Universal Health Realty Income Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2012

 

/s/ Alan B. Miller

President and Chief Executive Officer
EX-31.2 3 d404019dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION—Chief Financial Officer

I, Charles F. Boyle, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Universal Health Realty Income Trust;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 8, 2012

 

/s/ Charles F. Boyle

Vice President and Chief Financial Officer
EX-32.1 4 d404019dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Universal Health Realty Income Trust (the “Trust”) on Form 10-Q for the quarter ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan B. Miller, President and Chief Executive Officer of the Trust, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust at the end of, and for the period covered by, the Report.

 

/s/ Alan B. Miller

President and Chief Executive Officer
November 8, 2012

A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 d404019dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Universal Health Realty Income Trust (the “Trust”) on Form 10-Q for the quarter ended September 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Charles F. Boyle, Vice President and Chief Financial Officer of the Trust, hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

(i) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust at the end of, and for the period covered by, the Report.

 

/s/ Charles F. Boyle

Vice President and Chief Financial Officer
November 8, 2012

A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained and furnished to the Securities and Exchange Commission or its staff upon request.

EX-101.INS 6 uht-20120930.xml XBRL INSTANCE DOCUMENT 0000798783 uht:CentinelaMedicalBuildingComplexMember 2012-01-01 2012-09-30 0000798783 uht:PeaceHealthMedicalClinicMember 2012-07-01 2012-09-30 0000798783 us-gaap:MinimumMember us-gaap:RevolvingCreditFacilityMember 2012-01-01 2012-09-30 0000798783 us-gaap:MaximumMember us-gaap:RevolvingCreditFacilityMember 2012-01-01 2012-09-30 0000798783 uht:LondonInterbankOfferedRateMember us-gaap:MinimumMember 2012-01-01 2012-09-30 0000798783 uht:LondonInterbankOfferedRateMember us-gaap:MaximumMember 2012-01-01 2012-09-30 0000798783 uht:NewRevolvingCreditFacilityAgreementMember us-gaap:ShortTermDebtMember 2012-09-30 0000798783 us-gaap:MinimumMember uht:NewRevolvingCreditFacilityAgreementMember 2012-09-30 0000798783 us-gaap:MaximumMember uht:NewRevolvingCreditFacilityAgreementMember 2012-09-30 0000798783 uht:NewRevolvingCreditFacilityAgreementMember us-gaap:LetterOfCreditMember 2012-09-30 0000798783 us-gaap:RevolvingCreditFacilityMember 2012-09-30 0000798783 uht:NewRevolvingCreditFacilityAgreementMember 2012-09-30 0000798783 uht:LlcMember 2012-07-01 2012-09-30 0000798783 uht:LlcMember 2012-01-01 2012-09-30 0000798783 uht:LlcMember 2011-07-01 2011-09-30 0000798783 uht:LlcMember 2011-01-01 2011-09-30 0000798783 2012-01-01 2012-01-31 0000798783 uht:CanyonSpringsMedicalPlazaMember 2012-01-01 2012-09-30 0000798783 us-gaap:MajorityOwnedSubsidiaryUnconsolidatedMember 2012-09-30 0000798783 uht:FtxMobPhaseTwoLpMember 2012-09-30 0000798783 uht:CanyonHealthcarePropertiesMember 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember uht:CombinedMember 2012-07-01 2012-09-30 0000798783 uht:CombinedMember uht:UniversalHealthServicesIncMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember uht:CombinedMember 2011-07-01 2011-09-30 0000798783 uht:UniversalHealthServicesIncMember 2011-07-01 2011-09-30 0000798783 uht:CombinedMember uht:UniversalHealthServicesIncMember 2011-01-01 2011-09-30 0000798783 uht:UniversalHealthServicesIncMember 2011-01-01 2011-09-30 0000798783 uht:PalmdaleMedicalPlazaFixedRateMortgageLoanMember 2012-01-01 2012-09-30 0000798783 uht:CentennialHillsMedicalOfficeBuildingOneMortgageLoanMember 2012-01-01 2012-09-30 0000798783 uht:BrbMedicalOfficeBuildingMortgageLoanMember 2012-01-01 2012-09-30 0000798783 uht:SparksMedicalPropertiesMember 2012-01-01 2012-09-30 0000798783 uht:SierraMedicalPropertiesMember 2012-01-01 2012-09-30 0000798783 uht:PchSouthernPropertiesMember 2012-01-01 2012-09-30 0000798783 uht:PchMedicalPropertiesMember 2012-01-01 2012-09-30 0000798783 uht:GraysonPropertiesMember 2012-01-01 2012-09-30 0000798783 uht:FtxMobPhaseTwoMember 2012-01-01 2012-09-30 0000798783 uht:DvmcPropertiesMember 2012-01-01 2012-09-30 0000798783 uht:BrunswickAssociatesMember 2012-01-01 2012-09-30 0000798783 uht:ArlingtonMedicalPropertiesMember 2012-01-01 2012-09-30 0000798783 us-gaap:RevolvingCreditFacilityMember 2012-01-01 2012-09-30 0000798783 uht:AuburnMedicalTwoMortgageLoanMember 2012-01-01 2012-09-30 0000798783 uht:SummerlinThreeMedicalOfficeBuildingThreeMortgageLoanMember 2012-01-01 2012-09-30 0000798783 uht:PeaceHealthMedicalClinicFixedRateMortgageLoanMember 2012-01-01 2012-09-30 0000798783 uht:NewRevolvingCreditFacilityAgreementMember 2012-01-01 2012-09-30 0000798783 uht:LondonInterbankOfferedRateMember 2012-09-30 0000798783 uht:BaseRateMember 2012-09-30 0000798783 2011-09-30 0000798783 2010-12-31 0000798783 uht:PeaceHealthMedicalClinicMember 2012-01-01 2012-09-30 0000798783 uht:ForneyMedicalPlazaMember uht:LakePointeMedicalArtsMember 2011-07-31 0000798783 uht:PeaceHealthMedicalClinicMember 2012-01-31 0000798783 uht:LakePointeMedicalArtsMember 2011-09-30 0000798783 uht:ForneyMedicalPlazaMember 2011-09-30 0000798783 uht:ThirtyEightElevenBellMedicalPropertiesMember 2012-09-30 0000798783 uht:SuburbanPropertiesMember 2012-09-30 0000798783 uht:SparksMedicalPropertiesMember 2012-09-30 0000798783 uht:SierraMedicalPropertiesMember 2012-09-30 0000798783 uht:SantaFeScottsdaleMember 2012-09-30 0000798783 uht:PchSouthernPropertiesMember 2012-09-30 0000798783 uht:PchMedicalPropertiesMember 2012-09-30 0000798783 uht:GraysonPropertiesMember 2012-09-30 0000798783 uht:FtxMobPhaseTwoMember 2012-09-30 0000798783 uht:FiveSeventyFiveHardyInvestorMember 2012-09-30 0000798783 uht:DvmcPropertiesMember 2012-09-30 0000798783 uht:BrunswickAssociatesMember 2012-09-30 0000798783 uht:ArlingtonMedicalPropertiesMember 2012-09-30 0000798783 us-gaap:MinimumMember 2012-01-01 2012-09-30 0000798783 us-gaap:MaximumMember 2012-01-01 2012-09-30 0000798783 us-gaap:MinimumMember 2011-01-10 2011-12-31 0000798783 us-gaap:MaximumMember 2011-01-10 2011-12-31 0000798783 uht:UniversalHealthServicesOfDelawareIncMember us-gaap:MinimumMember 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember 2011-12-31 0000798783 us-gaap:MinimumMember uht:UniversalHealthServicesIncMember uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMember 2012-01-01 2012-09-30 0000798783 us-gaap:MinimumMember uht:BridgewayMember uht:UniversalHealthServicesIncMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember us-gaap:MaximumMember uht:BridgewayMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember us-gaap:MaximumMember uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMember 2012-01-01 2012-09-30 0000798783 us-gaap:MaximumMember uht:UniversalHealthServicesIncMember uht:McAllenMedicalCenterMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember uht:BridgewayMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember uht:WellingtonRegionalMedicalCenterAndSouthwestHealthcareSystemMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember uht:McAllenMedicalCenterMember 2012-01-01 2012-09-30 0000798783 uht:WellingtonRegionalMedicalCenterMember 2012-09-30 0000798783 uht:SouthwestHealthcareSystemInlandValleyCampusMember 2012-09-30 0000798783 uht:McAllenMedicalCenterMember 2012-09-30 0000798783 uht:BridgewayMember 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember 2012-09-30 0000798783 uht:CaliforniaMember 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember 2011-01-10 2011-12-31 0000798783 2011-01-10 2011-12-31 0000798783 uht:UnconsolidatedLlcsMember 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember 2012-01-01 2012-09-30 0000798783 us-gaap:MinimumMember 2011-12-31 0000798783 us-gaap:MaximumMember 2011-12-31 0000798783 uht:FtxMobPhaseTwoLpMember 2012-01-01 2012-09-30 0000798783 uht:WellingtonRegionalMedicalCenterMember 2012-01-01 2012-09-30 0000798783 uht:SouthwestHealthcareSystemInlandValleyCampusMember 2012-01-01 2012-09-30 0000798783 uht:McAllenMedicalCenterMember 2012-01-01 2012-09-30 0000798783 uht:BridgewayMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember us-gaap:MinimumMember 2012-01-01 2012-09-30 0000798783 uht:UniversalHealthServicesIncMember us-gaap:MaximumMember 2012-01-01 2012-09-30 0000798783 uht:TexomaMedicalPropertiesMember 2012-09-30 0000798783 uht:SparksMedicalPropertiesMember 2012-09-30 0000798783 uht:PalmdaleMedicalPropertiesMember 2012-09-30 0000798783 uht:PeaceHealthMedicalClinicMember 2012-01-01 2012-01-31 0000798783 uht:LakePointeMedicalArtsMember 2011-01-01 2011-09-30 0000798783 uht:ForneyMedicalPlazaMember 2011-01-01 2011-09-30 0000798783 2011-12-31 0000798783 uht:TuscanyProfessionalBuildingFixedRateMortgageLoanMember 2012-09-30 0000798783 uht:SummerlinThreeMedicalOfficeBuildingThreeMortgageLoanMember 2012-09-30 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingTwoMortgageLoanMember 2012-09-30 0000798783 uht:SummerlinHospitalMedicalOfficeBuildingOneMortgageLoanMember 2012-09-30 0000798783 uht:SpringValleyMedicalOfficeBuildingMortgageLoanMember 2012-09-30 0000798783 uht:SevenHundredShadowLaneAndGoldringMedicalOfficeBuildingMortgageLoanMember 2012-09-30 0000798783 uht:PeaceHealthMedicalClinicFixedRateMortgageLoanMember 2012-09-30 0000798783 uht:PalmdaleMedicalPlazaFixedRateMortgageLoanMember 2012-09-30 0000798783 uht:MedicalCenterOfWesternConnecticutFixedRateMortgageLoanMember 2012-09-30 0000798783 uht:KindredHospitalCorpusChristiFixedRateMortgageLoanMember 2012-09-30 0000798783 uht:CentennialHillsMedicalOfficeBuildingOneMortgageLoanMember 2012-09-30 0000798783 uht:BrbMedicalOfficeBuildingMortgageLoanMember 2012-09-30 0000798783 uht:AuburnMedicalTwoMortgageLoanMember 2012-09-30 0000798783 us-gaap:MaximumMember 2012-09-30 0000798783 us-gaap:MinimumMember 2012-09-30 0000798783 2012-09-30 0000798783 2012-07-01 2012-09-30 0000798783 2011-07-01 2011-09-30 0000798783 2011-01-01 2011-09-30 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2012-07-01 2012-09-30 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2011-07-01 2011-09-30 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2011-01-01 2011-09-30 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2012-09-30 0000798783 uht:UniversalHealthServicesOfDelawareIncMember 2012-01-01 2012-09-30 0000798783 2012-10-31 0000798783 2012-01-01 2012-09-30 0000798783 2012-01-30 2012-09-30 iso4217:USD xbrli:shares uht:Term_Renewal_Options uht:MortgagePool uht:Entity uht:Property utr:sqft xbrli:pure xbrli:shares iso4217:USD <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 1 - us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock--> <!-- xbrl,ns --> <!-- xbrl,nx --> <font style="font-family:times new roman" size="2"><b><u></u></b></font> <font style="font-family:times new roman" size="2"><b><u></u></b></font> <font style="font-family:times new roman" size="2"> </font> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(1) General </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">This Quarterly Report on Form 10-Q is for the Quarterly Period ended September&#160;30, 2012. In this Quarterly Report, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;Trust&#8221; refer to Universal Health Realty Income Trust. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">You should carefully review all of the information contained in this Quarterly Report, and should particularly consider any risk factors that we set forth in this Quarterly Report and in other reports or documents that we file from time to time with the Securities and Exchange Commission (the &#8220;SEC&#8221;). In this Quarterly Report, we state our beliefs of future events and of our future financial performance. In some cases, you can identify those so-called &#8220;forward-looking statements&#8221; by words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;appears,&#8221; &#8220;projects&#8221; and similar expressions, as well as statements in future tense. You should be aware that those statements are only our predictions. Actual events or results may differ materially. In evaluating those statements, you should specifically consider various factors, including the risks outlined herein and in our Annual Report on Form 10-K for the year ended December&#160;31, 2011 in <i>Item&#160;1A Risk Factors </i>and in<i> Item&#160;7 Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#160;- Forward Looking Statements</i>. Those factors may cause our actual results to differ materially from any of our forward-looking statements. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> In this Quarterly Report on Form 10-Q, the term &#8220;revenues&#8221; does not include the revenues of the unconsolidated limited liability companies (&#8220;LLCs&#8221;) in which we have various non-controlling equity interests ranging from 33% to 95%. We currently account for our share of the income/loss from these investments by the equity method (see Note 5). As of September&#160;30, 2012, we had investments or commitments in fourteen LLCs, thirteen of which are accounted for by the equity method and one that is currently consolidated in our financial statements. Additionally, as previously disclosed, during the fourth quarter of 2011, we purchased the third-party minority ownership interests in eleven LLCs of which we previously held non-controlling, majority ownership interests ranging from 85% to 99%. As a result, we now own 100% of each of these entities and began recording their financial results in our financial statements on a consolidated basis during the fourth quarter of 2011. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the SEC and reflect all normal and recurring adjustments which, in our opinion, are necessary to fairly present results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. It is suggested that these financial statements be read in conjunction with the financial statements, the notes thereto and accounting policies included in our Annual Report on Form 10-K for the year ended December&#160;31, 2011. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 2 - us-gaap:RelatedPartyTransactionsDisclosureTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(2) Relationship with Universal Health Services, Inc. (&#8220;UHS&#8221;) and Related Party Transactions </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Leases:</i>&#160;We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The combined revenues generated from the leases on the UHS hospital facilities comprised approximately 29% and 30% of our consolidated revenues during the three and nine months ended September&#160;30, 2012, respectively, and 55% and 59% of our consolidated revenues during the three and nine months ended September&#160;30, 2011, respectively. The decreases during the third quarter and the first nine months of 2012, as compared to the comparable quarter and nine months of the prior year, were due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of these entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (&#8220;MOBs&#8221;) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 21% and 18% of the combined consolidated and unconsolidated revenue for the three month periods ended September&#160;30, 2012 and 2011, respectively, and 21% and 19% of the combined consolidated and unconsolidated revenue for the nine months ended September&#160;30, 2012 and 2011, respectively. In addition, fourteen MOBs, twelve of which are owned by LLCs in which we hold either 100% of the ownership interest or various non-controlling, majority ownership interests, include or will include tenants which are subsidiaries of UHS. The leases to the hospital facilities of UHS are guaranteed by UHS and cross-defaulted with one another. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December&#160;24, 1986 (the &#8220;Master Lease&#8221;), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i)&#160;purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii)&#160;renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month&#8217;s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties listed below at their appraised fair market value. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals: </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="48%">&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:50pt"><font style="font-family:times new roman" size="1"><b>Hospital Name</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Type&#160;of&#160;Facility</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Annual</b></font><br /><font style="font-family:times new roman" size="1"><b>Minimum</b></font><br /><font style="font-family:times new roman" size="1"> <b>Rent</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>End&#160;of&#160;Lease&#160;Term</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Renewal</b></font><br /><font style="font-family:times new roman" size="1"><b>Term</b></font><br /><font style="font-family:times new roman" size="1"> <b>(years)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">McAllen Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,485,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December,&#160;2016</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(a)&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Wellington Regional Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,030,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December,&#160;2016</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(b)&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Southwest Healthcare System, Inland Valley Campus</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2,648,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December, 2016</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(b)&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">The Bridgeway</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Behavioral&#160;Health</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">930,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December,&#160;2014</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(c)&#160;</font></td> </tr> <!-- End Table Body --> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">UHS has three 5-year renewal options at existing lease rates (through 2031). </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031). </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(c)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024). </font></td> </tr> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">We are committed to invest up to a total of $8.9 million in equity and debt financing, of which $5.0 million has been funded as of September&#160;30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Palmdale Medical Properties) that constructed, owns, and operates the Palmdale Medical Plaza, located in Palmdale, California, on the campus of a UHS hospital. This MOB has a triple net, 75% master lease commitment by UHS of Palmdale, Inc., a wholly-owned subsidiary of UHS, pursuant to the terms of which the master lease for each suite will be cancelled at such time that the suite is leased to another tenant acceptable to the LLC and UHS of Palmdale, Inc. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. As of September&#160;30, 2012, the master lease threshold of 75% has not been met. The LLC has a third-party term loan of $6.3 million, which is non-recourse to us, outstanding as of September&#160;30, 2012. This LLC, which is deemed to be a variable interest entity, is consolidated in our financial statements since we are the primary beneficiary. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">We are committed to invest up to $6.4 million in equity and debt financing, of which $5.7 million has been funded as of September&#160;30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Sparks Medical Properties) that owns and operates the Vista Medical Terrace and The Sparks Medical Building, located in Sparks, Nevada, on the campus of a UHS hospital. This LLC has a third-party term loan of $5.2 million, which is non-recourse to us, outstanding as of September&#160;30, 2012. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">We are committed to invest up to a total of $4.4 million in equity and debt financing, of which $1.7 million has been funded as of September&#160;30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a newly constructed and recently opened replacement UHS acute care hospital owned and operated by Texoma Medical Center (&#8220;Texoma Hospital&#8221;), a wholly-owned subsidiary of UHS. Texoma Hospital has committed to lease 75% of this building, pursuant to which the master lease for each suite will be cancelled at such time that the suite is leased to another tenant acceptable to the LLC and Texoma Hospital. It is anticipated that the master lease threshold on this MOB will be met in the near future. This MOB will have tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $12.9 million, which is non-recourse to us, outstanding as of September&#160;30, 2012. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> <i>Advisory Agreement:</i>&#160;UHS of Delaware, Inc. (the &#8220;Advisor&#8221;), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the &#8220;Advisory Agreement&#8221;) dated December&#160;24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the &#8220;Independent Trustees&#8221;). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December&#160;31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor&#8217;s performance has been satisfactory. The Advisory Agreement was renewed for 2012 at the same terms and conditions as 2011. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> The Advisory Agreement provides that the Advisor is entitled to receive an annual advisory fee equal to 0.65% of our average invested real estate assets, as derived from our consolidated balance sheet. The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during the first nine months of 2012 or 2011 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $540,000 and $525,000 for the three months ended September&#160;30, 2012 and 2011, respectively, and were based upon average invested real estate assets of $332 million and $323 million for the three-month periods ended September&#160;30, 2012 and 2011, respectively. Advisory fees incurred and paid (or payable) to UHS amounted to $1.6 million and $1.5 million for the nine months ended September&#160;30, 2012 and 2011, respectively, and were based upon average invested real estate assets of $327 million and $303 million for the nine-month periods ended September&#160;30, 2012 and 2011, respectively. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> <i>Officers and Employees:</i> Our officers are all employees of UHS and although as of September&#160;30, 2012 we had no salaried employees, our officers do receive stock-based compensation from time-to-time. As previously disclosed on our Current Report on Form 8-K as filed on June&#160;11, 2012, in recognition of the efforts and contributions of our executive officers in connection with the various previously disclosed acquisitions, divestitures and purchases of third-party minority ownership interests in certain majority-owned limited liability companies, as completed at various times during 2011 and the first quarter of 2012, the Compensation Committee of the Board of Trustees of the Trust recommended, and the Board of Trustees of the Trust approved, one-time, special compensation awards to our executive officers in the form of a cash bonus and/or shares of restricted stock. The cash bonuses were paid and the restricted shares were granted during the second quarter of 2012. The restricted shares are scheduled to vest on the second anniversary of the date of grant. For additional disclosure, please refer to our Current Report on Form 8-K as filed on June&#160;11, 2012. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Share Ownership:</i> As of September&#160;30, 2012 and December&#160;31, 2011, UHS owned 6.2% of our outstanding shares of beneficial interest. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>SEC reporting requirements of UHS:</i> UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 29% and 30% of our consolidated revenues during the three and nine months ended September&#160;30, 2012, respectively, and 55% and 59% of our consolidated revenues during the three and nine months ended September&#160;30, 2011, respectively, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC&#8217;s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 3 - uht:DividendsTextBlock--> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(3) Dividends </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">We declared and paid dividends of $7.8 million, or $.615 per share, during the third quarter of 2012 and $7.7 million, or $.605 per share, during the third quarter of 2011. We declared and paid dividends of $23.3 million, or $1.84 per share, during the nine-month period ended September&#160;30, 2012 and $23.0 million, or $1.815 per share, during the nine-month period ended September&#160;30, 2011. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 4 - us-gaap:BusinessCombinationDisclosureTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(4) Acquisitions and Dispositions </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>Nine Months Ended September&#160;30, 2012: </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> <i>New Construction and Acquisition: </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">During the third quarter of 2012, we entered into an agreement whereby we will own a 95% non-controlling ownership interest in FTX MOB Phase II LP, which will develop, construct, own and operate the Forney Medical Plaza II, a newly constructed MOB, consisting of approximately 30,000 rentable square feet, located in Forney, Texas. We have committed to invest up to $2.5 million in this newly formed LLC. This MOB is expected to be completed and opened during the first quarter of 2013. </font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> In January, 2012, we purchased, as part of a planned, like-kind exchange transaction pursuant to Section&#160;1031 of the Internal Revenue Code, the PeaceHealth Medical Clinic, a single-tenant medical office building consisting of approximately 99,000 rentable square feet, located in Bellingham, Washington. The property was purchased for approximately $30.4 million, including the assumption of approximately $22.4 million of third-party financing. The aggregate purchase price of this MOB was allocated to the assets and liabilities acquired consisting of tangible property ($26.8 million) and identified intangible assets ($3.6 million), based on the respective fair values at acquisition, as determined by an appraisal. Intangible assets include the value of the in-place lease at the time of acquisition and will be amortized over the average remaining lease term of approximately ten years (amounts in thousands). </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="68%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="87%">&#160;</td> <td valign="bottom" width="6%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Land, buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2"> 26,810</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,399</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(23.240</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">)&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Other liabilities, net</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(111</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">)&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Deposits funded in 2011</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(534</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">)&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Net cash paid in 2012</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">7,324</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In connection with this MOB, during the three months ended September&#160;30, 2012, we recorded revenue of $698,000 and net income of approximately $106,000 (excluding transaction expenses of $14,000 and including the $108,000 favorable interest expense adjustment resulting from the amortization of the fair value of debt). During the nine months ended September&#160;30, 2012, we recorded revenue of $1.9 million and net income of approximately $158,000 (excluding transaction expenses of $663,000 and including the $108,000 favorable interest expense adjustment resulting from the amortization of the fair value of debt). </font></p> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><i>Divestitures: </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In February, 2012, Canyon Healthcare Properties, a limited liability company (&#8220;LLC&#8221;) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer has assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing costs and the minority members&#8217; share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the nine months ended September&#160;30, 2012 (recorded during the first quarter of 2012). </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Subsequent to September&#160;30, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.1 million of cash proceeds to us, net of closing costs and minority members&#8217; share of the proceeds. This divestiture is expected to result in a gain, which will be recorded during the fourth quarter of 2012 and is not expected to have a material impact on our financial statements. </font></p> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>Nine Months Ended September&#160;30, 2011: </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> <i>Acquisitions: </i></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In June and July, 2011, utilizing a qualified third-party intermediary in connection with planned like-kind exchange transactions pursuant to Section&#160;1031 of the Internal Revenue Code, we purchased the: </font></p> <p style="font-size:6px;margin-top:0px;margin-bottom:0px">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="5%"><font size="1">&#160;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="2">&#8226;</font></td> <td width="1%" valign="top"><font size="1">&#160;</font></td> <td align="left" valign="top"> <p align="left"><font style="font-family:times new roman" size="2">Lake Pointe Medical Arts Building&#8212;a 50,974 square foot, multi-tenant, medical office building located in Rowlett, Texas, which was acquired in June, 2011, for $12.2 million; the weighted average remaining lease term at the date of acquisition was 6.5 years, and; </font></p> </td> </tr> </table> <p style="font-size:1px;margin-top:6px;margin-bottom:0px">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="5%"><font size="1">&#160;</font></td> <td width="2%" valign="top" align="left"><font style="font-family:times new roman" size="2">&#8226;</font></td> <td width="1%" valign="top"><font size="1">&#160;</font></td> <td align="left" valign="top"> <p align="left"><font style="font-family:times new roman" size="2">Forney Medical Plaza&#8212;a 50,946 square foot, multi-tenant medical office building located in Forney, Texas, which was acquired in July, 2011, for $15.0 million; the weighted average remaining lease term at the date of acquisition was 6.2 years. </font></p> </td> </tr> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The aggregate purchase price for these MOBs was allocated to the assets acquired consisting of tangible property ($23.0 million) and identified intangible assets ($4.2 million), based on their respective fair values at acquisition, as determined by third-party appraisals. Intangible assets include the value of the in-place leases at the time of acquisition. The intangible assets at each MOB will be amortized over the remaining lease terms. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> There were no divestitures during the first nine months of 2011. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Assuming the 2012 acquisition and divestiture, as well as the 2011 acquisitions and divestitures as previously disclosed, occurred on January&#160;1, 2011, our 2011 pro forma net revenues for the three and nine months ended September&#160;30, 2011 would have been approximately $13.4 million and $39.8 million, respectively, and our 2011 pro forma net income for the three and nine months ended September&#160;30, 2011 would have been approximately $2.2 million, or $0.18 per diluted share, and $8.1 million, or $0.64 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2011. Assuming the 2012 acquisition and divestiture occurred on January&#160;1, 2012, our net revenues and net income for the three month period ended September&#160;30, 2012 would have remained unchanged from the actual net revenues and net income as reported, and our pro forma net revenues and net income for the nine months ended September&#160;30, 2012 would have been approximately $40.8 million and $8.3 million, or $.65 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 5 - us-gaap:EquityMethodInvestmentsDisclosureTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(5) Summarized Financial Information of Equity Affiliates </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i)&#160;divestiture of property; (ii)&#160;annual budget approval, and; (iii)&#160;financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In December, 2011, as previously disclosed on our Annual Report on Form 10-K for the year ended December&#160;31, 2011, we purchased the third-party minority ownership interests in eleven LLCs of which we previously held non-controlling, majority ownership interests ranging from 85% to 99%. As a result, we now own 100% of each of these entities and began recording their financial results in our financial statements on a consolidated basis. Prior to December, 2011, the financial results of these LLCs were included in our financial statements on an unconsolidated basis under the equity method of accounting. With the exception of no longer providing for the third-party&#8217;s share of the operating results of these entities, there was no material impact on our net income as a result of the consolidation of these entities. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">At September&#160;30, 2012, we have non-controlling equity investments or commitments in fourteen LLCs which own MOBs. As of September&#160;30, 2012, we accounted for: (i)&#160;thirteen of these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities, and; (ii)&#160;one of these LLCs (Palmdale Medical Properties) on a consolidated basis, as discussed below, since it is considered to be a variable interest entity where we are the primary beneficiary by virtue of its master lease with a subsidiary of Universal Health Services, Inc. (&#8220;UHS&#8221;), a related party to us. Additionally, as discussed above, subsequent to September&#160;30, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex, reducing the number of non-controlling equity investments or commitments in LLCs to thirteen. The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or short to intermediate term loans. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> Palmdale Medical Properties has a master lease with a subsidiary of UHS. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS. As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we account for this LLC on a consolidated basis, since the fourth quarter of 2007, since it is a variable interest entity and we are deemed to be the primary beneficiary. The master lease threshold on this MOB has not yet been met. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The other LLCs in which we hold various non-controlling ownership interests are not variable interest entities and therefore are not subject to consolidation. As a result of master lease arrangements between UHS and various LLCs in which we hold majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB&#8217;s standards and guidance. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Rental income is recorded by our consolidated and unconsolidated MOBs relating to leases in excess of one year in length using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors, including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisition and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The following property table represents the thirteen LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of September&#160;30, 2012: </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="37%">&#160;</td> <td valign="bottom" width="3%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="3%">&#160;</td> <td width="56%">&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:47pt"><font style="font-family:times new roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:times new roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Desert Valley Medical Center</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Suburban Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">33</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Suburban Medical Plaza II</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Santa Fe Professional Plaza</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">575 Hardy Investors(a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Centinela Medical Building Complex</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Brunswick Associates</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">74</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Mid Coast Hospital MOB</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">85</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Rosenberg Children&#8217;s Medical Plaza</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Arlington Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">75</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Saint Mary&#8217;s Professional Office Building</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Sierra San Antonio Medical Plaza</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Phoenix Children&#8217;s East Valley Care Center</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sparks Medical Properties(b.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Vista Medical Terrace &#038; The Sparks Medical Building</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Grayson Properties(b.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Texoma Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">3811 Bell Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">North Valley Medical Plaza</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">FTX MOB Phase II (c.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Forney Medical Plaza II</font></td> </tr> <!-- End Table Body --> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Subsequent to September&#160;30, 2012, this LLC divested the Centinela Medical Building Complex. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Tenants of this medical office building include or will include subsidiaries of UHS. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(c.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">During the third quarter of 2012, this LP entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which is scheduled to be completed during the first quarter of 2013. </font></td> </tr> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Below are the combined statements of income (unaudited) for the LLCs accounted for under the equity method at September&#160;30, 2012 and 2011: </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="65%">&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Three&#160;Months&#160; Ended</b></font><br /><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Nine&#160;Months&#160; Ended</b></font><br /><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2012(b.)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2012(b.)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="14" align="center"><font style="font-family:times new roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,514</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15,222</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">16,499</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">44,803</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Operating expenses</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2,327</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,882</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,992</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">19,986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,062</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,284</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,120</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10,009</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Interest, net</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,545</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,599</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,716</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">13,619</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">580</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">457</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,671</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,189</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Our share of net income (a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">645</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">875</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,803</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2,377</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Our share of net income includes interest income earned by us on various advances made to LLCs of approximately $438,000 and $715,000 for the three months ended September&#160;30, 2012 and 2011, respectively, and $1.3 million and $2.0 million for the nine months ended September&#160;30, 2012 and 2011, respectively. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">As previously disclosed, during the fourth quarter of 2011, eleven of our previously unconsolidated investments in LLCs are now owned 100% by us and are therefore included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011 and the first quarter of 2012, nine LLCs, in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method. </font></td> </tr> </table> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Below are the combined balance sheets (unaudited) for the LLCs accounted for under the equity method (including the balance sheet for the MOB that was divested subsequent to September&#160;30, 2012, as discussed above): </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="72%">&#160;</td> <td valign="bottom" width="7%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="7%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font><br /><font style="font-family:times new roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>December&#160;31,</b></font><br /><font style="font-family:times new roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="6" align="center"><font style="font-family:times new roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Net property, including CIP</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">111,206</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">127,755</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10,360</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,719</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total assets</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">121,566</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">140,474</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Liabilities</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,149</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,949</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Mortgage notes payable, non-recourse to us</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">76,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">101,839</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Advances payable to us</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">20,637</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,692</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Equity</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">18,755</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">20,994</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total liabilities and equity</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">121,566</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">140,474</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Our share of equity and advances to LLCs</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">38,895</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">33,057</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">As of September&#160;30, 2012, aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands): </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="68%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="88%">&#160;</td> <td valign="bottom" width="6%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2012</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2"> 4,210</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2013</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,766</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">13,854</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">35,231</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">316</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Later</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15,648</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">76,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="68%">&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:47pt"><font style="font-family:times new roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Mortgage/<br />Construction&#160; Loan</b></font><br /><font style="font-family:times new roman" size="1"><b>Balance</b></font><br /><font style="font-family:times new roman" size="1"><b>(b)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Maturity&#160;Date</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sierra Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,808</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12/31/2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sparks Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,245</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">02/12/2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Grayson Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,914</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">07/01/2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Brunswick Associates</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">8,124</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">01/01/2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Arlington Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">24,954</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10/10/2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,098</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">11/01/2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">FTX MOB Phase II(c.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,299</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">8/01/2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,766</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12/01/2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">8,817</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">05/01/2018</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr> <td valign="top">&#160;</td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">76,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <!-- End Table Body --> </table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">We believe the terms of these loans are within current market underwriting criteria. At this time, we expect to refinance these loans on or before the 2012 and 2013 maturity dates for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance these loans on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(c.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Construction loan. </font></td> </tr> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Pursuant to the operating agreements of the LLCs, the third-party member and the Trust, at any time, have the right to make an offer (&#8220;Offering Member&#8221;) to the other member(s) (&#8220;Non-Offering Member&#8221;) in which it either agrees to: (i)&#160;sell the entire ownership interest of the Offering Member to the Non-Offering Member (&#8220;Offer to Sell&#8221;) at a price as determined by the Offering Member (&#8220;Transfer Price&#8221;), or; (ii)&#160;purchase the entire ownership interest of the Non-Offering Member (&#8220;Offer to Purchase&#8221;) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i)&#160;purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii)&#160;sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member. </font></p> <p style="margin-top:0px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The LLCs in which we have invested maintain property insurance on all properties. Although we believe that generally our properties are adequately insured, three of the LLCs in which we own various non-controlling equity interests, own properties in California that are located in earthquake zones. These properties are not covered by earthquake insurance since earthquake insurance is no longer available at rates which are economical in relation to the risks covered. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 6 - us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(6) Recent Accounting Pronouncements </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">There were no new accounting pronouncements during the first nine months of 2012 that impacted, or are expected to impact, us. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In May 2011, the FASB issued an update to the accounting standard for measuring and disclosing fair value. The update modifies the wording used to describe the requirements for fair value measuring and for disclosing information about fair value measurements to improve consistency between U.S. GAAP and International Financial Reporting Standards (&#8220;IFRS&#8221;). This update is effective for the annual and interim periods beginning after December&#160;15, 2011. The adoption of this guidance in 2012 did not have a material impact on our consolidated financial position or results of operations as its impact was limited to disclosure requirements. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 7 - us-gaap:LongTermDebtTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(7) Long-term debt </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Our previous unsecured $100 million revolving credit agreement (the &#8220;Agreement&#8221;) was terminated by us on July&#160;25, 2011 and replaced with a new revolving credit facility. The Agreement provided for interest at our option, at the Eurodollar rate plus 0.75% to 1.125%, or the prime rate plus zero to 0.125%. A fee of 0.15% to 0.225% was payable on the unused portion of the commitment. The margins over the Eurodollar, prime rate and the commitment fee were based upon our debt to total capital ratio as defined by the Agreement. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2"> On July&#160;25, 2011, we entered into a new $150 million revolving credit agreement (&#8220;Credit Agreement&#8221;). The Credit Agreement, which is scheduled to expire on July&#160;24, 2015, replaced our previous revolving credit facility which was scheduled to mature in January, 2012 and increased our borrowing capacity from $100 million to $150 million. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines &#8220;Base Rate&#8221; as the greatest of: (a)&#160;the administrative agent&#8217;s prime rate, (b)&#160;the federal funds effective rate plus 1/2 of 1%, and; (c)&#160;one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At September&#160;30, 2012, the applicable margin over the LIBOR rate was 1.75%, the margin over the Base Rate was 0.75%, and the commitment fee was 0.30%. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">At September&#160;30, 2012, we had $83.0 million of outstanding borrowings and $13.6 million of letters of credit outstanding against our revolving credit agreement. We had $53.4 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of September&#160;30, 2012. There are no compensating balance requirements. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at September&#160;30, 2012. We also believe that we would remain in compliance if the full amount of our commitment was borrowed. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The following table includes a summary of the required compliance ratios, giving effect to the new covenants contained in the Credit Agreement (dollar amounts in thousands): </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="74%">&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Covenant</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font><br /><font style="font-family:times new roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Tangible net worth</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">125,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">155,381</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt to total capital</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">&lt; 55</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">31.4</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt service coverage ratio</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">&gt;&#160;5.00</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">29.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt to cash flow ratio</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">&lt;&#160;3.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1.30</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> </tr> <!-- End Table Body --> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">We have thirteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of September&#160;30, 2012, with a combined outstanding balance of $114.8 million (excluding net debt premium, resulting from fair value recognition of third-party debt related to majority-owned LLCs in which we purchased the minority ownership interests, as well as the purchase of the PeaceHealth Medical Clinic in January, 2012, of $1.4 million at September&#160;30, 2012). The following table summarizes our outstanding mortgages at September&#160;30, 2012 (amounts in thousands): </font></p> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="84%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="79%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:47pt"><font style="font-family:times new roman" size="1"><b>Facility Name</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Outstanding</b></font><br /><font style="font-family:times new roman" size="1"><b>Balance</b></font><br /><font style="font-family:times new roman" size="1"> <b>(in&#160;thousands)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Interest</b></font><br /><font style="font-family:times new roman" size="1"><b>Rate</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Maturity</b></font><br /><font style="font-family:times new roman" size="1"><b>Date</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">BRB Medical Office Building mortgage loan(b)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.25</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Centennial Hills Medical Office Building I mortgage loan(a)(e)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">11,691</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.00</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Palmdale Medical Plaza fixed rate mortgage loan(a)(f)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,327</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.10</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Summerlin Hospital Medical Office Building I mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">9,442</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.55</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Spring Valley Medical Office Building mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,360</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Summerlin III Medical Office Building III mortgage loan(a)&#160;(c)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">11,728</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">Floating</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PeaceHealth Medical Clinic fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">22,188</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.64</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Summerlin Hospital Medical Office Building II mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,366</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Auburn Medical II mortgage loan (a)(d)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">7,674</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">Floating</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Medical Center of Western Connecticut fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,033</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.00</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Kindred Hospital-Corpus Christi fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,077</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2019</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">700 Shadow Lane and Goldring MOB mortgage loan (a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,962</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4.54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2022</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Tuscan Professional Building fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,732</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.56</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">114,760</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <!-- End Table Body --> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Amortized principal payments made on a monthly basis. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Subsequent to September&#160;30, 2012, this loan was refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December&#160;1, 2022. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(c)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower&#8217;s option. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(d)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower&#8217;s option. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(e)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan on or before the January 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(f)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">We believe the terms of this loan are within current market underwriting criteria. We expect to refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility. </font></td> </tr> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $117.6 million as of September&#160;30, 2012. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note 8 - us-gaap:SegmentReportingDisclosureTextBlock--> <p style="margin-top:18px;margin-bottom:0px"><font style="font-family:times new roman" size="2"><b>(8) Segment Reporting </b></font></p> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: uht-20120930_note5_accounting_policy_table1 - us-gaap:RealEstateHeldForDevelopmentAndSalePolicy--> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i)&#160;divestiture of property; (ii)&#160;annual budget approval, and; (iii)&#160;financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Accounting Policy: uht-20120930_note6_accounting_policy_table1 - us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock--> <p style="margin-top:6px;margin-bottom:0px"><font style="font-family:times new roman" size="2">There were no new accounting pronouncements during the first nine months of 2012 that impacted, or are expected to impact, us. </font></p> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">In May 2011, the FASB issued an update to the accounting standard for measuring and disclosing fair value. The update modifies the wording used to describe the requirements for fair value measuring and for disclosing information about fair value measurements to improve consistency between U.S. GAAP and International Financial Reporting Standards (&#8220;IFRS&#8221;). This update is effective for the annual and interim periods beginning after December&#160;15, 2011. The adoption of this guidance in 2012 did not have a material impact on our consolidated financial position or results of operations as its impact was limited to disclosure requirements. </font></p> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note2_table1 - us-gaap:ScheduleOfPropertySubjectToOrAvailableForOperatingLeaseTextBlock--> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="48%">&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:50pt"><font style="font-family:times new roman" size="1"><b>Hospital Name</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Type&#160;of&#160;Facility</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Annual</b></font><br /><font style="font-family:times new roman" size="1"><b>Minimum</b></font><br /><font style="font-family:times new roman" size="1"> <b>Rent</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>End&#160;of&#160;Lease&#160;Term</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Renewal</b></font><br /><font style="font-family:times new roman" size="1"><b>Term</b></font><br /><font style="font-family:times new roman" size="1"> <b>(years)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">McAllen Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,485,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December,&#160;2016</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(a)&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Wellington Regional Medical Center</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,030,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December,&#160;2016</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(b)&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Southwest Healthcare System, Inland Valley Campus</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Acute Care</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2,648,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December, 2016</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(b)&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">The Bridgeway</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Behavioral&#160;Health</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">930,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center"><font style="font-family:times new roman" size="2">December,&#160;2014</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">(c)&#160;</font></td> </tr> <!-- End Table Body --> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">UHS has three 5-year renewal options at existing lease rates (through 2031). </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031). </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(c)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024). </font></td> </tr> </table> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note4_table1 - us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock--> <table cellspacing="0" cellpadding="0" width="68%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="87%">&#160;</td> <td valign="bottom" width="6%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Land, buildings and improvements</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2"> 26,810</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,399</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(23.240</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">)&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Other liabilities, net</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(111</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">)&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Deposits funded in 2011</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">(534</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">)&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Net cash paid in 2012</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">7,324</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note5_table1 - us-gaap:EquityMethodInvestmentsTextBlock--> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="37%">&#160;</td> <td valign="bottom" width="3%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="3%">&#160;</td> <td width="56%">&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:47pt"><font style="font-family:times new roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Ownership</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" align="center" style="border-bottom:1px solid #000000"> <p style="margin-top:0px;margin-bottom:1px" align="center"><font style="font-family:times new roman" size="1"><b>Property Owned by LLC</b></font></p> </td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Desert Valley Medical Center</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Suburban Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">33</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Suburban Medical Plaza II</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Santa Fe Scottsdale</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Santa Fe Professional Plaza</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">575 Hardy Investors(a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">90</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Centinela Medical Building Complex</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Brunswick Associates</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">74</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Mid Coast Hospital MOB</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">85</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Rosenberg Children&#8217;s Medical Plaza</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Arlington Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">75</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Saint Mary&#8217;s Professional Office Building</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sierra Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Sierra San Antonio Medical Plaza</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Phoenix Children&#8217;s East Valley Care Center</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sparks Medical Properties(b.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Vista Medical Terrace &#038; The Sparks Medical Building</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Grayson Properties(b.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Texoma Medical Plaza</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">3811 Bell Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">North Valley Medical Plaza</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">FTX MOB Phase II (c.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">95</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">Forney Medical Plaza II</font></td> </tr> <!-- End Table Body --> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Subsequent to September&#160;30, 2012, this LLC divested the Centinela Medical Building Complex. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Tenants of this medical office building include or will include subsidiaries of UHS. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(c.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">During the third quarter of 2012, this LP entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which is scheduled to be completed during the first quarter of 2013. </font></td> </tr> </table> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note5_table2 - uht:EquityMethodInvestmentsSummarizedIncomeStatementInformationTableTextBlock--> <table cellspacing="0" cellpadding="0" width="92%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="65%">&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="4%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Three&#160;Months&#160; Ended</b></font><br /><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Nine&#160;Months&#160; Ended</b></font><br /><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2012(b.)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2012(b.)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="14" align="center"><font style="font-family:times new roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Revenues</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,514</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15,222</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">16,499</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">44,803</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Operating expenses</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2,327</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,882</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,992</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">19,986</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Depreciation and amortization</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,062</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,284</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,120</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10,009</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Interest, net</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,545</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,599</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,716</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">13,619</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Net income</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">580</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">457</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,671</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,189</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Our share of net income (a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">645</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">875</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,803</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2,377</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Our share of net income includes interest income earned by us on various advances made to LLCs of approximately $438,000 and $715,000 for the three months ended September&#160;30, 2012 and 2011, respectively, and $1.3 million and $2.0 million for the nine months ended September&#160;30, 2012 and 2011, respectively. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">As previously disclosed, during the fourth quarter of 2011, eleven of our previously unconsolidated investments in LLCs are now owned 100% by us and are therefore included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011 and the first quarter of 2012, nine LLCs, in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method. </font></td> </tr> </table> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note5_table3 - uht:EquityMethodInvestmentsSummarizedCombinedBalanceSheetInformationTableTextBlock--> <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="72%">&#160;</td> <td valign="bottom" width="7%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="7%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font><br /><font style="font-family:times new roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>December&#160;31,</b></font><br /><font style="font-family:times new roman" size="1"><b>2011</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="6" align="center"><font style="font-family:times new roman" size="1"><b>(amounts in thousands)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Net property, including CIP</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">111,206</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">127,755</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Other assets</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10,360</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,719</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total assets</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">121,566</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">140,474</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Liabilities</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,149</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,949</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Mortgage notes payable, non-recourse to us</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">76,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">101,839</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Advances payable to us</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">20,637</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,692</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Equity</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">18,755</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">20,994</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total liabilities and equity</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">121,566</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">140,474</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Our share of equity and advances to LLCs</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">38,895</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">33,057</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note5_table4 - us-gaap:ContractualObligationFiscalYearMaturityScheduleTableTextBlock--> <table cellspacing="0" cellpadding="0" width="68%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="88%">&#160;</td> <td valign="bottom" width="6%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2012</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2"> 4,210</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2013</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,766</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2014</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">13,854</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2015</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">35,231</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">2016</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">316</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Later</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">15,648</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">76,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> </tr> <!-- End Table Body --> </table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="68%">&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:47pt"><font style="font-family:times new roman" size="1"><b>Name of LLC</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Mortgage/<br />Construction&#160; Loan</b></font><br /><font style="font-family:times new roman" size="1"><b>Balance</b></font><br /><font style="font-family:times new roman" size="1"><b>(b)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Maturity&#160;Date</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sierra Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,808</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12/31/2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Sparks Medical Properties(a.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,245</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">02/12/2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Grayson Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,914</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">07/01/2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Brunswick Associates</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">8,124</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">01/01/2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Arlington Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">24,954</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">10/10/2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">DVMC Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4,098</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">11/01/2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">FTX MOB Phase II(c.)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1,299</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">8/01/2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Southern Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,766</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12/01/2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PCH Medical Properties</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">8,817</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">05/01/2018</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr> <td valign="top">&#160;</td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">76,025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <!-- End Table Body --> </table> <p style="font-size:12px;margin-top:0px;margin-bottom:0px">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">We believe the terms of these loans are within current market underwriting criteria. At this time, we expect to refinance these loans on or before the 2012 and 2013 maturity dates for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance these loans on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b.)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity. </font></td> </tr> </table> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note7_table1 - uht:ScheduleOfFinancialCovenantsTableTextBlock--> <table cellspacing="0" cellpadding="0" width="76%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="74%">&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="8%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Covenant</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>September&#160;30,</b></font><br /><font style="font-family:times new roman" size="1"><b>2012</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Tangible net worth</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">125,000</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">155,381</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt to total capital</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">&lt; 55</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">31.4</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt service coverage ratio</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">&gt;&#160;5.00</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">29.24</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Debt to cash flow ratio</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">&lt;&#160;3.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">1.30</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">x&#160;</font></td> </tr> <!-- End Table Body --> </table> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <!-- Begin Block Tagged Note Table: uht-20120930_note7_table2 - us-gaap:ScheduleOfDebtInstrumentsTextBlock--> <table cellspacing="0" cellpadding="0" width="84%" border="0" style="border-collapse:collapse; text-align: left" align="center"> <!-- Begin Table Head --> <tr> <td width="79%">&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td valign="bottom" width="2%">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> <p style="border-bottom:1px solid #000000;width:47pt"><font style="font-family:times new roman" size="1"><b>Facility Name</b></font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Outstanding</b></font><br /><font style="font-family:times new roman" size="1"><b>Balance</b></font><br /><font style="font-family:times new roman" size="1"> <b>(in&#160;thousands)</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Interest</b></font><br /><font style="font-family:times new roman" size="1"><b>Rate</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000"><font style="font-family:times new roman" size="1"><b>Maturity</b></font><br /><font style="font-family:times new roman" size="1"><b>Date</b></font></td> <td valign="bottom"><font size="1">&#160;</font></td> </tr> <!-- End Table Head --> <!-- Begin Table Body --> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">BRB Medical Office Building mortgage loan(b)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,180</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.25</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2012</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Centennial Hills Medical Office Building I mortgage loan(a)(e)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">11,691</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.00</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Palmdale Medical Plaza fixed rate mortgage loan(a)(f)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,327</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.10</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2013</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Summerlin Hospital Medical Office Building I mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">9,442</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.55</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2014</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Spring Valley Medical Office Building mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,360</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2015</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Summerlin III Medical Office Building III mortgage loan(a)&#160;(c)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">11,728</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">Floating</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2016</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">PeaceHealth Medical Clinic fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">22,188</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.64</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Summerlin Hospital Medical Office Building II mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">12,366</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Auburn Medical II mortgage loan (a)(d)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">7,674</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">Floating</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Medical Center of Western Connecticut fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5,033</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.00</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2017</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Kindred Hospital-Corpus Christi fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">3,077</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6.50</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2019</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">700 Shadow Lane and Goldring MOB mortgage loan (a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,962</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">4.54</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2022</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr bgcolor="#cceeff"> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Tuscan Professional Building fixed rate mortgage loan(a)</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">6,732</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">5.56</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">%&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">2025</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:1px solid #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr> <td valign="top"> <p style="margin-left:1.00em; text-indent:-1.00em"><font style="font-family:times new roman" size="2">Total</font></p> </td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom"><font style="font-family:times new roman" size="2">$</font></td> <td valign="bottom" align="right"><font style="font-family:times new roman" size="2">114,760</font></td> <td nowrap="nowrap" valign="bottom"><font style="font-family:times new roman" size="2">&#160;</font></td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"><font size="1">&#160;</font></td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <tr style="font-size:1px"> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td valign="bottom"> <p style="border-top:3px double #000000">&#160;</p> </td> <td>&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> <td valign="bottom">&#160;</td> </tr> <!-- End Table Body --> </table> <p style="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&#160;</p> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(a)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Amortized principal payments made on a monthly basis. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(b)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">Subsequent to September&#160;30, 2012, this loan was refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December&#160;1, 2022. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(c)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower&#8217;s option. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(d)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower&#8217;s option. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(e)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan on or before the January 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility. </font></td> </tr> </table> <table style="border-collapse:collapse; text-align: left" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><font style="font-family:times new roman" size="2">(f)</font></td> <td align="left" valign="top"><font style="font-family:times new roman" size="2">We believe the terms of this loan are within current market underwriting criteria. We expect to refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility. </font></td> </tr> </table> <p style="margin-top:12px;margin-bottom:0px"><font style="font-family:times new roman" size="2">The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $117.6 million as of September&#160;30, 2012. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow. </font></p> false --12-31 Q3 2012 2012-09-30 10-Q 0000798783 12685646 Accelerated Filer UNIVERSAL HEALTH REALTY INCOME TRUST --12-31 0.0065 303000000 323000000 327000000 332000000 6727000 2676000 20265000 6623000 534000 4066000 2622000 2111000 0 0.0030 2500000 0 5.00 3.50 0.55 125000000 2017 2012 2013 2019 2017 2013 2017 2022 2015 2014 2017 2016 2025 29.24 1.30 0.314 Dividends Combined balance sheets (unaudited) for LLCs Equity method investments summarized income 127755000 111206000 13619000 4599000 4716000 1545000 101839000 76025000 12719000 10360000 12692000 20637000 P6Y2M12D P6Y6M P10Y 5000000 5700000 1700000 371000 1017000 -1000 543000 P15Y P13Y 1500000 525000 1600000 540000 8900000 6400000 4400000 2014 December 2016 December 2016 December 2016 December P10Y P15Y P15Y P15Y 4210000 30000 0.95 0.33 0.95 0.33 0.90 14 12 14 13 13 1 11 11 11 13 3 6 P60D 930000 5485000 2648000 3030000 3 1 2 2 2031 2021 2024 2015 2031 2022 P5Y P5Y P5Y P5Y 0 553000 0.20 0.95 0.75 0.75 0.062 0.062 1.00 0.15 P180D 0.99 0.85 0.99 0.85 Saint Mary&#8217;s Professional Office Building Mid Coast Hospital MOB Desert Valley Medical Center Centinela Medical Building Complex Forney Medical Plaza II Texoma Medical Plaza Rosenberg Children&#8217;s Medical Plaza Phoenix Children's East Valley Care Center Santa Fe Professional Plaza Sierra San Antonio Medical Plaza Vista Medical Terrace & The Sparks Medical Building Suburban Medical Plaza II North Valley Medical Plaza P5Y P180D 2056000 3016000 8000000 214000 11242000 Summary of required compliance ratios, giving effect to new covenants contained in credit agreement 155381000 45000 18000 356000 148000 1059000 421000 5341000 1816000 1691000 2234000 P90D 590000 455000 663000 14000 Behavioral&#160;Health Acute Care Acute Care Acute Care 4984000 4954000 213566000 214092000 0 -509000 370929000 388006000 15000000 12200000 30400000 0.64 0.18 0.65 4200000 3600000 26810000 7324000 111000 22400000 23240000 4399000 23000000 26800000 8100000 2200000 8300000 39800000 13400000 40800000 14000 663000 Acquisitions and Dispositions 987000 787000 11649000 3151000 -200000 -8498000 1.815 0.605 1.84 0.615 0.01 0.01 95000000 95000000 12666824 12685403 12666824 12685403 127000 127000 Aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, accounted under equity method 10581000 4203000 28985000 9395000 472230000 495558000 0.0075 0.0175 Greatest of: (a) the administrative agent&#8217;s prime rate, (b) the federal funds effective rate plus 1/2 of 1%, and; (c) one month LIBOR plus 1%. Floating Floating 0.0275 0.0325 0.0564 0.0625 0.06 0.065 0.055 0.051 0.0454 0.055 0.0655 0.06 0.0556 floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower&#8217;s option. One, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower&#8217;s option. Eurodollar rate plus 0.75% to 1.125%, or the prime rate plus zero to 0.125%. 2015-10-10 2015-01-01 2015-11-01 2017-08-01 2014-07-01 2018-05-01 2017-12-01 2012-12-31 2013-02-12 refinance these loan on or before the 2012 and 2013 maturity dates for three to ten year terms Refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December 1, 2022 Refinance this loan on or before the Janury 31, 2013 maturity date for a three to ten year term at the then current market interest rates. Refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates. 1100000 1400000 5471000 6143000 1982000 1963000 4841000 1799000 15484000 5263000 23000000 7700000 23300000 7800000 0.88 0.26 1.18 0.24 0.88 0.26 1.18 0.24 0.59 0.19 0.55 0.30 0.21 0.29 0.21 0.75 0.74 0.95 0.90 0.90 0.95 0.95 0.95 0.85 0.95 0.90 0.95 0.95 0.33 0.95 1.00 1.00 0.95 0.33 0 0 7375000 7400000 0 33057000 38895000 Summarized Financial Information of Equity Affiliates Limited liability companies accounted for under equity method 140474000 121566000 20994000 18755000 4949000 6149000 140474000 121566000 1189000 457000 1671000 580000 44803000 15222000 16499000 5514000 1200000 6600000 2377000 875000 1803000 645000 23000 -68000 -114000 -152000 -87000 -196000 28081000 25645000 108000 1464000 718000 5853000 1874000 2000000 1300000 715000 438000 1297000 6033000 473000 541000 338648000 366321000 33057000 38895000 24850000 27058000 13600000 181984000 206904000 370929000 388006000 77150000 83000000 83000000 150000000 100000000 2015-07-24 2011-07-25 50000000 50000000 150000000 100000000 20000000 53400000 0.0050 0.0030 0.00225 0.0015 76025000 24954000 8124000 4098000 1299000 12914000 8817000 6766000 3808000 5245000 117600000 15648000 316000 35231000 13854000 6766000 Long-term debt 6300000 5200000 12900000 84000 76000 0.95 0.95 0.95 13689000 -21952000 -29686000 -8989000 15797000 22443000 11168000 3348000 14967000 158000 2986000 106000 50946 50974 99000 Recent Accounting Pronouncements New Accounting Pronouncements 114760000 22188000 6180000 11691000 3077000 12366000 6327000 7674000 6962000 5360000 9442000 5033000 11728000 6732000 19986000 6882000 6992000 2327000 10255000 3191000 11642000 4215000 9788000 3266000 11556000 4068000 General 3674000 1424000 11244000 3578000 1476000 525000 1594000 540000 11541000 8000000 834000 -100000 22977000 23328000 1104000 524000 26505000 7324000 3475000 1677000 3217000 1013000 3109000 955000 0.01 0.01 5000000 5000000 0 0 0 0 0 0 6664000 499000 8100000 12100000 184000 292000 37800000 5850000 0 7000000 0 8077000 Real Estate Held for Development and Sale 74865000 84186000 263783000 282135000 288633000 309193000 -172000 -2733000 Relationship with Universal Health Services, Inc. (&#8220;UHS&#8221;) and Related Party Transactions 447398000 462365000 20836000 7394000 40627000 1900000 13610000 698000 Components of acquisition Outstanding mortgages Existing lease terms and renewal options for each of the UHS hospital facilities 97686000 116175000 Segment Reporting 210000 238000 188861000 181026000 188945000 181102000 5 3 7 10 12648 12651 12665 12676 12643 12648 12658 12666 EX-101.SCH 7 uht-20120930.xsd XBRL TAXONOMY EXTENSION SCHEMA 06072 - Disclosure - Long term Debt (Details Textual) link:presentationLink link:calculationLink link:definitionLink 06071 - Disclosure - Long-term Debt (Details 1) link:presentationLink link:calculationLink link:definitionLink 06054 - Disclosure - Summarized Financial Information of Equity Affiliates (Details Textual) link:presentationLink link:calculationLink link:definitionLink 0607 - Disclosure - Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 06053 - Disclosure - Summarized Financial Information of Equity Affiliates (Details 3) link:presentationLink link:calculationLink link:definitionLink 06052 - Disclosure - Summarized Financial Information of Equity Affiliates (Details 2) link:presentationLink link:calculationLink link:definitionLink 06051 - Disclosure - Summarized Financial Information of Equity Affiliates (Details 1) link:presentationLink link:calculationLink link:definitionLink 0605 - Disclosure - Summarized Financial Information of Equity Affiliates (Details) link:presentationLink link:calculationLink link:definitionLink 06041 - Disclosure - Acquisitions And Dispositions (Details Textual) link:presentationLink link:calculationLink link:definitionLink 0604 - Disclosure - Acquisitions and Dispositions (Details) link:presentationLink link:calculationLink link:definitionLink 0603 - Disclosure - Dividends (Details) link:presentationLink link:calculationLink link:definitionLink 06021 - Disclosure - Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details Textual) link:presentationLink link:calculationLink link:definitionLink 0602 - Disclosure - Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 0601 - Disclosure - General (Details) link:presentationLink link:calculationLink link:definitionLink 0507 - Disclosure - Long Term Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0505 - Disclosure - Summarized Financial Information Of Equity Affiliates (Tables) link:presentationLink link:calculationLink link:definitionLink 0504 - Disclosure - Acquisitions and Dispositions (Tables) link:presentationLink link:calculationLink link:definitionLink 0502 - Disclosure - Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 0401 - Disclosure - Recent Accounting Pronouncements (Policies) link:presentationLink link:calculationLink link:definitionLink 0208 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 0207 - Disclosure - Long-term Debt link:presentationLink link:calculationLink link:definitionLink 0206 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 0205 - Disclosure - Summarized Financial Information of Equity Affiliates link:presentationLink link:calculationLink link:definitionLink 0204 - Disclosure - Acquisitions and Dispositions link:presentationLink link:calculationLink link:definitionLink 0203 - Disclosure - Dividends link:presentationLink link:calculationLink link:definitionLink 0202 - Disclosure - Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 0201 - Disclosure - General link:presentationLink link:calculationLink link:definitionLink 0121 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0130 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0120 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 0110 - Statement - Condensed Consolidated Statements of Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 uht-20120930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 uht-20120930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 uht-20120930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 uht-20120930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ZIP 12 0001193125-12-458748-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-12-458748-xbrl.zip M4$L#!!0````(`/DP:$'^G@`&AJ```-JV!P`0`!P`=6AT+3(P,3(P.3,P+GAM M;%54"0`#A9*;4(62FU!U>`L``00E#@``!#D!``#L76USV[:R_GYG[G_`\9UV MDAG+LNRV21RW9VS9:=S:L8_EG+8SF=%`)"2AI@`&("VKO_[N`N"+9%&1$TLF M)?5#(Q,@@-UG7\$E>/CO^T%`[IC27(J?MQH[NUN$"4_Z7/1^WHIUC6J/\ZU_ M__*__W/XKUJ-_'E\?4Y^98(I&C&?#'G4-]Z6PH^WM-+*V"Z9ZT,:%CJCP&/&E%P^8B`Y(\^#3 M1PWK_*148[_QPZN]3R=,WT8R_/3QP]E_3Z];1^?D_>G1^3=6W9G@G)M?QAK_%JUJIMCW1H7>M1&J8W=*GNF,ZN MPC9J/]Y<=[R^FQ`:Y,3 M^&QB=,V\G9Z\JT/#E/7'D2I<_9LZM*;,%'=,1].'MFWYT4%N"#E$V`ZT6>N"4HV)G_:W2-V.@ZK1E")B]Q%I,2\"C;2* M`6V>N\[]G[<^<,$NX.^^/A4^\]O[NRT6XHCM)F@*-`:T?<%\[M&@?1SS`'6Y MW92XDGMH&'28LBN'ZG"EB*&)C;$LXT3S[?>N77?COU9O7 MKU[O']:SV[*A-.NAYJ87X))%_H#=AP'W>&370GP._:S]<1)XT.(]`<-Y5$1' MWN>8:X[H<<9:VY4#[:O'0%NOW!=`YB`<.Q?8UNY/!G=%N!9R(VN^HQP,@IB(P M7U/18PY8=\E1.!^6CYG+M$9Q!^*I.(9'[(DII2Z@A% M.I]>V+[54JZ!3(U9LHU,+=Y85D"FCFF`2>.1ONSFY.D#&\[P=$<]"*R1K$2R M6GVIHO8-4X,VPE81"9OJGD#"@/@"[Y02_O2B=GH/.5D/0OD^CG_913Z.2YYA M,O(8FQ8C?W8+(1H3J^3:4XC51'#^."DKNS@]>ZC^E*);.LD9C\)77W*6&I.O MLN0\TI6=LP@B"XB?DJ[5$*&*^3++Y5AR MJ.:J=@&Z@"Q#%1!U'E83'6=1;=6.1Q5K7RD)`T:F)A`'?7B5L0]TP"8M:\:#C`5E!W5&[OI1<*P>!O?H"LY:3-UQ#V`] M$TG$A\6''2Y*;SNS#:(`#>$5^*"\CP2/F6_)@$UY8%F0<``8\'3;CX71:<+; M-4C#)\1H+MDKJZP]$9YE%NL*A((S=A0VAFU]#-MR-D>^4=@VPE4YQ(NWPS:N M;'U!-GN]66W"QJ0 MO1!X*59-##+2#>6.<$MW0K9Y_K%6`G&L.H4RL%KX`Z53,5\SP%LA5;>YIU;K MM]%J.9!X@P7OLI8+>T!!T;7&WG!@';&_\B"REW'49TJL(_)`?T+^VN&^Q@H/ MY*^CMO^JZ$C+M51T1_I:P?VPO&%=T!XO@%@#J$_N!MXZJC72O58Z?:QBH8?< MNVT?:2T]#F.O#]HI\1GM:P#YD0JXZ$52K'/$EC)A'>.VS8MUJXCJ4=R)5:;4 M)CY;J;U52Z"C#^.P-=M3C0<#AF:K;8HX"C?47>M*09_2;NM7INVPN\J6M1*) M6:OF[>N%OGU=FI>#YCF"K.SH+NK,L;*]:X*GBZ\"+DA' M55%H//L+I3GZ&D]/WVZ9Z-NM`83X'NS7T?=U(4XU=*O$!TDOVY:'[4Y%@%*N/QD)2U+ MCU+M_O8V8D"1[:,#&/BS.(3>>"JSL`(YJJW:9->O) MHZ=9-KKL0"W$!I<+G[WV39\K2/!/\6-'[=.`W3'1/F9!L,Z/=2Q/#$LL1Y`A M2WK$L^BV5Q_`+=='MQ9^"]/Q8+K,R>N&`;HJ=EUGLO'`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`RF:_=NG[M:42@,WF[HH!NMD)KB9N\SV!KU:" M4>(G[FO]ZO]7E&UO9.WYBJTK(&L%QVVS>SFH\$FOUR`;IQI/L,^6GCLXVU!7 MN<-;ONZ4Y6I#M5+G)U_18.!.V5U)L!+Z*@?7I?.WR2.LS?=6RN/<&M_P/*XH MD-I\G&7!SYV_C&QC,2'RYDLN%01SZE.A9Z\?6-!3KRS&CK5'Q0B#@"Z`;G?J MTP];K^P7C1W9>:H3HI?X4>/%?[]F\_WRY_]^^?)0?B]UR*/G!9!O&+P&IHMR5.170%8S><"W\?" MQR_(M_K4ET/(`$%3\7V7@&]C7!&]DAN.%905R`AB1\&%%A6#67L[*!MM% M.SPK%&D_W%0U&?_J0CJQR8K4KA"<$]4LT/8'GL"O1+LIA6!>Q+TX6EUTQXI> M+KN.]ASI*P3U[]PZY#2F;DJ%E6K-ON(ZXJL+LB,\H=N2[:A>(7R-$`O!L5J! M!X%>HYPI(]U0OKH9T['JK$G<#)2N:&1\A-^;SNI(5V^GRA+HZ%N)#:F*E7@] MWQLSB^%^M8HY5^-+#@GWR_1<\,E?ER\-D9/%&J^>XRM*R3/]U09L@%X2T,]LWC8X+P_G99=V;8SV MXC%^WJ-1-O!5_`V@QJ47E2(!&9/CQNXB3KUX=AJ?`>S?J("[:ZXL(DQ^EY`5 M^U\\K.LK6/&O6@UT.R(M9EXRK-7LY1BO(7L^MDY.KUHI-WQ^!Y1DDV._#_&` M*1K)L3<*!XSJ6+%?N)8_[#5>'<`XA_7D8F8+IM]OACUA0@ZX*!H8K0P_T'VP M/;IHY(=#'-9S%-A.$P3?,#5H7S/!AKB!'YHW+U/RDVGL.W,/.XXO9.KXZ4;R ME93!U(&3'MAAC@&MJ9XZDFV:8XSDI?6IHR2-+;FAO1[SR0<9L;1/LBUYJ7I4\'\H#M!,#Y+#MR"$?P4TP/CF MS\ON.Q!SX7$:I"_"Z!.NO4#B^FY`W>UD3O>O67>&Y?L^B-["*D\NFS=_79V2 M?C0(R-7'X_.S)MFJU>M_[#?K]9.;$_+G^YN+<]+8V27F-67S>@8-ZO73#ULD M;Q2'^SM2]>HWU_5['*N!-[N?M2AWYXX?^5O`@^][T5O#=;>00G8U2(TLBE53 MEH'2LRWTM!7:IOO)IBZPF^AH%("7P-^U+AWP8'000-/;"^[?N[XZ, M(CDXV`WOTZ5_&\TO&B_)KV#%%0U(`;'FC_"+R_SIZ5=YT^>:_`=L:L14,"+7 M+`3?0,"8O)-J0"`(_`^!#EVI2-1GN8Y7QM\3AN$=&*`P,C'X]W00OOV_QD^[ M;_=WMPGJ^@XY$W#KE$FVB>W]>F]O]^V0;:=_-1P3LM98YUOS+3)6^18J?+/. M7(\;%>LHWT>Q+D16D21IQD%LRD'P3=MH!`OVY(`1<^,.^1J<%B%.?\F8Z+Z, M`Y_@*4S=.`!.*G;'H3L-`B*[9DE(/1>`U\#8(F..*43C/EPMP@&YYH8.H8U[ M<4"Q'0\6A4A&00>8BNM;TJ4>1#H:!J(1&3*B682R`;PK&MT,#HT2%J9@O7A- M$Q`G7WJQL8SI8%T>P/^`=(*,0(3,OT,.PR-9X.9BQ?'=9C/HZ;W7Q\=LANRF M'`RX>;6)O)@0@-9I,P?_RUD"B12AQ28@5J3#`LZZL-8NZ<81&&Z"5;R1G1PN M8A_7T$WL/8$PQO`>DCLSD49)\JAF>IN,`$&/"N("]1&L0FJ84=8\K`3W\XN& M02#G]6N!E+=<].RR#+ORHMP9D:%4OB8Z]OJ$ZDF]&=!1D>(,>1`4M5E9*&KU M9C4.9S6&"LL!HD)E#L'C`F=HX<)0F+F(65$[NP_9C/$AC^4>#X&3A5TLH$6M M^&:O\/4L4Q5"8E\XNA&IN^+9F0:)G[4\&H:,JF(&*ODW,F#2)&H.]H4J`OQ1 M]@5`$$>J0=[!<,"_F72AJCJA!E(U"''.[G08,3LQ5F.=]&:W8HL4H$ZH&0YK MG&J'''E13`/#*J=#$FV!C@/X"4)*?-Y%HXRT*\`_&!GE87O$9FT#:5X0^W8T9NP9K"..`F,=P3HQH#VQ5D#! MD1"PZ"D>\??4'8X8,M6XP!/F37K`AO&`#1@O=18<+?D9T)!U:QR1:S2M[YQI M-2[&]+-K26\CX_>](A=40`Z'[$CP;KQZJPE&FK$UA3C"$82](\V-'4OC4K"7 MPCES[:"`+I)EZA/++KT3BK:`4'E M@Q"8`J+3,4)K#)M/?(;LD/;.1'1Z+GIDT$\.N(?]+7R@PWT.MM_.8&='`099 M5PS=CG7,C(C8[,3"ND(FPP"7P@9A($2P_< M+FA/9!#-IO"9G<(W/4(0+&A%XT7P)F#)P!9_P9Q8NTGHNW)>%#H>V-C`,L0XHBG\SKOMCA1@'Q3F M;8$F+Z2=_T%8F&Q%;V-DN#-MSI=&BY`]J0N#"?OT#@PF"$T/P(2?R0+L-&X- M`;(0UX";/`1KZ4R`D<9R,5@7"%%0]-$:,J0K"-,37\#.^KY+=(/1MNF6 M2`X@!>)C@QN0_EN(V_K`_@YCHE`H\?Y)<'@P"@2_I4&$,!W;+ MXC3LS*/8KE;>,6O/0ZI!^T'^D&5HW+7ADI#(+="3U%CEL(QAG>_E$&\R+%?, M!'F@[$*"A(-"83!H52GC]`05AO(\_R`Z,]-FUC%5:2/!GH25`M/?7.!!!!>V7\3MD(""081K=&+ MW'SGY\W\7"]13)VU8A8W%[,8PH04-?0+2IISEPG['%O1!C)`D\%P0?:##<9E M[N]_AV"^^?&['?('2%>LT*X!-Z@'OD&8-,U`;+8F$T*X277K@=3:95Y]AK*2 M?B%')X;`S3Y@$(GYY(5FS&Z0_0@)U9%AS(Q-@&U+H#\VL$0IAJPMR@)/6%\$ M%LF0C\Q"V+BYA!-85N'J'4THD3#*U!6:)$TXO0/QR!@R!IV+]3+#D(\OQLTI M&((0\VW`)\"(U>SG,7^;^+%*@DI#09]\MK*(B\8(T)`?QLKK&W=I1!'H\FN8 M;<.*N9"0U]KX1P[!8.L^#W-`H]D-4`0-4S)6X*C9BOH,'-Z$T&R#'?C;##YU MX#$)>OVCE:`WWQE$J7/U9O%"#G$`T*7=[W!^1F%Z*T,@+N8Q4Y*6=\#=";C7 M@\34L87G&9Q$2).<-]3GL@D,3<>QZE`,8[_([?+8)W1?TR0KL2UIUF%TW_AB MP!.$POK?6&^;)>,&".0IA$+R`G"`(.D84EFS08+&*0X]\ILDEV9.2,#XA]-`CZU'0N.;\_9=RRE)%`8^*GF^2)"<256M]G&896 M8AI'4[YA#N>A[!F?9O:.7`QD;2$:*3\Q($@XOHKO\1!YF,&`KAC37Q^M%(0[ M$=Z49[S9<)G*>>!3@'CUC'ZZC#_)F*WI0M]@@I\[EG:X_@PL0,4XWYZT4^SME[2! M']^WQL)`NP5C&$`,!TB>!>5[9I1N29V;+8:#;`\HTU.,02&Z8V"%_?Q6"$A" MX\WKG]"_N8C(&N$DZ4/'E:1N.NYH[G.(B9D+3X%S=HMN@)L+P#`PZIA!PQAI MQIP;JT-!Y!(WR7";T"3B^7%WR(5+I;!38/=,AIC%,1,FH?%"$V>MMWT@44`: M+@PFQ^(/&YB"W\2M`)?5PQ2-?5Q-XT>76QK!B4/C3_@]6/\DW"0_ULS6XMBV M@$V'71R+P1!+MBX,Z3B[W4RP#@E;W,RX%A.QN1V+D7$VZ5+!1\FA'3T=U?JC MD'*?#+"."YTG#&M&<;,$6B9CV"ERZ\>H/-UK(5/Q5H6X8V(-4I9T3_\"Z.95E$11E$0I/'7VF=@FV0`:#:#1 MZ!^41_@B1`1!E()<&7"MK"P4?:;4%"N[]-$N2^+SZ\ MT+(@:YKZ/NP&0_4,$EICPP'+%!]1['!TVHO*13"2]DUFD/!WE%Z*?RSU"6$D M#5BCJ/RJL'8CGWX)N@4*$]C,(/R2!QG!%C;X2-8F-L\&-I[VR-C`QI,>2[>O M;RG`AA"/F$]L.3,VG//;U26;_X7;3W($^']@20G/'9PSL0A!E@9;F/Z.AP)? M;\[=N5A@2'A!8HI-CF-+7:%92*I'M/D-M1[/SH*3KF##GLAB1P%F@^\)Z)5C!!U/6@U3;0HJ(,S,,S>?>#+)ABN. MW-J\.MBP4+E!%1UQ!9M?HQ@(+-";Y:FIX+26XQ52%MT@>Q2I@&8]*KZ(73/# M;B$=51':.;\?UUNJ".C393?Q<>,63I4S]XBG+I:;,`ICRD]E'&TMC,I484*8 M*\\'19!HB\@Y]FT1(GO1;V1H#+'KT#$&011,VQ**:=&`P?2BY8;/^63X\45/ MZ3=`&"^N=*%2L?!K6`:.PX?>$1-),CK%OZ>68$"X@P=;VLZ8XA0VIM+278C<&JS17H/X)[+9V).G77$Y2-&X;$IAP)"K MT5ED_&`*I\AZ27A^&X_Q55BG'X'<.+VI.0AL_D+*7P(J.!58J7'Z8[2K*>(3 MM&<1+8X58TLCDX-3L=YQ5Q.H$\T,OI!?\@D.YJ1LRU*ZY&FO3`R"DV.&^)SA M!&>J=#R:4AQ\.KZZ*!P$YLD[A)%"HR-\@K2;F-`7]7*TPQ9V6.@ZE8H\8RY/ M&KT$_ZK8AMF!&TK4FL@5(NMPLD:04J!BRJ"4("Y1*O5P9`5CF-4/))ME"DR# MDIMBO0KA&4ZV^$@`4H15L=%TIDTANN!@Q,'HFD+@_"?"D<'T)9:FV,Z3Q@@# M%]O12YDMB*-4Y=%XHA@--'R8<`ML`/;W!'T!?)"'([@?\@N*6$;6$G)"N346 MBRVT#AE?%F(9Y/%K3>:>^%)TB#$%#+7ROE^=08Y,'(7#:+O7"9% M*(EN-\SIX+Q.IK]OV<\.F_WSE?AO4NUGJ64D5Z\V^ZG0%D7Y/PWZ?Q^)R`_M MQLPK:@VU9%8]`&94OH$GRY_QSB'0)'WQL9.B38R28YZ2UB.GX$J2%F*M1>3; MX^C?GV4LM4R$^Y,96&,P[1;ZPKW*3YQ$+I'1P%'>ES.4Q/W:YEBAQ.G[W[$@ MN(JS?XP+\9,UREZ'L7TO_HA7>2LY*959DO*>\T[6Y(K9*'E!OJ73OG=[F_YT MM)`(08MLB,/_SW#(8:_Q:B$WL#M8$''(_0)& MYA^TTT:#3V7(;F`ICO?A1/QRL\V7;'.O2%Q216!^5S?(V(C9LZ'O<>6".;Q" M]F8CCEYOXA\HF['9^&VUU6NK8/-RT9$*M$N5Q"%XXHT8#(\>8ZGFAM:I$+=[ MG+\255IK[UV7W[)WZSNQ7%O>/7N;OSB=='FVI7P')TJ5,;7G.4B.]NUYFFJC MV:@]3^UY:L]3IN<9;.AY#F?GOZ=>;H'UN@EH5XO9(7,[^=?GML(#+67"&E'4^ M])[*NK)=#V)OG4PXRO%#;U4-&1:9)<\B&Z?MF9=9F:(U,LMGLNK-"A2.QHU6'B\K$WKQ)N.]`W&GRSN6;O9=5SKM#42`^57UD#!E70`*PFSIS_/-.O M:^*:E/=L+U&BN2KJY.?@,[J25*E(4VJU*N)$]J]6&VJ$UHYIA-[:S,@LW&=M MJ[#\+Q[C"XG*Z]YI7X%/F@&JF[C#AZMJQ`=><"42 M;VF%=\)>MT\;X3LA>!Q"@N%--C>X@;@4!@J'DK"]XF8?7@Q<=:.0,%WHZJCR M]I:9TQ&#Q16!9?#+==S?`2Q4_%FF2OND8A[^@*T1)G_BLG^9JIB MVL,`%2IX1%4N0$N!5LN`!^05EB%E2.DR3*+T7I@0@M3^>G-.0@*A.X@N`[/F MJ4H7N)V*JQM"]R($K.#&&7PT&ANA(X!^F`$0S)IX$Y>SZ"[-'0'CA@7 M5_,DR@Z90$D.3AU.0B9_H;S4\&Y?2'APZ2_SYMB6TVFS>@JV>O.:3-8=L'=.4/7OY)P1D M+'SIGCL.&PH\!%3BU#>#)NV"]9A)%<^IRC?^Q$8YC&FHH"N72/M4W\X2.7,% MN"0288@%'.!+YUDF8ED0*E?R1GO:7B>P"P]H'<1#BE;>)1%$"G)):'M>$O?\ M)W"^>$F,^!,WX7<03LS%%O-+)?TU#"SBB^"26X8+:BHB!?Z3N8'&YG%G:C)[`IL$;. M'AU."S<3DDU&WT$_S0"8+H7;(#^VWK)4%9<[3YR@W>4')&P"07VCK9TG4/0W&HIP6!3A6'1,P?U,".D8M1*)<$]5,,B/S(3OLI_"-9+UCU[" MV8^<3DS_'&Y,!V@(P=<;8!31&1/^+VT2B?6,U8,D#R+DD0`KB?`EF(O(](C; MX!H_02D(/>/901]I!:`--()B)^0C=J49@_&?,\,1N$U9F*PA)C3FWCY"G"#Q M\(56BUP<01X0JC':C_](/`(F6@R$X"E28Q9-O1IYP92A(CR*6/NE*)9TXPZX)CP%V/,614?>:";`.()@ M;>KFH2%HK:5*K"09TDT0R4W%U>]/?8'<"@H+@C.8`&D9,G>@:!8H4:0\F/JQR/,DM$>/@,-` MM#YE0&/[0B'`)V:8H>L!_M6%U%MGJV@8<9B#5%#"[89_+C@76*]1UUQQM0J"Z)V"JF'3.QZ M1(]AZL:Q8+4+[MVUY8AY2FSF@J^-$:!&+)((YA9(1=E*^DCP"Q8'S2HJ.(A4 MAN2(>$X*+>(,3`P$W6Z"[AE!(P&,?"BF%!*(-J5B50DY&%.*-&0C05NV'@NQ M@D0+K3`2.U6^V4EUE%B_A$0[M\_.@-Y4A&O09$+3$STT8NHMF95`^OAMC.E` M+Q$&'A/*L07KRK0I@83%(''?XD9$+.1WU*@2=^%3N4O![&.[1650],;KMDY7 M$K/P##<%,B3ZXUB\JVT\[?N:S3`?)VALZF$..Z!3[H"!UI-RL!=3LBTB5^VT MDZ1;.VVGZ5X+`G:I>,6"+RIBO9L2<6-.Q$1J:=*M5(@3[GUO"%W5D2U!14>S M!"2Y@MW9[/`I[+(`.QD>/!G"/R(:8K`96YE\"/K96&`\P1S#:F^KCEBC@%;:Q8$,`Y;KWPOY3AR&HY$_BD"PDNF&JHT#OY M'^0`VZG2H__RK1@2A:;%,J>8@7FTC#AL8;"5E9%NZ"C"GFO\)Q_Z9.]"%D4# M"8NG^D<$R)^9/,3AZ#P0V]%&DWLALY,A;O*YC;T4918\W!LGD/)P8J8"TD\- M!PS>6_!.L.O&DQ5.&J2*UIA@0!+:ANF?4>@NL^=3(/&!-E'FF*(!$:[*-F.B MPSW^%:7N&)1.)OV6./7A&PD?*UDASN,OBJ_1JR.@0UMZQVU"KL)UEC97MR^1<"?BF79.=7#Z#N6 M`B:^(S4+#XK-<*U7462?+F23:]3=1#`H'$U&C-=]:^D'3I6[,").8GQG82Y' MAR39>>48+O."5@+$_6[:"52OE4`4/HIM")O/R%->&WLNB9A8]$MFU-8$#UW8 MHQ"_S%93188_,(TA;E.CS:)A$F(]QI.K&MR$'2)B_=8I)_?,@30,7CT%VPF! M`3Y]M)_(>+O1$$%="$A/0.SB28[TTO$036RH@HV3[!\N@SW\L39X:F*#ITQ&<_1P6H(ANXF5'E"U:O.=$A(EM&00 MJLB:[F0+_97^HC8A)DML7L.,#VW_NJ>]Z&`55N?KTX[6QDV>\)CJBAHXZ9_A M,]WT9QKTF.@B*'X*8M[8U$@&C`HQ M<+G"BE-SWF2C.K''9-'!I@3V?Y:U3'BFD5TCE]&^!=;@Y_O_I4*A6X+KO[I2 MKF_#BC7\GBR/BQ7'J6*,J#B,Z(?ML,5?4H5Q5U=J9ET:58-3,8^X"81)B$03 M('$/6+2YH[LV*!B15AC3F4RLY$Z,K(IJ.W)65.^TI+I7CZ5]#5E5)8C$_0ZG M#DG)JCO^$X/SL.RH2!U?L]AV=EO+YLI2P%T`A2^Q'MYA$VO1#ILYGL@/S4S8 M=^)O3>,'/_EA8*O`H"@S5C22**^Z$^G"6":D(0H)Q/D_",:B9K&B']*%/>(B MMW;+V9#+/4A8:D@=LU"7L!6DR4]DS9WLP26+L!-]N):J5[^?I5[SJG4N$-XF M;*HJ?S%W(M#>1&)*'D.]4&E!U/U[OJ'5ZV8C*IV-UY;0T:CK^M-9D*!-O:CK ML9K;5(XTK+>-G:(_@E7`TJ*H_0;U>@D+):D@$&OZS(!'F9.0!P_48S)^3#>4 MV8>D+#UL`(9B"T7P]K7>B2)6<7T/0R3/&!O"<@6OR)'>OFY&9S'O5'E",M]! MANYTT64NNN(52RJCALJ3]/!TEKH>!:U"J,AR;N"PS13EK_&2F-1(6%]T!!FT MOXPU!,6)B086)V>R_I)-,9?S-]+^)$N1HEJ&J4RMQ'K9S,TQ%NR(;J%O@_-4 MLDBV[\(X;N8=M4KVZ^CTJMNOH]?=L%]'ISJM-'+>U/\5T)ZO886HL<:+HG-P M5#"P:N4<*+C%OD%:%+VC]BH`;'&<0$HWL1JP(U7@RJ"SM-1FOW_@>GPXYOJ2 M#[Q:H[>KT6_UYJG>VK]M/E*4.V&<8ULD%8LI:Z7>LE)KFG;H&GU(9II2UVYP M1Q>V"W@J4BOYEI6\WK[MSV_N.EI@@T8V3[FY79J M>TH:-[?Q69"O7(XLJBRT0MNJ^+S**GD/<*SFZOWR5QD^KW MPBL_%H$Z#&TZ>A#'OH\6O2$A6[5?@V-'@KBDKT=0Z(M^PR[_R!R__K\Z#\8XE9;W?;RA?F@,N_ MHL(::0:@*'26P)'5NG>=:+YJ^R8()%@OQOMZ"29":JGX2 M:R=:.8EBL4$LNHEK+BP5"*"R2I0E*$Y\!*K>8@I*P3'$'7`V]()+D=FH!57R ME&N75FJ5+ZV,%[A6T^_CI3M2J'_YYDMPIT8@_M#E*%0^4U0CQ5T=V0ZL(L.; M-8:HK4S'_;+X;47MF[MQ\5N\_@Z?^U"D]*=38N5/]0#.VV]*2^#(+^I;@TP/ M@\7.6@1I;Y8!IQ?G=RDR>TRC2N/_FOV`0-O&%19ZVC.\=!BXV]`9Z1^9TFZH M_6XK+,2T;7#G4]P\R5)/-:CUG*OSC)5K?K>?P?U[ZCSP9EC):$1W=`,K,:9[ M)'J$,?N15NDSM2U!K[RLH$_6"0:7B^-U@CANY[0MROOH2M_'E2NZ2#>"K`+` MI!588G)K*U!;@6U:@:QK`7,+O]59O/#SK/O$#8`%RSX1&,"2)V9?:[&F!Z4N M>UTL^]61:84[3F37E!,9HJY<;FY!*%]OSMWEI>5KE)+'+OGE*B5O1:8[54IN M./F+R5.%Y/$H,:PH=T5>KG!9N;NDKEPD5>;YPXXYB'L6A_W-*#O/4M.B&Z,M M`AK4V\D.0U0`!^-)P*O'X]C^""85)$IS]@!AR\ M9.@AWLDR4@C9%?%,`BPE"1*8I?0+N%@O.[M"C5J-TYY(NL4UOY>^'W_::6?I MUO8T91D$4028D>_6]38NO'\B9,ZO!,5^%8$Z'O^E]W;LTGM^(>S]XGO[G7+G M3^'S%(A\#O.R5S'8(?#<@B/E+``$K^"%^)OT24YFCZ-XC)=X6L*]!@AZ01*1 MCBIX`J!4GF39+D_\E@";IXA&3-]V#,I\BW.&1?T-Q,7OE2V7KN8!:^FV=LC@ M6815>X?(7`0=1TAT"92?^$GHY[.[\\11J!N^B/P]^@:-)D_N$:H9?9,=A\5% MPYN62QP)$\PU!4&4%97OT4MHVWTK(?[X=PQJ^N)&1T@C.V@<@=.A^&[@)Q.= M'T0H'E`G(O'$B:@X/I'`>:G9(T<@8(^?;"]`-J.Z+%=(''=0$I'/`%_-W0AU M>@#&'0D,SJ`]^X/RUHC58:9.AX-]TD=X*OZ8Q`4;^*-''D`%(E@]99W@T?BS MX=7A6'LZ-P!LBG$6[*0='K0I:#;?(!/YT`4D["-S8H="!H)1"K!D3QZ@N@+Q MUPU/#_&/5$,A;U,'H4C8XT>X[-"+2S#N))BE9ZLR\G%CO\6P0I7[LAAJ<+RG M1(`M&2(L8.I.;&H#E$S8"'(W.H@C1!S''AO!#6H;-FYN<.3HRGH43S:#B6N. MA/B/]LQ`+4XP;NYL2X03$K>221"X+$1,-L93-8*"I#WRS`G`Q26PM`1ID(UD MW%CH(K#S#5ZAWB=740N"8"NS8"<4'`F>"=U/03-JC9/_"0,\ZADJ(KMEH(7Q M(YBP<&(=9%)N8J0I;%#8%0Z_&I$_X>8HO7K4$,HT\\,.I@2"*J)>6ZS!_ANJ M!&'R1):(M^QG`N?`=&K8LT$HG\N%XPA@LP=@DRRY,*5--&*GJ])XXY?=I9W_ M,+Y-HZ>[!BXJV`P0?&9Z-L4>/_A4,$9(I;#?Z-O2Q18+Q[?2+H%(B+4'66KL M_PJ<(J+%S\(=/#QEV;"883_BR"/^P'.EM"+A*!/'ZA)6G;`>4VP&DT'R0$=. M#207G7HGMSO!G`?#1+Q'566Q(:JSML^\E=619)L6MG>+;*?MQ+T7J@A5&7"> MB`!P,6!N,E>G3UELF.@8E?+&..LT1E)=ERCATHY3$(S@-L*Z^B]9UP$W[694DBDXO:_3?RA6?8J+U"20J\J4& MN<18[S,*GN;`+U<`5<8CU3^^W,4#5956CJAID_W,;&K#AQD`5MYE"?(P\0_3V! M^TNQK]#@N6B#^F>\-:@TT839%(T-J']?5OM3;.(E$>Z%3X&GO)<9J@'$'>!< MP)?9Y,,27M[UJ;U8A#5,_/MR3A.!0\I<(4LGQ%(D!S+B$-BJ,H='711M1<"5 M!QW+\&IAX$R#@#OLY;-D;X36Z-&"*'?(2.(">)@JKT>&W#"2Z:"&B8GF(?.- M2L593B@R::GF6K3!#M*%@8UQHNV9[P8[&$*T15L!P;8X2HI0Q<6<"V8E!FXX M'VSTA+MD:H(JUQGAKN-4$&)94)GD\:CM8H5\.0VXQ-7([I$Y##KVG$Q88&6N ME>$Z#0I91H-"6EE!TW3$B`I:B83;O/#4)C`SRQKE!6CF\;83X0_8J"C5?B(1 MJ0=O2Q,GU[I(E(!_12L6MLP+*Y]C4E0#B"K7]1U*Z]B!?!]]1NCZJ,JX:0CZ MU.#GLGNL)T(>&=S*NM2%D4+4&R>KL+/13<8,2T($T8.&I)?H3+XPFW4_R=4= M-6C&_L+C#=F++)PMH!0C#Z*1$CG$>#A`C`2-*7(D6!;'C/(0)K;?(X\`\QM9 MN1@N?6(#,:>L"8DG%"MPW8&J!K1G(*&!V-V*)WX3CRU2F/D9 MS;HH]QE+7XHM6V;ZLCJ6]CO"%)K!_L^('>Z`(YJ[A8`\I'8BN`.:R\;*@@31 M7QM[?J%9LF2J!'YK94LWG%)Y8.<(IRMS M?^"S\8P`_&5D<]E1SS12XX:DY!8@BMA MJKD(1:X'\8>;\IS)+\[,?%R-="DA,!>8UG]!XTTR(8V'TH^)?U5E8 M]^3"3`A@1:L^68(DZA[#K+<;QN51=B&UB1.;EKA)"UU=V&9^X#ZOTA3H#'P15HH2U++9*<(BQ) M;F'_J&52JP@P1WG2+R[Q-?<;"&.1800WG[?;P-W=/,N2UR*:GQ/>X5>`H[W\ M\^M%+/]17=.Q6?U/50"S^OM'.7Q32=NTF1)C5V9/^9.99NS:Q@49GD7$%`H& M]KQ8[_R![PR852_8G2W89K->L.5/;ZC(ZD;_-*(AXRT[?U6NV7K.'-[VKJVR.V_F> M.[[E/AO#'WCUS![2K8YZ)6\9I'7_"*U'N)*_&B-8LLSUE"]!&_.O-^?'Y'AO M+[YD%.?4JW6[J[77KE=K^=/[W7:Y->`.N-D)^%N'6XDZCB3(R%%[X#/'%+TH MZ[6]>T].MKB$8@UW1B5WPC((!"`+$C^0Z]6\ MC=4LU/F.6X4GQC#D_W`S/_'90YZ_K)7V(T_NGX7I1K'F/KAK":D%0H]G[2(7V M*;W?).@^',_]N\->7-NJ5WF]R@]^E=_SG_#+S>/NJJ[59D_3E'.\(%/OFNL5 M>PPK]IN-MVE3M9>_P'[Y\_W_TKW=6P1>4JZNE+?#VNG62_@0IS<+[WZ-8LSP MYW6Z8\ZO6KRC>3(A)/L/O577_O!>8/+B2N.T/?,R[UMICI7\@JJ1N7_(*/"*O$]J5`'!9X`G5J)EFA(=`L"\D M@0CA;$7GR^9&:K@PT-T6U,`Y@NF%4'A#`E>/MPQU8SU#W_H6\T<(>?4NA)L4 M`"?Y(`26@BP2YSA7L<:#2Z+L&DA@I<'HM#<$$F@=%I!`3>XVR=5W3FX12@KE M"P_SIG^(L]#9+\["/79:B7@1O66CGXD%ZC1+C`U"%N/\#ASE?3G49'N8)4-7 M93]_?(J!K89KO2CQ7./`U7'/>#`89(:;WE_.%NQ?^%HM^%KK?SGA[T_K?T47 MH[6V@TGU5F!K2O!VVW>9-7+WMZ9RGL[\"N!6WV4'Q7E1'<6I[.M"ZZ&\P]BV MVM;V?\&WDE;GH.=5:ZNZKM<3>WP3VU%;_7X]L4N-O7N`6AS/<$%">FHO5X=8!SU!/?[]00?\01K?;7? MZQS`#"^+.`XGDW&)?3T0LRSHH\*FV&_Y;_I%'8YL6=?51J8$W?/ZAH/<';,]$-M=$XA,S6(29`KL)6SA;WZF!CV\%&N[7_2VZUJ=I> MKE9MUSGXXY[@KG8(.^-Z@HN:Z*;:T0YA"2_-?KU?-ZA/.J]>K=W9ZCP":$8R/;QUL(.PT#2QJWEF0M MR5J2OYPD#_%T[\8';S%!D!][C`=\(:#/\78ZW7>$T:E/^(YP5GL5Z+%5SVKY MNX'#N%E3S^O:=TRZAY"5J7=Y!Q@'UI*L)5E+\E@EF3;)X<^;X9_'K'B98*4% M4$:/174FVX$O>YJ;?HA0-_U$'M1F=H( MK:=P!-,C"2R!V0TA=E4%J)SQH6<\P3BJ^+YVVE1`!F9P!>FU?MH(?Q$,:AE6 MN,G/X$VHP*.?(<(>F[?*1FD#%MGUL%Y.$Q8;YYR9B M]>#/\$#\,[Z%D-U8F,$\0O?&#@`"?-JP),(T+#@(SA'0&Y[`N9`KBB[*"?1J MAX.&"K1NN1KQ6S38V+!@L1G,1"7T38]6(E,2PPZ8:[BGRAEH@D=MG7%5K&2+ M"%B$!:ZK8K$@"RK2(B#&GWF<>\%28!8L&X7A.:"[,+`*UN$_MH,@VOB8XTZ, M66AA7#5")2>N1>L$P_,=@8F_`%-?",WA)K'M<'AB)AI4P;),V#?!UYSHQ!_" M1@W8HP%[6P%?3H*S)"PXF93T7)/0%R&&;P])?8FW+;HR%@"I#YB)9AYDRCG( M;C,(=>+IK5#N0"T3`X3?Q*Y%WH1YRC-SHYER\_?CH-?_"ZE;8P'[B[PX& ME+W;J2XH>S(W$(G-[M,KQT?`.;:J,OE`3ZC&5LR4%52 MJLWJV+# MJAC<`SO#TF#GK#?JNX9'.+-Z5^VV#Z&>X"!+GC`A!+M8%W;=1VJ:-O3B)6IR M0VUVZDLMQSS#NMJMKT/O^[#U.*]-UG*LKY]&2_S>]IAYW'Y[_X&GIK8[]9;B M"&>VU5!;W4.`.3QJ/WVL15&U)'_E2T37!AL8)IWTUXYY.W>&5*UU")NL>E[7 M18OK'\2\'L<.XJOM>(_L$>O%/'AJQE[PZ$7%RJH3AP]MWW&IWM(_5C-6F:Q1 MMZ,V]$-(<-=T:P/H(]VIFMCV"KX%V.]>"PEF1=+K40CD+>%:8K\4'J M4`)+U'Y\*]:^V5-[_7K3?803VU0;!X'H7WOQ`_0]M20KA=.E+'3>E#'0RP<+ M.2,4E>4`'(^/#G]D'B*J&-;0F&%9M+P7._(YPJE,@TH']/@(J^(Y_I#:QR=* M'P@I)PF[(@!I"(V&>,<`(A<"28BW,U]-H8JON/"Z:=K/KI)]C?=@4$0ZO>JB MB/1Z&Z*(=*H+R[%@"?\*UZM#S(HZ4B\[H%-:JJX=PAW%0\P@@]YFX&K-0V@/ M>#0V.<,!UBI=JDIGB?B@]+FJVGO-/.[4ZKOED**M=EJ]`]?@@T_;_WJE78?C M1*G8ZTC-T+YS3`=SW^VHK4]]U%6%EC1'`-7>V?20)>_[.W[H`,@M%.`'[*1L MZ]*%*Q5[+G3X2#+YT.K."ON$%*CQ-S:E(JWKZPMB;!#:Y$HZXLK`B0?7^=_3 M;R16^$7LL#OBD]BYMIFU1,#EH8V?B\8;.QGK[6!_\->_M/(QS\?N.Q$[E["- MW]M4U$?E89![9W#'8+H5H"2&]RM>YIO+SFH]AJ'D%PYM'FM3OI,?]_4 MWF=7H51NE@\Q"7PW8\X/]]>R6I71[K:JMPXA.U-/<$%"&OI[L Q4B5F^7C M2"?_[K`7U[9BEJRV8MOVT6H_JS:I<@I>SW!1,]9]WZ`H[!!F^1"CL'/'M]QG M8_A#.7-=>VC`EKXV6UM6ZIZJZ8>@S_4$%[5:FK1:AQ!B'T?P=>9@CW`/PJ_Y M#65MS[:K[GI+[1]$\7(]PX6Q;=_#_S\"@U95\W7YY]>+VF+M3)];:J-?9^^/ M>(*U.@+;M0G[?/^_RM>;<^5VPERN7%V]'=9I_*VKN:KW#P%QOI[@HJD":<8. M'7ZGJD;K]N*+.PW`=3OR%IJS.?>T^E]\[ M"!VO)[AH+K\M+=DAY`N66K)#O\QTG%9&VP(W8V'W:]+7;]+5<>?53:S3>I)?; MPGNQK3>O$@XL,.$T^$:F,[L*/F.JXR/..].BP__%E0$W#?[$"?C6X\Z4<'KA M!Y?"^ MX2HXLJH\6CR$)Q/2S89K(N8E,V9AZ5,3K*"QF MPH,6\XPG#D\;UM#T46%5Q#N&/]/CQ#>*_1$>F=G`I6,8<68\-U3)>\N),-D*+_RRA[L=66?@?:%:-FDJ:K40E!N*XF=+?_LH":! MLH(*>A/0LPB%>\9>4+%<7'.V_SB)EB,N4J&^L%J4`>BG#1^<>U/Q9XC>+=\Z MC52EF%[]RFJ5>=ZZ,[6Z2.O-1O9A80YU6RCTM[[C^LPB7X0F$@TD0_=%E+!' M\"A"T84/E*CQPIT8SNADQAP"AD<(>])]_-.]X[N>BGZ'62_2ZTV8=*FTR\/A MINP'PM;#E\?P[EL1!_5TO?'Q!G^#IO=K#!H?_J)]?!?222M7C/O6?9=X_9MM MG2S[!'@#@KU7P*IS@SY$C&*GG`_*6^-=%)*YH/H"`1]\C<-)*/:SQ1UW8LPB M[RF%DQHTH#6#GGEV\>$[&"U!*4H0;<>00/5'')VI88&?&KQD#AC_ZKT#-@P_ M?(OOQS\+=L_Y"'S&&9WYSI`*&")FES`:YXADLHRK6_GI-&=!8P%8BF@0T3F# M>89EA`T/DM2?*O<+Y`@?5CH-"()>J,^1F,[4)*['6WH$26F2H"P1HJZ0,`Q8 M+HN'D4JQ8)BU!#(T;1'T",J]X)&IC^P,(=8+XM1`1/))-ASRF4>1F]2D#-EF M&;(%71KR;72*VJA[:7>BA0O1)-D3$>+!>I@RD"_\+PKQ#,OU'>(0[#)XX>`O M!H:Y9R8VHWBD#T7A/O.(LT<.\&<(\[T)D`2V]&_;0N;N*19/T6W9'H0X3S`,&8_86Z&@B'G0)Q!9UI\5 M`^F'H:U'5-9`+2G=")GX&;`9.0=I>8[AOO##8A9HF3_ M>.^[)X^,S3Z([N%?J?O(51C5NY>&BRL`)N$>PIES$,J/WY")?P2;>/H5;.4? M'X'K;[!A@+U\](2`PEC\3##Z-_Y\)OJBP)3=.L":#^(@"LZLT04$CX_[O@L^/>KWV0"XO+FXO[?MY^4 MB3/_^\OY2^=\O]U^O%>VT(:R"03;"?/_^T[=7 MRJN)Y\T^O'___/Q\^MP\M9W']_??W__$;VGXLOSGB1=[\W3DC5XM1@N9%U%' M.5'*%$]JZ,S@IU>^8<$7!Q1#=MXIWSG"RR@1G4J2&:&H@U!+U[2+G:W81]!"+B)\EB1_Y9-EQ_8T-!]R#!7&$V-B05Z`$0V@"C2F$^Q[:-ML1*SI( M!\`:%G]400&*>8AMA+%7EO*5O2`7FHA./Y_=G8/%'!W]?G[73R>0Y&`?Y`R@7]QB"6&F,V1F2F,]"T?^U?1_A@38U,% M')1A8_H%S8Q%W(_A+\HE+,5D3RRM33VQ-"%Z-K)G)`WRN3#:HV^,A(^RA":/ MC!&Y/(H2&.ZS,1-G2MVE_!KX]D0_K'$H@)DM#",J/[AEWZ3MCXC]Q?;(QBR@ M2X&>_.(S_&@:4T.ND5'HFA+3GLO;E6%0M^$'K\'SW\,&Y)(/O&-U;-V88\OD M=^^>JOM.0<).<"L(]F7@5<\OW5#8S)\HY/4MEP\Q3E9>:XV&`F^;!F6(4^G5 M,-6@O$5K$;,U9\%?$AM(7'!B.TRK%_O;4>KY7[X9@VK3I=T0V0Q8"@Z?F6S( M1[0Q`LM`+"Q.]:*U"<='G_IDC&1WO'!#!P$P&A-ADM1@(_?)=^P1YML<"H^5 MF0GT-4Z[[3=H'[1336^_(?T@M2?9YB^B68V3%*1UHO>) M'`H\!@P'HV0F"H$4$KTL0DPK0S8S\+]D,D4&8QQ/7X22K4X@00/>+%(C<7A# M$T]>S)8:]%IKYU/MF%I?B#]F:K>8G_03:I"V1V3M.L/A-.E!6ER#R:&HME`\-BH4GFMAV^( M+6[B+1A:PC<"\01#MT+@GRCRU3K?O1C1E)54%\UL3;8S[" M/)(\8HP"XLC,:^]UU%8-'`&HZD?E[3#V"3O8G\5EKB6=0;,AG0&*E\Y78:\Q MG(``<0TN\`?X6Y+!4G]`@ZJQF5K@!=B\$Q#F'@;*]`9T'+ZT[2V)?DX?0B\E MQ$%21.M$2B9>2C\9$8\/-L2#DH^4!(1'HZ>:J&!5\4>K9$694(BM>LW3R"Z" MZ&&72%M;7$&#R%@@\Z^UYFDG_NR=J* MCQ!E"^?-H`JLA\GW)63/F_<$A:NZ*9.*.UPF0W'F9]QRZ:@+3VG#!&C.[=J. MU>`"=!JVIYXKLZF8RK&3,51X6BU6`IIX49N!\E?0D$W]J>*A5<6)0*$_@TV8 MD'#=&1]B&B.^#:9E[*K$J_"7./UL(/R9<'?XB\A_X7I7Y;.TB,/^U:(--)(2 M'L$[L,DWGE`IY/PN&$)XU)&!_A8-*>:\?PZY2Q/>!Z^`"L'<24S)9/[$(SJTJIB(N0BL@R: M5;%_`8LO:1B&&L*6F@SQ.8QAX@%0U,8"RE=?PH#O@22#/4@QGQ\+3P:9/V$0P^6 M(8X<30$F11CM=&3ET5RL\E;N#0^[/WJ56W=T6W7KCCV16^@>1-VE8"W+ENI2 M$`0(RY*!%;E2FMU58N;FH^#6O>!WLS+;;:K-WZ+VTJVJ@+K-R<4=JHRISB9X(@9>5]O[O MI+XY/HM5F7EN:J?[QX'-,<'+#-?AQ%IDRESN/&%=/-614CX14S2U0=N!04L0 MU#ZM0##VL[9M6YMRO7]:`=3^'#-\R%$9'6",3?NY-F.[C,MB^9K3=FW&CGG* MM=/F04QPSIS:]L%KA+?\IL0^C[!RX&C^0MCP75%46XS-2QZ.N,J(8K6A3?P0%:4,X4W'>51YBUG M0_Z%,Q,D$6`D7IB&90SG"OA4(8NH;D.422T]2Y9UBNFC57&>"LKABMJRF-Q# MK5CQ9>7M81^,]EH5/ACM;W@PJE?GI+$FMZKGN&D_FKU*5YS/?229?&AU9X6] M?^J\['-0C_N-39SO/M9_BKACW8RRY?[G.6Z4B+<*9Y_/P_W M(C?C,>;PSWW#3&P/Z`(.7JBHK%O>2`3[/FGOJ%IO_\F02MK&/7)4Y@2?5@`$ MN3YPWN*A3%#V5^T%?(A',A<8"5D6WH#Y8IBFN]!97:7<%7OWEA^KQZJ,XFN: MVND?0HU8/<.%?5<%"@IJW[55W]7<^P3_*K52M\R M1A0`5BDG-JZ=V-;W7TV];IYUQ!/>I5.[&M1^=JL[/_\+RV<5OO5CNR(9[A]VME_QJG>C6W5BQW":?9A[\96'X;5IV$[ MWX3I:K-S"`%X"/U78>S`SOS![YCA1XL[;&P`<_;4>VUMJSR7;73 MW7]`7MNT.G-8S_&O[+>JZJ7"W"!=B4=8I+^XBPU^E`O;LK#SSQ!;,-3E][LF.>8/!D_;U/\''NP[J-AG(W82/[6;EFEFA`_;MM MCJBD_NO-^7SRL'97V[ZWW._4M[^.>();I^W]9X9K=[5-=Z4?P@(^CHW7O>\. MP3'=.O:8NZYH.QZ6:]2[KCVZL6[S$%9!/<'%JS;V7Y53N[&MNK%#O_^5&`X_ MBRC+BUU9G.!5>/ZEO33O-R4N-'61R0:%3HY3R''M8-C=RK%^J?27#C&A<6\? M;\O=?4-::UI+[=:W^BN[7G]-KH\Z`&B")Q[9/O8DV&D$4-*X%5"/^J4R%U?X M\SJ=$N*8W3]LS+[&*E-3([>V5UF4LJ?:YV M<;%F<^F>=.F>=;+1F-:0!"V-G>3#V,\N'D8%KIL&W\AC9B:\,M0B/N!<1%=X M]#-,OL'/(P6AFH;&C)G*C+U,.?8>G+(1QWZ43)G"]R;FBS)@KN&>*GDW?!D* MI_S*4YW5T65G4WWG#US^7Q]F%KMP+FD^J6+[3E><*CXS5W'XV+"P%]DHZ"F* M(Y@:JWWV`W5>SW"K]U[.=`CWJZUOWH*O8, MN]+66E14B[)N)!V;%NFGW5J+MJI%6:UA=J9%?\&D=J2O;5$OM MPK;'L?<\P MC;_IV#A>>2]#!E[ZX;WWQZ"*J/G%)_BZ'2016!R\T M5R!MV`\[]HP[H!&DF*"QLH8%WG!!^B!Z)@05/FC").$'(4Q!A8"Y3XXT8:#P M3!G:TX%AP6AC9CBXJ'P*5-@,/O33`$7DH)BO-:U[VE&`&=/`O3BMCR6[MU/E M8L(L'`66C-1$4D!2?-^)5]Z,^`#4=`K&"7;[R%J2$/RS"NS",Q[0#&*TY=/X MK4"]B750*U3^$2ZM(7,G&'X]9RF#3/?\X[WOGCPR-OMP#4IX#YI\"8/=@UT] M-^WAC]_PH_\($EGT*^6>/3["`-]L(/SD)'I"-(==_$PPT!U_Q+3&=S[#E(?U M>&FX0]-V8;K#86%&++3MW_GXGZ_`0Y\T&R0=_#O5[_)'-OES<7]OV\_ M*1-O:BJW?YQ?7UTHKT[>O_^K>?'^_>7]I?*_7^Z_7BO::4.Y=YCE&AZ50+U_ M_^G;*^75Q/-F']Z_?WY^/GUNGMK.X_O[[^]_XK7,1=@K?Q'BBP-R1;UWBB13">D4*C0(]6?)T6$6P9WRZ;V! M-03[C2E&;P/?A07LPEK#Y08&EDB&R<"ECU8`?YP0YMX0S0O^>N+#)\'0.$^( M7R0-I\%Q`3JV_SA11H:#[LM^MKCC3HP9KJG@;_^Q8=D1Q^@Z8/;0`4R,(>QX M'A\=_HBK&IZPP;K@V"::,)2DB&N$<,E'PB(&AP#V!8C!VCNT#/C@V`8S@XL_ M+]7XQRE[4<8@*HJ&R4?B?Z?L!YJ8H8&U?R[^VD5C:>+>2@%#";YUBO*19A,_ M9MG@/3DG*2)%)AB'$_*S0KI(/G%O#_[#B0-I6^$;0\Y'9!Q=9DIK[KW,\"HS M<.EP\0&Q7\29'8'S->V9R'2BEQ_^US?$4@ME^AR%)^1BD30A*9-95F!%84B' MPUS`[O#*0TW`)]`Z!KX=*,@M3AIGP&GVR9I*.M%+V(ZTM8$HE)GOS&P7A7`C MO#*W?#&`10$(>!@15SQR4":&[(MY`I&AT!FRBPP(DJ/O!IJPQ(3OV%??)!24 M(J(A,A0$9[@\;%]$8W]8!K)ZYZ'?4Y4):-P3=RA4&MFD9".#EBK,^`2%_`BO MST@(H51$5@$T9$+39F'H+=27@R>VI\;0#8*N M:(F(S2*L+H8K%Q\.YTQ0#>)W<=JCZ"QF1X`3!^U=).W$Y.0(6')XT@W#E[/A MT/8MFK5;T/;ARP?%GW@4?33ZS<8#*#!O/[#PJ8<9/?5`PFQE+14&B5TW*A32(G@<>C,AZ\1R^AS?6MA/CCWP$-OKZ^<*.X0_HI.1V* M3Y$D2H!#F`)2G'*8CA&).J1.A$*PE7=&)S/FT%.X2:3/P[NIV2.K#I\#ZI]L M?%\PCB?_"1M-H9OANCXHHNMCJ.F*72$2:()A1V8\^X/RUH@U01@9%`Z310/H$:T]87]IXJ"I4?CST8Y#8AK8-AIN+=.**CT,JB<$XIC8P[D",T21)!,1X-`& MC<;9=\-C5?SCZ#\^!9G!E&,8)F=,S$$L,%/%3IF(,4">,DHFWBE`B7Z+09M* MK\?8/%5N?X\P$%S*88@,J%H)@B,PU`9AX$?QH;48W!BX#=% M>`T/8^@HG2^H9D)S,-Z'&%5^GA.U.,'H$,%64]X"O"XP"6I(RI$E9H6-$6#( MG<$686Q0"0(?<\HBB'A:A->8>',GMCF*QR$N<.7B2[E<=FXSOL1QE^.4-W!8 MG=P>_QM_CCYXZT`D!99'Z(3XNOB_1YCVV$R.,<>_K@CWX__OI2N%_V/9]%#, M5"\^+82]"^7S,34QX7$Q!#$`F.]JR21N,D3WY M?6:(^(B2H\+1RD].[1&:+Y%`?09W@<_[KA#5B+L0%@VXS":#)W#D?.!PL71K MG>J_'YV M=DNC7%GR9(!V3E%H%27?PLB*>(_'4E>?O]_%8RD4">R-I4S@7WP\%AD:8H:$ M+EP]CDP^P)CBWLNP\:@/E[)%W)-/R"@(:E-Z6Q.B9R-Q'A^>%06Q&WI9TN21 M,:+X1*;:,9GN(&]1_MI>'#S#UMX0G\>DBNN;%",+SQCE!\##H>N47\3ZA"@8 M"F;/=Y+3GLM=K6M\-O1:JQW+LB0S59EF?%5?X)SNAA,^\DU^,[Z5(>&=3\F\ M>_O&.7MBAHFO@8^^"5(7UWB:YF%Q3GNWT2GZ[G>K\X@!T;N MHD'TG%B#RUYU!9VT_C&ICS_ M"=O^+C.EK$=.P94DK?N7&8_(M\?1OS_+LH=E(MR?S,`:@VFW,$3>J_S.*/!; M(J.!H[PO9ZBOAF5,_>DVQPHE3M__#@*MY.P?XT*$\#9['5*@$_V(]225G)3* M+$E06_Z\HS6Y8C9*7I!OL3;/?;>WZ<]Y+2\KQ$V'P5E7]PX)`.KK\,PT>=3P M1"#*5S?(V(C9LZ$/V[D+YO`*V9N-.-HWID%;;?7:>*LL%QV_'*I!QH:Z,(-! MODV-2,K=F_<`-+DRP$W:_F&;$IWJ\SJQ0X"7^8O3@:YG6\IW<**4TZX]ST%R MM&_/TU0;S4;M>6K/4WN>,CW/8$//Z:#V0E@C<^X8 MHT?^S%Z.U+><\PE[,FR'F1$1PML>RU+=MZ_IUYN@?6Z"\K4B.0`]KH[+V;\N M(RA766=(-;1CQ;%5]@KM^,>7.P)M$,`E[1/"+''$N:^$LW+Q-@O_*>[""M0* MB17Q-KAPKC>:VKL:7><@$1\##V=N/WW;"]1(JI'EV@CHBP] M\3G$<522*A5I2JU6AX7L&!J6S31":\=7L[;\5[D;+O MULJJ^7,).7(6PZLX?XG]]*M5RK>65&M*G'SBRX*'6G29]\I$47OJ+T*;"./,VUY0UB$S'7YT2IP M97(A+;79/_36W8=CKA'=L-;H[6KT6[UYJK?V;YN/]$Q)&&?38(,`B`NQ3&JE MWK)2:YIVZ!I]2&::KOZ[A'XLL"(1=*!6\BTK>;N9[["KRDI^Z/WLCK.A[2%Z MVF_<$]!@,V8$-BBC8?M1V*!];^B[:E/?O^WYQ4W/L;;2+.4<7\D^V\B?V2YZ MGI$^BRB2G&\O.,_X1)B(7PG$\BI"%OS5SB[:\V<7JR1SK"@^S4W/*9K5.:J'JJR&H]'&=[QRR/*9^YX6K_;+K<& MW`$W.P%_ZW#K_\J.0-1Z,;$#/FX/?.8$T)/UVMZY)Z[7]E;VP0:\]94Y+XDU MG=@5WXS'V+T\"+:/R4W?&=QQ6+V:=[]#KE?S-E:S4.<[9BEG%K@IP_Z5O#/& MW(3(R9WZ@*E>RH>]E&\G-K>,G]DA]R?<.O\9`,LZ_!A/BF?,^>%F>.:W@SI_ M72_I0YS>/PW7BV+->W35$%8+@AK-WD=J>9O2^TV"[L/QW+\[[,6UK7J5UZO\ MX%?Y/?\)O]P\[J[J6FWV-$TYYZ99[YKK%7L4*_:;[7B3=.WE+[!?_GS_OWCL MIMQ.$+#OZDIY.ZR=;KV$#W%Z/]N.E5Z\:Q1CAC_7P,L'A8^:6>L M;^'A[_R!R__K@SU6/%NYXS./T-VC26HVJ*>(KBK>Q'#QHH\R,K`,CX_@-R)K ML[R@J49D+JH:F?O'G:G&/;>8Y;EXL9&F?BKGUQ9':0&>HV)80],?<<5V0"00 M4@<_NZ!:QLA@#@35^)$_OMS5JE!4%3*CFIVIPJ7OX$SC>@=5<$;*?WWF>-S! M:8T;AUN%W0XH7RB>1GQ)V[:,Q5OS+N>XP\]5;&?+0($M0G@ MF-,8"SRAJCQ/C.%$@9%$,TE`$&]S7UT,X`W#H"^B]\Z?@UV&^X9<@17[GP4S@7ZZLL>U,&4$TX,=^ M4W""6%\I^'B5P0XD9T]HL; M<8]M8B)>OL(')F[T,['P"4$1B;%!R&*^5@N^UOI?3OC[T_I?T<5HK>U@;+UE M4]O']"MLQ;V)[;O,&KG[6U,Y3YM^!;"N[_R)6_[1%HKL&^6XK;9SMA/^Y?HX M'_2\:FU5US.@P>N)/?2)[:BM@VC/5$_L>N.W6FJOL7_DM2W%G?MN410T=%7X MSQFWW*.-)RI3M::K3;U[`-I<3W!!0CIJKU<'&$<]P?U^/<%'/,%:7^WW.@

XJ>J].I%U MU!.LZ?L'2:TG>'LFNJ$V&H>0V3K$!,@558J[7MV:>2?!1KNU_TM[M:G:7JY6 M;=X*YV"#OC>H*+FNBFVM$.80DOS7W$A\//'EI[W^/L+%[+L99C+]"CG:O3E,=WZRVVG4UP_'-JJ9VNEH]KT,H1=V[==X31J4_XCG!6>Q7H&5;/:OF[@<.X65//Z]IW3+J'D)6I=WD'&`?6 MDJPE64OR6"69-LGASYOAN<>LN+X*SKTA[?Q2GGY!\.7]0K0OVDI+G&U$B!&5 MM,$?.',L/E(&+XKO*K8%E#B&#?]DHR=F#>&%*1MQ!$Z^OKX@9&XVFSGV3V/* M/&Z^**];S9X*ZDTW@EYWM3;],+8=B?_L<*Y,;8364SB"Z9$$EB#'TW<0ETA5 M@,H9'WK&$XRCBN]KITT%9&`&5Y!>ZZ>-\!?!H)9A)<""@^`<`*W:+"Q8<%B M,YB)2NB;'JU$IB2&'3#7<$^5,]`$`5R-JV(E6T3`(FQS716+!5E0D18!F?[, MX]P+E@*S8-DH#,\!W86!5;`._[$=PQ./.>[$F(46QE4CE'7B6K2",#S?$1C_ M"WH$"*$YW"2V'0Y/S$3#+5B6"?LF^)H3G?A#V'@">TY@KR[@RTEPQH9#1,V" M1]!TD$E)SS4)'7X)BY$^R@G4&RA'5._-D>'+A`G?$#Y>+P$^OKD6?/R%/1V` M]HW.F8F>YF[">8TA+P69%T-^+1EN`B3?[5072+Z;%_M[+I<3?."PH,XK1&ZA MTZ9=I@2/#[1S;:3H\D"JT50M&:@J:>#CF_-+/DQ/N;:S*:\A8G>I:7.@^.7, M8XT0NY";"A2T!_L;5>X,J2'>U>V\].K:AS+.4V&WKS?J^Y%'.+-Z5^VV#Z$& MXB#+M#")I3#7Y5Z-/[EM36ZHS4Y]$>>89UA7N_45[GT?$!_G5<]:CO65V6B) MW]L>,X_;;^\_\-34=J?>4ASAS+8::JM["-",1^VGC[60JY;DKWSQZ=I@`\.D MZH3:,6_GGI.JM0YADU7/Z[H(=_V#F-?CV$%\M1WOD3UBC9L'3\W8"QZ]J%@- M=N+PH>T[+M6(^L=JQBJ3->IVU(9^"`GN>H8+9WXUM=<\=-M654MV%I2U2QM6 M6ZU=Z+3>4#O-0[CJ6,]P\=.,SD&T6SJ.@$P4!M=F:\M*W3N0:H)ZAHL[IGZ_ M3N[6AX='D=H]3CD>XC9#'+F:47J7[K3Q8_;:^\X(UD>P1SNS]1%L%;S+L1X< MUI*LRZ460FC("]]TC3]('4HPC-J/;\7:-WMJKU]ONH]P8IMJXR"Z$-1>_`!] M3RW)2F&+*;GQ3=:"L-@0Y*19`LA)*P0Y<4\>&9M]N`!3X+"AYS/S9@!3261_ M-MPA,__-F?.5>3XBY-P-)WSD`R^_,*Y)"W%-RA#;)E`FG5YUH4QZO0VA3#K5 MQ0998$=^A3O>(7!&O5TH.ZI46JJN'<)%R4-,8X/>9@"/'X7>5N8(LJ-V#R)K M?1S)'=#HC$1RK=$E-Z?NM0\]75]A!]W?\T`&06RC`#]A)V=:E"UTV\D8/F%;;F> MXP_Q+#CBD]BYMIFU1,#E09[+0H2=C/5VL#\,[E]:^61U0<3.)6SC]S85]5%Y M&.3>&=QQF/)5]H:Z%U]]E5*)6; MY4-,`M_-F//#_;6L5F6TNZWJK4/(SM037)"0AOX>+%AV,5+E9ODXTLF_.^S% MM:V8):NMV+9]M-K/JDVJG(+7,US4C'7?-R@*.X19/L0H[-SQ+??9&/Y0SES7 M'AJPI:_-UI:5NJ=J^B'H6VNC7V?LCGF"MCL!V M;<(^W_^O\O7F7+F=,)X:*I`FK%#QP"JJM&Z MO?BBW-D^=FFN$_>[4^M#NTV?2U77OW4&HTWZ>6V\%YLZ\VK MA`,+3#@-OI'IS*Z"SYCJ^(CSSK3H\']Q94JB/?_;'@3PU*&ON/`3E:!J?W!/<6'?:WS[!@>R%89PG^Y8[!3Y,#SWL#N#PL6'A'<+$"+:EV+`%YV/;$73@?0SJ+("5S22%J;R6 MIHRP=$V!)^%!AU.74H];R@MGCB2?>8*7"9\CV,`+==SU%`>_(@8SS1=\'$?$[]B^$S1B M,$((:?@GL343Z8$7Q?<,T_@;GQ_#E+FX6AS[&;BE":2/./S)-I_$//*1X2EC M6#$F?/=4R;L+R3`9RJ^\L@=[7=EGH'W3H#DY::HJM1"4VT)P[?`ZFXL_@ MU\%;IY&J%-,K@E`O`RU[0]3TUB:HZ5WQ#2U$39]X'P(J;\:?A:U@YH4-)HF! M\'])>/1`2`B/OI9\-L%!KS)$1[=50W3LB=Q"^8X:C6`3-()@<1/=@Y"#:DCI MV(4/GL3CTP%W(GZ:#77)5)2'_A%>R-['G.?<+?\*F!/WS'HTD!$+=D_/$$Y. MYH5V%">-^\[D:GI;A96;BXI?,Y5[L#/;;JO-WJ%C9E?50%WR`266/&HK/60S MXWC!/BMS6$Z$P,M*>_]G3V^.SV)59IZ;VNG^[WOEF.#CJ.PB4^9RY\D8O^T`K?S<\SP(4=E0^9.E+%I M/]=F;)=Q62Q?<]JNS=@Q3[EVVCR("2ZE`D4)6B?G/P8J>L"7/IS;X.Q*3[=% MCJA'.WE%![%TO/J+'N[IL=['JV6SR<%>KU7A@[W^A@=[>G5.RFIRJWH.6=%6 M`9]EM9&"/0.(M04'/U4)&"MS2'?C>Z['++1T2^1V4#T`0K'3]]\:L7X'WL3V M7>#6K9L#[$/9KF3]Y$XT[?L^^P[\RK,WBN^&8\Q M!WWN&R;ZE60=:="8I9)N>2,1[/NDN*-JO?UOYBMI&_?(49D3?%J!RWKU@>D6 M#Q7J/B+;\D\7&`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`H5.CE/(<>U@V-W*L7ZI])<.,:%Q;Q]O MR]A]0UIK6DOMUK?Z*[M>?TVNCSH`:((G'MD^]B38:010TK@54(_ZI3(75_CS M.IW^YC7--"Q^,N'HDC[T9C\_RM``-:\1_2B(^Z##;Y*]4AJG[9F7V<5*:V1V M]DHJJN@REU3Z7.WB8LWFTCWITCWK9*,QK2$)6AH[R8>QGUT\C`I<-PV^DZ%.@,J4C;AB6PI3IO"]B?FB M#)AKN*=*W@U?AL(IO_)49W5TV=E4W_D#E__7AYG%CL%W?.;QZ8`[T7)L-E0% M&RNHBC%C:O[)443>!-0!1S`Y;`T<96P[RNNN"LL<_RX;.L,$;9)]CY21_.,E'Z9HT502".;K:W4KJFY9,#0[4[?[ MA`ZQ*:K+B!0`)"Q^,"SE#,R.&:B=U*ZQK-\/=4=3E8X">J;IPA`IUP9,BC(S M?5=IGNIMT"O0Z0G'J7+LYT"/>KK6_>@J]@R[J=9:5%2+LFXD'9L6Z:?=6HNV MJD59K6%VID5_P:1RT^!/G"887-/4196(_!QS."D.*-/0=QQTDA#I_N">XJ.; M>P9WA;HTA/]RQV"GRIDGWL9Q0>D8T;4R>-CA'#\+ZJZ\<.80^8&NPO_F*$[X7HC6KBQZU+<$ MB;!D0!`8!4S@(T`Y\NY;I)*+J7'XV3!,9-Y$K&P:!>$#T"0=9 M,1,OC<`:?.+P-`27IH_*JL(JMN'/XG&4^*,KG+WO&:;Q-QT.@]#=8!V.Q!0H MMN\`%4^V^21F@H\,3QG+?K;UPBRZ,+/:71SRPOQK_:7HF]$ZS%J#)(=?8AVF MUR!QOK-UN/!<@@Z^]+GL0T,F##>(+J+J$Y?D[W*81&!U\$)S!=*&_;!CS[@# M&D&*"1HK:UC@#1>D#Z)G0E#A@R9,$GX0PA14")C[Y$@3!@K/E*$]'1@6C#9F MAH.+RJ=`A/K"4)P3^KP"X\XP'-($9;/HW?"M2;6`>U0N4? MX=(:,G>"X==SEC+(=,\_WOONR2-CLP]WPPD?^2:_&5_"<%>6ZSD^I1_NP MF_;PQV\XPC^"K!;]2KEGCX\PVC<;N*`\UP?%GW@G*(!&O]EXL.`/W0?2+/WD M1'QAQ(T/9QA!XN<_FPR4%RB#4;[S\3]??8.9^(IQH?L)P\J'9@.$C-][]=N8 MF2[_Q_NY]Z//7HB5_]EPA\S\-Q@'^`8VW,T[PLF)II\T-3'&HH]%PUW:0Y*1 M>.06#)\]^@R_<_..]_^:8JB%'UHT%I*SUDCX?[/&"C\T/Y(@8TT)XO\]:?1/ MFHWD:(F/S8]U_S++/836./E_R8_CV]$W/UD>6$"\-NLP\PK>_OD__"7OQS%1 MVNWWNCTY,YD?FQO+GH(-O_-@1=Q-P'RYL2;UB8%E,_DS]V;\T-1NAAX-"@;= M$'\7;[^"%3\$NV.Z_WQU]>TS<*QW>NU.JY,@:^&)ZN._\T0#SP2SO&^P4\X[WQ[>K/S]]OSN[5KY\.KN^ M_Z)\Q__\6[GZ=G'S]9-R__V/N_LX"SZX1``;7CT\^9 M`6R`U9#P*J\>&..T_&D+L/,'67W&3/(/.'*VOX\)4<0,QV MY"`B1JT%^P\S>/PSY^Z9"VL%^Z"#B[H9GP$5\(\KZPDO?X^^`S&?8)H]T"&7 M>^YB[2K.2:2.M^"#X\K8@O5QVFATVI+)S6B/"6$-)A=-F;8)HW_<7<;Y/.F\ M^JW9:(IC$\GK-GBYQUAV)\SHVV>FQ+6T@I?N_B:F=&::>B%FSB&P_8[KS/QF M6]]A5'CZECF>P7.NEB5D-5_]UNF2D`512\9:GZ#%*K^<(KW3[6R'HL4N:3E! M#;W3WK&,5I#4Z=`R7X:UK M@PUP9VF@D7L5"`.UJ<]Y9]A+WIM3`T03?`]C*MFS"II';4:G4AK-R-GIVRMTOV.KF^? MK9OQ=QZF3VX=>\CYR-WZE.F:IBWF;7V:=L_@BLG;"FNP&3$\VE5R'H6`:YF& M!<%F,Z`W>X@L&N[M;_S9?/EL.U,D>UNR;(.RM&/.>UT"$J3/N.72.9D4TW<. M%M"AK<,F!K81S??2,2):DMF?"_N)@TIX^-L@T,'?893R'0UQC@W(5\,RIOYT M]?:"]KKMTT">:U*2AX5[&]7^LVD_YR:>_5R#^.9I>R7Q*1KRD4TUVQ>,@%/6 M65]KTM\X;;=7TY]-S"I&[IGU:`Q,_HU[?]F.-]DT;M#DXELJ\/2@BXC\*D\; M,!V60ZH"0?1!0K0]W#_;#U]E5OGAVF96F!1`A*$L^N+CE433N3,("1*@W`_! M+<_%Q.D[(HY`["S+P&V389KN0DIO++Z8VN:.J)5010\!5-&#@"IZD%!%#Y\Q M=?\`RW<)K?T=T1H(4L`$XB94P@0^Q&`"9TQ$P>DGYKLK]9+A)W MI0#4HR78X(<2IB8ME1+E'9Y112ADOUK5H[<2KBNBEU(?BXD5?UU$;F='Y`I` MA9>'.*)"1&0.^Z"OJ;@%(^]5T9[>/]5C*IDCJEX[?EY%@G;:C,5O2T/CXD'P M$B)P/WS:C"_,'.&M\62,N#6*3L;S'G&%;\KAYCX4#?()MF;>RU?N3>R12`?3 M83RN%.;@18$+6;0@.;Z;<`ZZ-(8M)^7'Z#!^;0*#CRH#\57%Q<^ZREO?8OX( MM['OJ!3G^OI"\E`NG6OP+W)+=Y@]74-SM:?R.F4T1MC\.B M!TNM=O]`."R8[VUUMF&]C1&S`ZXRKG^&LU.HT)< MQE\K0@;-Y(+R83V+V:MS)6&?&B-?Y?#!MY]B.EF=.::IQ1R/O,L M@G%0V]756NU7OR4.G):04A:]=S/F_'`+4]O=+;6PH;6GK"BUVMK4POX:;^%P M,.3TWRL+ZYV^\R$WGN9BD8(;H&8W*@99-5[)E*UTNEJW%-+NZ:#T.W>Y`^+^ MY`X=^]D-BJE@@WKK\!DS1M_GM*"@2$^6270=8G;*U*HBME9S"UR!0V7F-7XC M*A]?P\$L*U:-"E33)0)@K-O_#CA93,$>Z$S6D0"=S37I#,Q)K&3]%N2^^_IR MM'?QTJ&%I*U+_4XJRD6=3FR?5AKY.ZDA1^%W=BK\,LD7PF\5)'^W\5*OGRGF M!=Y\'S%2I[5]"C>+BUIK4)@R@*2*X%[FCC47+[-SQQ@]\F?VDCBV#H&!!!5+ MABF3EJ_#AS/3Y%&9E2QQB9_X[H>R.]OW)L\P$W(U#W'QWKVX'I_"&@8=&`4E M#1=LBH5#^R?Y+V["ENS1LZT'O#A'1];;E>M:`<"\WD5;QA5N?9-A5ZE8%`IM MD8C"VK03ZM90G/STV-;C/7>F>-XNJQ[`''[G`>+=S?@V0,&[LN:N86^:\VKI M6F11-R,E8HD*OB]L*N9`3(FPP48^*7_V?CY\M0%M$2H]:VD"['IKD5:;_@$.3FV8)(96+,\I18!%G4M>N,^[($ M9DU*MLK"6G7JC=-FLRHL%*[VKLXL%+PM4,XL7$0OAH\&[VY47J23D!LAAO>#Y3I+>)$WS--\[#*.52_:29R)_ MN^TT+I,#Q#X0??UFAEA(\&N*,5R!??/9AQTCER'KK=PR+CCG6W1K+Y7X6)[X M[<>V>44HVCH_*S(JJ]+:O7:UV2N:JUG.M]YI]:K-=_XLT').):K2%CC-M@YG MWJ>?>&53/O6=`!C+/)/,J^[9U\4SY9"?DXH)(X>2X+7$96LHG]RT7"*L?I- M;S2S5]:Z/.Q:&`7*7$I4,+S0N6.Y+53#G8DOZZ`XN$Q:#O%[$D8R_SS'9[X- M3NQR^D$+8^\+*Z=!JK844RJU8_\7PW/8J11Q:[_G\/NWV^!`NA"E%6*T1'78 MH4SV$S:OQ>&F`=T.&=V3#N20D-RFWXPE%&?L.M"-15B>SMJ'A"NJR&4*8`&]'W$\/"9^-?*^'HOSW/:$%BLCFCU1C5 M@I9=TYO)5#>#J10=91&[1NELN:3.G2(M@6O.KB9:M\3!SP"F:73T>?I7D%8R M/X5+-G;,CWLVAG_$<*/+P"9J9-BIU2-G4SQOR+[ZKG?.<>US\"+G+[NTT&N7 M66D9*VD#EA(R,NS1O1T^I/5I+._G:K M]8(3P,+$Q/AQ^)-A^Z[Y\H6;HV55:5_9?Y(GU@OJY)8WW&=C^.,!-C+VT,!]8G.^9XHOGZ;#+-E?XNU<3Q&G]XJ<)$7LJ_=,\F?P/P+JU7L1 M/WQASNCE0=P&LZ-T%U(+*\ID(?WA-000_]\W)W#6'@'0!Z!'238`>RM75 MGNG]W6$O+JS9#'T16Y,DP7NF]G8X669=OMLNM^!?H`P3T`J'6PDK4S5.*(^% M.-89K-Q.;&X9/T-&_C]7^81V1J[>"VPA6HFE>\?`H3Q\AN4[M#W/E1OOP-K# MWY3//&G?JR#^.X,[SK)M]V_B"0584,XL\&J&72G]674I^$%_]=N?L!^)UN\] M\@-^E98$M8D5WYBSI/OF##L/#%CFJ@C^5C4KBD6ZX+D^&8\3[^&329CEY]PT MERG8-VH1D?+&&ZA6(K--6[:ST8BVZT&_U3*OKD0)]M7C+J-1!OY+22UIZYM[ M\`2]7E291T!@F^*MZ8UV!%:9\?V"@^=+T#<;6N[!9T$"'Z&]2XSAEN,IQ/&G M4C1D$`<49*$AWHSC%TRVW$RK-4_O9F3MA\^5Z,!Z2]\>IU%O[A"!+VAPXQ9# MNQ:8?M1*W1%=H-"HP!;!(-AO.NQW5>71H.;R?#SF0T_Q;&K@/@R&IL$8X84; M5M"!G@4=;X4L\I,>L5MZIZ!VN]F+4*<6]P0*<)J,Z0"O:-`4GEDC6OQ1ZJ^, MA1$#K,TWZ$9$%L5&UGJ[I++@VFO&/,8^9;E*"5O;$>96^K]JC78_%[5+>HL6 M)[HPE+>N[8_HHD4!S=8>B2ZLS#TMWZ++0?7:$'U%8'P[_7DIKX?&5PZY.5%Y M]5A/W*+D.E-PN!BX0^@!@7_9.X=^L'%8,%*,%(=9+AOB`Q>V6PZ())FG0$"I M[^<T%9U.>49^F6&<)QS82\[]]'SYWCF?L"?#=I@I M\I-@:CX*590$)(;9D6.(D2\=I;_9[4U'5&+970G"!4_?;FA$:9&7``5Y;L6;5Q#D:#D+J3 M)"Y[I`W)R>D,P?8$&/QKD1.#$;\9([[7I>$2*@AXS*GA3\LJ0\T[WC;(6R&[ MDW:CGY3[+,Z*P<[]UT0J>O&ZK;0F]V, M@^);@9T0%`+=.GCHOHJTY7T)\L`!QZ@N0N%.>%S5M6`YG[I><3[7:6RPE-5F MH[4+5F\=&QO-LT_,P>X)+H3?=Q/PR)>&Z:>!BW):N4^W=W.EM)W64CY64%$J M%WDC]RPVM%YEV,AITS,GH[U=+N(*".&Q/10-[*3SH`+]1.^.92[B7[ZYRC1N M9E):.2S*^ASM6$AEV9Q.I61!;P?&;>-`L-/3"C.7H*05J*`=+5==SA`?K4[Y38>1< MN$*GJ\)IB9WO6LU^OR!C\RWOUO[$?658A>_0RB"Z4@2?+N4^JBZ1B4-3-[1/]'>N+_,T; MGV$@V<^AWNF!-Z.TJ#IHS1R.M%Q2"^I`JU&:4"_LZ4">NL7>E6>M\^<^&S1O M7,A1(SH66INX4IA:?(2Q(5OA05OY?&&ZU;1=WUF_9BNN(PJS1@I\BTZ!\1=+ MBT0*FH-TAT7RSC9.4D'&>L0L&725YWZ M]%K]7EFTV].I;=UY8#)"P(H@G8B?R]\_<6E6$]7YM*?%TIIY!MZ0U()Y9((R MZ#1V2VOA9#&(M54-J2XG54BU-`VX9A8R9C$KRXKM%-42EO&S>T3#(7 M#5HBE;ED63*5]%?WS/OZYN]5H;DK1C>^Y'H2SZ69IVQ-4;,0R:"M59'EH M*R=ZU+N+E#PK^LH]>L[T_YJC6Y[#AI[/S)N!:3S2IB;JPB?[]KT$=TV*78DY M>WQT.'R:*[.@XY_"IE@:XRHCX-BVE*F\S*-8F)569B(MK0Q>@-=AO%G0]?6% MJRHL:$*D8#M[1^&$/Z%,J0]1G/<-N$L+RJ6:X$\_9]QR2[L+T$M%[ZE1UJ"A M>&E_HUD6#06C:KW7#[I3;%$.*XCH-_MKT>!/?9,)]"4906U<8=G5]6;*/\Z/ ML@$9N>LGV^W>>F3@H=$5=<7$.PKGS#748WUI_,,7!=(;!E'M@3A*_` M9U?CT[0H$FMT8X%M3CJV1?RU;8ULZX%P<`;,^O%P,QYS!W1P'8:TDAFZY.[0 M,6:B+C'^$GTM9]KO&W]^^,Z?;!-O+3Y$LN)D8EB__#C1ZV./1 M'G]0WK)WBC?A"AM-#0NQRDB5%##WEI<`R@#W,*4KDEQ5W@[$2V,.!AXR#2'[`FXI8<` M_2'XZXY9#*$1X>&U._?I#V<(#!%=<2#/X?PQIA9;J8.(@MO])QY."X:M.< MNBP%?_L+/H905K#5LS`R&/I>"8RWJ\;X/+8T51B5P*E6,4X)R>7ABR]T^V[" M1O;SPS6#98L0_+_;YL@ARU6N16NUJV:V[V;$I[RE6#*[E=/O*.((K=DV+/@A M\[U!4%(USW7ONT-FO3S$X?DB1LLPWUOE>!XD>_,-PF]CN<41&UOUTT:P,I6 M%>_9AO^#&PL5N7>-G_,;>68I;#8S0:*8))XRY]&P0&[6(\IO[-A312,!>39( MJMUX@Q^2PL+\DO(]S!VL_E(C^)*&7]JO0,O82J^E9\U3_0#T;+&.!4Q_\AU[ M9)LF]+H[8>L M)8B%`*KX/C&/"Q[=#O%7R6JHB1;H@I MQ)`*GE^[RIB<#+AG]"@>MY07[';IH;_(PUR,Z*WQN7[&\+?O@6!&RK,!(00C M.$N3T^$\LORZJS8:#?R??,!2#.DOPT"D=:IWWY#@6%)J^,=+/J2Q,%R1;3>K M(:S-,X^1]$`S#'>!5OV+6;[SHC2)_[1>D8S9`L4*XC?X'S#E.PY0C*'N#^XE M)\%=&-OL7*H%\UTY1>F;!R3(/RPF[H]CV\)Y_)IU"PWP6D_Z;MJJ`,4( M*XQ1W$U=P2Z=LJ*8X.U6"HMN=S);!3JKSVE97LJ"RBHLP"_CGNG\S?'$$'E' M+WIWM-LM8_2"UT'U9OI.<+F\KQB^F[Z,NF3T-)(05JP,RX*6ZL4PF3('6I>6 M30"B]$[)Q&QP6@V*K6$]*TL(5VKUA):OT'X2@XK9B3R*>?*]5/^/-*=KZ]TY4OT^J*672OZ M(A?O(;R"H7@!=V[2ML?1LK/859RT*L7)!;->8&)B./YKSTV_6G.SX#1Z%1.- M2C&Q?MN]@^!J[DS^>G:82K:PNN"PV%AR:E6*D0-/IPYJI#?>I`I#DM%$M\T![ M*JR)I;[>J(VN,3*8\P+LQA$V#I<_ZJF=^Y)`Q73NJV&M1?[6;,)W4'FLK?B= M&19BY-Y8`@PSU6YJ\ZY.ZPY?(O%%3\2K07W!4_-NLYL$.*DB"\%N7]Q^B[G_ MW.V>NNGJH2KJV8JIVC+UF[<=:S;:W1Q"=C>D)G=?LGX>S564KT28GC!>VN3?VU,#3R6-&4;$.QJ M.9TQ"WLR1H!;6""Y%'1K%3EYB(\D&0HR)L=RBOFT5J/5;>70FSS$;)^IO.AO M6KK#Y#Z9DMJ^X4SIC7Y_\XD2[VR?IYP3U>NV\QBMW?!4:I_8%'3VAO3LB+G< MM;;590ZQZDI9;R59QBS2=LWP3JWF=A@NMS4-H=OW-E?B)7U4RF6R>#/Y/!%J M19@L6@C=2=U'J#23A6NJ>WDV=#MELJQV0*BGK5X*@'4#@K;#6>$+!&U=UZO- M6N&%U^IO;D/W,VFK5EM;V]SU9W(&#\+^\MIXXJ-T&]2SX5!`S/+%5S**7'1+ M=QI9GX3ML9#O*D$GW79V4Q8B,_C9L:=Y4C(%#9O>["8]<*Z1-R6VJ*WJI9*C M.R&VJ/5)>XS]2G;5GJE5AF03C72N+%!UQZ<5(#!7POM[Z9N"A94W3?,:!&R= M^%5=BCJ][5.?W.S0'=.;&7<(6VC1CKMHPR@MY9(V)6H/+*Z:,HB5=LIB\L4+ M1MAS)2V>D]Z?0]!$%XG?;'CT;IKEQ2K37 M2+6.R#-JF73F;.W0GC?_!>@D*P7JCD@`LA]#@K(%33B7MJ+4&FDKF35,-BE9 M-!3-QK0Z:>.6&",_`45#GZZ6+8C2)+!R?]].>]NR);`Z&5]@#D0@0S8AYYVR M:S-G!^STS>V,(=>C:DKU1L3M;@*(`]-#=3<.=NR)3'E)JG5S%Y, M*TG"GGLE^5]-[Z<=<&*,S0E8%?(WFMDK>@4!U/3I0@#K@!G^9EL!RLZFAU+= M1?0L'+)$&G.:P=:<0U^7QF#[%&!.P;W3ZC?6'!<6DCHD3VQR!N,HY5F]V M&WV]OXB6S"'+(C#W:FTT.AL1:/%`M3:55E<$=PE:HJ\7&3>?$'ISL$GYQ@TP MI\4Z*MK>-&,1+R=HX;!;H71=2/?%C'7P>+!1(-/UF3U080?"(PA'RU/!(N8V"K[ MR4M'^[".^V$[<5FI7+;S&=*]L+VFLM]-;,=[P%80#YA0SL6^OF7NO_,I,Q`@ MK`#_R\.4=C-]\6:]\5?3_H?ENWP4/(]]S0W:2'[F?&UHHCR=>M>^4MAHM%>P MGXN%*DIBS=N)C4;S\"21,N9K!(0+I:"O"D^J*(:D<2]##-H6I&!;CVA:T;)N MNN7K=AIZ,DL5__HFXZX)+)69KNJW6]NA+1]$5-866=.W1-)*9*2LW'ZCW]L. M-3D@=+)/7_K;H2M(K:SG",&:F;1G4MR9XVSF!39DP-8_LYG[(7.)F[& MMXYA#8T9,\_&$!G]FS,'0*\1"QF8_W;\?#R M"74!&L'KV60MN.,>/(*=BEQYG)_'C\WU0%K#9^#5@73!3A8=I5"ZLH7;\LQ! M^I;&UNB$^;&GQ7PPW2;IKTTH;*8(=2DHYMCT5"QUA)K^?-'!<^^3B@^>`4=T M_G++\E7.K+<6]AM!8;'WBNC\Y<_7+SQ M(*^K68]G0\]X*NV.@M;LI&Y5YQ]_JW2OJGK7M7[JZD')A(N*G](%?J+W.[U. M'L(S"-@JX:LDWNOGTY2B=(<7%$K6\'8W55::?_RMTKVJ!$AOI1KD;4!WV4@, M6NJJUI)[ZN5#)#2;K1)&+WJ)L=7OS*E3B:,_W'(VY`&"9^",+DS#,G(5-EA#6N;QO!%_-^U>8+O;LA0YO`IXA&=`=YV\&+CYF=G MFM82^=<8?K]O"((T'J];5*Y=L_T%3ACO:W*=/.F MY2N4HM/7MDG__QC6"&L4OM@NW<%]N+"=F>\^7$P<`T+FE7W"EX=%C11P1YG2WF]MU10AZQ+&B(S(\Y1K.?JNU7<'G9Z"8GVVG;WYNC0': MW"RF7ORU@.?JZEN-$^Y]=\BL%\R*CKGK4JUV1/9F]K/;7$-YPFR'O.->3D*C MG]ZXS@VS#A5%$QN=7D\OCXJBEZ#[_1*)*)Q)2#O5O%24G.EJZ"FXXXR!UJ.D M<-9+2\6F&U-2-`.F=5H+-*1TF:P@I:5K16?G&N^=N.*Q.P\L%VY$90TI_:U$ MK,Q^-[6)6YN*,IDHK(!Z9X&-W`<7A96WW:X0%X45O]$I5Z.<1V9)W,6+L*L2 M(NI;HUN'NY@[PQ]OQB%L9OCQ35I/_,XMH-N,\5$R(2DVL;CRPB:P).E'0L&5 ML=";Z1W5L@$+DE88U;:E;YVVPHM2;^U/;BNK[+J]HK1ARS)91_#RE5D0%J.> MXKOE1">M5&G+L@$+DE94W=JIJPE;(*VHMK5373EV*;658#J-@J3=RG+"S[8C ML4EBT"3E'/JFD7Z6#EDV=:O@#]+W#XL1!Z(>[S53Z9@U*P@*G\OR*ULA6R_1@)9*T^KK&!A3!TD?EX*>2V$TMZ8M-4M2;)-00[2PH+. M[^E"TZ)RTE-WS))#Y!Z^\%:AH37+&+_@7#2U1G^K[*\8OY]*^2T=WN%C[CA< M8$S=,N?&H?WHB"YOP9MW$^:LC:;WZ?8NZT*R%J,IU[CETIHMO5W02@^X9[XW ML46?RG7D*5[.*&1*ARI+ARR'O`P1[HJ\*]?URY'<"J+$0)L3E%]6)1&4"WBK M-#$M1-,J3%II`LM)6BE`H0M)R;C]NM;P^6S]>L-'&Y@+VS2QY`4SD=O9;WQ5F>E4Y6495,,6"&\4>+[#;\;GO@N4N2Y'"/Z;,5;$B[^G;,D6 M>W7WYG:Y!8C=';L<*RZY&5UM"L_M+^SIS.0_:PVZ!R=6>&THB, M7]3^9GL\\]IN06DNH'#1D%LB M>@'!>8;?`?$KL]GI;,1&+$0YUB_<''VVG4O^Q$V;GD1X9/B@J+W/?XN!F8KX MHH*?5,:VH\0^JB`0.7XVXB`W#8M(C_(O`=>QOH&7?.9PA(+:M/LB*GRKUTDF M``H0L44N MQO#T>J_7::Z6F;L1*3FS=HV^UM^`E%ON&-A+,=F\K)0KUUI77T!7]J!;(''E M=?;NPFG,1R.MW5L&FG?O,,MEM,W:I#2'/HG?F!@SY=GP)LH?%@3QC@NF7UQ& M4.ZX\V0,N:LJ0-VI\O;_LNGLX__IZ7KCXQ]?[L*?M(_OR"%((A6B4HF3&6<[ M-R-I"7@,F!E]8@[BM+H)BS8VAILC^[=:W68*LF_UH.41F7/[W=&;<]YK72*I M0*R<([)&KYGV0N+K.<8LW!BNF2KP6&/,HEF/1B=5KUS&F!M==Z8]>QKYIPSI MKX3RZFA;&'33J]^=N:6;1=3=<,)'OAG+8<2K$LY?8C^M;5`QV6);Y&KML<*B M+T5$%1E^$0-X=>+*8ZY(;3SE/Y:4.-XO410,M(BR(D.[\P7_XT+NW M;YRS)V:8N&^$?4&RDG5MLC_]-`A\1#')-R/RF4O>Q^$6?P;?9<]$M0MN64"E M)C@9L)=2P&,I$WF[2!D+A%\CF^-B'*3DP8?@S$;+K]_D-IQSA##&=8FAV!C M;N=5U.^E3&#V2*51L[*\J+<^-:7WD=)ZL%E)5A"N:LQ4?J\HK:/X586PYANV4V]RS! M-&V=V;^X\3B!,/@,MC7@W;[Y&$5<&J8/OYL["3T;_<<76]BU#<3\*2P$)#&L MN()TE,],KH@[DYMF!;G)8RTSF>E6D)E:?56 M,+*8AO(8*+Y$@(.V5@$."B\+8*"SRFKM=0KR<-#M;)>#N;<@SC*&Y:V!589V M$05E$;^1_N=8P=NE?A/=;^^;^(WTOK-:[Q=2_X_W/P>."?_X_P%02P,$%``` M``@`^3!H06Q[X]#+#P``-`L``00E#@``!#D!``#M76UOXS82_G[`_0=="AQV@7,< M._O2W>Y>X<3)UD!V;3C)M?>IH"7:YE6F7%)RXO[ZDGJQ)(N4*4N**%^Q']:Q MR=$\?(9#_\XLR`V'0LA!>?SSS:`=1$Z.S'?__] M;Y_^T>G\VLMP0MEJ[QZOIUJE:G$S[C"E`FD]7S']8_[P6_V`C_-F,_&4QA M3#^?+5UW_;';?7IZ.G^>$?O<(8MN_^+BLAL5/`M*?GRF*%7ZZ3(JV^O^\O7N MWES"%>@@3%V`S;@6%R.JQV!\Z/J_LJ(4?:1^_3O'!*[?A`?U,J0E^%^=J%B' M?]7I]3N7O?-G:IVQ-C",3\2QX13.#5^!C^YV#3^?4;1:VUQQ_[LE@7/&W-)E M`GK]BP^7%[SZ=\.0M`&V;K"+W.T(SQVR\I4^,[C8Q^DHI;VW),@]-YU5E__: MS1?0+:G>O=)31%)S4I;9`((>\`2NL@$=O'FV:M>5K4O$$.BJ,>N;-F'3J'MFSU=HO7/ MR%T^8L1]';!_@L!VE_>0;)`)*3-(UEG\PM!BN-WM`P&8`M.OJZ1R14\J"WB( M-LB"V%)3.E&Z[(,'YN\>HLB'P1`.$5T[X9]*JN36+]U/O=4*$/0'M&X19A:. M@)WPB>/Y#7NVNQW,Y\A&C!C%+EQ8:'EK-KE;-TW'8WX=+R;$P>RC&3@213/- M%U%6Q3L'+QX@60WAS%52*%VA--%PP8%,X=HA')X:D9E*]1(U<6QD(D4K4Q6E MA:=\`#-;&5>%SZO1>16`I"#EI1U9`>V/%5VEQRB@KJA:15.4(70!LM74V*_R MD81#)4_4PM?%&KS`)]=3W':6HW!ZM<)J]\8K,LZ85U6.\DHTFN$]1IJXR). MJ^PC:FAOM0XMKEB#.D5:,Z]ZJ)H);-,+9@]W3)&4BJPH&XJA%2G)91X?OPTE M(Y<+N;@P.D94/OD18,L(*ANBZ&^5ZHHBNVDE>SVNYJX<^WSML"=@GCU@GRA; MQ%I^>B(693AS(Q!FO'K$P+,0^_UU$%IG^MN.F=+9YD%]AZ3-(%39C]S/`9WY MX7N/=A8`K+O&,7_+OSZUV_0#12YOV M\UF_&6:F<`.Q!V5TQ#\WRD&._229B+7=-?_%.ZV;?P?L#@+J+]X8O)VC^8HP M6GDK_[<0VZ%NHRZG44+WS4[8G]2QQ'3W:J([,VJS+WZ]\G7`+K"_.3BQY$;9 M_G2HM'YL'-(X;G.]/=P$$AZD!@L?BJ3_[!?2CPZ)HC$+ER]I^0^03=S=*42K MF4=H,"MB,\*QNX1$I2\4K*\?'<4QQ$R]T86I6V"R)=81%"4KMHZ;I/(Q*6^U M=F+7#O4!W#RO^Z,XV?,//+Q&'6Z6Z_`LP&4^X@?/RR^75N M%>UIRU<_YNU[O7GCWIOK'*/=>1@9;[E5].T0\KMXRP$'<_"MTEXXUPAM(W7#?E+!K*-;5._:F""*FLZY54C5\ MB@%,(;!YMN0+0)A#'>,@S\NU%U);7(S>+!?'$Q->UV*KJ@[L0L+PA)Y)VE7W M2NE-5T;=F`WY*DN+Z?S/OC+0&FS8(+N`W[S5#)+Q?(ALCWU[OP0,UMAS^1$/ M2S[I*"Q%(Z@9[:X`168QH#(9C5KMD=0F[;H@W-CJ]?7Y\[TS27NI\[YBZCR48@1BFDZ:#RB%TFEQ M]&,SR5A@WU#>G(>G[Y*RC?:B=,.F,[-";=L2?A6I'X53V'2H`$6I6@V'SG., M[1!W*1CUYZ"JFFQ'ZE]YR/;=,+:BCZ/5FC@;F+]B5JZO';,":TU/V96AU9]K MK[_/#DS36WE^?BX9T3ZB'TLEMWH%["Q#Y#["E6YL*2]%T"E081UOVL/$;`A@> M_A\/U&V`[6?;W6M`R)8-'WGD*M;5E%)%[=N2%QW".20$6E,_N&I"!H@?791/ MM:?J:PL'`_P`C'%`W#,+&Z> M3=OCL^`OCF,](5N6WP=R83VX-32G+U5EE_Y0. M5-TA,`OWXC$(]ZYC_K9T;*8[#5)^LBG[P6H-@SFL=\-VI=KPJ<5'4OOC@]8O M30J&X_DUZRA(-HM)%]&%%C$#24W;X9&#F8R!5`F="4@IVI9-)5$Z M?@*V?$IV[1$2G-_\YF`S^./`OH/>13K MZLRE(@25O28U'K.@D&P@O:$,]A,=0O\V#J[HA,`U0/ZR,^^PA5IU+6DJC*(M M^R.RLZ,1#M=&$[[]G;6]ZQ(T\USN8QX<[EL<[+(&M?VC#X$+D@U]%0G7Q224 M9Y-5`=]945_O%++RXB9W.=,$N]7:?[X-)/G4>U;%?%FP`/=!Y,6XA24U8U3$ MCE#OV&GK?5;DVEFM''R0FVRQ%A"353IF1>_XZL"R4*#7A,T#1O@:K)$KW<8N M+=T"CJ2ZQ_Y-:Z:F_"8A#*T;0##SXC2U!6".3&DT1:5B"_A3@1%3J7>4]3K0 M'&U@XDIML3L4E6P!6T*]8WHTWYSR%6%?@0-+A6PQS9BI:EJ8!1I3631$\P); MI"5O2PA%1ENE+X^Z98S+,WR!36^:%N]UF$#6Y&QXXZ]PH7`(@_\+;?:0B6BB M)WZ#+M=N0ASN1:RK[2/C9X1W9VX')O,Q>7&V(@*:/1)[!)W)/EH$:$ORQF7N MTFOH'%Y!8]TC4'A?G>:[>D_IPHUR!"I>Q:'W,L,_&.6_J8LM:OEIT3PF985; M3*(,4EN.5/S?'E@OP7F)T^PY&[Y+KF2$2:W]B<`(IW?W"1)9AZNTD3DE8"J' MV;18;V:AR'.K\66^?8>>52MG`,5)/Q1".P5[_:8.J+\,I ME+$_7*V-Y"N#:\L)A<20E;3;*-8TQC'4Y`MC#P_MQ:2UV!:.QJQR#E:/"?[^ M.B6ZW4MYQ9:H<`),BV"I;&ZO8VX7ZL16$90U0"IG,,:AFM'K&\0#>6$);63P M&)PJ.^/UZ)\)MW,/;#B>^V'"Z`JVB0V"=ZXRB.N+BVFC)1P-MB6[[R7- MPG4X(QG/OSDNI.%=!0H",UR@/6?$I5.A.'C+3@[?$.#-BBTF>Z!F38!61>S^#2L4VLZH`+R99[[UJR3,1 MS$KAS!TB:CH>O]D?[H,/KPV`+2/4P?"5 M,-):U-`^F0$^QGBYCS$SQ%>J23('P;@(3HH@2?N_V=.V05.J%@8(GOP<^">+L/(A9I[&0:":'\]'0@UDC*K:7;F/Q2 M0=-WH4'J&+./9OI=,C&4=]G^P`48L01C7T0-6D7&")VP0,5'69M]DG?!,O6T5HZ3E;5!,5=;K_I%?:X,4W'/ M.Q9XWGJQ)IV9#(?0I1D/D4NK5\%PVC;DMPK9&>7>2>=YQJNP2M,.X7%)KS=P`:"(A<>91GS&A"Q8E'S"6@<$*8Z0QL_^$\EN&_22+:49$\Q!IL MO)`?ZZKX&4W$C8Z%4'&+-!QEJL58DH&HX]NE\*6_/=T-Z?!+:HZ4]9<)"1IE M9S_?OS\5`THF2]G0)5K>'VU0N;+_,C"%1@H-KI]O<9UVF5RV$4M;FDCD7P8F M;YO0KM[4:E?"K3!E](ZVU0OVP50C]D1-IK+V"9":E]%'HNT)X&;8+(?7Z&F%N"]`G`F9E43< MUPKQI0!Q)MQ3$O%E([$5A1FW9.+L1?WQ(;KYDHPAK[S6P!W,7DO]" M0&[11K8;^7AQS;ZO2)3[=*J`%%U4`WPA79P))6:?"?Q)3%%4X-?(= M+_-"\G*R3HQ\'U-(OM[7`!3&]L">7EG/#X6=%OLAJ,CQGY^:`3PYE='/19T8 M^1Q2_6\@%`9@"BD;OOGVELVR@R@K4D]H*@(4$7YR_*\SP"\1*DNBD M88.<_7SA[A<=`P+2(,_;3-*]Y)*QUN"/@"%!J.-])M21WG-9>PQ#H*:4@/>9 M*(6_FTJ@;+IE/W6YH!F@D/WQ)U!+`P04````"`#Y,&A!MS"689H>``"7;`(` M%``<`'5H="TR,#$R,#DS,%]D968N>&UL550)``.%DIM0A9*;4'5X"P`!!"4. M```$.0$``.U=;6_C.)+^?L#]!UT6.,P`ETZG>V;GIG?G%D[2F0XVZ01)>F;G MTX"1:)O;LN2AI"2>7W^D+/F5I$B),DF;:*#AV'RI(JN*#UG%XM__\3J)@V>( M,Y0F/QV=OGE[%,`D3".4C'XZ*K)CD(4('?WC__[S/_[^7\?'_SJ[OPZB-"PF M,,F#$$.0PRAXF@7W]\%%FB0PCN$L>`2C$<1UJ\'IVS?TW^F//_XM.$^G,XQ& MXSSXYOS;M5K'QU4?9R`C;9)Z96?OWIS.?XE1\O4#_>^)_!X0JI/LPRO]^Z>C M<9Y//YR_OV].1?-]?]24W)HGWR:Y0O*JP6_OYD_F-==(MH;LL9^I"5A%VG M(`^'03E^'_+9 M%/YTE*')-*8DE=^-,1P2Z1CGI)73=V]_?/^6MO&7GV$",8@O8`Y0G!T%M*$O M]U=K1!=CC/(W83HYH;^>;%8YT4''/8S+T\`+'FT5#H M5\N(#,(_"I2AL@/2]P7*IFGU9PL^%5K30OU#,9D`C/Z$T25*B*%"(+Y*ABF> ME*-]._Q(R,EG@^$0Q8B,J9($MV[;)&?O^V3MO5G>5`2Q:Q=:^+Q.D]$CQ),+ M^)2K2!ZS7E\4G;8EZ;0_FE1F6E1]E3Z`0UD2.8BAQBT4*GQ?DCXF3>"P>(+' M$2((D**[HZ#J:)7L12LHR4](T9.JS`FS@;ZI7G1U'*43@!1)WJZ]0WKA$!1Q MWIK@NGKO%)(%:E=K]HWI2".U>@K*U14D:GVA1@13_NL8346"81#"JN:)=J\#FJBV4TVIO M__KV-#@."!@)XS0K,"1_5!6";ZHJW\X!?TU:G(9K],1TOY%BYB"70S4$V5,Y M7F2+.`)@>D)-W`F,\ZS^IC1ZQV]/JPW&7ZJO?W_(R?I#MX^/X&DYC3%X@G&Y MX606.C%%[3U(1G#PBC(.H2N_K].XG.P!7J>62%;=6"5D+>WFO(TA3B?\@:LZ M3ID4ISB"F&SZ%P)^PI#3I>A?E*H:W)2JF@5>MO5)RZYIO*G,+9_*FS6#;(#. M&R)/DV(BI'2CC#E:P6LSK>ME^K06VY"%92JVA'7+2M2T;MJ)GJA>1P)97H#7%PANQUR:C(?B=IE=F`9!#''GRX#CX6A%!X6:++)HI7"O8I\R4H%L*/ M+8I7!7YS@)<2/X?K'ZCHP.BGHQP7B)D=_<'>+FKK=-2'T,J7<7 MT@H77^_XH$Z[6WA38=YM*LQJC\$+Z3)8]!G,.PWJ7O^'H*+P3?!-\-]_%&G^ MMR^?'N8?O@U`$@45*4%)2[!*C`7*2.,UHB*&M\-;,H6$X61T#6G@R"#+8)X) MX;U458-G"<2PW^&4T);/SF.090*;PRMLQUFDPARM[X?93-EY7.DUW!D],$K] MQ=I17"/]%VO.QNZ[CIMP$,IUO/5 M0I,K'M\[P^.60:@X^,Y:AX2'8'Z3I<89DZBM4[D-GIHJ&?&XR'&RYGV1FAIK M?#)B!KU)<AA`]LQ:.ULWH8J+L]./K%.%2 M#V^(:1L3S?X-`M:V25BZ)Y+NB+5,HV9BZG*&`:?"TL2036OV!FILM)-A:S8) M:LP*E6!SV^`F3[4N5=Q\;Y]+U4,5?P"]LP-H(S[B/LX#]\Q[K'"-=DN]MV(N M=JG?0467#:<K>NZ-XFF)A&[KBTG7R9-KVGW7O:O:?=>]JYGG;K.=!@!!4/UOS&_&!@]R%O MS.6H%-U&46A@OS;P*IRK7I3RF_J]L2X&-%V]Z]Q7893!\,TJ?3R*(YFR3#YOP$8 MMD!"S,IF?4Q5-HKHH7C*4(0`GGVA^2NR-$81E="&]&@*+>B:F/-T\D0`!HXUB2IVX-")(IV'8STT:$C1_(-TW/IN@K+MX>SCNVMA\R MG.]ROD(L$@1%P2'\XOL!^YOY5+Q,ZO<`^V,G>M(5PQPTG*KR*VC+ M)PCB201B6'E>EQUQ46UC#6T12U.`OV;RA#64UW9/#KZ2.9`GJZ&\#2?18LUJ M,LW6[!GD%6V1,;%)EAWDJ4$-C&\=U#EJT""_M_"8P>\MG'][1-ON8>N)$NEK MEWZ[L#>JO_?Y=OUC*OXQ%9/HS3^F(HDL[-^1<:JYF)-V9 M+#?LA&=*,U:9CK\>FIL$$6E#0(Q=XQD M*AE;-.>!$;^B"-[#9Y@4L(SM."^R/)U`S'^&2;FZ?P]K(9UG!8HCTK5(@E?* MF).-&`;YQU>4+4K=DZ66-?H=VNJ)G?6NZ8BV8T6VG9VPP>IZB2DXV4D[ MM[AC@;L$"-\`_!7FOX"X@#KD3M#D#L6O`V.*S>U(&+D4=)5)Z89UXX[Y6K%T M2@O@QW91?1N,&@BLHP[`%X/5L1K:. MY2D-SQ,BWX)&8%2U78@ M>D99BF>#$8;EP=S2B%P0F\(8T,8:VD@K,T+7W5U"`DZSU=D817K7%OL0X7.0C0?/`,5T8J^2CZ\AS++;X2/`(YA?$/B!T5-1GHH` M%%VF^"JA50ET7_V-`_JU=]+'`&P3<4/V_V>0$@F)V3R;M>6Z4\OZ%ZP5P:/# M+%RTMLIJTRIUK3&A%8N5I%Y:5DXRV=!#J;9V:(3(F@*C:P2>RJS\9)&9@H1T M5>^XH\/G!+5[4#]`K/O_7 M+3Y%Y_`51S\ZQU&'P_HZ]NRM-4_NP2J.KZ)F MR#U4)73!U`<&CN&F-EZ8FE7WT)/0DU.SY1@^$OIX:I[<@T"-/J*:-?<@3FPBG#X=2/1KNX1YMCJ9Z"-P#/@)W5\A'6H'=PT!*+K+:Y^`8)NK9 M3U:/BO3KAC8^;^QO(?D7#OU;Q^IO'7MEWB]E]B^;*+YL8D31>WL]1#;7@5=[ M&]7^H%/L[U01VV94EWZ^PNN7A?KET]?VDK[6T!*J->VI=$YJK]C[I=C[GFC. MC'*J9D1SZP7@0?A'@3(T#P=((J(^T[3ZLTG?OMO2M]7&`M):L-J<19JRS*1T M5F1DP+-LE?*SVT']`H04,BLDG.G'$0$WI73A`$ MD*9=4WN#T=NQK^H]\@#^4%3!+LY7B!7N!MHUI>UE89#,TN1A2H.L,BD4W%A# M&VDT7#.!`FH=PO M;N4D7,N;$AY%>Q3=!\?4PTE#UVM*'^;O$8@\U0UU]@<7B_E4#>_P`-A=*=XE M+W,RQ%AUO8PNI'<-OL*[E.A<_3KJ`.?\5VZ%I2U`=3(RL:;NZX-J#U)A"40- M0823H.AC\\##`P\#'+/3,VU_"^%G,!'%W71K(J1AY3E>&"C41E)V@9VFWX#541J]X6N*,9_IT_8=Y^^!+/SHE`$/4*$D[Z$A9L56["F+1\AOD]G4YB]@88`HY, M;)6R:04[3[/\=EC%%D;SNZ]U3ID[C$*>H+=KRB;.UT@C\)!VCLK,V[#.6T=, M;IW.[@(^\5Z.TM2V`V/S")(1HK0SWU?IW)P#(S"8I&1O\N<\4URN=SB$;>L[ MZ"!`!UZ3362TT)UF/#(WRAA7&+((/U4O%JS(=W4!F*X'35HATX`Q+NN\:13'$Q/]\74*DXRW M(/(*&Z/^#J]%+EI-T6S9JWO32PVV8;9LV+ M7_WQO[GOLN9AL/Y8%NZMK'DP3,4DM]R`6?.4F.I<+W=H]KP,UF)M6=V^V?/Z M5UO%D]F^V?/]YJ7+4;B-GSR->>K89HBVX M[$EOYSVD/CT//SV/D;1U#;/3,>&+5SU_L=Y6SG=YL=Z(:EMQ+]S"[.R':0K\ M%4/3ZJCG0I^%Z=@/4Z'\[1:EH/=.MUO,**R9"QJR5]?LN.[Z4$PF`-,CA4N4 M@"1$(+Y*ABF>E"=C]=`-AD,4(_I>=*6_VY;@^TU#L&PY6#0=K+0=I,-@WGJP M;'YA(.PU#)GA!*W M2]G%=!'Q4#P5^`DD$H3PBVHCAFSZP25\"-,\SR(0<][D$)4\F'O*9[A(LA<4 M?AUD61J6IH=+EZ"LME3I89WH64*21(5U$33`I,0H3Q-YLIJK:!-T!#$&\I0U ME-H\]E' M-!K3.Y[$^)S!.)8?,+7J_3SQ(/G`@\^F8-Q7KI9R@`U='&6&#W^LB3169(B' MH:P)*>XM=X?Y`!LUU@0`SIHP8C6.1!#0FLA@-9::X:,U\;^*AD*,/JV)ZE66 M0#Y\M29Z5W&FQ.C7GH!>-;:X&-J>P%XUAM1`MSV!O8H+,A.];P7U6I=FRI\H M>R_3&H'7#3EV5!HPDHM*G4,5KU&VGH^*F"G#^:CDV?4FY`"4K$..=]Z]VT$8 MI@61X^@RQ5^(8.!5F@9/68Y!N)7&1D.#%GG2K,_750&I&>TD.INQAW[&.MB6 MK&@ZU7TGHZZ>&,`\_&S)L<*4VAOVZ%<4'^;@8R)WZV;9YYC(]PS+\%ZO:0C> MVVL<]GO'ZN,B?5RDMPL.:LY^@8:]"Y#RT4A-I%@6EFAU%*`5`<`:(['V*O"P MIX!6'ZUFK;M2+LS!.:ZD0@+,G^WIC0AP+7:M.<#+M9`UZ6@HUR+7A$&MKL6L M"4,T7(M3DXGHC+BM:!W.8T8C M#$=D#.\P(F,]!?%@0N->LHL"WB8W*N8 MHFN#QA85)<(IK03,V'.(=/6N;^'E; MQGBG=%Z5;[I0\BJ*9Q?$"',8%%5P808'PQQB?9.XT9P5(R#!E?&]>?L`PZY+ MJS7GL-UV-^U65VL.;7?-_'QYM>:$=\?LSQ=8:XZ!=\U]:9JM.3?NQKUH_;7F M-'EG$[RQ_%IS]*QO`)0/G^V/E#_PXR(?^.:CY7VT/,\X<%.*?_^=9A-A?:IQ M&]Q3&0S?C-+GDPBB.6/DPR8_Y*O?K^$(Q//7-QEVC%G"T4AV)B][%9CNG`KN M3$A[HVS>)7-=W/Y9F]^ZJ=U#O`,Y7GYC*SF:KOPAV,BH-.`H0VK"J^JJ6QP]V:+M!?3#$ MI7#OSBJH"ZUL1XAPP0N_J/DK(NH2P[,IUH">9C&IX0]_8CP:VDO[Z`(:JO=H MJ&QXSMO\\R97\V]_7U+P,TQ'&$S'*+R'(\1\:%6RCJ-81Y([U60_'M[T<3QB MD8";Y(&)8*1KZ8(SYR!&1`X2!+@P9KN(.?BB)!E2EL$:^*(H,#66V9X=CV$L M-H+[C6$Z[.U`,A*YGE=^=Q2C,#A1?)+5XQ%+5+&UL.Z:1O::SBIAC,X;(K:3 M8B*D=*.,.5K!:S.MZV4L..G9%-8M8V1=P@N&[*X2O2$.SI"]+AF*9^W.7.8^ MH'5@OR&9O]BM]6+W]T?^8KT-7X=LA]I^&NP"'-EA/1)YSF3B6"/U)ZVV%!6$UI=E%@0CZA$Z41 MB\L>.]/WB`)\1FF1Q;-/,(Y$\W(#_KU.F7"&-;6KCQ,8-O(W0[)6WWWY&RV:J/:$"YJ;66LO))U+;QC?P&S M$*,IR]*IU34X;W/#.Y^#6YH2CCM+C)(:@=#YR-P#LN*NSFA>RDN1M7?EA4U5HK6.R4YT$ M`:VX4((VPL]^79.2L^B1&7K)*^6OO31=>Q&/K_A^BV7IR,R+K[?=UMU"Z7JS MPZ4;,_X62G_7.>PGFWEYQMY;*.:MM05@0X*$:UY'*5-6[F M'\@;YQ\X#!RT]&L0O0X)+-+)E&RKR83=TQWW>?H,R3X\%[P+UUA#IX(N_:YU M/X_$/B,BT)]A_FN*\S%GT&0J]DLH_?8Q?4QS$)^#*5&*6!C@WZ:1_AEX@/@9 MA33LY!EBTF.??<2L3'$/Y3 MAO2?\L5_3?J#4T>/W/2]AYM7H_E(.A-H([NH*UX_-O7..`!W+^)6RI=!RH7Q MCKS"NC;-9_CI!D8H!/'M<$C`UEF!8GJ9YX:`WQ'!7-46=)%. M(\`@)J4^I5FYU^@T%YU:T\;2E-X[_@7$,9RU5XM6K6B?E?+%;6;W\U^4)J5% M8[H8&A1/!4ZJOA]?4BG"92KI(K#JI30F^';X*WT]%-/[2@D,XFF1G1., ME^5(;69:MZ1M=N`S3#X5)14/8Q"E+]<@@8,D^CF-(VH_.]A?;4UK\QT560B2 MV1U.AS"CNPT0U]VJ35O;ALR'08GPNF@[9Z[:S6<+N&[>S:7$J@S`-^_O4F*I&_`W M[Q53,ZUM=@;6)&'1:5[%PFM!"A8Y9EMO*.Q)OB(YJ]IV%_9D9I'CO.WF0S4Y MBQ6A]@?I^O/1]C[:WFH%T"!]'4A9-'Y;Y!F9O%7#G@GB[F4K&G-)?DZ3>QBF M!LT8'3]>IA_>L?0H8.B1\81,=!AO MA^<81BB_!&&9.UOTBJ"@O#&]6J=&8`]8!GP0C#\I"*&U6B4-=\(`E? MYOFFR;H@$I$*K&>&%0J/._RH29F6W#P>EWE<5M'T\34G0E>@;$RE['9(AUBP M6O*+NX?1^+RH9ICV2,T^"33,0>/905,E0#7I`I-ULO*J&`Y[5@[DV**E<,,,<7-(SE[UJ!]0'+.I(UN@]6V M$TA+/RW@P9E/%V)'/NFN.9I=RGWM\TGWEYC9?K*9:;`]TK'`H.\#TED/[Q"L M3JR"[F$?%A>*;\1X$&2)O!FC^C.8B,^C^,5U^>'(_$9I4L;0/8'DZ^UP"'%U M-8+G?FNNHBW;#\B@D)3-`N;A#E\L^=9C=5ZM01--DEJ[R9JEP3F6-J7*0R5[ MS/X^0"7',-DC=6Z'_QY0!D*?86W7&=9\SL<-)CKF?/3Y MGWS^I_:L:<@RXTK&`X4L,Z[D?.J>OARTH@Z9K M7K("N3J[39JAPL?:>LV?C&5*,5.)-.8T?A`RY975+D$WS,O'URG"])V>Y((L M$Z<*'&W5M,0ILGJ?GPJDG%^'4?J2%,26G(,I^3N?G:>3"56-012"B(F[%$ M7^U,]-('IR4U#U,R)=%MLDJF%)."VMH.GN3,BJADQZ'.8/AFE#Z?1!#-1YE\ MV!Q<\M7O`])UM#'U&V3RBUDB#JM+SD5!4RF2@41II+Q>K5>VRI`-)FF1Y"MI MP!2L%Z.NX?LS64WB"E%S*GEL-5:S1!;K=#H4RO%52K&NZ6,3'7N[+91KS^FE M*GN-@->>TTH=,R>)<.TYS]3!-!_?VG.:J8-/,;*U)X]]-QV53-]F01+[;GP* MH*T]2>VE613!8WO2ULNRPX?1]J2GU[<2KD-IBY+2ZS":#$!M439Z90X;L;5% M">>[22@78:NFFC>;^'(?_`$^!9E^_9%+?JDS$997$Y__I04'FO._&%&C'M*1 M2*=4\FKE;^Z+;^X;40GE*^8>;IDYI3[P6YI&E$/3A43I2\U>9?P]'9^F7RHP MM_J>_O<$,DB^^7]02P,$%`````@`^3!H07.JO,$T:P``YV4%`!0`'`!U:'0M M,C`Q,C`Y,S!?;&%B+GAM;%54"0`#A9*;4(62FU!U>`L``00E#@``!#D!``#M MO6MSXSBR*/A](_8_8&M/Q*V.<%7IX8_O=LE'YS$]?UW__/S__E__.?_]>'#?UW=U M"MY?_E+I]>%#-L:%DR"8J!\9;/9Q2G\)_/"/)_030`B'R=_>K=-T^Y=/GUY? M7S_^?(J#CU'\_&DVFW#7<.!_\,$F= MT"UZ83"\?HB,Y2?R*VJ:^'])2/^;R'52PD(I7D#8`O_U@37[@+_Z,)U]F$\_ M_DR\=X@'`/QG'`7P'JX`0>`OZ7X+__8N\3?;`"-.OEO'<,7'(HCC3[C_IQ`^ MXWG#(RP^H$'H"/]W]O4[@!O]=G^=0R$0=LDG)`[/CK.E0`+G"0:?\CZ?AL%O MB3DP/2WC=X,'KB-YR,YE!5;6*<.2X'Z#L*G@"7^F,/0P,?1;W+]A/BD7L!P0 MH!ALY%8`!E@HHIA+.8&UO& M.T26[SSY@9_Z,#D/O=MT#>/25VQ@0B[19IV^GW*RW@'?^]L[W_M].C]>G$Q_/YG.%_.3WZ>_3]]]SJ""$@R` MX`("N/SM?U+D^J47V?6G*($WPY"=$P=_;F&8(,H<1%E$*`O$E!E4/<_SL:EW M@CO']Z[#2V?KIXZ0$Z+6EM2K&?F*0O&;FE>A)CRD2G,\/9YG2I/#`1@0N`Y! M!LJ:ENA0]CG[%?@A4@T7)@F(5F#K(#_+"7;0IC[\:Y>DV"%,'J-[B(70#^!W MF%XC/W(#;Z($?7_I).N[.'KQT?IZL?\->7C7X>T6QLAI"I_/W=1_H5;B*4EC MQTV%#!MB*%N:.!S;JFK<_S@6;,!01,@,R&1VX#1P28G1P@4&($?#*?_QYXI,L7@"AO3",0Y&T/$1I^R$7V/ M_W(Q%[>,BVB;&>7<<_+A_M+&].W6*;%GD^5\0JW9.D5,>/&3*-Z?/\<08@2_ M_-SZ,=G77:%-Q"'K5'KTK"-LZTU&T,='3>27R\5R\?N`HD76NBX:["'3LPC>/`U0UTXB>E7Y9()"]YV MQEK(GJ[/DT#WXW/T\LF#/G5WT(=#+P=]]?LY&MS#"'P-G.<#^CB_F_4GA`AB M2:C]:&S>!2-+]/)X>78V8_XZZPUP=],+HR+^$BS;+T5AN',"I@)?(5I5DSN( MR$.V_QG>KLX1ZNC#=?@"DQ1Z]]`)OB1H68#G20+36N2G#XBFE[)N^*HO`\ML MJ2/C@=SJX!'!>0**,?$RD(T*V+``CPOHP(".;&%%-,>J68E5#F/5"D+@)&!; MX923<0E14=.>VE>ZTMY\Q:O&< M1N$WZ/FN$Z!M"Q)/O%WX!C=/,.:Q1MK%M`64(*2JM\LI,W$,(,@@@@(D^$&! M@1I12<<9RK5/BCBFU:C55[2=DX/6D1\&;M18\@Q%,KL]T\*/):)?&LCPY M.YTO,X=Y0/P3]9D4Q87/VAD7%:U M8JK'R\7QZ:(LLT,'0,76KC,5LX**6B#2O`0W'@1P:-23:+ZGM7O:Q6RE>'R- MOD5Q^HS]XDOE;!&2^YB&@@$$%&*Q]GTMY[G*O M2Y%+IORNEI/6;6H&/9#I2M4F)^KZ&FP830'J^M[YY;WW2R=_BV\!]&-18XLU M]1,@64Z8XH\R2M0?D;,RD6,,\&@&<,84H&D7@#$86L'W<^\17.'B?MC`L#)7 MAU<3Z_EL.CVFNHN[`]S?^NK,9S036AZ9AF14A<.*?!QZ*>T)U6[*@H4U^!Z% M]S#`=Y'OG)AW.U?6VH8:\7%1/C`X.Z4Z];C&5SKP5M_91+LPQ><#`<1`I]<[@:[ MT,.W0Q%$&S$WM!=EW."??955(\+OH9P49:2*_A)1_!X]I/ M&([PIQOL/(0::H"OG.`SO@Q=82Q$_YIHH"!PSZR#;T^I.;6P9-]IDR%!UGM:>Y M&]Q@=";S_D)(9C4(\#1`!.`BWH7)J^_^@;8:D>LCNR4^9FUH:]QB"#!1/]\Z M808B@P0*4".P!9))*52_D0_&-%UK-O1Y/FQTI1=AFFD+D[F#J(L=/7-$R]G\'C*BDVBD>8\\4TNZ;((((22,!@@A\4JJ5C MK5ZIG8FH/5(CU]1)F+*@E@_'%#EEXP28A]I/7W1=0=C:LI(A'!2/59]BOY`-^2PK@++SBK`+V9+YE,(Q_@JP/9+2%6XYF2T:C`X>AEQAS08"="3` MA@)D+%N/]_KC2W8A:\O(VO+(LJK4-^B+ZQ1N--:_4A>[PIHCHNIVG9R<-*V$ M&!X@`,>S'K:BL6%1E-!HT<[6)%%B3P\X,Y)%\BZ.OD;QQOGBQ*$?/N/'``]K M)X97?K!+BUPX\HF7`AK-`JE(LF0Z)5#&L#@JH2C/H'%VW+3518,`,@I@P^!G M'X`,!+*11K0PMN+)9TSDBA!9>J2^161ZM!M(,(Q1+925U?X\"+($9>ELVK2/K[K.H!@9 ME(8&Q=AV[LW9XAN]8??\')/T=0<..;[)X!>,X=^U&Z7QH5?0LUU).3M8DNPV MT/L.12\<>AYCG"HGQUS1J9Z>+*;M5(\^Q\BWN94$FN=BV7.%5^CV73PR>CCGAG2>2!;&M\5-*P]HZNXJ(U M.5N>_K[`>E("<82]Y;>A(N*I;Z<1(D:.V&KJSM5@C-$__AZE,+ES]CBX<1YZ-U'X_`CCS15\ZKYM;X0]8H^Y`6]5 M)VH^.686\NF-N,L*DM#.;Y:RLV?+V/(0H2=9^/RX]F/O`WX:L@/KC$N#(_]GB,=@AO[ MT1&?_'8&\/&M'!#Q$)7?]IBV#$P_&C@%ZG4M4&%/XP%/?KRSI:G2]J,R!`D[ M1Z^DB%?GFJC_:%2]F4");O,[#Z+,;8XNF]`3;^2<$@`LE/4+$0&",@;G18>^ MFH,R.YXT7'=)2O==#LH^C%,_[^GC]!;,RWN.3R^R$"2Y`$X5YE3IKVM>6BIH2'D].EP=*6()=\=-9B@T" M?E2Z>.4G+G)#=C%\A#_3"S3X'^K\XW:VL/EJ1DEQ.B?+^>'UN_)T%H#!#PP: M$-B6WQ'T1SB]/U=>0W#*'@24Q-[Q%V,(M*H)KL2Z"CG50W+72R?PD9,1^HXP MGT.]B>$CX$,$%#.^'2_1/^0XMP!@/6>#B-_LA)%/JZ'30C5&J[)ST)6^5VP[ M:$^XC\*';8P?&K!<^H'S9Y,R27H8]@C5B2@DM+&Y88%5P(4C$;@7R+H5%0MP M1XL)1EH1PTDS,LMREMLC4V[0>Z-T7J(TR2C=9)1N,>OB? M+\A/>7$"G)'P/+UTXGB/,/T'+NLK<)@4^]K9/VH15G9NE#H:/Q+1P$I^^CDY MG5&GG!2(Q:>8Y$,),#A/`0,-_L$K[=P+Q32YYI>P\6RS=]*/<]*Q.TZNT\," M\!&`N-3[*LO\.2#=#ZD3IT8I/Y%0_@2?_1"_2!R8?H7X2`?:Q12.S<[>$19? MAVZ,<[A>0?JO%D=$(*S;)CYBBMOGD\5B(3-1=`#`1@!L"#OO@H9BPBF]DY71 MZ(=4IE6$V_YJVRS>\D6WB7N]Q!62]96?I+'_M"/1F.OPRT\7)LGMBIZH?44T MWO@;/RV>$^TOH\W6"?F9L[L"-!ZSZ(*N*H2VL"U[;1G$8<5!9!61+2P-"]BX;\,R]L4RGGE$ M1C$N,6;+&#.`B41Z"=%&V`E^]8.`A?^J6=%O0ZA4K:`#+-/FL"VFZK4,YEDP M-!\)D*&$6>/1<",K;M!9-'+KV(W;IFQBOS(QU,P/;N=LL8%3/1$.4#N!GN1# M3VS%#AJ8-DV5X=7LS'+UEW^]:#R^?<)'"H-*7G"@Q68^/@JJB%*9J/ M)`I\C]P4PU&S75CYRGY)`X3J)@H?TLC]X\I_\3T8>GD^0.P$W3F^Z(&H6E>3 MD6`%A%03D!V?,A>9``4$*LC!EO([$E<1@[9S;ZQOHF=9Q#=PXDQF2;(GC\$^ M(CD?N;D>C89\->2V$NI59I>-/$TE[.Z<^#9^P,5+/7+8Q)"4BX&XIZ6S<'6B M!#,EZF;^'%P5)_D3F\649V`05'"++`N!2X^^"U-C[3"T+=6,-F(ML.5`U+WP MCO.M:!A!/#G?I>LHQD4WY=37>UC7*!$1`DTZ;&Y3@_BX2,\E9R<+GN90:*`` M-P)M4:/P4$OHO\`14F)16ZZ39*>N*:SU2+2DBGRCAM"F]K6CC(?\DLUL=BK6 M#`IJ-%K11-FA1OATN35+D&_OALRJ]E2XC40@.&8U:46IO7S5JR,A? M=TU/)F+]*,$;C9)(:3S4E$A,A!5U:;S`6VMF72W$UW(/VM@4?YU[E[/C$]Z2 M,-R=6CTI;[Q&697L__@XF18;B+^"Y+DZ/CR9PDG@,?\!>GIT>+V;%-M0G3V''3G1/]H?AOSQ38$CX+@NA@?QB8`'8W*1%C%X M`Y$)L^KH)FER'GI?LA?]0J8?-K-E*/CH5G6_VL:".O,0D%9*7:!/3$,3_"0& M"=J7(1,MR.^8=R"$W".GA15%1!B4\AAZ?OK5<%2+M@*CFIF9MO`K:6+B;VAF3;CD24A_R;#%GS@$%5-F? M?L%IC1`PTWM0?<*TT&]]G1*GS"XR(MV(JH4WM31\P5*`AZ+Q6YR='=.;EAA. M):W7C;7RX/U0-6M#E8FKI!(98W=*&UE@Z'*IUC1H,;LG#25!*2GB62NKFDEP M4)/?X^G9]$2@E02,=874)H:OC&)BS.MA19+X.EBBVHK^-7!=E;?F]F\8H6L2 MW,4ZTA`IXC6TL^T7HUS>[=1;&=_LB%"0%U!8L+T.D9<"AO5(496D"R?QDX=M M#!WO-OR'$_M8F._K&POMWF,0+"EQ8FD3=K4L@A*\I)N4Y>GQ@B^7!#*@H,%M M"!AP<&]AUS(D\62%_.;$SWX(MI&/#\P<#U=X2R.0KB%^0`O1_L=%G_K>\!2D M7$8O,'3"%'_[`.,7WX4)_BYVGC%%?B18H[0@6'##-/!3?A([+[MH)8EE(Y"R M4H"-`=@@@(QBQX$;B`TT(60&\8C2G5"@P&5DQR*R3;EZ+:2\[`9J\\Z@B]AY M7OL1X@&,T&.$7Q9]#:)7??-3ZSL:PW.`F;JNG:F8'+1@D(=U&/[XK$T'VGEV M!A%+TJFM,+$CM3$"(99;%RZOK-L5I1F4R.BC5$8',2;D&L6EL_71/W<0<0II M[[,H?J0+9$3FA8^BNJ[-5>P,FD-Z+24;"!0CC&P/*0>S_(_A#(8[0[ MS?*N8H":>#<"2Z0SM?V)<\^VB15[_`[3?T9QNE;F0;WC*&S0(5KJFC:3V)V\ MCB MF]?,]&57'"&7<\A&>FE$J',9QA\$@03TJY=6])P/E#X&M!TK6@ MVMBJSU1&14V#9\OY\93O)^6OC3`TVPMN6\JR@Y",$M'E-/,^'D_"^'Y=G7(K MOIQ\`O0$R):Y_.YL8./3`7'S,9C*.OIB0UFTM7R@>XB(_!!S>GS&=ZLPJ!&\ M)ZC2]UOHX'>(^,7S70PW_FZCQ!9>MY[GB%88?=%P"NM(J:8#FIXM?I]3>UM^ ME!FE:QA77V,>H3_##S%T$3T)Q+&O77($/#S56SKF>!Q(\=R*%4_$0VL*V&U2 MN8I8`@GNQ)-F_@)%1UH'$N!.CJG.Y8GQ7)/H>!.@?)-\5/<>.M-57%\=W[T& MY1L,X[BKH'TKP<3E`[5K!F.X4-#Z^/RTI)QCN2'0@9A9F9@1W0!0..NW?:JO M<7X_\#&]YH'\J([>NQTKG\QGBTE)(T=WEMX'>14='<]1Y+WZ05#:3CH$PA$^[+6O/O=( MC^^A"_T7O+E-OL-4P@Q>![O*(R:!ISOUUM941X2*7'/.S@XU!\,")6#XOH1M MO5&E[_,%+FR,%>0I"G<)(*_SX[PCK>[VVZ\/-K5EB_#QB1N'#,$YC3)QO3J5 M'K;T14I$56&$S2UHC`07^8/%L]F,J4P!BRPU96BV[F9HDELPB>6I:C-1@QJ#KK1Q";*X]+-46#A^ M)3)\U38F%\;RR*IYRLXF60K^HI0:[FYI[6M+@:Q(FM5S9)[05)RK.M5]W&1C M4(4IR06-C"]@ARBH3?Q\<9S?[!\FKYY25+,3]C,I]F:649&D%$LFGTICRZ,: MDTLVK"D5>GN5RD09YUP.4S_=7X>K*-Y0'[?! M5_3=87A?TM90Q).!?A0_FN-+(BW1P,%&2;54G.Y2,SW39S/FM0 MI(SWT%+]B,`VD$)_MB?#9?0.11?_9D5BBX%5!/70"./>-J53C'TSCNVWJR\; M]RZ.MC!.?9A\@YLGR'W%R&UF.@K$04+YYN:4O5Q$0$`!!?R@<.R=3S1,0+ZA M%A)N:@.MS'DM_@X<=NLH+G03\H]OERKDF#M?^.+$H1\^)VAM(O5F<1)0]Y#\ MYK8&SQNX&"@>P1>.!(."%V1:^I>D9W7MG$!TIHE(%ND%(*,,"1BMB6KS&*)1 MMLK'$0TLL)'EX!"=*S_8B0LF"5M;U(L,!^6Z:_-3H69DH,:A&RWHR@X\2+^1 MZ\>!G#5I2(41PX=_:$3V$N)"J\%UZ,&?_PON.8ZGH)WY344CPFQWP6UD=)O1 M@('"?F.6A6RS>'D&!A`X``&RL?70H$@9[X&ENJA%3E0K*=T`$1/8V,F:O"N0 M0BW?6K*H)-K$\D@Z4J!I6`7BYC2I_VQ4 MD+1R?IR=+:LB(\KR,?QY5UOL9XK8F[-%]50Q?/I,.2]?_0#&ETX*GZ-8[+H< MM#(JLY6QE2=_/JV(+@$"&!1;`MR:E)D6*>:DF2L]5:'FT&Q*MN_ALX^O1]!\ M1\)9.6QFRTWAHUOE9K6-!5>$AX""#$_G%74LH)#\4?:<#15R%)$V&(@A^/S3 M]^`]?('A#GYS_A7%E[LDC38PEJ:"5>]N,E2CB)3B7>3Y"7M8E$T>A@PRT(#` M!@RX]22P0]!.5HRB*XA6(*;`$_`,0QB3]+?D#5\`G:1^E]]HQ$=3H"LA("WF M68F;_GN',/P&TW7D78WEMMBF!DG M5.=`QF5Q)'K:;'P:F3,>.W0/G0!GO_P[LI$W49+7O"RRO&`2(0OQR$`'W4_RJ%CFQ6WI+9$^T MU@-/>^"$8!(5WMSRUOC;U,__-2Q0;`Q`)P:/@ MPL%LG'XM]Y(R(E,%?LF68>,NIF_@\$&4]$[:VDX1&@KS<,IG/ M=-:(AW27ME@L3IOMS,A\0-'KD-M==F,':PJDM)"4+=Z+$^*TNFF$E<-BJ@8! M/44V"N&S^!8`1J4^#20J:!2G]UB43(B:=$.RG$].)'H'2FE4FAZ/V]R&=N4` MV9$][#8;)R:NS%<_1-KJD]L^Q>M>I-$9E\Y7*S_PT4K72H^Y;Q($A!5(74:; M)Q\MN!=.@"W)PQK"M(3=(TX"UY31HN\!#+^#Z!=]Q5P4RY-%EDE#K!XEL6$H M@`P'0)`HRY"M!Q?#2!=[JC'$W!AZY&%"K/H2'D`&&]X(2_)6&6%9SHVGC!L) MAI*`][O0V7D^VF/\`A#$NG!"F*0UZ%X!C4EX=%LC56@7:2!1>'57Y\[53EDA:&`25[AWLYFCO MFT6?::4#ATM4SUL@%2RSMZK[.X0D2?Z$(&U)8<5ZIO8!!QK%EJ@K&8K%8Z>3 M^;1Y:Z2J%.RE\1X0=&AJ,8:0*$.[O4U37_+8O'GJ9Q:M;J*&$40[XF9G3S40 M!]$O^2'.$?!#-]B1/,*7UW=ORX.C?7I<\QC`M^/!55G0U8.C?=Z$!U=&57[A M?7DB.5Z26P_:\RUY<$TL^LPGQZCO=IU=[_KR&KA>H;\`K.\!9W04[ MZ^J"L9%!-O1;\K4$\M/%L>).Q(B]*"7!&5@\QN@;J?&%M1KE595F`F^R^)P/ M^XQ@5:"^'2>(PXRNGE`)Y)MPAVKXRF.^DU/9U3ZI>2B-^I8<(RFS/C<0]F;L M0K89['6#Q`?_)BU%C3T]FHP<]ENS'0>(R^\'SY?'/1J1/!CSMC9:Z@S,`N=! MB61\.Q#:WXRQ(E+?HQ0F=\X>']+WY(SQ0;^!;1D/<>5DFMW#XVQX0,8'&0)O M:8?6)%1=MFGBB1GQ7DU=FHS(S!BW;1HLR@D-":%;VACMY*+P0PQ=1$T"\67K M[FGYS3IPW_%=*3?:0/Q$H\I+8[:@MGRC@W^MQ,[P@JN\BH3\\FBZUXP&_$M[0$;F?0Y^[4_ MKPBAX*?PQG^!",,4#>4CXT*$8]GM: M8:GX]'8R.\F>WM)1/I!A0#$.==./0#X4*(^553&TY=ETD@/FRG1@KR'?I4O_TR["$2?8176?EO?M13("YS4%QT/X5Z88@+8G`U5+L M:V<+H$58V>M7ZFC5I0LB`,,%HABC:;=K**K+!260VT5O MD.`$@?4\N-:NS'0@^G-6K!$1%':Z(-.G<7E`_@7$2)\_X;)/;BVSAZRU30,B M1+YN,FI-+1D)`1[RC)HS5M;B,D+^<)B0Y'8EI<@!$P'+;,N M(/WW.D1;_7A'(@#DH>`]=*'_@@\,.8EE6@(Q7BI`#T'525\N3FFA@`Q87KS# M9NK_=A-ZH)+:S#*KJ0/-)5O7"5C`X"-M!6R"\[?!Q1C]IT]1S_C?!RNDPCL" M6U1];$3N.]QN+1="V&YA[N8G2GH_^&[ M/7IG*!]W#(^#AV%8;B4@S2Y`W_!%A/Q@#`^'ZV3GQ%TZ6S]U`KD+K0S`JOR+ MT%)835@61*^F%+&?@&[Q48QO9`3A`CQ36J!V29;2=98?0H5>6Y[^,RY.3 MB72SI6]FFXU:91P<*V8I0U1GXR$&,()-AP@YU?ML2(#HAH,`XJ9PL2R@DNF3 M"&@C>^P:W1YFKL'H'K@1S/2.:FNAQX(&$6U]"EC'Z1Z&I3T.YZA!WL7PN:`, M(26!.IW,3]D!(5>@,,S2'K6;$.D;P)[I)":/D!0WDF3B\%-5!MDIJ!H?#!V' M]CDI8FO6J_"UL&"M"97)6(^&ZQ&&#D8H@?$+3+XD2/9>DRNXC1(_Q=NSNQAN M'=^[%UQ?Z@K0NM'305?UR'NQ.#DPB>_9@+]@%Y^."=B@1R`;]@BP@8G[GPU- MQ-C:,[%^)$9LA/3Y;\U$#24J8@-V("A,3@HQ.5<1DZ%O40S!J<\9Z7&N(Y#I MB%?6D6U&?-SK+:_K$&VZG>`&4_/EY]:/FQ^,-#?67+^OT>1]^H'XAVJ2E=;1S?J9%5C(O)^%J(AJDC)CUE.V#V)^FL(G)8F MAPL88'O'*&V)YCQM>H]O%$4KX2,(_-M_G'X\!1L$%?^-U]C_F'Z<%5^DX`') M'+GR".:3(X#UB31#RW_V[91\B_X7L60+W=1_@<'^%ZNZW93K7M3*0IRV12;Z M*?KGA$8F\DL!V=G8".*RXB3Q332;M2EM>3ZM\'R0).TZ85*=I.N-$F)>,>^0 M"]]TMG+0RMI2RD.6)\Q9$VO"7!E?_DQP/ED>"#,&8*4N/)LF]7,(3Q%38O?=S[\5/HGC_%4*LW]R-I;"M\6B*`!/%$XK)Y&S& M0BGYPT0&"B!8Q-3:B*/T0!<)HN3$K*#%LS");!6ADT:RC<5-M)BO)3HFESV& MU<7.#_!V%-D7]O%ZLXVC%]C\\DRYOZTE4)/`ZD*HV-G"&0]S/\H0[>W-'8B_S-K2L\?_`:*>E@JFW-'C"-K1(>D"K/9?)(MCZ6^ M.!\@S:SPT>;"V)*:=BDB[*^<#4DA[*>#T$D$T5\&B/(ZF4#WXW/T\HG.)UTE MZ>?#]9%^6T+Y[S!ZCIWMVG?OX3.N'?S3/]1FQ3X&N*V$B6KEU\7QK+8R%/`` M!0A^8)"&[W3W3N:L`YE#*[J61&*EU^!.^]O:/6K4582SONE.,>LU!JVBN"A7 M5)Y.5?2*`AV;9NF3JJ!;#:1:UZZJ="KI5YE'=MY#Y$D*KD/D'[.4S8_1^6KE M![Z3PN0\_>KX\3^<0)@&61N*[7V>%K'\W9X2"(M[/@W\%*J8+FOK>T)>*2+_ M-L_R_1B!8A!PG@(\#"#CV-\#=F!'A6B?'I4[C&BTA0E\Y'O"XA77'KC19NN$ M)/'1.YR+M++M>QGZ3^5_\G].X13:QL MUTWDA,*\9:TA&=YVML13.6W529;(,!L'L($`'0ED0P$R%L"#%?7?\'#6LZ-U M%`FV^>O$9T/;PUYE89@9']2L#OJ\);5#&!:@P$`!PUNV,PO0P M6R+EAR%[H3TO[;@_;*2R)^&:M1(N%C23?[#*OLOJG2>4@WTA(H=RWC0ITX:^G#HFZ&O$*K/3O`E3/UT MSSG0Y+8PP$3.N*HG#6?L&@OI#R@`*X>3'8F8:1`QM.XU2`K6.B&E-@X];F"* MIN1V=1FC'5#*#S`T-K6T$VE`N[(SX;0SOU,1(J%21/&$*2@&`FY7@(*Q%WC3 MIHKA'DEQ-RWW"4/_=IN&^(^EO1$AI#\F>OR M]*RL,TE):4HP`05J5WUTB<4%1*/@!:/O4HJJ.0Z6:GG9Q.9MF)[]`)9M,H=8)&H6F'_"E&_A$#MUZ$72P?%=,DSGEL M188EV6NY+>W(M&8VUNG9?%J3;>M)9SO2,SN@QVH>V08I$DB\_VW,32SH*#9I7!Q>_F=PRUP>7W]V;+!5/H M$!9;`VO[`"D)%%&T>JB4=9CAWD.C@N%2P. M1JZ<%$XUV%/K.1[U$Q`E4[Z#;J-0/2Y.\H#6;#IK5KS2@1@&#*9C6,VTB/[\ M6YA`=X?O7\;B$!=.5^F'."W4N/2.98,]]]"7B%`GN,@7:0U.-8.Q++M-R"G: MTK.3Z;Q9D/.,P,4HX$+H[]A;3?IB1G9GX$#@\]4%N,X6C8A?3Q?\<(1Q:YM6 M6D4%9"9;SE7;&S6&Z3?GI[_9;7+T+K-YTA`A,0C+BBY"3%6NSR;'S4J>#5`H M-F!#C$?!^V""JG*/395EPBU3XV;>C46%[R%^;HK0ZZ+$34#&XT'+295-J1C" M*/QJ&7IR%WMR/&DV6OD0ILQ62V];EQ6?SU\??@(]"+PI) M)L\G)_SC=K6"EB25G MFH-FQ6"6?C?O"-<&ERYOR^D9NTZ,.M-'*KB[I8L+4@+H581QB*DL\8^@K26! MT$UK,Y_-YSS)&#IQC=SCZTH4\>:^E1,V@!6FZ45$DPWCTIAHJ8$%5H(I)72^ M.>DN)K=K[B'REDE>H-O57>R'KK]U@O,5FE_\1/*K_Z*B-WK@+*F6#I*J#]1/ MSV9<[2O&`L5@>-^6#P?(>.0=*L`CVM?2H?B3)6U`O<>BM6VD7Z38^ESK9[NE MBL!UF!54^.HGKA.(L@ET!&A^J]8!7<7'P:?+)=O(J2AW5%9N/\R+;-!Q;>4N M,,8HHN584"WNY_C%NO9M9+(C]+=N0[[\W7*L,;IZ!08 M*E^]71RW]7*05+P=%Z<=9YCE.WTC[DU=VEOZ-H?L&OFF)D,725AODD)@C5K+ MT?"*OCH2Y=/.6HZ&>RM:KLD9IN4G;TO+2]+>3VF&?`QJSG M!$7%16LRSY_&M59T,MX;T71MWC!5/WY3JEX1^4ZZ7F+8VU#VUZ@W6<&@1JWH MKY%RU?C3:6BI+K\86I^/QMJ7@AZ-T4G#'+MGH_PI_I!1KK#P4Q*+6U MI*`Y!JJ%UT\G_-.!'Q@2(*!L96KH2M:,D?4!O^TA!>+&HDHUH1+IR@'AMI0A M9>B@P3C9"9N;&E:%0P14W:KCLT6A"6FN"!B,E:R%?=%TH`88S)&,*I,Z(9*M M0Y7@\V`,&L$MER9K;%$K-"J&G4RGB]-3L5Y8*8G6'UT-NF&Q`IJ:G#7IA^UZ M9VP)PX51DCMZU5FRS%>;6G"?R@BHQM9/CFMWW@@8D,&QZSFUI8AHQ>/:C[T/ M6R=.]^1M-+G>9%L;1#+%]@]);[G._'^MQ!1 MG$2![^$7YXVY<;4@V+G+VH+(\HQI=#=^$U8;-X5D6+,E-1H,-B#`00$=5,%; MS\?;F0DYJ1\.23U2I=6PRM[%T18BVW<9.$G2L.41-38MHC445'?*,Q9I)V`` M@P,((*L;G^YTS5K09=1F"J6L9AX%?+"VI%7P:=P`B9M;U1&=S<)D<3PY:](2 MJ]N@/FAKT)01;(1D$M>L+;8W0UG.`HF35VECRXWC(%KE;:F!!5>L-KI\&9B< MS)GBTLP@]GTI*1527%M?RO[FG@0'GG%2-K'8DE,71+J%3$7R^P@,P-EE#;9%?U^R)N+R?O8G^*6 M<;Q=_1,FZ-_P,@I#Z*:^NTOUBI)W`V?X)4479)4KMQYGM1T/Y#-:@6P\4!IP MO$7*^Y"3W(YVYKLI2]N[@!R*P6V/8C"HDV&$&P*E&*J(>4]>N!_*O?!J&TM> M.`_1BA=>;F#>"Z^/KO#&0S_\Y1/8,F8\[=$^@C'!:62"*476 M%_*R'NLR6]$IDRS'N)\>G;&K('I-`)8PKO6J58FTKMK7X0OR*3JLT%P`]L6:@Y:J7SD[.U,0YWR` ML:[0'3E07:&S!1K]/Z-ZU$MR@U0K6&TAYT:T)'-P;+%BFD,WSX;+%TW"KQ8W;*T`[5;=?&EF`Z^T6XA)G[9=J+@#[*LY! M2W6AFB@MU?D`8UVJ.W*@NE27=]!13OFHE^L&R5;082'WQJV[[9;K1D"CVD$K MD-QNV@Y:B**\(Q]`14U-M94WM>,@>*%ZYR2"JI[*IK"/!G?XX:P8 M!VIVO%S.RM%H!@"<OYZZ+2^JBU0PME"'ZZ))RT\EYZ%VN$4$PN0[+ M;4@2I``FLK1#_8`V:OZ[(ZSZZ.-L?LIDX144$$%U6(#&!=G`V,^J-&1CCR`1 MDFG.9;5E\24#,?/L;B?[4ZNJF>Z+T3W43_@>A:7++5_(9:V&NR"'LM,&@N%[ M_9KX*8GPZ62^G$SH5?XJ?$`'R*]+'7'O2YE_8S,@%[BWI`ZN_1V!*&>#Y7M3 M[86>O5AHQ4M#CQ1ZF6>)3"N)M$'W)PK1,H(XF,"&8GRU5I;<>#ZRE?6AVL3\ M#IHWOM0S7IR=LH.P*`0,P("U^:3^3'LRB$6[W:5)ZH0>5H`G!W5R[6VH54CY M?$&1Q.]F*E/`WM_4G*GV3L,.OU2X75WL_`#SIQ:OXKY"QJQ*1K1:^4A"GA@HNBR3PYR;FTOTIQ^"U[7OKD&ZAK@^ M]-8)]V`=!5Y26L!%=_F-+=\B\ZC4TMZ>LA(JKR?C([/53;@(#"AY89+'OJVX6J&8)VJ)A\9AC63[49*:DI[0#NA.SNKJ[^QD^A=^,[3Z1T_26QP!*]%?>QI<`B MC-1WE;-#3K-5 M5GQUX1O.!&3Q0.A]C>*+/=V2?X/I.O+:T-P$;6QF0XRKNI[--0S*$C\6\ZK(<';QLI36M0U[JOW'9OO*V*FK))NK*UJG-Q+/9)/K^*%JE)CH>S/W>(46N\,22I[.]P)GOVJ#X_)V$G M)\G5+L8'NC#VV[EM'08;FV5K38JR#9C6XD&-9C!'"!",`$$)Y`DPBD.O'*LC M0/$"%+$1VDXC3-8QM-N9Q[OK[:SXRK:[XRR.Q=#W+(R* MJX*^6C=K=>>51"D:/X(XO'ZL^GBY/+2XXF"I:3V61Z4MQZ,U(M'-7#6SYK03 MCX.U`I\ZELXOLL-')X8@C%*T;KP@C23'DQ!I[?K?.^=A0TL:6D5#>1H.CK>1/&6`0`;)GE"UI^A`L$@MJ3@C*Q*3 M9=("\<7KT`KQ6$JG,@KKT=%;+Q]C!I^-7SKY))RNM+"ED"0)K+0%G/'=(+<<16,`!6TX!():Q\ M05="NXW$`#E*TC?$W)8VM$+SB>OQ(%HG8?%R M(GL?BU?17;5X84.$#;Q_A_=4[WXY*E9+2,44.*$'GAT_/`(AM%JCOD%:N7HF M?DYN0D%$@C[Q#Y!TX*V(A,DO&8UMV/8=AS$.H^.&W"S(", M&?3)5BQBA@4/15]/!&Z*+F_M^"I=):!NPH7G7^!<30N&MGA?'3_^YL1_P/0? M3K"#?1B^!I#CM']"A-7U_+B5&<0#`SHR($._"7O8"[OD9G&%F;.AS'DAS'D[ M]E&J59IF4L+R<5E+3?G0-)I:.M.7]90O"%]^;OV8V*'_A@ZOS'5GB'9MIRZ^ MZK;@3&0Z%?W&(U",#/#0U@WGD+S*$N(I.9'X3(M(MJJL(9DV$58:EN"TY4 M[2@>:K2!S/ZYPK60:<:#$<V:";E=9:6DGR,_KDRL_<8,HV<505NZC_V%,7N/H M&7G5RDO+658\JHP`J&!`:H"4<<`1\!R+XAI(`@H\1E`2Q"9'B:W^.]+2V`FL MWJ\=2/,J5Z0&X;.56_+X01^]42Q[H\5K:>F:FQCIRBS5FYF_JB;"05ZY:G&< M5:XB,/)K[-8+/"J35$'<8J5&@L9EE*1(.[,78+E[T42CL(M%J9>041-_07L[ M>M"(C'25F1TO*PJ!H9%U.H-7%$2UJAE:1&:D%*5-LZ=?-CU77&`@RQ6R_^:$ MSC-9MC!9PE=3C5TL:8L"&15M:6AO7ENDR,A]LI-E5NR.`&,9:/:@`$MTYP<9S`O@->K[K!'>!\Z?SU?\) M/;R39"59;B(GI'D+.-M@;0B&8UN:^"D':HZS&W<,/L@&`&0$0(8@^_&\L@W` MHX`?=!P[K_':SS@+S[1BIZ&(3"]3W>N$#FI2AJ9X12C&@46P810'"-9[YY?W MJU]$9/=FBO)T6\JFI];#LJDYP$?9M+",H/5Y*5*0C58-/&-1")QLD-ZJ2!$N[/*-4TFE/H7P69#&?D`^+'KE M@QD3V4KL"Y/9@I?&3.A@\SPMS_/M"F0C@-(0X!;7)\_F>:@DHTO*@4S6Q=:W M!T;T(];F@B7LN?O7*$:;4YSC]#$Z7ZT0NHA5@HVOI$];N=6W4BKX*&8'FTYF MF5W*0"1@XW@0[]%Q=B.;YT%*4U2.!"GPPV`HJ+?9*5N3A)2`R>"!QPCD$(U; MCO9DJHF:%5N`S)P+H9=\19)X!;=1XJ?("-Y#)_B2X'-`8@[1E[RLQ5VAV;0? M.I@JRN[I;'9*+4L&$*\!,8(((`&)EPEHJ>A`/Q,OL#WZO+1CE8::\[J]8B,! M/!1@8V$7"(\&Z'"@/-X(K%EW]N@)OGE[=[NZ\E]\#X:>S)956EJS4R4L%,]2 MCJ>3D\P&L9Y@Z_AV"D_)N<\S*#6B+1B+EHRO&@*T#\JAV%9O*4$2>;&AJ]F% MI/"YZ4!7W-RBUE914;U%,YU-J>KFW8&+^Y,)P28U#^CC;*L1.8X/(_Q*:.OL M1:GXS"LY?]KXFLYCE!5U;S]C-9TO9F^`0^LVFJ]"6V\R9]Y0H-T7C;-<[/P` M9Y27F0I>!VO&HHZ,HN=Y?+:<47/Q':;`=9(UG3-<$,$I/#4;]%DT'-?A"]JH MD.]4N5+I8M]XE-!13A%_G`4K2GUQ9OBQ!$&;9J?1-M1X8=,ZM)P8H7THP1N- MA9#2J")B[<^IW;7&Y9.&QJ9/GX6HJ%\Y80?-[GJ4MTVD,Y.?FDIX8>J`5'-* MVC"^,_*-KUW[$2KR/NKN\E!HIIS=?'47G:3K*2'&0,0`?)#3$=9L3WU-N+0&Y&VO+6E'GI:^[[G^'. M-,MNK1HAO>$&NSF;I6V>1F:)=->*,[G1&:MMT3,C([(8K37$HE_2F[C-VHI; M!U5'G$":]`QO5Y=.LCY_/3OP,TRL_26/_:8=5[L[Q MO:]1?!WBKOX++/_&O?,^P"#&34K?)*C)Q?%T?C9A9HBA@`/(&`F08X$#2!0/ M4L^:8`+*PX$[%HC.L:G\;B$)E5V6ENN9^3E+5I!<1,P>J@(G`=L*UTE,W\FY MCOGIE3"PMPH,I<7%RC',9!E;;ITKZ6V#DGY55])>S#[)MW49 M;38^"49+N%=K;=$0'^"B_#9C><:SJ#3O6`'.KD7L0-NL3MO&2=#(68(]MY%$ MT_9*('X\P\/EB04+HC0W!Z9`)EV]J#+.R1`G:W][G96BOHF"I_HY=,#`@PP^R`:P:PQZI+YF''+2$1^B79JD3HAO(H!D M[<067QSJ2S7/8B@QSH(%:36A!Q9%7VB'L3')^0I]*-V#UZ6=`V!,EJ:&GJJZ M'2^7-6/#G;<$D"'*3Q]&9F\Z\8#6)XO"#TCG4X1(0!)E(5#I'FV]&`NR*Q#` M(:QPFEEAW00)A5[)"@G8.09#I#C3?8485 MP:FQ19IZ4#V>M>P\"1;,:.^"KA;GI-QSXDN"1G:R M3O)1K=RLK;0P?Y>6,[ST=OWB-'^&5TC5_5`A+H7#5[A(H? M>8_1'2)SC8L:P&0+7:P^)&+C?V-A8H!B,1L4\4`R7N?\T6D9&M.(1#,^<694Y6\:BF0R4WH`OGS2W\?Q_Z?XY9RDTQ@44$2*6/$.>UA6.#XZ4D4[FRSF M?$6C`$$!<1S*I4:GNE)E/SM",NTJUW62[+04BW48CU)529`I%&T]"F4JHR(O MJ'`Z;58D"FU,2M1$G[H"^5RZ[&K-;7'0K,&/2J_QZ`^'&)D2E;J,0I-J^,C5 M*:_F(U"G$L@QZ9244G7%BL04VM(NXLXJ<2-K.08MJB`MUAS2S+*VE'!06'!F M$[Z&_(.W1["C%`T$J2O"?WR<3(O-SU_!R=%D,L'_K3MO?P5A%,)L3:+ID[II M$3^H&\,7/]HEP?Y7&'C?D4`6-P^^D),V=DS]S?D70BS=YP?816B:%_GI!Z[I M8&\?6"L)_>EDOIRPQ]OYJ``/"ZKC`CIP?EW@"+"Q2W<)BM$M!(%-,VUVP+0U M9EK8?&OF"&P8UXI[?-M&KAF)!_>I?GELN+\),14G'DZ$-+5+3[E,.B]%>.JN^JY^#4`V')U=$FL>D"JO2TX1GJHR?VE61%2+B>*+H"3(AJ#)[W7 M<:6ZL>#S/=RR=%:X8,;(\N&7,U_[.%>5G^YB>+NZV"5^"),$)M]A2M]3T=\; MXF!M0-E76%VR1:JK"F<0)996G6^/*6=9RC07\Q1X!3"R=\C!@1"F^7-*+P,Y MB!:K6K!N=-=K'9\=3WBVK#0,-F;%0`!GC&0O!J\$'+&C^S@*B>W2;?S@!(@[ MU+=0X*FHHWV];B9)I,7\7E87WB:4Y$*Z.)[QA)0!)<>XN+(>DDL*>`P+K0[) MGW-2D+&1!#&021J'OMU$X3.^UG.R/C'T?.&M27D_^]K62)!(V;B=K.I: M`T;R"D[3*5?5,$QRAP<0J&0%('#'H&D:!).$QT]1'$>O."LRSI&.H-.4"5QZ M[*A6X6_?KK[CA.UW-%^[`C/$7>TKF(PLD8Z)^EE5LV:DY"5'YG.NII6V6DC) M"&!P)ZX085K7]*@^\+/SC&!C*4)0(HPNTKNC*_DPS"$G3N`1D&H'%`/M`8M+<] M0SZ3#=^6T1Y#%Z+-G\?=/V\9%W"LGSRDW"/,(;G M/WU179'2[P87N'Q4U9(URY,SNG*1GN`'[FLZ^V07W&2WL.*(<)&ML-)WJ532VO.3+\"9!5 M6]I^GBOFHBW[3)J58:>8FI]2<>IBE&)/6A:!*XD(M&>&>BFJWGBB+-SC,&'? MH2B0).TU$HE%N"@Z<,O%8TB/PB-$: MJ_$M2:BJH# M+)N:PM_^B;DP&JTX?TK2V'%U5J!2'TO;115"I!/!.HS"]SO`1GXN?S*9-.H] M^,$@FB\NU)Y.$35_&8/G1M.=7(=NC#.87$'ZKY1X43?;NM-,#E]]^'TL:E`3 M0O*MTLF"LWAF66T83,"`VE25Z:X`O9,:8/4OI\\2IJ1:OR&H9- MD75A7'.R,(V$LD3V#X.%RQZ\,5 M&-'XK,;$L@Z6=8>BH6BKIXO%<;/VV`VS]T*?2(-D]-G4G:KTR;2GS!,[^I.7 M*]A+]*;>T*B^'`ZO>'JSG$SS`%M14V%O73VZD#/3(\><-HADJ:H%?-)M2_]C M[(2)0Q[^W?@AO$YA/36L3N8GQSP]*8$$/S!00*".0&^Z$LO1 M(AUB;6A5DXR*=$S,IA%I7'*Q+__2N/-1!V!?"SEHJ:8+/)U.)?J8X&MA!\N` MU2W3$"S@K74CV#/I2K&"=@H9-28]O?(3-XB270P?X<_T`F'PAZ8X<"&,0%,Y M>"G*Z?QX>B95U0(\^($'`&2$D:EJ1QX4NHJ!X?#&JY^NP6^A_X(P0KNXK!;V M`XQ??!3TA%[QST`""I-F7@<%U"S@ M;?YV?[^DTKK8!55Q1K75`@/J4LDN]JLRQ="E_K9SU%+H>E3_;\Y/?[/;M+(" MPK[6C8$`,V5%64P;;$(&?)RVH0?*9V7*M_28+UJ]RX]2/H0D0>WR3Y)X08AZ!+0 ML9--/&F'WYOCH;:(PY17+^1]*D8@];&2.RG2ZA"7='U=^^X:[!*"#,V[D@($ MXAGYL]AA1]]Z2)CR)Z\81F8]MOG-3DR$BUO3\H@E4ORP3BN(T+:!(H,3:V2( MU8`B/M+ODP23'9-/$!Z5[%BP_P@>=@C_.)]RC#N:A9V;S4001*\T:1NBF=3: M(ZW2Z"@KWHASV[H(*DV#`6(_^0,X:$A\E1K!(#L=)QO[HT4S*%+`DL'C2[XY MT]9%\[)]=HAO0N9S2:`8OX^B0PQ%N21^'ZB"]FAZB[P3W[(T$N7\$[>KR]+S M?#JDD"U=[.X';V?+XM=($Z(2WCM(?3 MX`<'[9._P@=T-T[@@*\0%)#`#PK+SA4B M^6RP#6$C"PQM\+2F09O9PYZ9]2!",UT1,K<&/;AKZ.V"4I6#<_??.S_QL[MD MI;\>&U(CZX,QN(;I(J>X,LQ.3K.[SFR`<@T'4!X#7[$L_0U^D'$L+81#LF-6 M84=IRU<3%3!U/)#JHM+`/BHG.E6IYYT<5%I,Q M%!32FD3?8+K&>298GHCZMQ!^=S9-J9"[@;0BS_J(JE;VF,UF=4G/*IU2R.7$ M<+P?(`1X4*OOG4QQBF@(GPE',BZ8-^?M-89OZ-ORUJYOSLQL^A!+&37%9SO+Z6*2G6N5A#`'#G+HUHZVM&5NLW'B/7U7EKU\<:/--O!).5_R("4Y`L_^ M"][\P]4*NBE^'A+"5]2.,0E)779OS`_9"XS\T9)` M54>AJ:L5-T&,D*K?-YMR@LPY6$#A`@IX+"Y"/U37'(065)MW#^32RW<.9#RS MNPEGZ38?=D__0E;E,;J-SU\AAN/;YRT\_(926GHW3 MQZG9H^5H2\\?\;M+Z+AK]O+SMU\?P#I*MCZ^`UH\21_#\J^6TDG-']""946) M-#!4W%PO3AF%^&6J@*?^W19K45;P2Z MNQ@_'WD271*OM+#D(]21K+"\^-G\RGTXMOS:]WS"(I2T+SE#M[:&RO#__$WR M-.\(_1E^P*D2=C%>+B.P2\![/W2#'3DOQP^./'Q+8!O#C;\C>1+^8_KQ&&S\ M(,#W=C!<],6T^"(%#T@BR`56,)\<`2R[I-D5=+-OI^3;:36)PB\6EUKXO"%O M[;>(78AL]3R$2CV-2K04'T5W-%KS=.",]#[^]1X,5H\&_0\UTGN%VM?!=>[/P` M6Q=FG&XB)Q0_&>D-M.GP?$^(*[\H.,XR!Y&!038RH$,#/#:QPFQTD`T/Z/B` M(5"\=\."046J07#.^Q6<07VCX?ET-IDTJ-7M19$0 M(4"@WCN_C.%!S]J)X06.H^(KR!#M9QH*=XL:6]I`-*)>6?*X+&)T.&6>K),;#:5`BDJ M3E^(=U!\#Z2II2UU$")=U85:,PN*(,!!J@7'D^62:0&"07),TNOJUM8579H^ M/[RB]0"!@)\2W.<#R3.(5X2DTWK`=\!]&,=.MJP5!:#$7G5S>].N(=!R-Z5**;=3?WI:3L+`%U'Z$K-9>S$;W/7M M.Q]'X;OZSZ&//'4G3,M/\I`_?^4GVRAQ@N2B'*1O>BG3"I3));,%@JH%>&=+ M=H!<#%)]E(GW>?DX^!BL4K/*YG.8@=DR:V2+4V'+DRI;C'F$'?2CXC*V9K*5 MPR\YMB5<&\M/M@,U+JM00U#U6LDL/QQ7LPH5V;=:YW)HKF@8A2-EMHS(*`C5 M0],H")C.H?K/BE%DZPDH+&-+UAJSESU-?>\3/+SE,4OY&"\V M((M`'FK>R-*?K2R=9?PVB5UG>^.8NENXT*)#!G0).>_.W'*3(*(0;)R>'.HZ+>"%P M@,!K2)-O1=CRE_QW$0T(J@M=0U?KPB.2/T2<0>K.J.U5A\O%\O3N5!WK-=8ZH>\4JI:J[66Y$+6K!Y=ZB\- MI2;7[,7O'7XLB%S%4IGRQ^@[8DH4IHA!")7GZQ!-.$S45:H=<*OJUP9EU8(H MQ[.I6%7S@4$V,B@/C;.[5`<';/2Q+)!#RB2,UFHSUC^[B(LWO: MQ4].J'+4+6QJ^D1(@(AZB2YVP)T!&M71MF1"\K.;1B:8.J#1F@EM?@]\BMV# M&,UTQ:B#HFXV,$:M?LUR67&/A6Y#J';PVP6:<75OC:OZ0?`)LPC96(`-)CPR M0P..[42XNX@4UJ4CSXT9H)YE8S@)&/S(V"8KKOL]0>Y@`1]?HQXMH`#:*"T@ M%U=U"[C0MH!HP#=I`1M%1,\"-O!\5!900S:&DX!Q6,"!6'%MU`0^HD:03Q[Y M1I*+P6;?F.GK MGQ'7R+*)C5[=ZKUW1W%[<+?=!N1TUPG8Y9WK<*9 MFTG9M//0N\4IGK_FU0MXJ"MV-*U^2F@I/WP^R\(4UR%P7#>*/7)1\=5/UZ38 MPS:.7OR$/..GY1_\."L8D==]2H[0]WX"(+69((9;1#G`1H+8"D&/FJ9$JH^HG4$]4\=/P`)FEY(DP=$U$LBXZ+12$&* MG\YFB[-RTXZH4YD?8./L2=FJ&`&'FP0D.W<-'#2,\Q-#V*49FXX(?#?:;'!" M[A@Z+-5>\M&:.FO):Z[D&E)A2O5[%U3B@%"PH`J79-X@D,%78442$_N&+D0S MT@YDN4A(_X'47NE6D_(HM9PTY='L^Z&L[_WVZ:LIM" M&58QGP(1&8$5[22\2L84C5`I8C-"JZK(!`7C^IT4^*#$;OG$=K:P"8Q?8/(E M02+]FES!+7YP@DFY0]KO^-X]1JJ!`6K=+=E7%>24)72172DZWT0[-&U.2JSJ M4_:0)L$/:0!^7(.^1K^MD8UZ@A`;01?Z+V@"G_:D`QH37Q8DC4H&UHV"`&8U MK-BN'EE'*@D.+0W)1"&-T$X$X2]H=2%OFNE/\895>LM7JH_@`0]$8=)5@E:^04BN]PD)968#(AHR MW$FI.KS&P15YH\>^*ND:1V6#KB MC1\2D_,]2I'>W\'8CSPNI8*6QA<$+AZ*,;;"M2[!`100H)`LQ`N[DS0[)"FD M)&V%))FQ>HW251BX!OJ-V3*-.5`7G@Z*^3/::*22E[0WKJ0-V*A?V(#AC]((M)CDW"9H,]&4B>@\N[W-X<#.UT!B M3#RR^6(ZU::YO;4I,D!?1@D_UE-K8MIJ'""@Z.1.T/]EEJ&4X=O%$.SMZ07L MSG6;2ZHI_>W`Y^DAGPD$*\N[$A5UF>A/I7:)ZX1[I+4KF.`3%R=@]^F^^C^A M=^^D:O=WVP(RK9ZMT%2VBR=9<=1L&%`>I[BH2$8">*B17=GM)@VY7>C`8U/6 MHT*MF(NMU2=/'T6S1SUD M)V77H2M<]N5=#*N8#"'UHB:9/U[+J?60'R`BH-:7;-4Y8\*MQA]#XMYNLL13 M(IV1H=?5O@EJEK&^%?UV=04#Y]6)80N5YW8>A_)S4%./=)Q(S`!>SQCX,5N$ MALF5V`8A^^Q:">59;9B[6XVYLV0[^B!3543-O8C[)\0!2>B=(XS1EN#[#N-S MY0<[]!U)4)G<[M(D=4*\B3CW_K5+4JSXAVSK"LW@F[*6."JF]IZ<3+)*YFP< MD`T$Z$@@&XJF_T227PP&BM'L)&XTP)I9A35.QIJ0L@:I1X*'`?#?.__%"427 M;4R]J.RH'.47EIU8:R-I)!=A9`,%*.M(5!,4VX9`C)MJP8O9=-)L`/!:)[0! M=O(Z#LB*4Q6%IS?/2EH/HI)9_,#X-3I;(-<'J0V0<7E$NE_#\,))?%=/I$0P M[.L]'S/5M6VRD&L]9\4G8XQHL>^##4I+_*&&"QEA6;^;95Y!NYOXV4.FUG]" MD@$VQ>]'GDG(/[L`<`EQ4EAA\$"QG^&X@1)6ZI'#[/5%`14PL/DU"0K8>JQ` M:QI9F$"#6X8B!!WFK^LL#1T5L$2:N47_'!\+^G\2U<2QCJ?TRD]<_&[I+H8; M?[<1K",*_>SDPU$F".L3@J-/R2!ZI(A)3M/Q^>`_*0XZB5M^5CQ]9AIY,$#GM[$B>$&$F M:E),!Y,M'FJ'PI2WZ3C[PGR>3HR?V>8U_4IYOVY765V9U2FYB1@@,YO$HZ.^009"5G"IA#Y[A3R=\Z#`]6.0_\ M*@\@Y8%3\*!VJ]N=U&[(LQK/[G+G&FT1;SJ M!\+2AJX%F?G>K@-]PVWS]`BJ>[0N3H=10,%7?T/TV@VP\P&O$0D MU)X&%B8.LHA\:Z)OE9,)D.`$HC M@%(8EHX!\D&J!58>:8ES>]IOD$\;RB>_Q*>DX)-/QK`2@Q\1_2#)Y:04M;<8 MG[\A*<=O::I<:71"V-J.6R)!GCDABE@/YG*(T:S%K[($\'E;BR6:]##_\M-/ M",(T=3Z.P=&#A!CMG%^1!Q%MZ5D"R6WON&N6NA@72EBS$I,#5$PH7XGXIY^N MQ:]FD2,DNG*!+<#."1H.H8<9QKR+,22[F+?,]GO?9J+_8K/UFD8-]WHDRQDN9?V.5F;NY"6 M!FWE^'#-?'Y926ZJQ4W-FUL9VLQDBMH9-7O-2#3<'QN+U1D_`3)5;TM!?XIV M&6VV48AW-[>KTJV1!GV3]C"O=HI$,.V3-#>JA$JXU`2AZ(4?Z97ZV1;HSN3@ MDBM%/V[^TJ'-2L\T]*:J7Z,XA'N6?C=P_G2$3^7$34X[.U%Y(<(L'B_%=+!(/`^U0SDH8N^LD8W(NQZF4(!IZX7LQM_X*?1N M?.>)I'W%SJH3XCMR]/8-Q)<(?@L]&)S=[A(Z/H9866$'84.0L2'(V>#F;'`J;-@1 M-L#R67N_42V$`C((]YC\R^B%%)*41+4:>]B):BD048YJ-30W'M62XL(-H=!> M@'0#K)]E@]&.&GH?98^C0?=8S&,D^(<4)D?@[_X+<4Y6*U)^.`+X4BP;(D&? MD`;[(;EQ`BX1##\%YZP\L+407Z>Y)56<2;5[W*\_I<>OA7#Q2?R\2+X];VQM MP3V1(Y_['N*F9AT+&1[<]UP`=Z&97L:RIWX[A$C7]':4%$_L4MJI/Z5$UNP> MOD0!-G+4?+'2$[D5$T:Q-?J:5UAMPICZ*G_=V0P6$]&"9D>;]P`A(5I,%.7LDEA0YVPNQR M$LI1=G%KXT%V&2K<."SK!)YH+[3?R[O9BJ_W3L@PSK]*<%R;%%=&2G_AN#L8 MXP1LSC,R*=>@!I%$;TAN^-:$N(./%R,]@`R]_A.&'`!+P^'<7#0`<-@(Y M(/9*8]BP2O\[LT9FYH;CS;;"&W:)((VZLFDT\4H6&L'ADZM=C',GP=B//*5( MI;CS&&*4,M+XT4E5F@S%)1N(D$8D\[`7"4'2WH!VMQ_$TR#L)G)"I%T9,8'_ MA)0)1_+Z.Q7,*DU]C\(8NHCN!'Z+XO09J7UM.REM;N'L3P']_+BOH:W9$SXI M(O6SH+P.7*D3R'M9.<-K305:(\(H_)"3L1F4#.DQ7?]T=%[B$NA^?(Y>/GG0 MIZL;^G"XJ*&O?C]'A'D'YP(')(J;F=56&;I%'24YKH,M0`($Z^6%LF;EDZ_> M3/)O(6)C$@6^AQ_WWP1N(KR7(6YJWA3+T"[JT_/;&:Y&WX0$IRA[N3G`[2U7 MF=="_^;F,L%EL)`OL:M28O6"1/=)Z/'*8N`*M:STFX7KB(>(Y9"P[J)6#C>!#O9HEN6%4#!9:.9L_\S4G1AB7=7^&MB]#G MT.P[AAVSA##^AEF!HC$$-_`]5+7[5YQ>8Y@<(3'R.`:7"@L!#(:V9N2"=!M7 MQ$)$R67U@J(2)5U..S<^R07Z%<(B!LH_!^*WM'*^V81TZ6"3U\STB:88!]X) M8-8:H.:@:&_I#+,=ZBMH)XMN%X1!$:6WZ"-\^8D/3'=^LL9XT2*]YS^%=W[% MS>TL-C+TV2JCBO=@RTL#HO6TL>6F>4GG'[BYQ>M+/`H>T:!7T<;Q16ZDK--X MI*9.2I/LB&DP*D$5I-7DZ`C@3N`'[=;?)::+V/>>X:LCN-[):V%^&1<@R9;O M@Y^-+MOMWVUDKJSMU-5P?UQ`8PE>V3NLR=T.:]1>B.G]^CN$S\J7O8C]T M_:T3G&_P,_[D:@=O0W9F\3U*87+G[/'9^\6^'F++#N(8^#LD`Z$&`FPI5B`I_UA:!P'!H]* MJ3(X:3)L9R![.\S&:;_PP&F\(PFJ^^"^G6QH;X?G4A8C1&0"[F3H])H0Y@EG MT"W,JH!32@( MZ]J.);/*N)&7J6,K[+MD4.DIVL6MCU:41_OJA\@P^$Y0*HQV4#)-4C>LUQ$L MQ='Z9U(>=!N..\-%Z'IEAVKEQ:-RY<5\B'+)Q:-Z04:[)=2,,*I-Z45S]H6= ML%*R;M.U\$4\MZ4=?6]`FNFM`K:#Z1\?/6%:#=KL")"&-M1`$]^L6B9T8N*9 MHDTAN1GX@B0Z0A^=['J4/9G.E?-BER#O.4D>X#-1O(8#14D?.W*N1`B3>"T* M!I-]&(_DW3N@=@:>='WA^^$S+VLR!588]=B#N'Z*MQ`\0CTMTIB9^4EX#(5'K?F-A-. MZ7"X=+2O7I?^_!8]W6%D'E^CFZVX=IV@H87*=8THYW7KN*W,5JUK0*%>.BW] M"5!K0)H#U![<;"W7K.N*OIV*=5I8/_X7^'9[D6%]?0UN[OHO5_<=O@;[2W;> M#;V+;.'E("]N:B63=B/:I<39W':F\V0W(,'+IAS@4C!Y>\`ZV$H.K8^]6\*> M^7)6-*XS]D@#!W@+\AB1D;Y&\0:7TQ%4U>$?]VJ"L/EZ1(_,^K,2M?Z6WIOH M(-?T..*1U&]!8D-[1[5\%$_/*UIQGGP`YL:DL(S$%)K%;^&R=K:/+:18OW5>4%C MDRM\.0&B^IFME]![N'7V]$4(SCC%4=Y:"_,+H`!)MKX=_&QT^>*.S4DLG;7" M>9QP.QM66!?5:`6"H5"5K9$M<>WO.MU7_P4^P!<$>X\__NK$WI[>-8AB<=A$ MH9.%$(HR*7DX1=K#;&A%$9VZ!46M0=83D#](7\`Z6WT%U9JJD[,3HW1(0T?= M"?&SYCW6/(M"7+81$8!:/M^^AC!.UOZ6+:2\G:VLAX6HC!H1>7"FN;G9&(T* M+O5P012"4C>0]\L]("LQCUYHB7):_"%ID8:?6A/C-A(SS,92Y/JKIO"1)EW9 M9%T![GLTKI)/ZF3=PQ6Y\PB9(T3*21J;$7EB);Y8`=_[VSO?^WTZ/UZ<3'\_ MF_3W^?UB8*?"O/D]F:8OU2-\/4-5+3/AR*T/)#&#C?H.>[3L!BLZ3N M+_PI=%L5^UD(?.H0E$<[53J9#7&J8U2/>;&^(.N<'UZ`K+M5)_8MDR:-T_9" MVR:CC9W:D,`DZM[CNTHGW$?AK]`)TK7KQ/`NCK8P3GTHSAXK[V)!V17)R/5< MTMZLBBLA4Q<3T@T4_4#1T:Y>OS5ZI,K+I:]2? M%?@G)'OK-`KOX3-"U`DRQP,[$S`^#[V':)>N7]%FN[!C#_LDA1NAR>@!IGG[ MTALCF#'J#-"HY>H)VYKH%G`!`YQ[WA0T0+!!#KR\C%/P5JW+_ZYLD1DO`WR) M&5_89L:E?,''Z4G.EY*3E!#P%=.8?;Y!V*._T5_HPQ.RH>B/_Q=02P,$%``` M``@`^3!H00TA8,%$-```[*,#`!0`'`!U:'0M,C`Q,C`Y,S!?<')E+GAM;%54 M"0`#A9*;4(62FU!U>`L``00E#@``!#D!``#M?6UOXSB6[O<+W/_@K04N>H"M M5)S4Z^S,73AOW<$FY2!Q=>]\:C`2;7-:ECQZ2>+^]4OJ719)D1(5D8HQP'0J M(:ESSO.0/"0/#__V7R\;9_($_0!Y[M_?38^.WTV@:WDV=Y/[^\F%Y[K0<>!NL@"K M%?2S5B?3XR/RO^FW;_\Y.?>V.Q^MUN'DI_._5&J]?Y]^XPP$N$U<+_[8R=$T M^8N#W#\>\9\F6&`W^/N[=1AN__KAP_/S\]'+H^\<>?[JP\GQ\>F'K."[I.1? M7P)4*?U\FI6=?OB?VYL':PTWX#UR@Q"X5E&+-$.KA]7X]B'^*RX:H+\&5M/I"_?N`W\*&C>`\A9A)I/I@OKS'_-E!(*%JU MKJ*<`8<0X6$-81@(2;%70Z4MSD&POG*\9S%!ʐN0.^/@#:Q@B"SCRYMFK MWE6TGZ$+?4$Y\K)=/WH/G9CVP1IM?T/A^H>+R%@'G%\@<,+U`_2?D`4#3$C< M6>+"T,9ZA[N%#]P`6'%=(9$5?:FKPA?H"=G0M<6$+I7N^N&9]:\(!2A6`VMX M@8*ME_Y32!1N_<[]--IL@(_^A/858F_'>YFRR5R$`9&L`M+ M-]J=S189UBW+B_"X[J[N?,_%/UK)0")(4WX3746\\=S5`OJ;"_@8"@E4K=`9 M:+@BBMS#K><3]<2`K%7J%Z@[ST$6$F29:%-:C)0+\.@(ZZ7P>ST.7A(J";3R MV@.9A/1MFU8Y8DB(2ZNFR$6Y@"%`CI@8^U5>KQO^6`>^W17<;PK=L>2*EIGUI- M!U/KI$^U3@93Z[1/M4[5.ADRO89:;R`;RPQ:73_1@[W%.C2]8@_BR%B35ST5 M;>O#`"_(8O/>8$DJ,N*R>"Z&=B8E:;3]!F[:,@I)(\?'D_>3K'SY1^#:DZ3R MI%P[EA;+ZWA6142'[(I[?H,=\2]^YPDW>PQ"'_M!63,.>(1.W(Y@M0]2\J46 MC+?F`V@=K;RG#S9$'XC,Y(=8^/?'TW1C_M_QKWY//GX/5XA\TPV_@PW<$Y== M+!>O#/?,KXH*?"MK$/]8P[IZD)"6^+"--UO?6VODY#19^MY&QGBI$!Y/`\^W MH8]I<_3IW20*L&3>EC1"F(QU6D+?A_9-8@:FS+'`V#%^]`(8ER5UD8,ZR33?2ZWTU";$_T`K+/7\W&+#/&%0HLX/P#`O\*_R;@ M=+=:29-P9"I1(/KM9#HJ3.\@_KHMAFJEK+FX5M0H(?OY6,$0&T)_*&#/(]^O MD/?2M2_P"HV"*[NH2;"RM2BA^O7XX^=O)O?7Q!Q7R('^.59NY?EL=W6OE$E@ M4A4HX?CM^.3TH]'],W7'OS,;)9,.>T1FE#,)6H8*!9J?3JF4[*[EY?#/YQ[^@DNB7O%/@><@.PZK+9J:>,M)TMCDIQ\NB&R$__X7 MN6VW,D67('B,K1<%[U<`;!.>0B<,LM_L$S;]]>^)%+EDK*VYIM+M>U=[T>_A M$W0C(7"\V2$\3LS?I8&S!T_YUQOD6^H#$+-U`$,3'YF4#W2(7 M;:)-_+?4(`R<6[0S)!%8["TSH(5**46F1\$K,&87\48N/EJ%'A/1P8X\2F(DF2K M-#%3;C86X-PJY@#.5:,`7)L>3O>3B_L7U$Y*+:(_1E2Q"TQ&MK<0ZU?0D#72 MUHOI#R13]`+,KEL->OK#B4=YXP7,>9-6TC0?N"Q[BNCGSMZO3G@6"EYA8R67 M!VYAN/;L:_<)!F%Z>9QSLM18UQ#,!;5)6?!U5&L@NK;W$#CDHLG/`+G$+G,W MN2)'E*420KX90[@AKU@V_!]WY8EF4_FUBXF+]4\G.N;(L%?*$)QKX1D=K.#W:/,(_?FR%F#)Z\N2;1A"!$FM\HBJ\=,C[1(U2\SL?T:)#RI# M%)'63*:,B'X9><85C\?H02R#R(TN[%9,)@M/KXPD?3N-KQ(,O9<8-6TJBX,^ M$8R#3EN9),T,'0&="SQ?YEDP[M+N/VPTF`"?JWMIPGH5W-#R*JC:02"+P9A95K2) MXNC5&08G0P=UH4M:=<62CM=QD*S]1%;!P<(K$BS. MPBN`_%^!P[SE*-V*WHZ^M#J%>S>R:QQQB*70LIU:4F^8J2(74/:5]F&H$$40 MK#&7R7](L,<3<.*1,#P'OK_#"Q9>_Q:L.V@P(YNIE3!&,4WZO[`\V%V01/;[ M.+K'@M@"Y/T!ML?-JV``WCSQ^[_I+`TR-4*\*GNL."5(G%I*9X18,O=_A7DP M7RL$[@IA31.K8!)>OEA.1+:+?O8\^QDYK+A#L:HZHRVE2/]WG`<>?K-H^I+5 M&L9?:@T#`.?*/]KKSUQ(=4"O&;@:1M.O8UKXWB#PF%[#;UC94$N:>"I)5624 M-YYOD`OGRW,L.V*C6BXR))P<)E;1*PNL[O*59B/G`[0BGQR"/#+C&\HE#`"N M(F^!V^@.B9.+!7=@1WSY-#4NGO"_>ZZ5_(/MVS;7-`!G(3T*_,?F\5B6'V'1 M2[9*G;W2KU@.D5A=`S@@J$G!`FTV&;DYG`+H/\'@,L#6>@XN8/R('-'LSH=; M@.+-%5XF)['J.L,KK4R!<%>O6;-^WMR;3>NSC)[9-5!'J]5.G.EZ[3E8N2!] M/ZTIB)1=P<2U#T\?9=?>=5H"W66BQYKS#G>H)8?%N(FLE0R8-/'5Y6K3;/@M M):[G'MC5BID#:%WV`LV13:8SVT:)(G?8=;AVS\$6A:(J>8/ZT.6O8II4T M!V2J^`6JK6'5,X*Y;AMA7]HD4&G2%YAV#8_1:I5TB]Q8@&PGCX%GO9@Y:-9E M+[`<64Z^NF&NW332X(YD@L4(A:&/'J.0;-JTA02)N& M-.G)3/3VDHQ)ZZ?JEKMF,7N&99)K3W&!)'-'VD1*J]J`RQ+G!`OO'F*'Q4(. MK"B_\-2,&/U\RGRF]6.7@K!];28='O/H'(/:8^>3?P>D\R40K8[_LE22)/!Z M0U*]\AC"*OP6R,'2?;2W4-YD)NS78E/[--H=KKKHN3TN[AUT7F*-P0V2T;9P M;D:U_=L@ZUF06C'+YN<>XX#XV>GYLLT=4PV5R\NFNRH-F)^JT M:75D_&EC`@619'I.1$7*N3N(9<&FM7P(`G@!D_\R(T2;JAE,&F$=U<6B:<:* MTDQ<[B#9E;.Y6]@F=O63L(RF=8]T:^9SJ+7J"D+C-%TM[2\2LZS5PJOF4H7Q M$(2FG8)PM5=Q>%,=\!(N"*)-Y0KRW$W5REY'I[LITBT8#'P;=17D]]=T-"@- MB@_`@?-E?&,]RT1]YX`XC0$YV]AR7F22;\9@`K76N?]4L=KOWG?>M1\#3UH3SGJML6=CUO(?;T`C.>[CZJ;K4KMDH4]DJ\-S5`OJ;&^3"H"'=ET`] M#<<4@:[`FHT82JI+8Z\Q,>[A-O7HY\OO7@B#-"63`#?85<=%#[:>_6>64Y45 MN=#@UO/#%7GXL*0)YGSI6H7,?JVRE@VFC$HS*,AYI^G"*;=/;M8XS6W#)DJ] MN,%$:=1-0<8[W=%ONM9/+3DFS&G7_=NGMM,4[M+L>1T$$3D:G_O)HI][Q5.D MX@C((*!E_TGQM%_)=E[!CH$K,MJ.-"$?_1T:J>-?N29,VN^0T^R5KI+KP(_1 MO-:DAA',9YN.NW)A&W,-2^F';X81OY^,D!-$J8P5G2^F)ZRX=+7Q21^B[=:) M;0:($"RXO(D]%P@Z(-`VF!>F_A9J:`&4I7 MP<@ MS56&1%J>TMG!1K->"MX\TW,3LZXZ^\62W)S-3SYT;]9`)BG3O6!;7[FO^QI" M.KX/T[5!`TFC0.MB1U07MO0\-F4^?C%"\]8U;HH9*V-M M:DL9SK`;&!-?V%H67&D]QHARY54RM)X!AYQ'/JPA#(.[V-!K&"*KR&Z4IVD] MF8JE:4V;G"1MEI.S3GZJ?&'H9*V-B7O925LY58?HZ%@<;.`;]!2/<95GQ$O/ M20ADQ&O3D"9[H%)IF-OHV7<2UX$V0,B&S[6+3141.^+.FBA-;OCP-L^:JYG( MBV:M5&4+THP%U;?"\#`]]V,;VO%9T1WTXVR`S#@>L*BBK'^L: MS*)PC:7ZL_`RN'RH5S*?!W6=5,5::#TN)&J3(#8I[+,*8\$]TT=94(4!H,^C M,,".$KG[+8%\I=98X*\HI2R$0C,.E-Z:E/0&A&J:R`4AQ<8:/%%27M`+X-8P M''_F_#_MS0'4!7?N[,\L/0J\]^?]L3E[-86;)WU^E5&@3ION3_IW^5YE^_=G MZ$*_OM>+^3%Y/R%A0(X71#[$_\A*#A'?9<712/%S>@ZR!!Z4X508HE_-_15P MTWW$8JL.NL0&&!T3W#8O[!4%O]9P8-?VM$O=QKU>NN:KNW M(73I5;KY/73BAH(UVOZ&PO4/%^'Q)P#.+Q`XX?H!^D_(PO.;:V%SQ86AC5W< M<+?P@1L`JY(^KQ@D3O8'B?)W)L_X0Y/\2Y/D4Y/L6_\QF>#/'4U^^G__BKSP M/W_\\I#\\)<)'FHGJ0R36(A)18I!LE#2+=(P##57&R:E)ETJ\7%&JH4AAQ!1 MW*II-264&],84;NJ7?3ST_U^7I0=XL`J^WA#]Z.44Q#JE;?*["6,0D-V!*;) MLL@KFL!C(GRF>XI)'AA!C6ONX3_=R[7AZJM0?H`N<10%)7A3@MYT(2N6I1U2G,77,AVBS`?$66NZ7E^XW90D2\F<6 M*+WUTWYO+9JE=KO/#+*JL#ILIZ;T>3=/PJ&4:6"0#JT` MW>:W\,;O8I*X6SQ]S\4_6K#R+%71M3_7UY>D@4G1PF2OB4%WI\[7P%W% M5QHN?=_SSST,CM!"4:Z)8=*X/+-@(Q?-$ZGC..N\#,)]9.M`MI^LM&D]=JK$ M&5!-^J+"`F,:*+(4G208"KY$W=+0E:+8[LBI[SM>8K)U4F19TA0O+W MY&X*PV<6'R31R)XTXEZO4,U!3U`;<*DD%Q%19DR=C>_+9D=6^UWP8_U@M9=LE!+%G-/W!;FN7)M//G4\@V]U M!#_Y*1%FD/EH5&?Q#]8:VA%)!)R]B_00/?X3]Z6%-_=G3P`YQ-"XJQ3I,<@% MY4;/LG.SIIW:=]>X[]N=VIQWL@82N5//0<>`41Q_%I3-9"L;_&Q7^I=X?Y=I MRJ2CT78:CFF]*7O^Q.KF\L>E<\IQ:#\`P+_%H01D2^;=ODT5-.FT=M^ILJ)>NX]Q0DW M@\:.*E-9\P`!26TT[K[DHQPM[\GQY^P%L9*^ ME_ZN10:$"M4J1[*%H.,%ZA9N'J'/@RHK,>BIUSZG:CAE4F;91\8$U"URT2;: M<*':*S,X6%5ARW#M2:KAN_&*4`,OS:A5R^B,6E72T3[)FT\+V(6$U_A'UC1& M*ZCW?$:3^)5\]DY+\3L?/B$O"IP="8WZ[KD6V4CT'%QOE>P#94\7W()_QE^> M/V-GG(3XW$&?Q(^"%>V=(D7M:@%ZC:W9XEV1DLH2.?9)%)YV8I20;D%O\*75 MR6">Z@QSNM0F.P\1^P$Z3D$#%HPW9@7Z74FJ.<-J5",E,21QRF>[\EE,&U1YK1F. M-T^U?EVO5V)"^6V;-MA7ZQN.=E495>?5?>);S/WS9>X09!Y",%OB'TK!@S0? M6K(!O1&6U499BOM!^_!=Y%MK$$![L49^$EE^B]SJ6B`WPD7D$]\E?M&^38?O M\#&]N=.GYBG/OO1,,\WN^_Q8!YPK/\RC.15W?B;2EWZ&//8;Z:V?ZFT4.WF` MC'LP*%35W-L[/*U&>4(5;TEE=Y;.'1`$G'-%5N%!MV@DR%S=;:?K\D90OO`V M`+%>8607'Q)I/E7YV&;RZW5V274F;ZV9XT#W%MKDC=)S2/P5^@E70V&]L*H2 M+G/I>/+G!V#'GS6&ZS<8[_R&GGL/5[%T8L@)UC,!1$%5"CR_Z'*@28]+]:)P M_8R7"(GG:F$[/>R"$&ZN70?[J+\"S-C=.=ALHX");HLV3$"ZA5H%ZB,[QJ:Z M&[5SHKV9M:F2B9Y4DTXF'(`O1#,7#<" MSE441CY,@]?NP"Z.?B?IR=`3;4NB=3,&8-I.,1-&VEBARY2`&86]H`'+GR]WM\U0M,MP7*/NN(8EW]FN M\A>A\QNIMLP]T)%24S//N=^^4+4`[S:91`-Z[%^TZ"Y! M$:V@CF,%F^LLW`TZ,&([#TRWL+F*+BC2/<1F^8O;4[3-H<&WG0-H':V\IP\V M1$FWQ#_L]T;\*[PX60'GT@T1=82FEC!Z"*9JE%^9T*,3ML$Q48)%)D]>+^`=NA09,R- M?]IU8-6L)Q:/+Z0;@.3J#F_-R2INM'O3K%Y^"UB/>;4_\!O6E>P*PZY,^"QN MPM@@Y^D..!L;.#`-Y2IT8(ZWC35T0XX^)#>J44R07>,2>XYCPU;Y(Q#'KZ&\ M&>@U*%',KQIWO05\P;J)`]=0W@S@&I0H@.LZ,^KF&!F2RTV9ZU-+^3;5I"\> M4KX=4KX=4KYI/EP>4KZ9B!ICSKAIB)9OKC:.*;%1S2PAD28S)=5K5?/*9&/& MJ7X^H\MQ)Z]S9)YR/Q9(*79\].E5PNG;\^S:12$"CFA@*K_X4`DO^NPL&4_X MFFL6Z\3-JW(/7?@,G'DL(B^MV7[!,GJHV6/M"5,N/WP M5G+1OM9\TC:3;4^IV=2Z$&<1-BS6B^<]E,J,&NBZNKKEGE8T;U!?L!,8&N3K MCY8O\J;(N*2U`TKB$W$]#J9)4<+.4_I#%Q='$Q6RE4L[,++TD'> MPV`+L=Y/,,DZD%Z5)[$;)-]H_,O8GZ8%-;1O:\P$Z6"6C$):^Y;UM5:Z5=]J MGAK!<=,^!LK3-\=7$O&?O*F5MS[FTV M*'GMF+JA3"TW9F09*F>P:NWI747D8KXHN-S28X:8JW@&M"Y>G[(`D%@`SB;' MV>XN1H8='B+>PFC9T\88&:-Z<@+5/]T03VI%IZ"O%-BE1PM^D^+Y4TJC&CIN M/'=%7-H;#UOI#NPX&3?H14?+!Z[6&1FT]@-G]A,*/'\W6_DP?ONM.#N_P.:@ M]/S&&J-%6T3Y#'2MO<0DP5ZFRQ6$P2PHCVLS;#?\0^(?0;L(:T\R6-)(T;7% M49.FJW$R4NGBD3;Z#^<@6,^>`'+(2'CM7KY@$P;SY0+X*QA>(&PF]!C%\3D` MD:?,L'EQ56SY\M\8&Y3*/S)FZO5AKXR-6F]IEA6O:W@;!>$9)!:`>!UXMFM+ MP4XMOQ7>=3)2'M^E,]F*C832($]Z$7=#K59VS(3@J)U!K+>?+.\2O6F71]"E M^:BUG\Q]OK%D&?JYB%3M,9-!RA`9,;3V=?<2EM.#DV=X<8@GLZS4/5:31I,. M;8V9-!W,DB=0-HA"5;W(9E([^HBV\X:H(VJ2G#9=/1@C+P91 MBS8:=Z"59'-OB%*2ELGI].WHU%P^<53L.A$*-_QF.29AHQ+;/G_5A6X*L[". MXXWICID>&AZ='CGJAS>G-0"7.H,G-;XS6DJZH?W M^Y0!HB;B-[_"@C8(.W,W"#S&C^J>>YLM:^4^LSX^-><75I]VRLS:MX](;YCYL6>:8V=8U$&G3A*%)@9H911B#F=)$ M::_R&.D%>D(VKI$]*)K;+'])]'3_(=&\2O[6]B3V1-4O] MIP8ZMR\T,.\6=10%R81`D#T4EOG7#;,>OHN;E MK:WGDJO!\V7)=)SYK['&D-.@B(E+[W7Q%5$UMBI;YZJE84GG;)5UY^,5WSQN7\8G%&$L$$0;2!]G?8Q%M%WQAJO!;L'>5A6['F>5Z&H\^XWW8_ M2_1"X.@RS;ID-OV*`G&U3@CW+>C3Z?3]D/6MX1Q M+ER1#6KS&%=W##H3C=;D*/E%4S3WZH^^'.O$*_JI8@=5+V"\[J6%F:IIU@3* M*%.V./<\^?KMN(,+)`W],6^D4Y3D!N\S2>D3LRM&]P66HOELZ>M"3 M?0#(C=L5J*?#$,#@>YH8$,I[!X$%D]B%++0!5T$6^]GVA@JZH4\4H@59SAOUY3I8WT[K3,V:3(> MO!J72H;@S@WMFAJ42QTZDB2?*)H;,+V<`W?GN0];$C09I$/LG0/^!,SYI;&& MYG@SR9Z?"3K8U>4P].CXHR[7X%Z;;@O@KA"QC9KPC?WF MQDFJ?2T+'KW9$([9QO-#]&>2)SI42RINV^-D&%=E,^[@7R$7A?`&/9%7DRHJ MW$.R2L2+P4S+V!"L6Z`MVS&"%^W5Z__>_L!#3NE(LF3&]$8L<26;QA61!HP@ M20N]B@V5<9'CSO=(`OC@"EOR`I%$T2B,_-*>!`SP:C1YMR#Y.S.PJUU3)A&F MG88%=319O-,G%\]WX4YH>Y5=5#,P^0=W;#6*(*JIWLDC.'%1S3>$92KK`*S( M92D9G=[.O:D`#UR8[1MP#Y^@&TGLH=5K#A5-*4_UAG5"7;64$+HDXNB?#GBR MNG8M;P-OO$!B4Z3%U\M@3^A/:/^.%#S'!W,VB2QA8RS=C$AWDM2NM`;LN MVS4CS`-Y`HRHGQGQ`:[(/WDILAOJF!Y&TZ!>S@5^ZJE!P$P$Y<=$5LL,"I8( M]RK(5&473`*F8&OE!OP![SSDAC#=(9KY(3L1+K?TH`:G\2/;+>%*W6_*+C4@ M784OM][C'3GN6SQ[-UOVEB6CH&9S6,.&)4.)%*GCHT^=7=2><]W"9V=WCD?E MT(\LO"@ZB[!Q\&*)`AB[J&:0,8\AV1KD>'WYK#=>)+<;BCVEA1>K0U:X)`<0 M(PLN+11;N@E3\)77+,?]:W^+D('<$+I_G:<^+AX?E5I]4.L;P0]YM7)RG'P: MU3Y#EO6:;++!Q_#R90O=@$4#5F&3,&?I4!P#]Q5"H.8@^!YNP2ZFZ?+&`[4U M!:V$$?#0!"\2:^NSR*?/Q%AHK)4#4D<]C MS2L=JG-MT*><^F\A_`XVD+?ETZE)XW>$.FF?$4V3:-*^?+Q$9>[>4U,E/7C2 MOM/PO;VJKIHE06?$&#_!!W+X%>[(C[\`W]XENGCL1[Y$*@T)M!ASB_CA9FVT MBQWBW)PN7A5)7RO!B]&&J].\*N8`V:P++RV]TCX M%@+.M;LD00FD^6R4FRV7R$'D/5AFMOI/^RG3BI8G>=.34ML3;SE)6I\4S;?- M8D]_K4Y2-T[<8_NF=/3L`K'<:?S*0T7A=$55QF,+JOG3=)F%#_[_J_MU0;]> M_[B2M!V\?C5>OR8Y..C/BCUM+`'?D%[,''^0+K]VN348_L]CY#\"5P`F=E%S MH&+KH"ZA1:]P`6S=*_A@>6$8V,"!;+18)0T"BZ6"NFP0?6)UYD=N\(RL/V9! MX%FQG\EY')E9UAR\.$J8<1'^SLI2;0H,A[S"YF#&TT+=S?4^09OY3O(,KCAT MS57,`;!9%W5/R/G@8B5^;AKZ()\DM;0YR M7#64)7;HM=-AD_P12'0Z?GESH&M01%U,39_H_>R#7>")=#AF27,08ZI@1AJ, MQ1KYX>X2K=;AI4,.`<^@XXAW/+GJYJ`JIU"58< M`?82VO)B>G295@Y1=C)1=CIE`1:XABIX"=5`R*CRE^Y0])YB7N$3DX``[^-'Q80Q@&/UP0V2@YA[AQ+)[P MDO6-WKN15Y=WE#^\"YN\\I:=']TY)-.,:Y.6MJ0RGMT4>;4B'QJ*&:TZ0!N1[L&T[UT*5T#F,DN!TGUOWQA$K"R@ M@I+.556K;XIB%GZX`BM8?AU.7`J4S9AV<],KG&SGO-6F4`=Z_8ZWSH<(IY5#A5/&APND;/50X)'/4.9GCN%+N M'9(Y:I3,49/$`H=DCJW8\0:3.1X2]/2=*Z3?+;-#KIJ!TFW1<_-YKFK!?0W MY)7=6Q!&?GP,F+_Q&LR7N;FNW?/()_A5:W MCO8:Y4M,4D8A=E@\>XPYM%U3;XJ%G2RE6::PH?B'O\XZ6LK!W MK<:OLCT$"'8@C<+8\]`+@=-7_NE#PN+X?%3G`]+#H[P)1M1=:(4@O4I$?WF, M2$/IZ\'Z7_9C]4FM]UC\S61"*N91^)(Q^.I\V4*ZAD3(K,(J^D6E:6K`/*O4 MD+V";[Z\-]#$'N4^^3UP5[R(]=+?AW(J.$PKS_\E24=Y'2'6CS[_T$H,VF<'!J@I;AFM/TN(M$&W"?Q6AAMQFU*IE=$:M M*FF!FMYAP-6AOA:(P70L;@:.8A*8I7@RF_`$'WG8R4'DPO`],>FY]P1=P'Z) M0Z2&'E#56%9*OLB7/X7M^.@3;2S4)T*GNGN;Z4%^N_`69'OC'&P1_@_[H;N6 MC0QXPUV$J^5^*:N:9D$+DK@_0/\)63`@O_.Q/K&9I$!GM&`\X@R]-(L.D.[F MYR!87SG>LSS0M;K&0US32+-S=RJX"^SO(>Q3?(?A;YX?KBD8UHL8`E5=<-V. MH9G]37("'<54V3@I]G44K`XVF?G/_)F./Z=IF7`5(4_T$@&YA1S.D$W.3G M?5B3W_Y>D/]GZ*U\L%TCZQZN"#KU_BY8QZPN+JA4WJN_ZMBM%>).[=O"M8;` M7HK*0I#KV='IA^3`07@)X2+`#!2N%]$2)7J4<%UX#1/,O8W`R.Y>5"U>\OCH MVZF.X^DA9G+\,9-O(OI.GY2WATA7"FJ,2-?.:3@U0^V05*Z/I')X\ORLS6J$ MZIQ^]\A-RQ!_!Y=<)8I=N_B+6*GYLXN_O$9;;@B#=`M:HU^C>>;E2JNI+BB^ M5_PC,K#-ES=H0Q[ZR=YLVI'33N`B&-Q%OD4N:=J+-?*3318\D\4RY&IG=@@N M(A\;!UL!>3:-*CU^S%!6]6@1=?']O>:L]>$3\J+`V?T"'9O7RV[!/ZMZV:22M%RA<,TCGI>"'Q?%GO$W$NB)F%E0X0D9U&%W4!F]>:R-E`D_E@B,Z)[MO5/&\E$&F M#2NJ]4?*@ZJ2!?*:9,SG(K_P@8T=F@NPXXWRE5)FHUA1I<#JFP%8%6ED.%"5 M"YF-5%F38L]08YSJ";>8AY7LHKK$D-#/*=ER9Q&8/;Y?)IVQD)Y6W[&8L)3^ M-E2<'BV8,$](7XBG*N!5F:W5;*%?8WYMX(T7!%?8(G+O@0O6-7!0E%.PU!/' M=;["3I9Z`0/+1UO:WH1<77/)(:A@_E(/E1R#I%90-7(DNS!))YF3-\B8XP2E MI+G`4]7)+XQJA#/K[.R\V%>M[:G1S\KX-0R$4D2M_%9I?^/ZZ]YTH^2,G.96 M*9)&3ME9(RM)(R?30]K(0]I(T^.U"+G#M%,L\,NV6_:PW-L&>BZ"#B_(,<)J/K-72B$=H>V]`>_@W+J3D/[Y<(= M<#8V<&#VU+$#_@17Z`7:]WB-+,0`Z1;TQUU:)77GFOVB39(00/*4_"]>$*=3 MZM3W.[6F/PLZJ:?NO+-G1FQ)8-^OP''@KOVO-!;$+U)2 MU4O^(C44M&C,`!YTT$[9&6V_;)A%CY'OIJJ19W-$4!>II#^Z(EIH>*>*"F.J M1>RX^O/E;^09'I]LH;K0"I$5A7*^7;?F](>^FWX%*?HZVU<5Q@PL^`L$3KC. M%,95D"7IY[=I17\*M%)+PVOH'?Q]T>&^4VOZ,Z&3>AI>WZ0RXK^1:V-),A7/ M/7\;!>=K'P4ADAL/6K>D/Q-:JU9ZP$YK%CS`)^C^$L5:/JR![3W?`!?.7/MG MS[')FJ?#4E!9T_KS1)VN!7'TWBY<1($%W-V=[RUA$,0"9FK)C1YM&]*?%&TU M*RB@]Q[BVWXT2>_LY;G@\R@,0N"6AQM>GF#1BGH`5^-<#IZ@&D5Z55X8V-2\ M<+_OGGL/+2_"%.,\WETK-1BL4GPM'Z[75!AEK$0U>C4+>B,3R$,87TE@7E-O MT8!Y))#1SHCAFQJL_`\(:`X4K[!!4#9HHME#6'UTZU(@^GSY*_`1<4L(B<]` MP(QRDVO"(#ZTTB]ER2<:2Y3.YD-%`#/?L?AR0HL#GE#B@-L]4&%L-+"B8$7L M:\YN'$S0KP/*R![\=5Y>4$!],*#KJCT,2O,C8T MX8T!A1OF2R\Z)#!L1K$1V0OPU1$3&M^8.SAB=8SI/@UZ\!8(`Z-V#Y\\YPF[ M3E7A^8F&^77TZ5N4350Q%02[F6E;.(8D`I?J>O7 MLV5YKNVY\8G3(W#_F"^Q9&ED!S.)5F,5?;I4?5S(Z`]W>,=/FR17Z,$\FN.&6-VR(U=9N?:R=D3<=*-8VR%6?G&5LW M5XRB_`\7:VB?@RW^=YP.?H/B)']7$#;&*W9HSWC2".J9+9"/^GH[52,JI5NE M9Y[O>\]D[R`UC@1[V$T83QBV:CE'>GLB4".27+N6#_'*=V;;*%$QMXA,2`._ M&>/)PE>D>G.;\G5WSM-DK[Z^'WD'C@ MF*E=)@)>(T/%1PNPN:E?\]3*O$Y]GD.@IR/T-EOH!MCH6`O@`->"]_!?$?+C M@P%*MVZJH#N<`BIDT.G3O1F918J7_[(9Y@(](1NZ=G#M7KY8,`@P94&PGCT! MY)"-SBO/QT-?Z*/'B/8R@:I6#2"!$CTSINASX%*>"`)H':V\IP\V1,D<@'_8 M'_K)^RXS3'M[[ZK''C/8Q8QPSMCBY\[7M\^X?U2P&NMW.,_>&/ONN7YZNS:_K46+4.`6-V``YBN0C:Q?1A9A;-@E M<4DGF7DS_%O#P&H:C&6[7`'D_PJW`)YMR(NZ MI3NT$NM>2EVC9EI!G?(%4S+3]O-PZ5![(C`D\F16*.F=&(+%AL9J9A&A49W, MV4HXT-?1N78^.!D:Q6*K*;6,HD"C-ODYZ]?IB3:N]B%IQ&LS0S!?Q,>CKU]/ M%#!%J\FB:HE8X0>L#K#G;MD20A3AU#:8'1RMBN7Z\"7- M@)&G00'9]&3*VC\;S;C_PP4;SP_1G]"^\^$&11NACDRK9LCBKUF1_$IQ]X!H MS;"_?"'G0Q$*UD3W^9+8@A/MSBZN6S=G1KRS5G1I4_-7I\](EZR]S@CDO/!DKBZ-FA`9)U=?.&)-:N3)VR:[>: M[7T>WI_M,B)T?W_V1*?+1X<':/M^@/;C:\!-38+[MP]$@4<00/R/_P502P,$ M%`````@`^3!H0>_Q-(.E$@``;LD``!``'`!U:'0M,C`Q,C`Y,S`N>'-D550) M``.%DIM0A9*;4'5X"P`!!"4.```$.0$``.T]:W/CN)'?4W7_@=&GV:KX(7MG M@:G)+$(75SU7G"!A$M+[ZU_^ZP]?_GAR M\H_KR8-A,=-=8>H8)L?(P98QVQJ3B7'+*,6VC;?&%"T6F`=4C?[YJ?RO_^G3 M_Q@W;+WE9+%TC`\WOR2P3D[\-JZ1`)J`IQJ[..U[;X2YQ"MD`+M47/66CK/^ M?';V\O)R^G)YROCB[.+\O'_VC\>'9P77\P`_O\ZX31+@\DF`<'E&J'`0-7$` M;Q/ZLP17>5+:SG\3+9P!D`G M`(4Y,4.\:J0D@@2P(J[B*OUXYKT,0$WF4H=OD[`"FZ<+MCGS7^8(;6&2CP(O M3F>O@!(!+(Q#H[X;Q!5'*'.3`$%)_RR?K-:%SYO\)#V0'^\R9C:>@ M=D/^^#ZY+^!/OCU[8'0QQ;+9F7.+'41L,<6O#K3<,XAUU2MY'[8:M&OA.:%$ M\7?^V_F?+XP3XY8(TV;"Y1C^D+0,!X@9DIKQP:=G^`1_^7*6)I-NP8698$3_ MHGZO.1:@5*6/!WC@8_L@99@FLDW7W@$QXJP8SW\:V*!;T_0+C=*O-$<_SQPG M.>;H'PV1-,2SNUHA3G['UI!06!P(LN]AU/&5XGPTO_NW2YSM8#XG-H'U3^2- MHY8T*HS[\=>T<:/VC+!!(]:BP>:&UZ81-7H,Q.2"/1NAD M.%ZV&HB7E4/PLN,A>'FT>R=VOVAE]XM*NV?AV=6/W5F:OM'JW1C^:/&GR@0FJ$JHY,:`6:'K-_#_SG.KZX!5F_34S MF..D#:!MQ(D?_>36=JQKP$K+E1H.%1GN:+"DP6[)AEB86DGS9)Y6&"/C`H<$ MCHHO4/P$>SR*)5G_(,[R.R4R38[L;QC9SO(9\PTQL;BG)HP/!8RM,>+.=LH1 M%<@LG!OW0;C"_!>9633.A/$"7!@A&X;'AQ$P\B=8-+&KH^ M6X;BRX@S=IR!.^M7WY>BN@D&/WGI:K_F)]A-*91QM\C,RX5YZ^XZ:>E!KDX_^_,6NH1,$(*1[47^J-93[1*W26[W!+]J.L& M\U.=>:G*'K\UG8^.%FH5'.P6%E19L9MMJ*-IZ\8!E1%`E<&:^?Y'P^1O3J1V M):J47KP=<51P]S%5A]%4E6';Q5%-`JEC1\E+!R?RP%7&*DH`'U6;4.TULN6Y MD^]+#=!7NW+/H#GES\'O&T9A$@0YY"\!P::E.K_? M@.&U8'SX3I%K$7CS"X2D\?:.<6G*)0QT*T;S&R260YN]!'Y?[JMR>UV>U[-7 M1%LZ=Y*ZHT5/$8RQE652.IIF6*1]+1'H4C!Q9EML+98>,_+[=,?Z^$^0]O1U90<0DGS) MB55EV+2"_'8#$HB;&2J9D^@W42O[D=Q&LZ:2`PJV]RCS@Z3?@;2M^:FCC.2`36DD1]\` M']>W+_)M2"57[B]G\1.Z\%?R!.\7$)MQQZ"Y)XF+#J9[!]\?F*D(E:#(OTX" MO!/YZ*1_<7+9/WT55L!C$Q8B-3=C(0E#&3QY>\$<[3M*7&]3A(L"1/]JUGG-10AT&8FC^[W9LX%=S MV9B)$$G]*F+`O\=!>;ZP./QS8&V(8'P[6'"LWMR]K@E7S=Q"H-%3K%[U*L&\ M15!=3?)Y\HB.^!RB+$8B#'F\6J&>4SJ2DA?+'6]RF>+K1"A>8)5FZ\3 MP=R9RP->IR_L$<;4`JSRP!#-B%8#5B_A:G?5>EW1:W#%*'80WS;JC9%@WKN9 MEQ6"%WA&.NJD\FJD"3"=MEOZN58V4LS)*<%^8C2V!1167H42%`'MSS8FA[[> ME7'XS!\YH_F.P7'%`]OV?8D'@F;$)K)3@DS@UUJW6&WBQSMR)]1:]_AP M;=QCA[^1UU4Q3@E*FS[[1A.+1PS2+://:PYC303KN(U^#_D-)*P`2W->*N:^ M_3JY)W1+A'>YF-S-OJ=WKR;TQ2"K/N1L]4!6,O4==+[M#5NM$4W,Q6WI',12 MFA%R-)_(Y(ZLI5)%=B;&EMA58[L0.PRUP4],86#;WX":R%V\1A27K7DM2&@R MB_BJ8*L93/561K[4YAI>9J+^R&;3!,&8Y\&I0OR6XPU4Q*B)E.Z+6PLV/R3.-]B^(^+; MSMJMFBXS]!L!&O:XR917F_.;VS:[H:]>PR MQ96?R_*V`OP>L1V#X*JK`Z6U1`:7I$J![>D?@K>SB^SW$/-S@+Q[7T@NME05OCA![+!(*GCQZ/*\A,LO0'P8`8K>77`[TK*L6(OTM2.Z(G0 MPY^-WG']'+K4PC%+@S^P(D[L6+H2M0SH$,;(5XZV`FQ0Z"(6`FCE)=Y3^24F M@6^Q]^\]E5OI\J0_V217C&K(P]AKS\HQ5>FC"1:80W>\$R9G+R+84`4W:\SQ M&A%KDNS!;>DX/(4@!V*U MTKGW@&?=OQ%JP5SPC0F5K[IA?.V*FR4G0&E(7K&E2IE*=A!W)J#5K/V`?N(Q M(U26;:DMT`%W,@M0*9`FXH2\)J<.5=@*,Z:7XO9E+@-YSTQ1Q>1X&+/B`Z.6 M'QW/$/TYFL\A3+;R"@:K(37I6Z%@X0U4_LX)^&(36(FW_K'1,707DZQE_''C MAUN3,EE7H7E@>Y,-&+Q1S>2=*?`LHT$%C MQ)*]H[?>R7MRI25&\Z`\*.8'Y;R*CU*YT%[G/-O2<*LJFNRXGNKUTA0FF^`79 MH[4JZ(NV.1(D7K8.9CKE?P24D;R?5*V*PCMJ.'3!9\

D0'VKBW4V:J]HF!$J[^/YB@8:B M#Q'ACXC_Q,[?D>WBG3500N>=%)'+?K7AHLQ%,AYN32BNAN:%B]VN.17"%!IS M1^74IGB:I6AG77#XS5Y;6E-0ME`+I)0Y&)O;N;`ZRM#9XZ&:]V6<7Y(,0OZZDF@H5W0$C M3U@,-H@HHM%!XBGB"^S$S\S*K?DAX_=4HI(-3IRGC2NB>]H:9;KCXBE_(=K= MS]=!!DA383+YJZ*;0!HA'8JP8C"''[$[(6K*FX.GJ$&EM]5`&$&&ZH@6!\CAC MSV?`QAQO"'.%O?V&;:ML`_(1_2N9Y<[;P>R(7+N^T7713'`<1+(*?3I_:V`; M]H2:T'LMI2DW>B(05KUP8%EJ[E)'$Q,;(G5@-8N4LRP_HE>94&XB92&*7CGX M9&VP*N=/2)5]J7<&/9`J*O?).PT#?F5LF[+&9G=G!`\CFGX&^Z`A?C:9XP@O M*9*,50H!M`I2GLTEMEQIG?#L2G`)@2@Z-MD$)R&L#DUUW5'4JV<0S#FJS!A5@.DEDDP&O8!GY*403,3Q\U8` M_#V%&<+Z.[)MO+U!J[6;%;,YJEZBKQ'_*:JM60ZFF4AR<'F:;SYH=T'62WQY M2^T,E:0_BR$T$V2UP@!#@Y,,NURGUHK(`:JCX@KC5D3T5,=TR3'.%T.]J:.- M'6AHI8SB>Z0.\\:HX)@A6<%,);QO5('CI,*H*)T3D[(F_&&$$&72E%P2W1#M ML'31[.#J&Q]3?8MS]S(S`E&51('H&6:H=!ZE$$"OK`G$@#!95CJ<%6!ZS;Y+ MPIWM'5DLG3M;!GW7V+:K)6R$I9?`T3>!;YA(#+S,F_U-,UVN-ZXP$=V"VN=8 M")5S#!R`6COMN^+K956@.9K[R^4V)ESJ>5GV_,W3-L5?U$[;J!I2*VL4L#N: MW\(Z_H(XKB]B+HY6PO[`MO_5F`E>J.&3>_8RD+,FN"8BQJ.-DNN`YMXFW0#" M#UM]#B)]P>#N^'I<.EC[=CWO&OWPZ[0E%^O5O`:P/L&JM/3^M:/<=+E-OR3K M'\19%D];X,?&?/IM;.E5MVK*;T^E>M!^:.O5NQ(WB^;HH/B]7G+(C2]PE]2V M6:S")2U.)9A>4@T9IV%B->>3(L7O-3EW'WXQ*]*U#"AOB5#!90>EED(1"82,-CGS!N>I6!Z216_`:2@&Y>"Z"7- M$WZ9X`VS-]#NC4K%!$%,^.W)Y.S3`$&SZ4CV,PQ+M#QQXU]*/,'J0()7]AKU MQC*H\EA];Y51>?6-X=5SP7(=%3`GZIIASH@7-\9J`MN3*BF%V[LN@D.73XQR M#/,C%V$"(2Q\+(>)&[/[,YA5_'^7Y8=158]MBN10*WZOV<@"UI*W:TVL)S[MH7WRGR+6(YS`JL;).5Q,DO23^BBGFR"[P MOHK>ZB7#T'E]9+.Q+,:?OK"'=2K&*WC[SD,:G#][*TM1@8()_21(X,>7<.J39["9-DZ.),KMU6B/%?J\5LY MMHV8'Y(-5C6BSE;^_(:XM?72ERQU'V$=2,T6R">Y`1B>/\F_HF M`Q0````(`/DP:$'^ MG@`&AJ```-JV!P`0`!@```````$```"D@0````!U:'0M,C`Q,C`Y,S`N>&UL M550%``.%DIM0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`^3!H06Q[X]#+ M#P``-&UL M550%``.%DIM0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`^3!H0;&UL M550%``.%DIM0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`^3!H00TA8,%$ M-```[*,#`!0`&````````0```*2!4SL!`'5H="TR,#$R,#DS,%]P&UL M550%``.%DIM0=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`^3!H0>_Q-(.E M$@``;LD``!``&````````0```*2!Y6\!`'5H="TR,#$R,#DS,"YX`L``00E#@``!#D!``!02P4&``````8`!@`4`@``U((!```` ` end XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Financial Information of Equity Affiliates (Details)
Sep. 30, 2012
DVMC Properties [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 90.00%
Property Owned by LLC Desert Valley Medical Center
Suburban Properties [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 33.00%
Property Owned by LLC Suburban Medical Plaza II
Santa Fe Scottsdale [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 90.00%
Property Owned by LLC Santa Fe Professional Plaza
575 Hardy Investor [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 90.00%
Property Owned by LLC Centinela Medical Building Complex
Brunswick Associates [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 74.00%
Property Owned by LLC Mid Coast Hospital MOB
PCH Medical Properties [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 85.00%
Property Owned by LLC Rosenberg Children’s Medical Plaza
Arlington Medical Properties [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 75.00%
Property Owned by LLC Saint Mary’s Professional Office Building
Sierra Medical Properties [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 95.00%
Property Owned by LLC Sierra San Antonio Medical Plaza
PCH Southern Properties [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 95.00%
Property Owned by LLC Phoenix Children's East Valley Care Center
Sparks Medical Properties (b) [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 95.00%
Property Owned by LLC Vista Medical Terrace & The Sparks Medical Building
Grayson Properties (b) [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 95.00%
Property Owned by LLC Texoma Medical Plaza
3811 Bell Medical Properties [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 95.00%
Property Owned by LLC North Valley Medical Plaza
FTX MOB Phase II [Member]
 
Limited Liability Companies Accounted for Under Equity Method  
Ownership 95.00%
Property Owned by LLC Forney Medical Plaza II

XML 15 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions and Dispositions
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Acquisitions and Dispositions [Abstract]    
Acquisitions and Dispositions

(4) Acquisitions and Dispositions

Nine Months Ended September 30, 2012:

New Construction and Acquisition:

During the third quarter of 2012, we entered into an agreement whereby we will own a 95% non-controlling ownership interest in FTX MOB Phase II LP, which will develop, construct, own and operate the Forney Medical Plaza II, a newly constructed MOB, consisting of approximately 30,000 rentable square feet, located in Forney, Texas. We have committed to invest up to $2.5 million in this newly formed LLC. This MOB is expected to be completed and opened during the first quarter of 2013.

In January, 2012, we purchased, as part of a planned, like-kind exchange transaction pursuant to Section 1031 of the Internal Revenue Code, the PeaceHealth Medical Clinic, a single-tenant medical office building consisting of approximately 99,000 rentable square feet, located in Bellingham, Washington. The property was purchased for approximately $30.4 million, including the assumption of approximately $22.4 million of third-party financing. The aggregate purchase price of this MOB was allocated to the assets and liabilities acquired consisting of tangible property ($26.8 million) and identified intangible assets ($3.6 million), based on the respective fair values at acquisition, as determined by an appraisal. Intangible assets include the value of the in-place lease at the time of acquisition and will be amortized over the average remaining lease term of approximately ten years (amounts in thousands).

 

         

Land, buildings and improvements

  $ 26,810  

Other assets

    4,399  

Debt

    (23.240

Other liabilities, net

    (111

Deposits funded in 2011

    (534
   

 

 

 

Net cash paid in 2012

  $ 7,324  
   

 

 

 

In connection with this MOB, during the three months ended September 30, 2012, we recorded revenue of $698,000 and net income of approximately $106,000 (excluding transaction expenses of $14,000 and including the $108,000 favorable interest expense adjustment resulting from the amortization of the fair value of debt). During the nine months ended September 30, 2012, we recorded revenue of $1.9 million and net income of approximately $158,000 (excluding transaction expenses of $663,000 and including the $108,000 favorable interest expense adjustment resulting from the amortization of the fair value of debt).

Divestitures:

In February, 2012, Canyon Healthcare Properties, a limited liability company (“LLC”) in which we owned a 95% noncontrolling ownership interest, completed the divestiture of the Canyon Springs Medical Plaza. As partial consideration for the transaction, the buyer has assumed an existing third-party mortgage related to this property. The divestiture by this LLC generated approximately $8.1 million of cash proceeds to us, net of closing costs and the minority members’ share of the proceeds. This divestiture resulted in a gain of approximately $7.4 million which is included in our consolidated statement of income for the nine months ended September 30, 2012 (recorded during the first quarter of 2012).

Subsequent to September 30, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex. Including the repayment to us of a previously provided $8.0 million member loan, the divestiture by this LLC generated approximately $12.1 million of cash proceeds to us, net of closing costs and minority members’ share of the proceeds. This divestiture is expected to result in a gain, which will be recorded during the fourth quarter of 2012 and is not expected to have a material impact on our financial statements.

Nine Months Ended September 30, 2011:

Acquisitions:

In June and July, 2011, utilizing a qualified third-party intermediary in connection with planned like-kind exchange transactions pursuant to Section 1031 of the Internal Revenue Code, we purchased the:

 

   

Lake Pointe Medical Arts Building—a 50,974 square foot, multi-tenant, medical office building located in Rowlett, Texas, which was acquired in June, 2011, for $12.2 million; the weighted average remaining lease term at the date of acquisition was 6.5 years, and;

 

   

Forney Medical Plaza—a 50,946 square foot, multi-tenant medical office building located in Forney, Texas, which was acquired in July, 2011, for $15.0 million; the weighted average remaining lease term at the date of acquisition was 6.2 years.

The aggregate purchase price for these MOBs was allocated to the assets acquired consisting of tangible property ($23.0 million) and identified intangible assets ($4.2 million), based on their respective fair values at acquisition, as determined by third-party appraisals. Intangible assets include the value of the in-place leases at the time of acquisition. The intangible assets at each MOB will be amortized over the remaining lease terms.

There were no divestitures during the first nine months of 2011.

Assuming the 2012 acquisition and divestiture, as well as the 2011 acquisitions and divestitures as previously disclosed, occurred on January 1, 2011, our 2011 pro forma net revenues for the three and nine months ended September 30, 2011 would have been approximately $13.4 million and $39.8 million, respectively, and our 2011 pro forma net income for the three and nine months ended September 30, 2011 would have been approximately $2.2 million, or $0.18 per diluted share, and $8.1 million, or $0.64 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2011. Assuming the 2012 acquisition and divestiture occurred on January 1, 2012, our net revenues and net income for the three month period ended September 30, 2012 would have remained unchanged from the actual net revenues and net income as reported, and our pro forma net revenues and net income for the nine months ended September 30, 2012 would have been approximately $40.8 million and $8.3 million, or $.65 per diluted share, respectively, without giving effect to the gains and transaction costs recorded during 2012.

Acquisitions and Dispositions
EXCEL 16 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E M9F5F-60X,&$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I7;W)KF5D7T9I;F%N8VEA;%]);F9O#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D%C<75I#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D1I=FED96YD#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C<75I#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)KF5D7T9I;F%N8VEA;%]);F9O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)KF5D7T9I;F%N8VEA;%]);F9O#I%>&-E;%=O#I%>&-E;%=O#I7;W)K'1U86P\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I3='EL97-H965T($A2968],T0B M5V]R:W-H965T&-E M;"!84"!O3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\P-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F M-60X,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)? M.3DP-E\T93EF7SAD,31?-&5C969E9C5D.#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!);F9O2!);F9O2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO'0^43,\2!&:6QE3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^06-C96QE2!#;VUM;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E'!E;G-E'!E;G-E2!C;VUP86YI97,@*"),3$-S(BDL(&EN M=&5R97-T(&5X<&5N7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2P@3F5T+"!4;W1A;#PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!C;VUP86YI97,@*"),3$-S(BD\+W1D/@T*("`@("`@ M("`\=&0@8VQA6%B;&4L(&YO;BUR96-O=7)S92!T;R!U&-E2!);F-O;64@5')U M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$F%T:6]N M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8N-CQS<&%N/CPO MF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XY-2PP,#`L,#`P M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-V(P8S8T8E\Y.3`V7S1E.69? M.&0Q-%\T96-E9F5F-60X,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,#=B,&,V-&)?.3DP-E\T93EF7SAD,31?-&5C969E9C5D.#!A+U=O'0O:'1M;#L@ M8VAA2!O<&5R871I;F<@86-T:79I=&EE'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G1S M(&]F(&UO6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA2!F:6YA;F-I;F<@86-T:79I=&EE'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^ M/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT M;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`\(2TM M($)E9VEN($)L;V-K(%1A9V=E9"!.;W1E(#$@+2!U3IT:6UEF4],T0R/CQB/CQU M/CPO=3X\+V(^/"]F;VYT/@T*("`@/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/CQB M/B@Q*2!'96YE#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/E1H:7,@ M475A2!297!O2!2 M97!O&-H86YG90T*("`@0V]M;6ES6]U(&-A M;B!I9&5N=&EF>2!T:&]S92!S;RUC86QL960@)B,X,C(P.V9O2!W;W)D'!E8W1S+"8C.#(R,3L@)B,X,C(P.V%N=&EC:7!A=&5S+"8C.#(R,3L@ M)B,X,C(P.V9U='5R92PF(S@R,C$[("8C.#(R,#MI;G1E;F1S+"8C.#(R,3L- M"B`@("8C.#(R,#MP;&%N6]U('-H;W5L9"!S<&5C:69I8V%L;'D@ M8V]N65A2!C875S92!O M=7(@86-T=6%L(')E6QE/3-$;6%R9VEN+71O<#HQ,G!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@2!R97-U;'0@:6X@9&5C M2!R871E2!I;7!A8W0@ M;W5R(&9U='5R92!B;VYU2P@=&AE(&=E;F5R86P@2!I;7!A8W0@=&AE('5N9&5R;'EI;F<@=F%L=64@ M;V8@;W5R#0H@("!P2!I;B!C97)T86EN M(&)A;FMI;F<@86YD(&9I;F%N8VEA;"!I;G-T:71U=&EO;G,@;W9E3IT:6UEF4] M,T0R/@T*("`@26X@=&AI2!I;G1E2!A8V-O=6YT(&9O2!M M971H;V0@*'-E92!.;W1E(#4I+B!!2!T:&4@97%U:71Y(&UE=&AO9"!A;F0@;VYE('1H870@:7,@ M8W5R2!D:7-C;&]S960L M(&1U2!M:6YO0T*("`@;W=N97)S:&EP(&EN M=&5R97-T2!O=VYE6QE/3-$;6%R9VEN+71O<#HQ,G!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@2!T;R!F86ER;'D@<')E2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L M97,@:&%V92!B965N(&-O;F1E;G-E9"!O6EN9R!D:7-C;&]S=7)E65A<@T*("`@96YD960@ M1&5C96UB97(F(S$V,#LS,2P@,C`Q,2X@/"]F;VYT/CPO<#X-"CQS<&%N/CPO M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!42!4#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/CQB/B@R*2!2 M96QA=&EO;G-H:7`@=VET:"!5;FEV97)S86P@2&5A;'1H(%-E#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/CQI/DQE87-E M2!P=7)C:&%S:6YG('!R;W!E#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/@T*("`@5&AE(&-O;6)I;F5D M(')E=F5N=65S(&=E;F5R871E9"!F2!M:6YO2!O=VYE2!O=VYE&EM871E;'D@,C$E M(&%N9"`Q."4@;V8@=&AE#0H@("!C;VUB:6YE9"!C;VYS;VQI9&%T960@86YD M('5N8V]N2!O=VYE6QE/3-$ M;6%R9VEN+71O<#HQ,G!X.VUA6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!T:&ER9"UP87)T>2!O9F9E6QE M/3-$;6%R9VEN+71O<#HQ,G!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4Z,3)P>#MM87)G:6XM=&]P.C!P>#MM87)G:6XM M8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B;&4@8V5L;'-P86-I;F<] M,T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#DR)2!B;W)D97(],T0P('-T M>6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB/E1Y<&4F M(S$V,#MO9B8C,38P.T9A8VEL:71Y/"]B/CPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/CQB/D%N;G5A;#PO8CX\+V9O;G0^/&)R("\^ M/&9O;G0@3IT:6UEF4],T0Q/@T* M("`@/&(^4F5N=#PO8CX\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/CQB/D5N9"8C,38P.V]F)B,Q-C`[3&5A"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB M/E)E;F5W86P\+V(^/"]F;VYT/CQB6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/D%C=71E($-AF4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/BAA*28C,38P.SPO9F]N=#X\+W1D/@T* M("`@/"]T6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/D1E M8V5M8F5R+"8C,38P.S(P,38\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E-O=71H M=V5S="!(96%L=&AC87)E(%-Y2!#86UP=7,\ M+V9O;G0^/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C(L-C0X+#`P,#PO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/E1H92!"F4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/CDS,"PP,#`\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0R/D1E8V5M8F5R+"8C,38P.S(P,30\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M2`M+3X-"B`@(#PO=&%B;&4^#0H@("`\<"!S M='EL93TS1"=L:6YE+6AE:6=H=#HX<'@[;6%R9VEN+71O<#HP<'@[;6%R9VEN M+6)O='1O;3HR<'@[8F]R9&5R+6)O='1O;3HP+C5P="!S;VQI9"`C,#`P,#`P M.W=I9'1H.C$P)2<^)B,Q-C`[/"]P/@T*("`@/'1A8FQE('-T>6QE/3-$)V)O M3IT:6UEF4],T0R/BAA*3PO9F]N=#X\+W1D/B`- M"B`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M86QI9VXZ(&QE9G0G(&)O3IT:6UEF4],T0R/E5(4R!H M87,@;VYE(#4M>65A&ES=&EN9R!L96%S M92!R871E65A6QE/3-$)V)O3IT:6UEF4],T0R/BAC*3PO9F]N=#X\+W1D/B`-"B`@(#QT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!B96YE9FEC:6%R>2X@/"]F;VYT/CPO<#X-"B`@(#QP M('-T>6QE/3-$;6%R9VEN+71O<#HQ,G!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@&-H86YG92!F;W(@82`Y-24@;F]N M+6-O;G1R;VQL:6YG(&5Q=6ET>2!I;G1E2!C;VYS=')U8W1E9"!A;F0@2!497AO;6$@365D:6-A;"!#96YT97(@*"8C.#(R,#M497AO;6$-"B`@($AO M&]M M82!(;W-P:71A;"X@270@:7,@86YT:6-I<&%T960@=&AA="!T:&4@;6%S=&5R M(&QE87-E('1H2!T97)M(&QO86X@;V8@)#$R+CD@;6EL;&EO;BP@=VAI M8V@@:7,-"B`@(&YO;BUR96-O=7)S92!T;R!U2!O9B!52%,L('-E2!!9W)E96UE;G0F(S@R,C$[*0T*("`@9&%T960@1&5C96UB97(F(S$V,#LR M-"P@,3DX-BX@4'5R0T*("`@<&%R=&EC=6QA2!A9F9A:7)S+B!!;&P@=')A M;G-A8W1I;VYS(&)E='=E96X@=7,@86YD(%5(4R!M=7-T(&)E(&%P<')O=F5D M(&)Y('1H92!4F4@:6YD97!E M;F1E;G0@<')O9F5S"!A;F0@;W1H97(@'1Y(&1A>7,@=W)I='1E;B!N;W1I8V4@ M8GD@=7,@;W(@=&AE($%D=FES;W(N(%1H92!!9'9I2!!9W)E96UE;G0@ M97AP:7)E65A2!T:&4@26YD97!E;F1E;G0-"B`@(%1R=7-T965S+"!T M:&%T('1H92!!9'9I#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UEF4],T0R/@T*("`@5&AE($%D M=FES;W)Y($%G2!F M964@:7,@<&%Y86)L92!Q=6%R=&5R;'DL('-U8FIE8W0@=&\@861J=7-T;65N M="!A="!Y96%R+65N9"!B87-E9"!U<&]N(&]U2!A2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,- M"B`@('=I=&AO=70@2!!9W)E96UE;G0@9&5F:6YE2!F M965S#0H@("!I;F-U2X@061V:7-O2P@86YD#0H@("!W97)E(&)A2X@/"]F M;VYT/CPO<#X-"B`@(#QP('-T>6QE/3-$;6%R9VEN+71O<#HQ,G!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@65E2!D:7-C;&]S960@;VX@;W5R M($-U2!D:7-C M;&]S960@86-Q=6ES:71I;VYS+`T*("`@9&EV97-T:71U2!O9B!T:&4@9&%T92!O9B!G6QE/3-$ M;6%R9VEN+71O<#HQ,G!X.VUA6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@0T*("`@ M,CDE(&%N9"`S,"4@;V8@;W5R(&-O;G-O;&ED871E9"!R979E;G5E2!O M9B!52%,@:7,@;W5R($%D=FES;W(L('EO=2!A3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\P-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X M,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)?.3DP M-E\T93EF7SAD,31?-&5C969E9C5D.#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$#MM87)G:6XM8F]T=&]M.C!P M>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/CQB/B@S*2!$:79I9&5N9',@/"]B/CPO9F]N=#X\+W`^#0H@ M("`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054), M24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I M=&EO;F%L+F1T9"(@+2T^#0H@("`\(2TM($)E9VEN($)L;V-K(%1A9V=E9"!. M;W1E(#0@+2!U#MM M87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0R/CQB/B@T*2!!8W%U:7-I=&EO;G,@ M86YD($1I6QE M/3-$;6%R9VEN+71O<#HV<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!C;VYS=')U8W1E9"!-3T(L(&-O;G-I2`S,"PP,#`@2P@5&5X87,N(%=E(&AA=F4@8V]M;6ET M=&5D('1O(&EN=F5S="!U<"!T;R`D,BXU(&UI;&QI;VX@:6X@=&AI2!F;W)M960@3$Q#+B!4:&ES($U/0B!I'!E8W1E9"!T;R!B92!C;VUP M;&5T960@86YD(&]P96YE9"!D=7)I;F<@=&AE(&9I6QE/3-$;6%R9VEN+71O<#HV M<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@&-H86YG92!T2`D,S`N-"!M:6QL:6]N M+"!I;F-L=61I;F<@=&AE(&%S2`D M,C(N-"!M:6QL:6]N(&]F('1H:7)D+7!A&EM871E;'D@=&5N('EE87)S("AA M;6]U;G1S(&EN('1H;W5S86YD'0M M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/D]T:&5R(&%S3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UEF4],T0R/C0L,SDY/"]F;VYT M/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0R/B@R,RXR-#`\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/BDF(S$V,#L\+V9O;G0^/"]T9#X-"B`@(#PO='(^(`T*("`@/'1R/B`- M"B`@(#QT9"!V86QI9VX],T1T;W`^#0H@("`\<"!S='EL93TS1"=M87)G:6XM M;&5F=#HQ+C`P96T[('1E>'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/B@Q,3$\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M;F]W3IT:6UEF4],T0R/BDF(S$V M,#L\+V9O;G0^/"]T9#X-"B`@(#PO='(^(`T*("`@/'1R(&)G8V]L;W(],T0C M8V-E969F/B`-"B`@(#QT9"!V86QI9VX],T1T;W`^#0H@("`\<"!S='EL93TS M1"=M87)G:6XM;&5F=#HQ+C`P96T[('1E>'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/C6QE/3-$ M9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P M.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@2`M+3X-"B`@(#PO=&%B;&4^(`T*("`@/'`@&-L=61I;F<@=')A;G-A M8W1I;VX@97AP96YS97,@;V8@)#$T+#`P,"!A;F0@:6YC;'5D:6YG('1H92`D M,3`X+#`P,"!F879O&-L=61I;F<@=')A;G-A8W1I;VX@97AP96YS M97,@;V8@)#8V,RPP,#`@86YD(&EN8VQU9&EN9R!T:&4@)#$P."PP,#`@9F%V M;W)A8FQE(&EN=&5R97-T(&5X<&5NF%T:6]N(&]F('1H92!F86ER('9A;'5E(&]F(&1E M8G0I+@T*("`@/"]F;VYT/CPO<#X-"B`@(#QP('-T>6QE/3-$;6%R9VEN+71O M<#HQ.'!X.VUA6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O M<#HV<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@2P- M"B`@(#(P,3(L($-A;GEO;B!(96%L=&AC87)E(%!R;W!E&EM871E;'D@)#@N,2!M:6QL:6]N M(&]F(&-A2`D-RXT(&UI;&QI;VX@=VAI8V@@:7,@ M:6YC;'5D960@:6X@;W5R(&-O;G-O;&ED871E9"!S=&%T96UE;G0@;V8@:6YC M;VUE(&9O6QE/3-$;6%R9VEN+71O M<#HQ,G!X.VUA6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!P0T*("`@;65M8F5R3IT:6UEF4],T0R/CQB/DYI;F4@36]N=&AS($5N9&5D(%-E<'1E;6)E6QE/3-$;6%R M9VEN+71O<#HV<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2P@,C`Q,2P@=71I;&EZ:6YG(&$@<75A;&EF:65D('1H M:7)D+7!A2!I;@T*("`@8V]N;F5C=&EO;B!W:71H M('!L86YN960@;&EK92UK:6YD(&5X8VAA;F=E('1R86YS86-T:6]NF4Z-G!X.VUA'0M86QI9VXZ(&QE9G0G(&)O MF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!W:61T:#TS M1#(E('9A;&EG;CTS1'1O<"!A;&EG;CTS1&QE9G0^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P/@T*("`@/'`@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M65A6QE/3-$)V)O3IT:6UEF4],T0R/B8C.#(R-CL\+V9O;G0^/"]T9#X@#0H@("`\=&0@=VED=&@] M,T0Q)2!V86QI9VX],T1T;W`^/&9O;G0@6QE/3-$;6%R9VEN+71O<#HQ,G!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE/3-$;6%R9VEN+71O<#HQ,G!X.VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@&EM871E;'D-"B`@("0Q,RXT(&UI;&QI;VX@86YD("0S.2XX M(&UI;&QI;VXL(')E2P@86YD(&]U2`D M-#`N.`T*("`@;6EL;&EO;B!A;F0@)#@N,R!M:6QL:6]N+"!O'0^06-Q=6ES:71I;VYS M(&%N9"!$:7-P;W-I=&EO;G,\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D($9I;F%N8VEA;"!);F9O'0^/"$M+41/0U194$4@ M:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`\(2TM($)E9VEN($)L;V-K M(%1A9V=E9"!.;W1E(#4@+2!U4UE=&AO9$EN=F5S=&UE M;G1S1&ES8VQO'1";&]C:RTM/@T*("`@/'`@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!B96YE9FEC:6%R>2X@26X@86-C;W)D86YC92!W M:71H('1H92!&:6YA;F-I86P@06-C;W5N=&EN9R!3=&%N9&%R9',@0F]A2!M96UB97)S(&EN('1H97-E M(&EN=F5S=&UE;G1S(&AA=F4@97%U86P@=F]T:6YG#0H@("!R:6=H=',@=VET M:"!R96=A2!A="!O M=7(@8V]S="!A;F0@2!I;B!T:&4@;F5T(&EN8V]M92P@8V%S:"!C;VYT3IT:6UEF4],T0R/DEN($1E8V5M8F5R+"`R,#$Q+"!A2!H96QD(&YO;BUC;VYT2!T;R!U0T*("`@2!D96)T("AI9B!A<'!L:6-A8FQE*2!T M:&%T(&ES(&YO;BUR96-O=7)S92!T;R!U2!A M2P@9G)O;2!T:6UE('1O M('1I;64L('!R;W9I9&4@9G5N9&EN9R!F;W(@8V5R=&%I;B!P=7)P;W-E2!U2!A9'9A;F-E9"!A#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/@T*("`@ M4&%L;61A;&4@365D:6-A;"!02!O9B!52%,N($%D9&ET:6]N86QL>2P@54A3 M(&]F($1E;&%W87)E+"!A('=H;VQL>2UO=VYE9"!S=6)S:61I87)Y(&]F(%5( M4RP@2UT;RUD87D@869F86ER6QE/3-$;6%R9VEN+71O M<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/E)E;G1A;"!I;F-O;64@:7,@ M65AF5D(&5V96YL>2!O=F5R('1H92!L96%S92!T97)M(')E9V%R9&QE&ES=&EN9R!L96%S97,L(&%S('=E;&P@ M87,@=&AE(&%C<75I&ES=&EN9PT*("`@:6XM<&QA8V4@;&5A3IT:6UEF4],T0Q/CQB/DYA M;64@;V8@3$Q#/"]B/CPO9F]N=#X\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/CQB/D]W;F5RF4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M"!S;VQI9"`C,#`P,#`P)SX-"B`@(#QP('-T>6QE/3-$;6%R9VEN+71O M<#HP<'@[;6%R9VEN+6)O='1O;3HQ<'@@86QI9VX],T1C96YT97(^/&9O;G0@ M2!/=VYE9"!B>2!,3$,\+V(^/"]F;VYT/CPO<#X-"B`@ M(#PO=&0^#0H@("`\+W1R/@T*("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X- M"B`@(#PA+2T@0F5G:6X@5&%B;&4@0F]D>2`M+3X-"B`@(#QT3IT:6UEF4],T0R/D1634,@4')O<&5R=&EE3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^(`T*("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@2!-961I8V%L($-E M;G1E6QE/3-$)VUA6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT:6UEF4],T0R/B4F(S$V,#L\+V9O;G0^/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4],T0R/E-A;G1A($9E(%-C M;W1TF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/E-A;G1A($9E(%!R;V9E6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/CDP/"]F M;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@#PO9F]N=#X\+W1D/@T*("`@/"]T M6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0R/C6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE M/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/B4F(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0R/D%R;&EN9W1O;B!-961I8V%L(%!R M;W!EF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/E-A:6YT($UA3IT:6UEF4],T0R/E-I97)R82!- M961I8V%L(%!R;W!EF4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E-I97)R82!386X@06YT;VYI;R!-961I8V%L(%!L87IA M/"]F;VYT/CPO=&0^#0H@("`\+W1R/B`-"B`@(#QT3IT:6UEF4] M,T0R/E!#2"!3;W5T:&5R;B!06QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@F4],T0R M/B4F(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/E9I3IT:6UEF4],T0R/D=R87ES;VX@4')O<&5R=&EEF4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/E1E>&]M82!-961I8V%L(%!L87IA M/"]F;VYT/CPO=&0^#0H@("`\+W1R/B`-"B`@(#QT3IT:6UEF4],T0R/C,X,3$@0F5L;"!-961I M8V%L(%!R;W!EF4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/DYO2!-961I8V%L(%!L87IA/"]F;VYT/CPO M=&0^#0H@("`\+W1R/B`-"B`@(#QT3IT:6UEF4],T0R/D946"!- M3T(@4&AA3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/CDU/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@F$@24D\+V9O;G0^/"]T M9#X-"B`@(#PO='(^#0H@("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*("`@ M/"]T86)L93X-"B`@(#QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.CAP>#MM87)G M:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C)P>#MB;W)D97(M8F]T=&]M.C`N M-7!T('-O;&ED(",P,#`P,#`[=VED=&@Z,3`E)SXF(S$V,#L\+W`^#0H@("`\ M=&%B;&4@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V)O3IT:6UEF4],T0R/BAB+BD\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M86QI9VX],T1L969T('9A;&EG;CTS1'1O<#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UEF4],T0R/E1E;F%N=',@;V8@ M=&AI'0M86QI9VXZ(&QE9G0G(&)O#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/D)E;&]W(&%R92!T:&4@8V]M M8FEN960@2!M971H;V0@ M870@4V5P=&5M8F5R)B,Q-C`[,S`L(#(P,3(-"B`@(&%N9"`R,#$Q.B`\+V9O M;G0^/"]P/@T*("`@/'`@F4Z,3)P>#MM87)G:6XM M=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B M;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#DR M)2!B;W)D97(],T0P('-T>6QE/3-$)V)OF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P M)SX\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB/E1HF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L M6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@2`M+3X-"B`@(#QT3IT:6UEF4],T0R/E)E=F5N=65S/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C4L-3$T/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M'0M M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C8L.#@R/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C,L,3(P/"]F;VYT/CPO=&0^(`T*("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE M/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C0L-3DY M/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF M(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\ M+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\ M<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V M,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*("`@/'`@6QE/3-$ M)V)O6QE M/3-$)V)O"!S;VQI9"`C,#`P M,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C M,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@/"]T6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0R M/C4X,#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C0U-SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT M:6UEF4],T0R/C$L-CF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3IT:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C(L,S6QE/3-$9F]N="US:7IE.C%P>#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D M('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B M;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*("`@/'`@"!D;W5B;&4@ M(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*("`@/'`@2`M+3X-"B`@(#PO=&%B;&4^#0H@("`\<"!S M='EL93TS1&9O;G0M'0M86QI9VXZ(&QE9G0G(&)O&EM871E;'D@)#0S."PP,#`@86YD("0W,34L,#`P(&9O'0M M86QI9VXZ(&QE9G0G(&)O2!O=VYE9"!V M87)I;W5S(&YO;F-O;G1R;VQL:6YG+"!M86IO2!O=VYE2X@ M3W5R('-H87)E(&]F('1H92!F:6YA;F-I86P@2!M M971H;V0N(#PO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ MF4Z M,3)P>#MM87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\ M+W`^#0H@("`\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!W:61T:#TS1#6QE/3-$)V)OF4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB M/E-E<'1E;6)E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/@T*("`@/"]TF4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L2`M+3X-"B`@(#QT3IT:6UEF4],T0R/DYE M="!P2P@:6YC;'5D:6YG($-)4#PO9F]N=#X\+W`^#0H@("`\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4] M,T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/D]T:&5R(&%S3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$P+#,V,#PO9F]N=#X\+W1D/B`-"B`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O M='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF M(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P M)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C$R,2PU-C8\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M;F]W3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF M(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S M='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[ M/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@ M/'`@"!D M;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@3IT:6UEF4],T0R/DQI86)I;&ET:65S M/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C8L,30Y M/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$P,2PX,SD\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W M3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(P+#DY M-#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O3IT:6UEF4],T0R/E1O=&%L(&QI M86)I;&ET:65S(&%N9"!E<75I='D\+V9O;G0^/"]P/@T*("`@/"]T9#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/C$T,"PT-S0\+V9O;G0^ M/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)V)O6QE/3-$)V)O'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!A;F0@861V86YC97,@=&\@3$Q# M3IT M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/@T*("`@/"]TF4Z M,7!X/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`@(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O3IT:6UEF4],T0R/D%S(&]F(%-E<'1E;6)E'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE M/3-$)VUA6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M:6YD96YT M.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/C,U+#(S,3PO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C(P,38\+V9O;G0^/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0R/C$U+#8T.#PO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS M1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T* M("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@2`M+3X-"B`@(#PO=&%B;&4^#0H@("`\ M<"!S='EL93TS1&9O;G0M3IT:6UEF4],T0Q/CQB M/DYA;64@;V8@3$Q#/"]B/CPO9F]N=#X\+W`^#0H@("`\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/CQB/DUO3IT:6UEF4],T0Q/CQB/BAB*3PO8CX\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB/DUA='5R:71Y)B,Q-C`[1&%T93PO8CX\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E-P87)K6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/C`R+S$R+S(P M,3,\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T M6QE/3-$)VUAF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/C`W+S`Q+S(P,30\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C@L,3(T/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(T+#DU-#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4] M,T0R/D1634,@4')O<&5R=&EE3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C0L,#DX/"]F;VYT/CPO=&0^(`T*("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E!#2"!-961I8V%L(%!R M;W!EF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/C6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$ M9F]N="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P M.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D M97(M=&]P.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@F4Z,3)P>#MM87)G:6XM=&]P.C!P M>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B;&4@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@65A2!I;F-R96%S M:6YG(&]U'0M86QI9VXZ(&QE9G0G(&)O6UE;G1S('1H6QE/3-$)V)O3IT:6UEF4] M,T0R/BAC+BD\+V9O;G0^/"]T9#X@#0H@("`\=&0@86QI9VX],T1L969T('9A M;&EG;CTS1'1O<#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/D-O;G-T2!T:6UE+"!H879E('1H92!R:6=H="!T;R!M86ME(&%N(&]F9F5R("@F M(S@R,C`[3V9F97)I;F<@365M8F5R)B,X,C(Q.RD@=&\@=&AE(&]T:&5R(&UE M;6)E2!T:&4@3V9F97)I;F<@365M8F5R("@F(S@R,C`[5')A;G-F97(@4')I M8V4F(S@R,C$[*2P@;W([("AI:2DF(S$V,#MP=7)C:&%S92!T:&4@96YT:7)E M(&]W;F5R2!T:&4@3F]N+4]F9F5R:6YG($UE;6)E M6QE/3-$;6%R9VEN+71O<#HP<'@[ M;6%R9VEN+6)O='1O;3HP<'@^/&9O;G0@2!I;G1E2!E87)T:'%U86ME(&EN2!!9F9I;&EA=&5S/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-V(P8S8T8E\Y.3`V7S1E.69? M.&0Q-%\T96-E9F5F-60X,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,#=B,&,V-&)?.3DP-E\T93EF7SAD,31?-&5C969E9C5D.#!A+U=O'0O:'1M;#L@ M8VAA'1";&]C:RTM M/@T*("`@/'`@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'!E8W1E9"!T;R!I;7!A8W0L('5S+B`\+V9O;G0^/"]P/@T* M("`@/'`@'0^4F5C96YT($%C8V]U;G1I;F<@4')O;F]U;F-E M;65N=',\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M+41/ M0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`\(2TM($)E9VEN M($)L;V-K(%1A9V=E9"!.;W1E(#<@+2!U'1";&]C:RTM/@T*("`@/'`@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@28C,38P.S(U+"`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`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/@T*("`@/"]T6QE M/3-$)VUAF4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C$U-2PS.#$\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE M/3-$)VUAF4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)VUAF4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@"8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0R/C(Y+C(T/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/D1E8G0@=&\@8V%S:"!F;&]W(')A=&EO/"]F M;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/G@F(S$V,#L\+V9O;G0^/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@2`M+3X-"B`@(#PO=&%B;&4^(`T*("`@/'`@&-L=61I;F<@;F5T(&1E8G0@<')E;6EU;2P@2!D96)T(')E;&%T960@=&\@;6%J;W)I='DM;W=N960@3$Q#F5S(&]U6QE/3-$9F]N M="US:7IE.C$R<'@[;6%R9VEN+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^ M)B,Q-C`[/"]P/@T*("`@/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`@=VED=&@],T0X-"4@8F]R9&5R/3-$,"!S='EL93TS1"=B;W)D M97(M8V]L;&%P'0M86QI9VXZ(&QE9G0G(&%L:6=N M/3-$8V5N=&5R/@T*("`@/"$M+2!"96=I;B!486)L92!(96%D("TM/@T*("`@ M/'1R/B`-"B`@(#QT9"!W:61T:#TS1#"!S;VQI9"`C,#`P,#`P.W=I9'1H.C0W<'0G/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L M3IT:6UEF4],T0Q/@T*("`@/&(^*&EN)B,Q-C`[=&AO=7-A;F1S*3PO8CX\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB/DEN=&5R97-T/"]B/CPO9F]N=#X\8G(@+SX\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB M/E)A=&4\+V(^/"]F;VYT/CPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L2`M+3X-"B`@(#QT3IT:6UEF4] M,T0R/D)20B!-961I8V%L($]F9FEC92!"=6EL9&EN9R!M;W)T9V%G92!L;V%N M*&(I/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C8L M,3@P/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4] M,T0R/D-E;G1E;FYI86P@2&EL;',@365D:6-A;"!/9F9I8V4@0G5I;&1I;F<@ M22!M;W)T9V%G92!L;V%N*&$I*&4I/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T* M("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0R M/E!A;&UD86QE($UE9&EC86P@4&QA>F$@9FEX960@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/C4N,3`\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B4F(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0R/CDL-#0R/"]F;VYT/CPO M=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E-P3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C4L,S8P/"]F;VYT/CPO=&0^(`T*("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/E-U;6UEF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/D9L;V%T:6YG/"]F;VYT/CPO=&0^(`T* M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ MF4],T0R M/E-U;6UE6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/D%U M8G5R;B!-961I8V%L($E)(&UO6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/D9L;V%T:6YG/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(P,3<\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C,L,#F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3IT:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C0N M-30\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B4F(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(P,C4\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/@T*("`@/"]TF4Z,7!X/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`@(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O'0M:6YD96YT.BTQ+C`P96TG M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ MF4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/@T*("`@/"]T6QE/3-$)V)O'0M86QI9VXZ(&QE9G0G(&)O3IT:6UEF4],T0R/D%M;W)T:7IE9"!P M6QE/3-$)V)O3IT:6UEF4],T0R/BAB*3PO M9F]N=#X\+W1D/B`-"B`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M2!D871E(&]F($1E8V5M8F5R)B,Q-C`[,2P-"B`@ M(#(P,C(N(#PO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)V)O3IT:6UEF4] M,T0R/BAC*3PO9F]N=#X\+W1D/B`-"B`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L M:6=N/3-$=&]P/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@'1E;F1E9"!I;B!!<')I;"P@,C`Q,BP@=VET:"!A(&9L;V%T:6YG(')A=&4@ M;V8@,2P@-B!O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@'0M86QI9VXZ M(&QE9G0G(&)O3IT:6UEF4],T0R/E=E(&)E;&EE=F4@=&AE('1E'!E8W0@=&\@'!L M;W)E(&]T:&5R(&9I;F%N8VEN9R!A;'1E'0M86QI9VXZ M(&QE9G0G(&)O3IT:6UEF4],T0R/E=E(&)E;&EE=F4@=&AE('1E6QE/3-$;6%R9VEN+71O<#HQ,G!X M.VUA6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@2!T:&4@2!O9B!T:&4@8G5I;&1I;F=S M(&%S('=E;&P@87,-"B`@('!R;W!E2`D,3$W+C8@;6EL;&EO;B!A&5D(')A=&4@9&5B="!I;7!A8W1S('1H92!F86ER('9A;'5E(&]F(&1E8G0L M(&)U="!I="!H87,@;F\@:6UP86-T(&]N(&EN=&5R97-T#0H@("!I;F-U7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$;6%R M9VEN+71O<#HQ.'!X.VUA6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R M/D]U7!I8V%L;'D@2!O M;B!A;B!I;F1I=FED=6%L#0H@("!B87-I7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@ M:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`\(2TM($)E9VEN($)L;V-K M(%1A9V=E9"!!8V-O=6YT:6YG(%!O;&EC>3H@=6AT+3(P,3(P.3,P7VYO=&4V M7V%C8V]U;G1I;F=?<&]L:6-Y7W1A8FQE,2`M('5S+6=A87`Z3F5W06-C;W5N M=&EN9U!R;VYO=6YC96UE;G1S4&]L:6-Y4&]L:6-Y5&5X=$)L;V-K+2T^#0H@ M("`\<"!S='EL93TS1&UA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M'!E8W1E9"!T;R!I;7!A8W0L M('5S+B`\+V9O;G0^/"]P/@T*("`@/'`@'0^3F5W($%C8V]U M;G1I;F<@4')O;F]U;F-E;65N=',\2TM/@T*("`@/'`@#MM87)G:6XM M8F]T=&]M.C!P>#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/D]U2!W:&5R92!W92!A2!A9&IU2!A'0^4F5A;"!%'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA&AT;6PQ+71R86YS:71I;VYA;"YD M=&0B("TM/@T*("`@/"$M+2!"96=I;B!";&]C:R!486=G960@3F]T92!486)L M93H@=6AT+3(P,3(P.3,P7VYO=&4R7W1A8FQE,2`M('5S+6=A87`Z4V-H961U M;&5/9E!R;W!E'1";&]C:RTM/@T*("`@/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C M96QL<&%D9&EN9STS1#`@=VED=&@],T0Y,B4@8F]R9&5R/3-$,"!S='EL93TS M1"=B;W)D97(M8V]L;&%P'0M86QI9VXZ(&QE9G0G M(&%L:6=N/3-$8V5N=&5R/@T*("`@/"$M+2!"96=I;B!486)L92!(96%D("TM M/@T*("`@/'1R/B`-"B`@(#QT9"!W:61T:#TS1#0X)3XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T)3XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0T)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T)3XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0R)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0R)3XF(S$V,#L\+W1D/@T*("`@/"]T"!S;VQI9"`C,#`P,#`P M.W=I9'1H.C4P<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(@ MF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT@8V]L3IT:6UEF4],T0Q/CQB/E1E6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@65A2`M+3X-"B`@(#QT M3IT:6UEF4],T0R/DUC06QL96X@365D:6-A;"!#96YT97(\+V9O M;G0^/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C4L-#@U+#`P,#PO9F]N=#X\+W1D/B`-"B`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$U M/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT M:6UEF4],T0R/D%C=71E($-AF4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/BAB*28C,38P.SPO9F]N=#X\+W1D/@T* M("`@/"]T6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/B0\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3IT:6UEF4],T0R/D1E8V5M8F5R+"`R,#$V M/"]F;VYT/CPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/BAB*28C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$ M)VUA6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1C96YT97(^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/BAC*28C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T'0M86QI9VXZ(&QE9G0G(&)O3IT:6UEF4],T0R/E5(4R!H87,@ M=&AR964@-2UY96%R(')E;F5W86P@;W!T:6]N&ES=&EN9R!L96%S M92!R871E6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@'0M86QI9VXZ(&QE9G0G(&)O3IT:6UEF4],T0R/E5(4R!H87,@='=O(#4M>65A M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\P-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X,&$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)?.3DP-E\T93EF M7SAD,31?-&5C969E9C5D.#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`\ M(2TM($)E9VEN($)L;V-K(%1A9V=E9"!.;W1E(%1A8FQE.B!U:'0M,C`Q,C`Y M,S!?;F]T931?=&%B;&4Q("T@=7,M9V%A<#I38VAE9'5L94]F0G5S:6YE4%C<75I6QE/3-$)V)O2`M+3X-"B`@(#QT3IT:6UEF4],T0R/DQA M;F0L(&)U:6QD:6YG6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT M:6UEF4],T0R/B`R-BPX,3`\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/D1E8G0\ M+V9O;G0^/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/D]T:&5R(&QI86)I;&ET:65S+"!N970\+V9O;G0^ M/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0R/D1E<&]S:71S(&9U;F1E9"!I;B`R M,#$Q/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O3IT M:6UEF4],T0R/DYE="!C87-H('!A:60@:6X@,C`Q M,CPO9F]N=#X\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$)V)O'1087)T7S`W8C!C-C1B7SDY,#9? M-&4Y9E\X9#$T7S1E8V5F968U9#@P80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL M93HO+R]#.B\P-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X,&$O M5V]R:W-H965T'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQAF5D($9I;F%N8VEA;"!);F9OF5D($9I;F%N8VEA;"!);F9O2!M971H;V0\+W1D/@T* M("`@("`@("`\=&0@8VQA3IT:6UEF4],T0Q/CQB/DYA;64@;V8@3$Q#/"]B M/CPO9F]N=#X\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0Q/CQB/D]W;F5RF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$;6%R9VEN+71O<#HP<'@[;6%R9VEN M+6)O='1O;3HQ<'@@86QI9VX],T1C96YT97(^/&9O;G0@2!,3$,\+V(^/"]F;VYT/CPO<#X-"B`@(#PO=&0^#0H@("`\ M+W1R/@T*("`@/"$M+2!%;F0@5&%B;&4@2&5A9"`M+3X-"B`@(#PA+2T@0F5G M:6X@5&%B;&4@0F]D>2`M+3X-"B`@(#QT3IT:6UEF4],T0R/D16 M34,@4')O<&5R=&EE3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M2!-961I8V%L($-E;G1E6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B4F(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UE MF4],T0R/E-A;G1A($9E(%-C;W1TF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/E-A;G1A($9E M(%!R;V9E6QE/3-$ M)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/CDP/"]F;VYT/CPO=&0^(`T* M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@#PO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/C6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)VUA6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/B4F(S$V,#L\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I M>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/D%R;&EN9W1O;B!-961I8V%L(%!R;W!EF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/E-A:6YT($UA M3IT M:6UEF4],T0R/E-I97)R82!-961I8V%L(%!R;W!E MF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@F4],T0R M/E-I97)R82!386X@06YT;VYI;R!-961I8V%L(%!L87IA/"]F;VYT/CPO=&0^ M#0H@("`\+W1R/B`-"B`@(#QT3IT:6UEF4],T0R/E!#2"!3;W5T M:&5R;B!06QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B4F(S$V,#L\+V9O M;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T M>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/E9I3IT:6UEF4],T0R/D=R87ES M;VX@4')O<&5R=&EEF4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E1E>&]M82!-961I8V%L(%!L87IA/"]F;VYT/CPO=&0^ M#0H@("`\+W1R/B`-"B`@(#QT3IT:6UEF4],T0R/C,X,3$@0F5L;"!-961I8V%L(%!R;W!EF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/DYO M2!-961I8V%L(%!L87IA/"]F;VYT/CPO=&0^#0H@("`\+W1R M/B`-"B`@(#QT3IT:6UEF4],T0R/D946"!-3T(@4&AA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0R/CDU/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F$@24D\+V9O;G0^/"]T9#X-"B`@(#PO='(^ M#0H@("`\(2TM($5N9"!486)L92!";V1Y("TM/@T*("`@/"]T86)L93X-"B`@ M(#QP('-T>6QE/3-$)VQI;F4M:&5I9VAT.CAP>#MM87)G:6XM=&]P.C!P>#MM M87)G:6XM8F]T=&]M.C)P>#MB;W)D97(M8F]T=&]M.C`N-7!T('-O;&ED(",P M,#`P,#`[=VED=&@Z,3`E)SXF(S$V,#L\+W`^#0H@("`\=&%B;&4@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V)O3IT:6UEF4],T0R/BAB+BD\+V9O;G0^/"]T9#X@#0H@("`\=&0@86QI9VX],T1L969T M('9A;&EG;CTS1'1O<#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/E1E;F%N=',@;V8@=&AI'0M86QI9VXZ(&QE9G0G(&)O2!C;VUP86YI97,@86-C;W5N=&5D(&9O M'0M86QI9VXZ(&QE9G0G(&%L M:6=N/3-$8V5N=&5R/@T*("`@/"$M+2!"96=I;B!486)L92!(96%D("TM/@T* M("`@/'1R/B`-"B`@(#QT9"!W:61T:#TS1#8U)3XF(S$V,#L\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T)3XF(S$V,#L\+W1D/B`- M"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@ M(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0T)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@ M(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0T)3XF(S$V,#L\+W1D/B`-"B`@ M(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT M9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0R)3XF(S$V,#L\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT M9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0R)3XF(S$V,#L\+W1D/@T*("`@/"]TF4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M8V]L6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V)O6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0Q/CQB/C(P,3(H8BXI/"]B/CPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT M:6UEF4],T0Q/CQB/C(P,3(H8BXI/"]B/CPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@ M/"]TF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0R M/C$U+#(R,CPO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C$V+#0Y.3PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/C0T+#@P,SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ MF4],T0R M/D]P97)A=&EN9R!E>'!E;G-E3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(L,S(W/"]F;VYT/CPO=&0^(`T*("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0R/C$Y+#DX-CPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT:6UEF4],T0R/D1E<')E8VEA=&EO;B!A;F0@86UOF%T M:6]N/"]F;VYT/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/C,L,C@T/"]F;VYT/CPO=&0^(`T*("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL M93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$L M-30U/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$S+#8Q.3PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE M/3-$)V)O6QE/3-$)V)O"!S;VQI9"`C M,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S;VQI M9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V M,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@'0M:6YD96YT M.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C$L,3@Y/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$9F]N="US M:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^ M(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P M.C-P>"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@"!D;W5B;&4@(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@3IT:6UEF4],T0R/D]UF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)V)OF4Z,3)P>#MM M87)G:6XM=&]P.C!P>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@ M("`\=&%B;&4@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@2!U2P@86YD("0Q+C,@;6EL;&EO;B!A;F0@)#(N,"!M:6QL:6]N(&9O2X@/"]F;VYT/CPO=&0^#0H@("`\+W1R M/@T*("`@/"]T86)L93X@#0H@("`\=&%B;&4@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!D:7-C;&]S960L(&1U2!A8V-O=6YT960@9F]R(&]N(&%N('5N8V]N'0^17%U:71Y(&UE=&AO9"!I;G9EF5D(&EN8V]M93QS<&%N/CPO&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T* M("`@/"$M+2!"96=I;B!";&]C:R!486=G960@3F]T92!486)L93H@=6AT+3(P M,3(P.3,P7VYO=&4U7W1A8FQE,R`M('5H=#I%<75I='E-971H;V1);G9E6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^(`T*("`@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M8V]LF4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3IT:6UEF4],T0Q/CQB M/BAA;6]U;G1S(&EN('1H;W5S86YD'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/C$Q,2PR,#8\+V9O M;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$'0M:6YD M96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/@T*("`@/"]TF4Z,7!X M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`@(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^ M#0H@("`\+W1D/B`-"B`@(#QT9#XF(S$V,#L\+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0R M/C$T,"PT-S0\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T* M("`@/"]TF4Z,7!X/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`@(#QP('-T>6QE/3-$)V)O6QE/3-$)V)O M'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/DUO6%B;&4L(&YO;BUR96-O=7)S M92!T;R!U3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/D%D M=F%N8V5S('!A>6%B;&4@=&\@=7,\+V9O;G0^/"]P/@T*("`@/"]T9#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$R+#8Y M,CPO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/D5Q=6ET>3PO9F]N=#X\+W`^ M#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UEF4],T0R/C$X+#6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$9F]N="US:7IE.C%P M>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P>"!S M;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C%P M>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`-"B`@(#QT M9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*("`@/'`@'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3PO9F]N=#X\+W`^ M#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$)VUA6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/C,X+#@Y-3PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT M:6UEF4],T0R/C,S+#`U-SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE M/3-$)V)O6QE/3-$)V)O2!U;F-O;G-O;&ED871E9"!,3$-S+"!A8V-O=6YT960@=6YD97(@97%U M:71Y(&UE=&AO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/"$M M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H@("`\(2TM($)E M9VEN($)L;V-K(%1A9V=E9"!.;W1E(%1A8FQE.B!U:'0M,C`Q,C`Y,S!?;F]T M935?=&%B;&4T("T@=7,M9V%A<#I#;VYT6QE/3-$)V)O2`M+3X-"B`@(#QTF4],T0R M/C(P,3(\+V9O;G0^/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M:6YD96YT.BTQ M+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C8L-S8V/"]F;VYT/CPO=&0^(`T*("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C$S+#@U-#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/C(P,34\+V9O;G0^/"]P/@T*("`@ M/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)V)O6QE/3-$)V)O3IT:6UEF4],T0R/E1O=&%L/"]F;VYT M/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@3IT:6UEF4],T0R/C6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V)OF4Z,3)P>#MM87)G:6XM=&]P.C!P M>#MM87)G:6XM8F]T=&]M.C!P>#XF(S$V,#L\+W`^#0H@("`\=&%B;&4@8V5L M;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!W:61T:#TS1#6QE/3-$)V)O6QE/3-$)V)O MF4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L'0M M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/C$R+S,Q+S(P,3(\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0R/C4L,C0U/"]F;VYT/CPO=&0^(`T* M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ MF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@7-O;B!0 M6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ MF4],T0Q M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/D%R;&EN9W1O;B!- M961I8V%L(%!R;W!EF4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/C$P+S$P+S(P M,34\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T M6QE/3-$)VUAF4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/D946"!-3T(@ M4&AA6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0R/C@O,#$O,C`Q-SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4] M,T0R/E!#2"!3;W5T:&5R;B!06QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R M/C$R+S`Q+S(P,3<\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/@T*("`@/"]T6QE/3-$)VUA6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UEF4],T0R/C`U+S`Q+S(P,3@\ M+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)V)O6QE/3-$)V)O3IT:6UE MF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V)O6QE/3-$9F]N="US:7IE.C$R<'@[;6%R9VEN M+71O<#HP<'@[;6%R9VEN+6)O='1O;3HP<'@^)B,Q-C`[/"]P/@T*("`@/'1A M8FQE('-T>6QE/3-$)V)O3IT:6UEF4],T0R/BAA M+BD\+V9O;G0^/"]T9#X@#0H@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS M1'1O<#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/E=E(&)E;&EE=F4@=&AE('1E2!D871E'!L;W)E(&]T:&5R(&9I;F%N8VEN9R!A;'1EFEN9R!F=6YD6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!O9B!R97%U:7)E M9"!C;VUP;&EA;F-E(')A=&EO6QE/3-$)V)OF4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@"!S;VQI9"`C,#`P,#`P)SX\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0Q/CQB/D-O=F5N M86YT/"]B/CPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@3IT:6UEF4],T0Q/CQB/C(P,3(\+V(^/"]F;VYT/CPO=&0^(`T*("`@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(S$V,#L\+V9O M;G0^/"]T9#X-"B`@(#PO='(^#0H@("`\(2TM($5N9"!486)L92!(96%D("TM M/@T*("`@/"$M+2!"96=I;B!486)L92!";V1Y("TM/@T*("`@/'1R(&)G8V]L M;W(],T0C8V-E969F/B`-"B`@(#QT9"!V86QI9VX],T1T;W`^#0H@("`\<"!S M='EL93TS1"=M87)G:6XM;&5F=#HQ+C`P96T[('1E>'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M3IT M:6UEF4],T0R/C$R-2PP,#`\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT M:6UEF4],T0R/B0\+V9O;G0^/"]T9#X@#0H@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C,Q+C0\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B4F(S$V,#L\+V9O;G0^ M/"]T9#X-"B`@(#PO='(^(`T*("`@/'1R(&)G8V]L;W(],T0C8V-E969F/B`- M"B`@(#QT9"!V86QI9VX],T1T;W`^#0H@("`\<"!S='EL93TS1"=M87)G:6XM M;&5F=#HQ+C`P96T[('1E>'0M:6YD96YT.BTQ+C`P96TG/CQF;VYT('-T>6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/G@F(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@"8C,38P.SPO9F]N=#X\ M+W1D/@T*("`@/"]T6QE/3-$)VUA3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R M/B9L=#LF(S$V,#LS+C4P/"]F;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@"8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T3IT:6UEF4],T0Q/CQB/D9A8VEL:71Y($YA;64\+V(^/"]F;VYT M/CPO<#X-"B`@(#PO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S:7IE/3-$,3XF(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R('-T>6QE/3-$ M)V)O6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N M=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)V)O6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@F4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B0\+V9O M;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0R/C(P,3(\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T* M("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT M+69A;6EL>3IT:6UEF4],T0R/C$Q+#8Y,3PO9F]N M=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL M>3IT:6UEF4],T0R/C(P,3,\+V9O;G0^/"]T9#X@ M#0H@("`\=&0@;F]W3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUAF4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UE MF4],T0R/C8L,S(W/"]F;VYT/CPO=&0^(`T*("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E-U;6UEF4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@6QE M/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE M=R!R;VUA;B<@6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/C(P,30\+V9O M;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUAF4] M,T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0R/C(P,34\+V9O;G0^/"]T9#X@#0H@ M("`\=&0@;F]W3IT:6UEF4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA6QE/3-$ M)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R M;VUA;B<@6QE/3-$)V9O M;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E!E M86-E2&5A;'1H($UE9&EC86P@0VQI;FEC(&9I>&5D(')A=&4@;6]R=&=A9V4@ M;&]A;BAA*3PO9F]N=#X\+W`^#0H@("`\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(R+#$X.#PO9F]N=#X\+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N M;W=R87`@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R M/C(P,3<\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@ M/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A M;6EL>3IT:6UEF4],T0R/C$R+#,V-CPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT M:6UEF4],T0R/C(P,3<\+V9O;G0^/"]T9#X@#0H@ M("`\=&0@;F]W3IT:6UEF4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N M="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4] M,T0R/CF4],T0Q/B8C,38P M.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@ M6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/DUE9&EC86P@0V5N=&5R(&]F(%=E6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C8N,#`\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UEF4],T0R/B4F(S$V,#L\+V9O;G0^/"]T M9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@'0M:6YD96YT.BTQ+C`P M96TG/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA M;B<@F4],T0Q/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I M;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S M(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/C(P,3D\+V9O;G0^/"]T9#X@#0H@("`\=&0@ M;F]W3IT:6UEF4],T0R/B8C,38P M.SPO9F]N=#X\+W1D/@T*("`@/"]T6QE/3-$)VUA3IT:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=F M;VYT+69A;6EL>3IT:6UEF4],T0R/C8L.38R/"]F M;VYT/CPO=&0^(`T*("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT^/&9O;G0@F4],T0Q/B8C,38P.SPO9F]N=#X\+W1D M/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@ M6QE/3-$)V9O;G0M9F%M M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4],T0R/E1U6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@6QE/3-$)V9O;G0M9F%M:6QY M.G1I;65S(&YE=R!R;VUA;B<@3IT:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@3IT M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=F;VYT+69A;6EL>3IT:6UEF4],T0R M/C4N-38\+V9O;G0^/"]T9#X@#0H@("`\=&0@;F]W3IT:6UE MF4],T0R/B4F(S$V,#L\+V9O;G0^/"]T9#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-I>F4],T0Q/B8C,38P.SPO M9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$9F]N M="US:7IE.C%P>#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO M=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@ M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D M97(M=&]P.C%P>"!S;VQI9"`C,#`P,#`P)SXF(S$V,#L\+W`^#0H@("`\+W1D M/B`-"B`@(#QT9#XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T M;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P M.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`- M"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^)B,Q-C`[/"]T9#X@#0H@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A;&EG;CTS M1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B,Q-C`[/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO M=&0^#0H@("`\+W1R/B`-"B`@(#QT3IT:6UE MF4],T0R/E1O=&%L/"]F;VYT/CPO<#X-"B`@(#PO M=&0^(`T*("`@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(S$V,#L\+V9O;G0^/"]T9#X@#0H@("`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@3IT:6UE MF4],T0R/C$Q-"PW-C`\+V9O;G0^/"]T9#X@#0H@ M("`\=&0@;F]W3IT:6UEF4],T0R M/B8C,38P.SPO9F]N=#X\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B;W1T;VT^ M/&9O;G0@6QE/3-$9F]N="US:7IE.C%P>#X@#0H@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C,38P.SPO=&0^(`T*("`@/'1D('9A M;&EG;CTS1&)O='1O;3XF(S$V,#L\+W1D/B`-"B`@(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@("`\<"!S='EL93TS1"=B;W)D97(M=&]P.C-P>"!D;W5B;&4@ M(S`P,#`P,"<^)B,Q-C`[/"]P/@T*("`@/"]T9#X@#0H@("`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*("`@/'`@6QE/3-$)VQI;F4M:&5I9VAT.CAP>#MM87)G:6XM=&]P.C!P>#MM M87)G:6XM8F]T=&]M.C)P>#MB;W)D97(M8F]T=&]M.C`N-7!T('-O;&ED(",P M,#`P,#`[=VED=&@Z,3`E)SXF(S$V,#L\+W`^#0H@("`\=&%B;&4@6QE/3-$)V9O;G0M M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'0M86QI9VXZ(&QE9G0G(&)O3IT:6UE MF4],T0R/E-U8G-E<75E;G0@=&\@4V5P=&5M8F5R M)B,Q-C`[,S`L(#(P,3(L('1H:7,@;&]A;B!W87,@'0M86QI9VXZ(&QE9G0G(&)O3IT:6UEF4],T0R/E1H:7,@;&]A;B!W87,@ M86UE;F1E9"!A;F0@97AT96YD960@:6X@07!R:6PL(#(P,3(L('=I=&@@82!F M;&]A=&EN9R!R871E(&]F(#$L(#8@;W(@,3(@;6]N=&@@3&EB;W(@<&QU6QE M/3-$)V)O3IT:6UEF4],T0R/BAD*3PO9F]N=#X\ M+W1D/B`-"B`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P/CQF;VYT M('-T>6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@'1E;F1E9"!I;B!!<')I M;"P@,C`Q,BP@=VET:"!A(&9L;V%T:6YG(')A=&4@;V8@,2P@-B!O6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2!D871E(&9OFEN M9R!F=6YD2X@/"]F;VYT/CPO=&0^#0H@("`\+W1R/@T*("`@/"]T86)L93X@ M#0H@("`\=&%B;&4@6QE/3-$)V9O;G0M9F%M:6QY.G1I;65S(&YE=R!R;VUA;B<@2`S,2P@,C`Q,R!M871U2!D871E M(&9O65A'!E M8W1E9"!E=F5N="!T:&%T('=E(&%R92!U;F%B;&4@=&\@FEN9R!F=6YD#MM87)G:6XM8F]T=&]M.C!P>#X\9F]N="!S='EL93TS M1"=F;VYT+69A;6EL>3IT:6UEF4],T0R/E1H92!M M;W)T9V%G97,@87)E('-E8W5R960@8GD@=&AE(')E86P@<')O<&5R='D@;V8@ M=&AE(&)U:6QD:6YG2!L96%S97,@ M86YD(')E;G1S+B!4:&4@;6]R=&=A9V5S(&AA=F4@82!C;VUB:6YE9"!F86ER M('9A;'5E(&]F(&%P<')O>&EM871E;'D@)#$Q-RXV(&UI;&QI;VX@87,@;V8@ M4V5P=&5M8F5R)B,Q-C`[,S`L(#(P,3(N($-H86YG97,@:6X@;6%R:V5T(')A M=&5S(&]N(&]U'0^3W5T M3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\P-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F M-60X,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)? M.3DP-E\T93EF7SAD,31?-&5C969E9C5D.#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!I;G1E2!H96QD M(&YO;BUC;VYT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!E<75I='D@;65T:&]D/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!I;G1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A&ES=&EN9R!L M96%S92!T97)M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E(&]F($9A8VEL:71Y/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y!8W5T92!#87)E/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$65A2!; M365M8F5R73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M65A7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^ M/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L&EM=6T@6TUE;6)E2!;365M8F5R M73QB2!;365M8F5R73QB7-T96T@6TUE;6)E7-T96T@6TUE;6)E&EM=6T@ M6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-2!Y96%R2!I;G1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^.3`@9&%Y'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^,3@P(&1A>7,\'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,3@P(&1A M>7,\'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$&ES=&EN9R!L96%S92!R871E'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-2!Y96%R65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`R-#QS<&%N/CPO M'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@ M9&5B="!F:6YA;F-I;F'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!F964@87,@<&5R M8V5N=&%G92!O9B!A=F5R86=E(&EN=F5S=&5D(')E86P@97-T871E(&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI(%M!8G-T7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-V(P8S8T M8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X,&$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)?.3DP-E\T93EF7SAD,31?-&5C969E M9C5D.#!A+U=O'0O:'1M;#L@8VAA"!;365M M8F5R73QBF$@6TUE;6)E2!-961I8V%L(%!L87IA(%M-96UB97)=/&)R/DQA:V4@4&]I M;G1E($UE9&EC86P@07)T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$65A65A65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE;G0@;V8@ M;&]A;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X,&$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)?.3DP-E\T93EF7SAD,31? M-&5C969E9C5D.#!A+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!-971H;V0\ M+W-T'0^1&5S97)T(%9A;&QE>2!-961I8V%L($-E;G1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!-971H;V0\+W-T'0^ M4W5B=7)B86X@365D:6-A;"!0;&%Z82!)23QS<&%N/CPO'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!-971H;V0\+W-T'0^4V%N=&$@1F4@4')O M9F5S2!#;VUP86YI97,@06-C;W5N=&5D(&9O2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!-971H;V0\+W-T'0^4VEEF$\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!#;VUP86YI97,@06-C;W5N=&5D(&9O2!/=VYE9"!B>2!,3$,\+W1D/@T*("`@ M("`@("`\=&0@8VQA&]M82!-961I8V%L(%!L87IA/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!-971H;V0\+W-T'0^ M1F]R;F5Y($UE9&EC86P@4&QA>F$@24D\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA MF5D($9I;F%N8VEA;"!);F9OF5D(&EN8V]M M93PO'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$F%T:6]N/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#(V,SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!!9F9I;&EA=&5S("A$971A:6QS(#(I("A54T0@)"D\8G(^26X@ M5&AO=7-A;F1S+"!U;FQE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6%B;&4@=&\@=7,\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P M-V(P8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X,&$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)?.3DP-E\T93EF7SAD,31? M-&5C969E9C5D.#!A+U=O'0O:'1M;#L@8VAA2!U M;F-O;G-O;&ED871E9"!,3$-S+"!A8V-O=6YT960@=6YD97(@97%U:71Y(&UE M=&AO9#PO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$6%B;&4@8GD@=6YC;VYS;VQI9&%T960@3$Q#2!M971H;V0\+W-T'0^1&5C(#,Q+`T*"0DR,#$R/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!U;F-O;G-O;&ED871E9"!,3$-S+"!A8V-O=6YT960@=6YD97(@ M97%U:71Y(&UE=&AO9#PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#Y&96(@,3(L#0H)"3(P,3,\2!U M;F-O;G-O;&ED871E9"!,3$-S+"!A8V-O=6YT960@=6YD97(@97%U:71Y(&UE M=&AO9#PO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#Y*=6P@,2P-"@D),C`Q-#QS<&%N/CPO6%B;&4@8GD@=6YC;VYS;VQI9&%T M960@3$Q#2!M971H;V0\+W-T'0^2F%N(#$L#0H) M"3(P,34\'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!$871E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y/8W0@,3`L#0H)"3(P M,34\2!U;F-O;G-O;&ED871E9"!,3$-S+"!A8V-O=6YT960@ M=6YD97(@97%U:71Y(&UE=&AO9#PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!$871E/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#Y.;W8@,2P-"@D),C`Q-3QS<&%N/CPO2!U;F-O;G-O;&ED871E9"!,3$-S+"!A8V-O=6YT960@=6YD97(@97%U:71Y M(&UE=&AO9#PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#Y!=6<@,2P-"@D),C`Q-SQS<&%N/CPO2!U;F-O;G-O M;&ED871E9"!,3$-S+"!A8V-O=6YT960@=6YD97(@97%U:71Y(&UE=&AO9#PO M'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#Y$96,@ M,2P-"@D),C`Q-SQS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`Q+`T*"0DR,#$X M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF5D($9I;F%N M8VEA;"!);F9O3QB3QB3QB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!I;G1E2!C;VUP M86YI97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!C;VUP86YI97,L(&%C8V]U;G1E M9"!F;W(@8GD@97%U:71Y(&UE=&AO9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M7,@9F]R($YO;BU/9F9E7,\'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!I;G1E2!H96QD(&YO;BUC;VYT&EM=6T@6TUE;6)E M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M2!I;G1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!M971H M;V0@:6YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!M971H;V0@:6YV97-T;65N=',@6TQI;F4@271E;7-=/"]S=')O;F<^/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!C;VUP86YI97,\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!M971H;V0@:6YV97-T;65N=',@6TQI;F4@271E M;7-=/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA&EM=6T@6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-V(P M8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X,&$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)?.3DP-E\T93EF7SAD,31?-&5C M969E9C5D.#!A+U=O'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F$@9FEX960@2!$871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XR,#$S M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^,C`Q-#QS<&%N/CPO2!-961I8V%L M($]F9FEC92!"=6EL9&EN9R!M;W)T9V%G92!L;V%N*&$I(%M-96UB97)=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^,C`Q-3QS<&%N/CPO M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!$871E/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#XR,#$V/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q-SQS<&%N/CPO'0^,C`Q-SQS<&%N/CPO&5D(')A M=&4@;6]R=&=A9V4@;&]A;BAA*2!;365M8F5R73PO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^1FQO871I;F<\'0^,C`Q-SQS<&%N/CPO2!$871E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XR,#$Y/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`R,CQS M<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^65A'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4L(&YO;BUR96-O=7)S92!T;R!U M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^1FQO871I;F<\'1U86PI(%M!8G-T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^4F5F:6YA M;F-E('1H:7,@;&]A;B!O;B!O2`S,2P@,C`Q M,R!M871U2!D871E(&9O'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2`S,2P@,C`Q,R!M M871U2!D871E(&9O'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^2G5L(#(U M+`T*"0DR,#$Q/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$"!M;VYT:"!,24)/4B!P;'5S(&%N(&%P<&QI8V%B;&4@ M;6%R9VEN(')A;F=I;F<@9G)O;2`Q+C'0^1W)E871E'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P-V(P M8S8T8E\Y.3`V7S1E.69?.&0Q-%\T96-E9F5F-60X,&$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,#=B,&,V-&)?.3DP-E\T93EF7SAD,31?-&5C M969E9C5D.#!A+U=O&UL#0I#;VYT96YT+51R M86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I#;VYT96YT+51Y M<&4Z('1E>'0O:'1M;#L@8VAA&UL M;G,Z;STS1")U XML 17 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Financial Information of Equity Affiliates (Details Textual) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2012
Entity
Sep. 30, 2011
Sep. 30, 2012
Entity
Sep. 30, 2011
Entity
Dec. 31, 2011
Entity
Schedule of equity method investments [Line Items]          
Number of limited liability companies, purchased third party minority ownership interests       11 11
Non-controlling equity interests in LLCs after acquisition 100.00%   100.00%    
Number of limited liability companies 14   14    
Number of limited liability companies, accounted for by equity method 13   13    
Number of limited liability companies, consolidated 1   1    
Number of days for Non-Offering Member either to purchase or sell its entire ownership interest to or from Offering Member 60 days   60 days    
Shares of net income $ 645,000 $ 875,000 $ 1,803,000 $ 2,377,000  
Refinance of loan term     refinance these loan on or before the 2012 and 2013 maturity dates for three to ten year terms    
Non Controlling ownership interest 90.00%   90.00%    
Minimum [Member]
         
Schedule of equity method investments [Line Items]          
Non-controlling equity interest, ownership percentage 33.00%   33.00%   33.00%
Previously held non-controlling equity interest, majority ownership percentage     85.00%   85.00%
Maximum [Member]
         
Schedule of equity method investments [Line Items]          
Non-controlling equity interest, ownership percentage 95.00%   95.00%   95.00%
Previously held non-controlling equity interest, majority ownership percentage     99.00%   99.00%
California [Member]
         
Schedule of equity method investments [Line Items]          
Number of LLCs properties which are not covered by earthquake insurance 3   3    
LLCs on an unconsolidated [Member]
         
Schedule of equity method investments [Line Items]          
Number of limited liability companies 13   13    
Advances made to LLCs [Member]
         
Schedule of equity method investments [Line Items]          
Interest income earned by us on various advances $ 438,000 $ 1,300,000 $ 715,000 $ 2,000,000  
XML 18 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Financial Information of Equity Affiliates (Details 3) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
2012 $ 4,210
2013 6,766
2014 13,854
2015 35,231
2016 316
Later 15,648
Total 76,025
Sierra Medical Properties(a.) [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Dec. 31, 2012
Total 3,808
Sparks Medical Properties (a.)
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Feb. 12, 2013
Total 5,245
Grayson Properties(c.) [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Jul. 01, 2014
Total 12,914
Brunswick Associates [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Jan. 01, 2015
Total 8,124
Arlington Medical Properties [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Oct. 10, 2015
Total 24,954
DVMC Properties [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Nov. 01, 2015
Total 4,098
FTX MOB Phase II(C.) [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Aug. 01, 2017
Total 1,299
PCH Southern Properties [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date Dec. 01, 2017
Total 6,766
PCH Medical Properties [Member]
 
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method  
Maturity Date May 01, 2018
Total $ 8,817
XML 19 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-term Debt (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Summary of Required Compliance Ratios, Giving Effect to New Covenants Contained in Credit Agreement  
Covenant, Tangible net worth $ 125,000
Tangible net worth $ 155,381
Debt to total capital 31.40%
Debt service coverage ratio 29.24
Debt to cash flow ratio 1.30
Maximum [Member]
 
Summary of Required Compliance Ratios, Giving Effect to New Covenants Contained in Credit Agreement  
Covenant, Debt to total capital 55.00%
Covenant, Debt to cash flow ratio 3.50
Minimum [Member]
 
Summary of Required Compliance Ratios, Giving Effect to New Covenants Contained in Credit Agreement  
Covenant, Debt service coverage ratio 5.00
XML 20 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-term Debt (Details 1) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Outstanding Mortgages  
Outstanding balance $ 114,760
BRB Medical Office Building mortgage loan(b) [Member]
 
Outstanding Mortgages  
Outstanding balance 6,180
Interest Rate 6.25%
Maturity Date 2012
Centennial Hills Medical Office Building I mortgage loan(a)(e) [Member]
 
Outstanding Mortgages  
Outstanding balance 11,691
Interest Rate 6.00%
Maturity Date 2013
Palmdale Medical Plaza fixed rate mortgage loan(a)(f)[Member]
 
Outstanding Mortgages  
Outstanding balance 6,327
Interest Rate 5.10%
Maturity Date 2013
Summerlin Hospital Medical Office Building I mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance 9,442
Interest Rate 6.55%
Maturity Date 2014
Spring Valley Medical Office Building mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance 5,360
Interest Rate 5.50%
Maturity Date 2015
Summerlin III Medical Office Building III mortgage loan(a)(c) [Member]
 
Outstanding Mortgages  
Outstanding balance 11,728
Interest rate floating Floating
Maturity Date 2016
Aubum Medical II mortgage loan(a)(d) [Member]
 
Outstanding Mortgages  
Outstanding balance 22,188
Interest Rate 5.64%
Maturity Date 2017
Medical Center of Western Connecticut fixed rate mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance 12,366
Interest Rate 5.50%
Maturity Date 2017
Peace Health Medical Clinic fixed rate mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance 7,674
Interest rate floating Floating
Maturity Date 2017
Summerlin Hospital Medical Office Building II mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance 5,033
Interest Rate 6.00%
Maturity Date 2017
Kindred Hospital-Corpus Christi fixed rate mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance 3,077
Interest Rate 6.50%
Maturity Date 2019
700 Shadow Lane and Goldring MOB mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance 6,962
Interest Rate 4.54%
Maturity Date 2022
Tuscan Professional Building fixed rate mortgage loan(a) [Member]
 
Outstanding Mortgages  
Outstanding balance $ 6,732
Interest Rate 5.56%
Maturity Date 2025
XML 21 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Dividends
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Dividends [Abstract]    
Dividends

(3) Dividends

We declared and paid dividends of $7.8 million, or $.615 per share, during the third quarter of 2012 and $7.7 million, or $.605 per share, during the third quarter of 2011. We declared and paid dividends of $23.3 million, or $1.84 per share, during the nine-month period ended September 30, 2012 and $23.0 million, or $1.815 per share, during the nine-month period ended September 30, 2011.

Dividends
XML 22 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long term Debt (Details Textual) (USD $)
9 Months Ended
Sep. 30, 2012
MortgagePool
Dec. 31, 2011
Line of Credit Facility [Line Items]    
Commitment fee 0.30%  
Outstanding borrowing $ 83,000,000  
Revolving credit agreement amount outstanding 13,600,000  
Refinance of loan term refinance these loan on or before the 2012 and 2013 maturity dates for three to ten year terms  
Long Term Debt (Textual) [Abstract]    
Available borrowing capacity 53,400,000  
Compensating balance requirements 0  
Percentage of increase dividends in excess of cash available for distribution 95.00%  
Number of non-recourse mortgages 13  
Balance of Non Recourse Mortgages 114,760,000  
Mortgage and other notes payable, non-recourse to us, debt premium 1,400,000 1,100,000
Mortgage loan fair value 117,600,000  
BRB Medical Office Building mortgage loan(b) [Member]
   
Line of Credit Facility [Line Items]    
Refinance of loan term Refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December 1, 2022  
Long Term Debt (Textual) [Abstract]    
Balance of Non Recourse Mortgages 6,180,000  
Summerlin III Medical Office Building III mortgage loan(a)(c) [Member]
   
Line of Credit Facility [Line Items]    
Credit facility, Interest Rate Terms floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower’s option.  
Base rate description Floating  
Loan interest libor rate 3.25%  
Long Term Debt (Textual) [Abstract]    
Balance of Non Recourse Mortgages 11,728,000  
Aubum Medical II mortgage loan(a)(d) [Member]
   
Line of Credit Facility [Line Items]    
Credit facility, Interest Rate Terms floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower’s option.  
Loan interest libor rate 2.75%  
Long Term Debt (Textual) [Abstract]    
Balance of Non Recourse Mortgages 22,188,000  
Centennial Hills Medical Office Building I mortgage loan(a)(e) [Member]
   
Line of Credit Facility [Line Items]    
Refinance of loan term Refinance this loan on or before the Janury 31, 2013 maturity date for a three to ten year term at the then current market interest rates.  
Long Term Debt (Textual) [Abstract]    
Balance of Non Recourse Mortgages 11,691,000  
Palmdale Medical Plaza fixed rate mortgage loan(a)(f)[Member]
   
Line of Credit Facility [Line Items]    
Refinance of loan term Refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates.  
Long Term Debt (Textual) [Abstract]    
Balance of Non Recourse Mortgages 6,327,000  
LIBOR [Member]
   
Line of Credit Facility [Line Items]    
Margin points added to the reference rate 1.75%  
Base Rate [Member]
   
Line of Credit Facility [Line Items]    
Margin points added to the reference rate 0.75%  
Minimum [Member] | LIBOR [Member]
   
Line of Credit Facility [Line Items]    
Fee payable on unused portion of commitment 0.30%  
Maximum [Member] | LIBOR [Member]
   
Line of Credit Facility [Line Items]    
Fee payable on unused portion of commitment 0.50%  
Revolving Credit Agreement [Member]
   
Line of Credit Facility [Line Items]    
Unsecured revolving credit agreement terminated Jul. 25, 2011  
Credit facility, Interest Rate Terms Eurodollar rate plus 0.75% to 1.125%, or the prime rate plus zero to 0.125%.  
Outstanding borrowing 100,000,000  
Revolving Credit Agreement [Member] | Minimum [Member]
   
Line of Credit Facility [Line Items]    
Fee payable on unused portion of commitment 0.15%  
Revolving Credit Agreement [Member] | Maximum [Member]
   
Line of Credit Facility [Line Items]    
Fee payable on unused portion of commitment 0.225%  
New Revolving Credit Facility Agreement [Member]
   
Line of Credit Facility [Line Items]    
Unsecured revolving credit agreement terminated Jul. 24, 2015  
Credit facility, Interest Rate Terms One, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%.  
Revolving credit borrowing capacity additional amount 50,000,000  
Base rate description Greatest of: (a) the administrative agent’s prime rate, (b) the federal funds effective rate plus 1/2 of 1%, and; (c) one month LIBOR plus 1%.  
Outstanding borrowing 150,000,000  
New Revolving Credit Facility Agreement [Member] | Minimum [Member]
   
Line of Credit Facility [Line Items]    
Revolving credit borrowing capacity 100,000,000  
New Revolving Credit Facility Agreement [Member] | Maximum [Member]
   
Line of Credit Facility [Line Items]    
Revolving credit borrowing capacity 150,000,000  
New Revolving Credit Facility Agreement [Member] | Letter of Credit [Member]
   
Line of Credit Facility [Line Items]    
Revolving credit borrowing capacity 50,000,000  
New Revolving Credit Facility Agreement [Member] | Swingline/short-term loans [Member]
   
Line of Credit Facility [Line Items]    
Revolving credit borrowing capacity $ 20,000,000  
XML 23 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Income (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues:        
Base rental - UHS facilities $ 4,068 $ 3,266 $ 11,556 $ 9,788
Base rental - Non-related parties 6,623 2,676 20,265 6,727
Bonus rental - UHS facilities 955 1,013 3,109 3,217
Tenant reimbursements and other - Non-related parties 1,816 421 5,341 1,059
Tenant reimbursements and other - UHS facilities 148 18 356 45
Total Revenue 13,610 7,394 40,627 20,836
Expenses:        
Depreciation and amortization 5,263 1,799 15,484 4,841
Advisory fees to UHS 540 525 1,594 1,476
Other operating expenses 3,578 1,424 11,244 3,674
Transaction costs 14 455 663 590
Total Expenses 9,395 4,203 28,985 10,581
Income before equity in income of unconsolidated limited liability companies ("LLCs"), interest expense and gain, net 4,215 3,191 11,642 10,255
Equity in income of unconsolidated LLCs 645 875 1,803 2,377
Gain on divestiture of property owned by an unconsolidated LLC, net 0 0 7,375 0
Interest expense, net (1,874) (718) (5,853) (1,464)
Net income $ 2,986 $ 3,348 $ 14,967 $ 11,168
Basic earnings per share $ 0.24 $ 0.26 $ 1.18 $ 0.88
Diluted earnings per share $ 0.24 $ 0.26 $ 1.18 $ 0.88
Weighted average number of shares outstanding - Basic 12,666 12,648 12,658 12,643
Weighted average number of share equivalents 10 3 7 5
Weighted average number of shares and equivalents outstanding - Diluted 12,676 12,651 12,665 12,648
XML 24 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
General
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
General [Abstract]    
General

(1) General

This Quarterly Report on Form 10-Q is for the Quarterly Period ended September 30, 2012. In this Quarterly Report, “we,” “us,” “our” and the “Trust” refer to Universal Health Realty Income Trust.

You should carefully review all of the information contained in this Quarterly Report, and should particularly consider any risk factors that we set forth in this Quarterly Report and in other reports or documents that we file from time to time with the Securities and Exchange Commission (the “SEC”). In this Quarterly Report, we state our beliefs of future events and of our future financial performance. In some cases, you can identify those so-called “forward-looking statements” by words such as “may,” “will,” “should,” “could,” “would,” “predicts,” “potential,” “continue,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “appears,” “projects” and similar expressions, as well as statements in future tense. You should be aware that those statements are only our predictions. Actual events or results may differ materially. In evaluating those statements, you should specifically consider various factors, including the risks outlined herein and in our Annual Report on Form 10-K for the year ended December 31, 2011 in Item 1A Risk Factors and in Item 7 Management’s Discussion and Analysis of Financial Condition and Results of Operations - Forward Looking Statements. Those factors may cause our actual results to differ materially from any of our forward-looking statements.

Our future results of operations could be unfavorably impacted by continued deterioration in general economic conditions which could result in increases in the number of people unemployed and/or uninsured. Should that occur, it may result in decreased occupancy rates at our medical office buildings as well as a reduction in the revenues earned by the operators of our hospital facilities which would unfavorably impact our future bonus rentals (on the Universal Health Services, Inc. hospital facilities) and may potentially have a negative impact on the future lease renewal terms and the underlying value of the hospital properties. Additionally, the general real estate market has been unfavorably impacted by the deterioration in economic and credit market conditions which may adversely impact the underlying value of our properties. The tightening in the credit markets and the instability in certain banking and financial institutions over the past several years has not had a material impact on us. However, there can be no assurance that unfavorable credit market conditions will not materially increase our cost of borrowings and/or have a material adverse impact on our ability to finance our future growth through borrowed funds.

In this Quarterly Report on Form 10-Q, the term “revenues” does not include the revenues of the unconsolidated limited liability companies (“LLCs”) in which we have various non-controlling equity interests ranging from 33% to 95%. We currently account for our share of the income/loss from these investments by the equity method (see Note 5). As of September 30, 2012, we had investments or commitments in fourteen LLCs, thirteen of which are accounted for by the equity method and one that is currently consolidated in our financial statements. Additionally, as previously disclosed, during the fourth quarter of 2011, we purchased the third-party minority ownership interests in eleven LLCs of which we previously held non-controlling, majority ownership interests ranging from 85% to 99%. As a result, we now own 100% of each of these entities and began recording their financial results in our financial statements on a consolidated basis during the fourth quarter of 2011.

The financial statements included herein have been prepared by us, without audit, pursuant to the rules and regulations of the SEC and reflect all normal and recurring adjustments which, in our opinion, are necessary to fairly present results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the accompanying disclosures are adequate to make the information presented not misleading. It is suggested that these financial statements be read in conjunction with the financial statements, the notes thereto and accounting policies included in our Annual Report on Form 10-K for the year ended December 31, 2011.

General
XML 25 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Dividends (Details) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Dividends (Textual) [Abstract]        
Declared and paid dividends $ 7.8 $ 7.7 $ 23.3 $ 23.0
Declared and paid dividends, per share $ 0.615 $ 0.605 $ 1.84 $ 1.815
XML 26 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions And Dispositions (Details Textual) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended 9 Months Ended 1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2012
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
575 Hardy Investor [Member]
Sep. 30, 2012
Canyon Healthcare Properties [Member]
Sep. 30, 2011
Lake Pointe Medical Arts [Member]
sqft
Sep. 30, 2012
Canyon Springs Medical Plaza [Member]
Sep. 30, 2012
Centinela Medical Building Complex [Member]
Sep. 30, 2012
FTX MOB Phase II LP [Member]
sqft
Jan. 31, 2012
Peace Health Medical Clinic [Member]
sqft
Sep. 30, 2012
Peace Health Medical Clinic [Member]
Sep. 30, 2012
Peace Health Medical Clinic [Member]
Sep. 30, 2011
Forney Medical Plaza [Member]
sqft
Jul. 31, 2011
Forney Medical Plaza [Member]
Lake Pointe Medical Arts [Member]
Business Acquisition [Line Items]                                
Non-controlling ownership interests           90.00% 95.00%       95.00%          
Newly constructed MOB                     30,000          
Commitment to newly formed limited liability companies       $ 2,500,000                        
Net rentable area               50,974       99,000     50,946  
Total purchase price               12,200,000       30,400,000     15,000,000  
Third-Party financing   23,240,000   23,240,000               22,400,000        
Aggregate purchase price of tangible property                       26,800,000       23,000,000
Aggregate purchase price of intangible assets                       3,600,000       4,200,000
Intangible assets amortization period, years               6 years 6 months       10 years     6 years 2 months 12 days  
Revenue   13,610,000 7,394,000 40,627,000 20,836,000               698,000 1,900,000    
Net income   2,986,000 3,348,000 14,967,000 11,168,000               106,000 158,000    
Transaction expenses                       14,000   663,000    
Favourable Interest Expenses 108,000                              
Proceeds from divestiture of businesses net of cash divested                 8,100,000 12,100,000            
Gain on divestiture of property owned by an unconsolidated LLC, net   0 0 7,375,000 0       7,400,000              
Repayment of loan           8,000,000                    
Acquisitions and Dispositions (Textual) [Abstract]                                
Business acquisitions pro forma Revenue     13,400,000 40,800,000 39,800,000                      
Business acquisitions pro forma net income loss     $ 2,200,000 $ 8,300,000 $ 8,100,000                      
Pro forma net income per diluted share     $ 0.18 $ 0.65 $ 0.64                      
XML 27 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 28 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions [Abstract]    
Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions

(2) Relationship with Universal Health Services, Inc. (“UHS”) and Related Party Transactions

Leases: We commenced operations in 1986 by purchasing properties of certain subsidiaries from UHS and immediately leasing the properties back to the respective subsidiaries. Most of the leases were entered into at the time we commenced operations and provided for initial terms of 13 to 15 years with up to six additional 5-year renewal terms. The current base rentals and lease and rental terms for each facility are provided below. The base rents are paid monthly and each lease also provides for additional or bonus rents which are computed and paid on a quarterly basis based upon a computation that compares current quarter revenue to a corresponding quarter in the base year. The leases with subsidiaries of UHS are unconditionally guaranteed by UHS and are cross-defaulted with one another.

The combined revenues generated from the leases on the UHS hospital facilities comprised approximately 29% and 30% of our consolidated revenues during the three and nine months ended September 30, 2012, respectively, and 55% and 59% of our consolidated revenues during the three and nine months ended September 30, 2011, respectively. The decreases during the third quarter and the first nine months of 2012, as compared to the comparable quarter and nine months of the prior year, were due primarily to the December, 2011 purchase of the third-party minority ownership interests in eleven LLCs in which we previously held noncontrolling majority ownership interests (we began recording the financial results of these entities in our financial statements on a consolidated basis at that time) and various acquisitions of medical office buildings (“MOBs”) and clinics completed during 2011 and the first quarter of 2012. Including 100% of the revenues generated at the unconsolidated LLCs in which we have various non-controlling equity interests ranging from 33% to 95%, the leases on the UHS hospital facilities accounted for approximately 21% and 18% of the combined consolidated and unconsolidated revenue for the three month periods ended September 30, 2012 and 2011, respectively, and 21% and 19% of the combined consolidated and unconsolidated revenue for the nine months ended September 30, 2012 and 2011, respectively. In addition, fourteen MOBs, twelve of which are owned by LLCs in which we hold either 100% of the ownership interest or various non-controlling, majority ownership interests, include or will include tenants which are subsidiaries of UHS. The leases to the hospital facilities of UHS are guaranteed by UHS and cross-defaulted with one another.

Pursuant to the Master Lease Document by and among us and certain subsidiaries of UHS, dated December 24, 1986 (the “Master Lease”), which governs the leases of all hospital properties with subsidiaries of UHS, UHS has the option to renew the leases at the lease terms described below by providing notice to us at least 90 days prior to the termination of the then current term. In addition, UHS has rights of first refusal to: (i) purchase the respective leased facilities during and for 180 days after the lease terms at the same price, terms and conditions of any third-party offer, or; (ii) renew the lease on the respective leased facility at the end of, and for 180 days after, the lease term at the same terms and conditions pursuant to any third-party offer. UHS also has the right to purchase the respective leased facilities at the end of the lease terms or any renewal terms at the appraised fair market value. In addition, the Master Lease, as amended during 2006, includes a change of control provision whereby UHS has the right, upon one month’s notice should a change of control of the Trust occur, to purchase any or all of the four leased hospital properties listed below at their appraised fair market value.

The table below details the existing lease terms and renewal options for each of the UHS hospital facilities, giving effect to the above-mentioned renewals:

 

                         

Hospital Name

  Type of Facility   Annual
Minimum
Rent
    End of Lease Term   Renewal
Term
(years)
 

McAllen Medical Center

  Acute Care   $ 5,485,000     December, 2016     15 (a) 

Wellington Regional Medical Center

  Acute Care   $ 3,030,000     December, 2016     15 (b) 

Southwest Healthcare System, Inland Valley Campus

  Acute Care   $ 2,648,000     December, 2016     15 (b) 

The Bridgeway

  Behavioral Health   $ 930,000     December, 2014     10 (c) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
(c) UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).

We are committed to invest up to a total of $8.9 million in equity and debt financing, of which $5.0 million has been funded as of September 30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Palmdale Medical Properties) that constructed, owns, and operates the Palmdale Medical Plaza, located in Palmdale, California, on the campus of a UHS hospital. This MOB has a triple net, 75% master lease commitment by UHS of Palmdale, Inc., a wholly-owned subsidiary of UHS, pursuant to the terms of which the master lease for each suite will be cancelled at such time that the suite is leased to another tenant acceptable to the LLC and UHS of Palmdale, Inc. This MOB, tenants of which include subsidiaries of UHS, was completed and opened during the third quarter of 2008 at which time the master lease commenced. As of September 30, 2012, the master lease threshold of 75% has not been met. The LLC has a third-party term loan of $6.3 million, which is non-recourse to us, outstanding as of September 30, 2012. This LLC, which is deemed to be a variable interest entity, is consolidated in our financial statements since we are the primary beneficiary.

We are committed to invest up to $6.4 million in equity and debt financing, of which $5.7 million has been funded as of September 30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Sparks Medical Properties) that owns and operates the Vista Medical Terrace and The Sparks Medical Building, located in Sparks, Nevada, on the campus of a UHS hospital. This LLC has a third-party term loan of $5.2 million, which is non-recourse to us, outstanding as of September 30, 2012. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

We are committed to invest up to a total of $4.4 million in equity and debt financing, of which $1.7 million has been funded as of September 30, 2012, in exchange for a 95% non-controlling equity interest in an LLC (Texoma Medical Properties) that developed, constructed, owns and operates the Texoma Medical Plaza located in Denison, Texas, which was completed and opened during the first quarter of 2010. This MOB is located on the campus of a newly constructed and recently opened replacement UHS acute care hospital owned and operated by Texoma Medical Center (“Texoma Hospital”), a wholly-owned subsidiary of UHS. Texoma Hospital has committed to lease 75% of this building, pursuant to which the master lease for each suite will be cancelled at such time that the suite is leased to another tenant acceptable to the LLC and Texoma Hospital. It is anticipated that the master lease threshold on this MOB will be met in the near future. This MOB will have tenants that include subsidiaries of UHS. This LLC has a third-party term loan of $12.9 million, which is non-recourse to us, outstanding as of September 30, 2012. As this LLC is not considered to be a variable interest entity, it is accounted for pursuant to the equity method.

Advisory Agreement: UHS of Delaware, Inc. (the “Advisor”), a wholly-owned subsidiary of UHS, serves as Advisor to us under an Advisory Agreement (the “Advisory Agreement”) dated December 24, 1986. Pursuant to the Advisory Agreement, the Advisor is obligated to present an investment program to us, to use its best efforts to obtain investments suitable for such program (although it is not obligated to present any particular investment opportunity to us), to provide administrative services to us and to conduct our day-to-day affairs. All transactions between us and UHS must be approved by the Trustees who are unaffiliated with UHS (the “Independent Trustees”). In performing its services under the Advisory Agreement, the Advisor may utilize independent professional services, including accounting, legal, tax and other services, for which the Advisor is reimbursed directly by us. The Advisory Agreement may be terminated for any reason upon sixty days written notice by us or the Advisor. The Advisory Agreement expires on December 31 of each year; however, it is renewable by us, subject to a determination by the Independent Trustees, that the Advisor’s performance has been satisfactory. The Advisory Agreement was renewed for 2012 at the same terms and conditions as 2011.

The Advisory Agreement provides that the Advisor is entitled to receive an annual advisory fee equal to 0.65% of our average invested real estate assets, as derived from our consolidated balance sheet. The average real estate assets for advisory fee calculation purposes exclude certain items from our consolidated balance sheet such as, among other things, accumulated depreciation, cash and cash equivalents, base and bonus rent receivables, deferred charges and other assets. The advisory fee is payable quarterly, subject to adjustment at year-end based upon our audited financial statements. In addition, the Advisor is entitled to an annual incentive fee equal to 20% of the amount by which cash available for distribution to shareholders for each year, as defined in the Advisory Agreement, exceeds 15% of our equity as shown on our consolidated balance sheet, determined in accordance with generally accepted accounting principles without reduction for return of capital dividends. The Advisory Agreement defines cash available for distribution to shareholders as net cash flow from operations less deductions for, among other things, amounts required to discharge our debt and liabilities and reserves for replacement and capital improvements to our properties and investments. No incentive fees were paid during the first nine months of 2012 or 2011 since the incentive fee requirements were not achieved. Advisory fees incurred and paid (or payable) to UHS amounted to $540,000 and $525,000 for the three months ended September 30, 2012 and 2011, respectively, and were based upon average invested real estate assets of $332 million and $323 million for the three-month periods ended September 30, 2012 and 2011, respectively. Advisory fees incurred and paid (or payable) to UHS amounted to $1.6 million and $1.5 million for the nine months ended September 30, 2012 and 2011, respectively, and were based upon average invested real estate assets of $327 million and $303 million for the nine-month periods ended September 30, 2012 and 2011, respectively.

Officers and Employees: Our officers are all employees of UHS and although as of September 30, 2012 we had no salaried employees, our officers do receive stock-based compensation from time-to-time. As previously disclosed on our Current Report on Form 8-K as filed on June 11, 2012, in recognition of the efforts and contributions of our executive officers in connection with the various previously disclosed acquisitions, divestitures and purchases of third-party minority ownership interests in certain majority-owned limited liability companies, as completed at various times during 2011 and the first quarter of 2012, the Compensation Committee of the Board of Trustees of the Trust recommended, and the Board of Trustees of the Trust approved, one-time, special compensation awards to our executive officers in the form of a cash bonus and/or shares of restricted stock. The cash bonuses were paid and the restricted shares were granted during the second quarter of 2012. The restricted shares are scheduled to vest on the second anniversary of the date of grant. For additional disclosure, please refer to our Current Report on Form 8-K as filed on June 11, 2012.

Share Ownership: As of September 30, 2012 and December 31, 2011, UHS owned 6.2% of our outstanding shares of beneficial interest.

SEC reporting requirements of UHS: UHS is subject to the reporting requirements of the SEC and is required to file annual reports containing audited financial information and quarterly reports containing unaudited financial information. Since the leases on the hospital facilities leased to wholly-owned subsidiaries of UHS comprised approximately 29% and 30% of our consolidated revenues during the three and nine months ended September 30, 2012, respectively, and 55% and 59% of our consolidated revenues during the three and nine months ended September 30, 2011, respectively, and since a subsidiary of UHS is our Advisor, you are encouraged to obtain the publicly available filings for Universal Health Services, Inc. from the SEC’s website at www.sec.gov. These filings are the sole responsibility of UHS and are not incorporated by reference herein.

Relationship with Universal Health Services, Inc. (“UHS”) and Related Party Transactions
XML 29 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Dec. 31, 2011
Real Estate Investments:    
Buildings and improvements $ 366,321 $ 338,648
Accumulated depreciation (84,186) (74,865)
Real Estate Investment Property, Net, Total 282,135 263,783
Land 27,058 24,850
Net Real Estate Investments 309,193 288,633
Investments in and advances to limited liability companies ("LLCs") 38,895 33,057
Other Assets:    
Cash and cash equivalents 3,151 11,649
Base and bonus rent receivable from UHS 1,963 1,982
Rent receivable - other 3,016 2,056
Intangible assets (net of accumulated amortization of $6.6 million and $1.2 million at September 30, 2012 and December 31, 2011, respectively) 25,645 28,081
Deferred charges, goodwill and other assets, net 6,143 5,471
Total Assets 388,006 370,929
Liabilities:    
Line of credit borrowings 83,000 77,150
Mortgage and other notes payable, non-recourse to us (including net debt premium of $1.4 million and $1.1 million at September 30, 2012 and December 31, 2011, respectively) 116,175 97,686
Accrued interest 541 473
Accrued expenses and other liabilities 4,954 4,984
Tenant reserves, escrows, deposits and prepaid rents 2,234 1,691
Total Liabilities 206,904 181,984
Equity:    
Preferred shares of beneficial interest, $.01 par value; 5,000,000 shares authorized; none issued and outstanding 0 0
Common shares, $.01 par value; 95,000,000 shares authorized; issued and outstanding: 2012 - 12,685,403 2011 -12,666,824 127 127
Capital in excess of par value 214,092 213,566
Cumulative net income 462,365 447,398
Cumulative dividends (495,558) (472,230)
Total Universal Health Realty Income Trust Shareholders' Equity 181,026 188,861
Non-controlling equity interest 76 84
Total Equity 181,102 188,945
Total Liabilities and Equity $ 388,006 $ 370,929
XML 30 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Financial Information Of Equity Affiliates (Tables)
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Summarized Financial Information of Equity Affiliates [Abstract]    
Limited liability companies accounted for under equity method
             

Name of LLC

  Ownership    

Property Owned by LLC

DVMC Properties

    90   Desert Valley Medical Center

Suburban Properties

    33   Suburban Medical Plaza II

Santa Fe Scottsdale

    90   Santa Fe Professional Plaza

575 Hardy Investors(a.)

    90   Centinela Medical Building Complex

Brunswick Associates

    74   Mid Coast Hospital MOB

PCH Medical Properties

    85   Rosenberg Children’s Medical Plaza

Arlington Medical Properties

    75   Saint Mary’s Professional Office Building

Sierra Medical Properties

    95   Sierra San Antonio Medical Plaza

PCH Southern Properties

    95   Phoenix Children’s East Valley Care Center

Sparks Medical Properties(b.)

    95   Vista Medical Terrace & The Sparks Medical Building

Grayson Properties(b.)

    95   Texoma Medical Plaza

3811 Bell Medical Properties

    95   North Valley Medical Plaza

FTX MOB Phase II (c.)

    95   Forney Medical Plaza II

 

(a.) Subsequent to September 30, 2012, this LLC divested the Centinela Medical Building Complex.
(b.) Tenants of this medical office building include or will include subsidiaries of UHS.
(c.) During the third quarter of 2012, this LP entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which is scheduled to be completed during the first quarter of 2013.
Limited liability companies accounted for under equity method
Equity method investments summarized income
                                 
    Three Months  Ended
September 30,
    Nine Months  Ended
September 30,
 
    2012(b.)     2011     2012(b.)     2011  
    (amounts in thousands)  

Revenues

  $ 5,514     $ 15,222     $ 16,499     $ 44,803  

Operating expenses

    2,327       6,882       6,992       19,986  

Depreciation and amortization

    1,062       3,284       3,120       10,009  

Interest, net

    1,545       4,599       4,716       13,619  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 580     $ 457     $ 1,671     $ 1,189  
   

 

 

   

 

 

   

 

 

   

 

 

 

Our share of net income (a.)

  $ 645     $ 875     $ 1,803     $ 2,377  
   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a.) Our share of net income includes interest income earned by us on various advances made to LLCs of approximately $438,000 and $715,000 for the three months ended September 30, 2012 and 2011, respectively, and $1.3 million and $2.0 million for the nine months ended September 30, 2012 and 2011, respectively.
(b.) As previously disclosed, during the fourth quarter of 2011, eleven of our previously unconsolidated investments in LLCs are now owned 100% by us and are therefore included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011 and the first quarter of 2012, nine LLCs, in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.
Equity method investments summarized income
Combined balance sheets (unaudited) for LLCs
                 
    September 30,
2012
    December 31,
2011
 
    (amounts in thousands)  

Net property, including CIP

  $ 111,206     $ 127,755  

Other assets

    10,360       12,719  
   

 

 

   

 

 

 

Total assets

  $ 121,566     $ 140,474  
   

 

 

   

 

 

 

Liabilities

  $ 6,149     $ 4,949  

Mortgage notes payable, non-recourse to us

    76,025       101,839  

Advances payable to us

    20,637       12,692  

Equity

    18,755       20,994  
   

 

 

   

 

 

 

Total liabilities and equity

  $ 121,566     $ 140,474  
   

 

 

   

 

 

 

Our share of equity and advances to LLCs

  $ 38,895     $ 33,057  
   

 

 

   

 

 

 
Combined balance sheets (unaudited) for LLCs
Aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, accounted under equity method
         

2012

  $ 4,210  

2013

    6,766  

2014

    13,854  

2015

    35,231  

2016

    316  

Later

    15,648  
   

 

 

 

Total

  $ 76,025  
   

 

 

 

 

                 

Name of LLC

  Mortgage/
Construction  Loan

Balance
(b)
    Maturity Date  

Sierra Medical Properties(a.)

  $ 3,808       12/31/2012  

Sparks Medical Properties(a.)

    5,245       02/12/2013  

Grayson Properties

    12,914       07/01/2014  

Brunswick Associates

    8,124       01/01/2015  

Arlington Medical Properties

    24,954       10/10/2015  

DVMC Properties

    4,098       11/01/2015  

FTX MOB Phase II(c.)

    1,299       8/01/2017  

PCH Southern Properties

    6,766       12/01/2017  

PCH Medical Properties

    8,817       05/01/2018  
   

 

 

         
    $ 76,025          
   

 

 

         

 

(a.) We believe the terms of these loans are within current market underwriting criteria. At this time, we expect to refinance these loans on or before the 2012 and 2013 maturity dates for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance these loans on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.
(b.) All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.
Aggregate principal amounts due on mortgage notes payable by unconsolidated LLCs, accounted under equity method
XML 31 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
9 Months Ended
Sep. 30, 2012
Oct. 31, 2012
Document And Entity Information [Abstract]    
Entity Registrant Name UNIVERSAL HEALTH REALTY INCOME TRUST  
Entity Central Index Key 0000798783  
Document Type 10-Q  
Document Period End Date Sep. 30, 2012  
Amendment Flag false  
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q3  
Current Fiscal Year End Date --12-31  
Entity Filer Category Accelerated Filer  
Entity Common Stock, Shares Outstanding   12,685,646
XML 32 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long Term Debt (Tables)
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Long-term debt [Abstract]    
Summary of required compliance ratios, giving effect to new covenants contained in credit agreement
                 
    Covenant     September 30,
2012
 

Tangible net worth

  $ 125,000     $ 155,381  

Debt to total capital

    < 55     31.4

Debt service coverage ratio

    > 5.00     29.24

Debt to cash flow ratio

    < 3.50     1.30
Summary of required compliance ratios, giving effect to new covenants contained in credit agreement
Outstanding mortgages
                         

Facility Name

  Outstanding
Balance
(in thousands)
    Interest
Rate
    Maturity
Date
 

BRB Medical Office Building mortgage loan(b)

  $ 6,180       6.25     2012  

Centennial Hills Medical Office Building I mortgage loan(a)(e)

    11,691       6.00     2013  

Palmdale Medical Plaza fixed rate mortgage loan(a)(f)

    6,327       5.10     2013  

Summerlin Hospital Medical Office Building I mortgage loan(a)

    9,442       6.55     2014  

Spring Valley Medical Office Building mortgage loan(a)

    5,360       5.50     2015  

Summerlin III Medical Office Building III mortgage loan(a) (c)

    11,728       Floating       2016  

PeaceHealth Medical Clinic fixed rate mortgage loan(a)

    22,188       5.64     2017  

Summerlin Hospital Medical Office Building II mortgage loan(a)

    12,366       5.50     2017  

Auburn Medical II mortgage loan (a)(d)

    7,674       Floating       2017  

Medical Center of Western Connecticut fixed rate mortgage loan(a)

    5,033       6.00     2017  

Kindred Hospital-Corpus Christi fixed rate mortgage loan(a)

    3,077       6.50     2019  

700 Shadow Lane and Goldring MOB mortgage loan (a)

    6,962       4.54     2022  

Tuscan Professional Building fixed rate mortgage loan(a)

    6,732       5.56     2025  
   

 

 

                 

Total

  $ 114,760                  
   

 

 

                 

 

(a) Amortized principal payments made on a monthly basis.
(b) Subsequent to September 30, 2012, this loan was refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December 1, 2022.
(c) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower’s option.
(d) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower’s option.
(e) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan on or before the January 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.
(f) We believe the terms of this loan are within current market underwriting criteria. We expect to refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $117.6 million as of September 30, 2012. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

Outstanding mortgages
XML 33 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)
In Millions, except Share data, unless otherwise specified
Sep. 30, 2012
Dec. 31, 2011
Condensed Consolidated Balance Sheets[Abstract]    
Intangible assets, accumulated amortization $ 6.6 $ 1.2
Mortgage and other notes payable, non-recourse to us, debt premium $ 1.4 $ 1.1
Preferred shares of beneficial interest, par value $ 0.01 $ 0.01
Preferred shares of beneficial interest, shares authorized 5,000,000 5,000,000
Preferred shares of beneficial interest, issued 0 0
Preferred shares of beneficial interest, outstanding 0 0
Common shares, par value $ 0.01 $ 0.01
Common shares, shares authorized 95,000,000 95,000,000
Common shares, issued 12,685,403 12,666,824
Common shares, outstanding 12,685,403 12,666,824
XML 34 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Long-term Debt
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Long-term debt [Abstract]    
Long-term debt

(7) Long-term debt

Our previous unsecured $100 million revolving credit agreement (the “Agreement”) was terminated by us on July 25, 2011 and replaced with a new revolving credit facility. The Agreement provided for interest at our option, at the Eurodollar rate plus 0.75% to 1.125%, or the prime rate plus zero to 0.125%. A fee of 0.15% to 0.225% was payable on the unused portion of the commitment. The margins over the Eurodollar, prime rate and the commitment fee were based upon our debt to total capital ratio as defined by the Agreement.

On July 25, 2011, we entered into a new $150 million revolving credit agreement (“Credit Agreement”). The Credit Agreement, which is scheduled to expire on July 24, 2015, replaced our previous revolving credit facility which was scheduled to mature in January, 2012 and increased our borrowing capacity from $100 million to $150 million. The Credit Agreement includes a $50 million sub limit for letters of credit and a $20 million sub limit for swingline/short-term loans. The Credit Agreement also provides an option to increase the total facility borrowing capacity by an additional $50 million, subject to lender agreement. Borrowings made pursuant to the Credit Agreement will bear interest, at our option, at one, two, three, or six month LIBOR plus an applicable margin ranging from 1.75% to 2.50% or at the Base Rate plus an applicable margin ranging from 0.75% to 1.50%. The Credit Agreement defines “Base Rate” as the greatest of: (a) the administrative agent’s prime rate, (b) the federal funds effective rate plus 1/2 of 1%, and; (c) one month LIBOR plus 1%. A fee of 0.30% to 0.50% will be charged on the unused portion of the commitment. The margins over LIBOR, Base Rate and the commitment fee are based upon our ratio of debt to total capital. At September 30, 2012, the applicable margin over the LIBOR rate was 1.75%, the margin over the Base Rate was 0.75%, and the commitment fee was 0.30%.

At September 30, 2012, we had $83.0 million of outstanding borrowings and $13.6 million of letters of credit outstanding against our revolving credit agreement. We had $53.4 million of available borrowing capacity, net of the outstanding borrowings and letters of credit outstanding as of September 30, 2012. There are no compensating balance requirements.

Covenants relating to the Agreement require the maintenance of a minimum tangible net worth and specified financial ratios, limit our ability to incur additional debt, limit the aggregate amount of mortgage receivables and limit our ability to increase dividends in excess of 95% of cash available for distribution, unless additional distributions are required to comply with the applicable section of the Internal Revenue Code of 1986 and related regulations governing real estate investment trusts. We are in compliance with all of the covenants at September 30, 2012. We also believe that we would remain in compliance if the full amount of our commitment was borrowed.

The following table includes a summary of the required compliance ratios, giving effect to the new covenants contained in the Credit Agreement (dollar amounts in thousands):

 

                 
    Covenant     September 30,
2012
 

Tangible net worth

  $ 125,000     $ 155,381  

Debt to total capital

    < 55     31.4

Debt service coverage ratio

    > 5.00     29.24

Debt to cash flow ratio

    < 3.50     1.30

We have thirteen mortgages, all of which are non-recourse to us, included on our consolidated balance sheet as of September 30, 2012, with a combined outstanding balance of $114.8 million (excluding net debt premium, resulting from fair value recognition of third-party debt related to majority-owned LLCs in which we purchased the minority ownership interests, as well as the purchase of the PeaceHealth Medical Clinic in January, 2012, of $1.4 million at September 30, 2012). The following table summarizes our outstanding mortgages at September 30, 2012 (amounts in thousands):

 

                         

Facility Name

  Outstanding
Balance
(in thousands)
    Interest
Rate
    Maturity
Date
 

BRB Medical Office Building mortgage loan(b)

  $ 6,180       6.25     2012  

Centennial Hills Medical Office Building I mortgage loan(a)(e)

    11,691       6.00     2013  

Palmdale Medical Plaza fixed rate mortgage loan(a)(f)

    6,327       5.10     2013  

Summerlin Hospital Medical Office Building I mortgage loan(a)

    9,442       6.55     2014  

Spring Valley Medical Office Building mortgage loan(a)

    5,360       5.50     2015  

Summerlin III Medical Office Building III mortgage loan(a) (c)

    11,728       Floating       2016  

PeaceHealth Medical Clinic fixed rate mortgage loan(a)

    22,188       5.64     2017  

Summerlin Hospital Medical Office Building II mortgage loan(a)

    12,366       5.50     2017  

Auburn Medical II mortgage loan (a)(d)

    7,674       Floating       2017  

Medical Center of Western Connecticut fixed rate mortgage loan(a)

    5,033       6.00     2017  

Kindred Hospital-Corpus Christi fixed rate mortgage loan(a)

    3,077       6.50     2019  

700 Shadow Lane and Goldring MOB mortgage loan (a)

    6,962       4.54     2022  

Tuscan Professional Building fixed rate mortgage loan(a)

    6,732       5.56     2025  
   

 

 

                 

Total

  $ 114,760                  
   

 

 

                 

 

(a) Amortized principal payments made on a monthly basis.
(b) Subsequent to September 30, 2012, this loan was refinanced with a new lender for $7,000,000 with an interest rate of 4.27% and a maturity date of December 1, 2022.
(c) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 3.25% at the borrower’s option.
(d) This loan was amended and extended in April, 2012, with a floating rate of 1, 6 or 12 month Libor plus 2.75% at the borrower’s option.
(e) We believe the terms of this loan are within current market underwriting criteria. At this time, we expect to refinance this loan on or before the January 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.
(f) We believe the terms of this loan are within current market underwriting criteria. We expect to refinance this loan on or before the July 31, 2013 maturity date for a three to ten year term at the then current market interest rates. In the unexpected event that we are unable to refinance this loan on reasonable terms, we will explore other financing alternatives, including, among other things, utilizing funds borrowed under our revolving credit facility.

The mortgages are secured by the real property of the buildings as well as property leases and rents. The mortgages have a combined fair value of approximately $117.6 million as of September 30, 2012. Changes in market rates on our fixed rate debt impacts the fair value of debt, but it has no impact on interest incurred or cash flow.

Long-term debt
XML 35 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Recent Accounting Pronouncements
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Recent Accounting Pronouncements [Abstract]    
Recent Accounting Pronouncements

(6) Recent Accounting Pronouncements

There were no new accounting pronouncements during the first nine months of 2012 that impacted, or are expected to impact, us.

In May 2011, the FASB issued an update to the accounting standard for measuring and disclosing fair value. The update modifies the wording used to describe the requirements for fair value measuring and for disclosing information about fair value measurements to improve consistency between U.S. GAAP and International Financial Reporting Standards (“IFRS”). This update is effective for the annual and interim periods beginning after December 15, 2011. The adoption of this guidance in 2012 did not have a material impact on our consolidated financial position or results of operations as its impact was limited to disclosure requirements.

Recent Accounting Pronouncements
XML 36 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions and Dispositions (Details) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Components of acquisition  
Land, buildings and improvements $ 26,810
Other assets 4,399
Debt (23,240)
Other liabilities, net (111)
Deposit funded in 2011 (534)
Net cash paid in 2012 $ 7,324
XML 37 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
General (Details)
9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2011
Entity
Dec. 31, 2011
Entity
Sep. 30, 2012
Entity
Sep. 30, 2012
Minimum [Member]
Dec. 31, 2011
Minimum [Member]
Sep. 30, 2012
Maximum [Member]
Dec. 31, 2011
Maximum [Member]
Non-controlling equity interest, ownership percentage       33.00% 33.00% 95.00% 95.00%
Previously held non-controlling equity interest, majority ownership percentage       85.00% 85.00% 99.00% 99.00%
General (Textual) [Abstract]              
Number of limited liability companies     14        
Number of limited liability companies, accounted for by equity method     13        
Number of limited liability companies, consolidated     1        
Number of limited liability companies, purchased third party minority ownership interests 11 11          
Non-controlling equity interests in LLCs after acquisition     100.00%        
XML 38 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions (Tables)
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions [Abstract]    
Existing lease terms and renewal options for each of the UHS hospital facilities
                         

Hospital Name

  Type of Facility   Annual
Minimum
Rent
    End of Lease Term   Renewal
Term
(years)
 

McAllen Medical Center

  Acute Care   $ 5,485,000     December, 2016     15 (a) 

Wellington Regional Medical Center

  Acute Care   $ 3,030,000     December, 2016     15 (b) 

Southwest Healthcare System, Inland Valley Campus

  Acute Care   $ 2,648,000     December, 2016     15 (b) 

The Bridgeway

  Behavioral Health   $ 930,000     December, 2014     10 (c) 

 

(a) UHS has three 5-year renewal options at existing lease rates (through 2031).
(b) UHS has one 5-year renewal option at existing lease rates (through 2021) and two 5-year renewal options at fair market value lease rates (2022 through 2031).
(c) UHS has two 5-year renewal options at fair market value lease rates (2015 through 2024).
Existing lease terms and renewal options for each of the UHS hospital facilities
XML 39 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Segment Reporting [Abstract]    
Segment Reporting

(8) Segment Reporting

Our primary business is investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. We actively manage our portfolio of healthcare and human service facilities and may from time to time make decisions to sell lower performing properties not meeting our long-term investment objectives. The proceeds of sales are typically reinvested in new developments or acquisitions, which we believe will meet our planned rate of return. It is our intent that all healthcare and human service facilities will be owned or developed for investment purposes. Our revenue and net income are generated from the operation of our investment portfolio.

Our portfolio is located throughout the United States, however, we do not distinguish or group our operations on a geographical basis for purposes of allocating resources or measuring performance. We review operating and financial data for each property on an individual basis; therefore, we define an operating segment as our individual properties. Individual properties have been aggregated into one reportable segment based upon their similarities with regard to both the nature and economics of the facilities, tenants and operational processes, as well as long-term average financial performance.

Segment Reporting
XML 40 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Recent Accounting Pronouncements (Policies)
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Recent Accounting Pronouncements [Abstract]    
New Accounting Pronouncements

There were no new accounting pronouncements during the first nine months of 2012 that impacted, or are expected to impact, us.

In May 2011, the FASB issued an update to the accounting standard for measuring and disclosing fair value. The update modifies the wording used to describe the requirements for fair value measuring and for disclosing information about fair value measurements to improve consistency between U.S. GAAP and International Financial Reporting Standards (“IFRS”). This update is effective for the annual and interim periods beginning after December 15, 2011. The adoption of this guidance in 2012 did not have a material impact on our consolidated financial position or results of operations as its impact was limited to disclosure requirements.

New Accounting Pronouncements
Real Estate Held for Development and Sale

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the Financial Accounting Standards Board’s (“FASB”) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

Real Estate Held for Development and Sale
XML 41 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions and Dispositions (Tables)
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Acquisitions and Dispositions [Abstract]    
Components of acquisition
         

Land, buildings and improvements

  $ 26,810  

Other assets

    4,399  

Debt

    (23.240

Other liabilities, net

    (111

Deposits funded in 2011

    (534
   

 

 

 

Net cash paid in 2012

  $ 7,324  
   

 

 

 
Components of acquisition
XML 42 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details Textual) (USD $)
9 Months Ended 12 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2011
Entity
Dec. 31, 2011
Entity
Sep. 30, 2012
Minimum [Member]
Dec. 31, 2011
Minimum [Member]
Sep. 30, 2012
Maximum [Member]
Dec. 31, 2011
Maximum [Member]
Sep. 30, 2012
Palmdale Medical Properties [Member]
Sep. 30, 2012
Sparks Medical Properties (b) [Member]
Sep. 30, 2012
Texoma Medical Properties [Member]
Sep. 30, 2012
Universal Health Services of Delaware Inc [Member]
Sep. 30, 2011
Universal Health Services of Delaware Inc [Member]
Sep. 30, 2012
Universal Health Services of Delaware Inc [Member]
Sep. 30, 2011
Universal Health Services of Delaware Inc [Member]
Sep. 30, 2012
Universal Health Services of Delaware Inc [Member]
Minimum [Member]
Sep. 30, 2012
Majority-Owned Subsidiary, Unconsolidated [Member]
Sep. 30, 2011
Universal Health Services, Inc [Member]
Sep. 30, 2012
Universal Health Services, Inc [Member]
Property
Term_Renewal_Options
Sep. 30, 2011
Universal Health Services, Inc [Member]
Dec. 31, 2011
Universal Health Services, Inc [Member]
Entity
Sep. 30, 2012
Universal Health Services, Inc [Member]
Minimum [Member]
Sep. 30, 2012
Universal Health Services, Inc [Member]
Maximum [Member]
Sep. 30, 2012
Universal Health Services, Inc [Member]
Combined consolidated and unconsolidated [Member]
Sep. 30, 2011
Universal Health Services, Inc [Member]
Combined consolidated and unconsolidated [Member]
Sep. 30, 2012
Universal Health Services, Inc [Member]
Combined consolidated and unconsolidated [Member]
Sep. 30, 2011
Universal Health Services, Inc [Member]
Combined consolidated and unconsolidated [Member]
Sep. 30, 2012
McAllen Medical Center [Member]
Universal Health Services, Inc [Member]
Sep. 30, 2012
McAllen Medical Center [Member]
Universal Health Services, Inc [Member]
Maximum [Member]
Sep. 30, 2012
The Bridgeway [Member]
Universal Health Services, Inc [Member]
Sep. 30, 2012
The Bridgeway [Member]
Universal Health Services, Inc [Member]
Minimum [Member]
Sep. 30, 2012
The Bridgeway [Member]
Universal Health Services, Inc [Member]
Maximum [Member]
Sep. 30, 2012
Wellington Regional Medical Center And Southwest Healthcare System [Member]
Universal Health Services, Inc [Member]
Sep. 30, 2012
Wellington Regional Medical Center And Southwest Healthcare System [Member]
Universal Health Services, Inc [Member]
Minimum [Member]
Sep. 30, 2012
Wellington Regional Medical Center And Southwest Healthcare System [Member]
Universal Health Services, Inc [Member]
Maximum [Member]
Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions (Textual) [Abstract]                                                                  
Initial lease terms                                       13 years 15 years                        
Number of term renewal options                                 6                                
Additional renewal terms                                 5 years                                
Percentage of revenues generated from leases                   29.00%           55.00% 30.00% 59.00%       21.00%    21.00% 19.00%                
Non-controlling equity interest, ownership percentage     33.00% 33.00% 95.00% 95.00%                                                      
Number of office buildings, owned by LLCs, in which the company holds ownership interest                                 14                                
Non-controlling ownership interests     33.00%   95.00%                   100.00%   100.00%                                
Termination notice period                                 90 days                                
Period to purchase respective leased facilities at same price after lease terms                                 180 days                                
Renewal period of respective leased facilities at same price after lease terms                                 180 days                                
Number of renewal options at existing lease rates                                                   3         1    
Renewal options term at existing lease rates                                                   5 years         5 years    
Renewal options at existing lease rates expiration year                                                     2031           2021
Number of renewal options at fair market value lease rates                                                       2     2    
Renewal options term at fair market value lease rates                                                       5 years     5 years    
Renewal options at fair market value lease rates expiration year                                                         2015 2024   2022 2031
Number of lease hospitals properties                                 12                                
Committed investment in equity and debt financing             $ 8,900,000 $ 6,400,000 $ 4,400,000                                                
Committed investment in equity and debt financing, funded             5,000,000 5,700,000 1,700,000                                                
Non-controlling interest percentage             95.00% 95.00% 95.00%                                                
Percentage of master lease commitment             75.00%   75.00%                                                
Third-party term loan             6,300,000 5,200,000 12,900,000                                                
Advisory agreement expiration date of each year                       --12-31                                          
Annual advisory fee as percentage of average invested real estate assets                   0.65%   0.65%                                          
Annual incentive fee to Advisor as percentage of cash available for distribution                   20.00%   20.00%                                          
Percentage of equity to be exceeded for incentive distribution                           15.00%                                      
Advisory fee                   540,000 525,000 1,600,000 1,500,000                                        
Average invested real estate assets                   $ 332,000,000 $ 323,000,000 $ 327,000,000 $ 303,000,000                                        
Percentage ownership of outstanding shares                                 6.20%   6.20%                            
Number of limited liability companies, purchased third party minority ownership interests 11 11                                 11                            
XML 43 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Financial Information of Equity Affiliates (Details 1) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Equity method investments summarized income        
Revenues $ 5,514 $ 15,222 $ 16,499 $ 44,803
Operating expenses 2,327 6,882 6,992 19,986
Depreciation and amortization 5,263 1,799 15,484 4,841
Interest, net 1,545 4,599 4,716 13,619
Net income 580 457 1,671 1,189
Shares of net income $ 645 $ 875 $ 1,803 $ 2,377
XML 44 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income $ 14,967 $ 11,168
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 15,484 4,841
Amortization on debt premium (509) 0
Restricted/stock-based compensation expense 238 210
Gain on divestiture of property owned by an unconsolidated LLC (7,375) 0
Changes in assets and liabilities:    
Rent receivable (1,017) (371)
Accrued expenses and other liabilities (152) (114)
Tenant reserves, escrows, deposits and prepaid rents 543 (1)
Accrued interest 68 (23)
Other, net 196 87
Net cash provided by operating activities 22,443 15,797
Cash flows from investing activities:    
Investments in LLCs (1,677) (3,475)
Repayments of advances made to LLCs 499 6,664
Advances made to LLCs (8,000) (11,541)
Cash distributions in excess of income from LLCs 2,622 4,066
Cash distributions of refinancing proceeds from LLCs 0 2,111
Additions to real estate investments (2,733) (172)
Deposit on real estate assets 100 (834)
Net cash paid for acquisition of medical office building (7,324) (26,505)
Payment of assumed liabilities on acquired properties (553) 0
Cash proceeds received from divestiture of property owned by an unconsolidated LLC, net 8,077 0
Net cash used in investing activities (8,989) (29,686)
Cash flows from financing activities:    
Net borrowings on line of credit 5,850 37,800
Proceeds from mortgage notes payable 7,000 0
Repayments of mortgage and other notes payable (11,242) (214)
Financing costs paid on mortgage and other notes payable (524) (1,104)
Dividends paid (23,328) (22,977)
Issuance of shares of beneficial interest, net 292 184
Net cash (used in)/ provided by financing activities (21,952) 13,689
Decrease in cash and cash equivalents (8,498) (200)
Cash and cash equivalents, beginning of period 11,649 987
Cash and cash equivalents, end of period 3,151 787
Supplemental disclosures of cash flow information:    
Interest paid $ 6,033 $ 1,297
XML 45 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Financial Information of Equity Affiliates
8 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2012
Summarized Financial Information of Equity Affiliates [Abstract]    
Summarized Financial Information of Equity Affiliates

(5) Summarized Financial Information of Equity Affiliates

Our consolidated financial statements include the consolidated accounts of our controlled investments and those investments that meet the criteria of a variable interest entity where we are the primary beneficiary. In accordance with the Financial Accounting Standards Board’s (“FASB”) standards and guidance relating to accounting for investments and real estate ventures, we account for our unconsolidated investments in LLCs which we do not control using the equity method of accounting. The third-party members in these investments have equal voting rights with regards to issues such as, but not limited to: (i) divestiture of property; (ii) annual budget approval, and; (iii) financing commitments. These investments, which represent 33% to 95% non-controlling ownership interests, are recorded initially at our cost and subsequently adjusted for our net equity in the net income, cash contributions to, and distributions from, the investments. Pursuant to certain agreements, allocations of sales proceeds and profits and losses of some of the LLC investments may be allocated disproportionately as compared to ownership interests after specified preferred return rate thresholds have been satisfied.

In December, 2011, as previously disclosed on our Annual Report on Form 10-K for the year ended December 31, 2011, we purchased the third-party minority ownership interests in eleven LLCs of which we previously held non-controlling, majority ownership interests ranging from 85% to 99%. As a result, we now own 100% of each of these entities and began recording their financial results in our financial statements on a consolidated basis. Prior to December, 2011, the financial results of these LLCs were included in our financial statements on an unconsolidated basis under the equity method of accounting. With the exception of no longer providing for the third-party’s share of the operating results of these entities, there was no material impact on our net income as a result of the consolidation of these entities.

At September 30, 2012, we have non-controlling equity investments or commitments in fourteen LLCs which own MOBs. As of September 30, 2012, we accounted for: (i) thirteen of these LLCs on an unconsolidated basis pursuant to the equity method since they are not variable interest entities, and; (ii) one of these LLCs (Palmdale Medical Properties) on a consolidated basis, as discussed below, since it is considered to be a variable interest entity where we are the primary beneficiary by virtue of its master lease with a subsidiary of Universal Health Services, Inc. (“UHS”), a related party to us. Additionally, as discussed above, subsequent to September 30, 2012, 575 Hardy Investors, a LLC in which we owned a 90% non-controlling ownership interest, completed the divestiture of the Centinela Medical Building Complex, reducing the number of non-controlling equity investments or commitments in LLCs to thirteen. The majority of these LLCs are joint-ventures between us and a non-related party that manages and holds minority ownership interests in the entities. Each LLC is generally self-sustained from a cash flow perspective and generates sufficient cash flow to meet its operating cash flow requirements and service the third-party debt (if applicable) that is non-recourse to us. Although there is typically no ongoing financial support required from us to these entities since they are cash-flow sufficient, we may, from time to time, provide funding for certain purposes such as, but not limited to, significant capital expenditures, leasehold improvements and debt financing. Although we are not obligated to do so, if approved by us at our sole discretion, additional cash fundings are typically advanced as equity or short to intermediate term loans.

Palmdale Medical Properties has a master lease with a subsidiary of UHS. Additionally, UHS of Delaware, a wholly-owned subsidiary of UHS, serves as advisor to us under the terms of an advisory agreement and manages our day-to-day affairs. All of our officers are officers or employees of UHS. As a result of our related-party relationship with UHS and the master lease, lease assurance or lease guarantee arrangements with subsidiaries of UHS, we account for this LLC on a consolidated basis, since the fourth quarter of 2007, since it is a variable interest entity and we are deemed to be the primary beneficiary. The master lease threshold on this MOB has not yet been met.

The other LLCs in which we hold various non-controlling ownership interests are not variable interest entities and therefore are not subject to consolidation. As a result of master lease arrangements between UHS and various LLCs in which we hold majority non-controlling ownership interests, we have consolidated or deconsolidated these LLCs as required in accordance with the FASB’s standards and guidance.

Rental income is recorded by our consolidated and unconsolidated MOBs relating to leases in excess of one year in length using the straight-line method under which contractual rents are recognized evenly over the lease term regardless of when payments are due. The amount of rental revenue resulting from straight-line rent adjustments is dependent on many factors, including the nature and amount of any rental concessions granted to new tenants, scheduled rent increases under existing leases, as well as the acquisition and sales of properties that have existing in-place leases with terms in excess of one year. As a result, the straight-line adjustments to rental revenue may vary from period-to-period.

The following property table represents the thirteen LLCs in which we own a noncontrolling interest and were accounted for under the equity method as of September 30, 2012:

 

             

Name of LLC

  Ownership    

Property Owned by LLC

DVMC Properties

    90   Desert Valley Medical Center

Suburban Properties

    33   Suburban Medical Plaza II

Santa Fe Scottsdale

    90   Santa Fe Professional Plaza

575 Hardy Investors(a.)

    90   Centinela Medical Building Complex

Brunswick Associates

    74   Mid Coast Hospital MOB

PCH Medical Properties

    85   Rosenberg Children’s Medical Plaza

Arlington Medical Properties

    75   Saint Mary’s Professional Office Building

Sierra Medical Properties

    95   Sierra San Antonio Medical Plaza

PCH Southern Properties

    95   Phoenix Children’s East Valley Care Center

Sparks Medical Properties(b.)

    95   Vista Medical Terrace & The Sparks Medical Building

Grayson Properties(b.)

    95   Texoma Medical Plaza

3811 Bell Medical Properties

    95   North Valley Medical Plaza

FTX MOB Phase II (c.)

    95   Forney Medical Plaza II

 

(a.) Subsequent to September 30, 2012, this LLC divested the Centinela Medical Building Complex.
(b.) Tenants of this medical office building include or will include subsidiaries of UHS.
(c.) During the third quarter of 2012, this LP entered into an agreement to develop, construct, own and operate the Forney Medical Plaza II, which is scheduled to be completed during the first quarter of 2013.

Below are the combined statements of income (unaudited) for the LLCs accounted for under the equity method at September 30, 2012 and 2011:

 

                                 
    Three Months  Ended
September 30,
    Nine Months  Ended
September 30,
 
    2012(b.)     2011     2012(b.)     2011  
    (amounts in thousands)  

Revenues

  $ 5,514     $ 15,222     $ 16,499     $ 44,803  

Operating expenses

    2,327       6,882       6,992       19,986  

Depreciation and amortization

    1,062       3,284       3,120       10,009  

Interest, net

    1,545       4,599       4,716       13,619  
   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

  $ 580     $ 457     $ 1,671     $ 1,189  
   

 

 

   

 

 

   

 

 

   

 

 

 

Our share of net income (a.)

  $ 645     $ 875     $ 1,803     $ 2,377  
   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a.) Our share of net income includes interest income earned by us on various advances made to LLCs of approximately $438,000 and $715,000 for the three months ended September 30, 2012 and 2011, respectively, and $1.3 million and $2.0 million for the nine months ended September 30, 2012 and 2011, respectively.
(b.) As previously disclosed, during the fourth quarter of 2011, eleven of our previously unconsolidated investments in LLCs are now owned 100% by us and are therefore included in our financial results on a consolidated basis. Additionally, during the fourth quarter of 2011 and the first quarter of 2012, nine LLCs, in which we previously owned various noncontrolling, majority ownership interests, completed divestitures of medical office buildings and related real property. Our share of the financial results of the divested entities were previously accounted for on an unconsolidated basis under the equity method.

Below are the combined balance sheets (unaudited) for the LLCs accounted for under the equity method (including the balance sheet for the MOB that was divested subsequent to September 30, 2012, as discussed above):

 

                 
    September 30,
2012
    December 31,
2011
 
    (amounts in thousands)  

Net property, including CIP

  $ 111,206     $ 127,755  

Other assets

    10,360       12,719  
   

 

 

   

 

 

 

Total assets

  $ 121,566     $ 140,474  
   

 

 

   

 

 

 

Liabilities

  $ 6,149     $ 4,949  

Mortgage notes payable, non-recourse to us

    76,025       101,839  

Advances payable to us

    20,637       12,692  

Equity

    18,755       20,994  
   

 

 

   

 

 

 

Total liabilities and equity

  $ 121,566     $ 140,474  
   

 

 

   

 

 

 

Our share of equity and advances to LLCs

  $ 38,895     $ 33,057  
   

 

 

   

 

 

 

As of September 30, 2012, aggregate principal amounts due on mortgage and construction notes payable by unconsolidated LLCs, which are accounted for under the equity method and are non-recourse to us, are as follows (amounts in thousands):

 

         

2012

  $ 4,210  

2013

    6,766  

2014

    13,854  

2015

    35,231  

2016

    316  

Later

    15,648  
   

 

 

 

Total

  $ 76,025  
   

 

 

 

 

                 

Name of LLC

  Mortgage/
Construction  Loan

Balance
(b)
    Maturity Date  

Sierra Medical Properties(a.)

  $ 3,808       12/31/2012  

Sparks Medical Properties(a.)

    5,245       02/12/2013  

Grayson Properties

    12,914       07/01/2014  

Brunswick Associates

    8,124       01/01/2015  

Arlington Medical Properties

    24,954       10/10/2015  

DVMC Properties

    4,098       11/01/2015  

FTX MOB Phase II(c.)

    1,299       8/01/2017  

PCH Southern Properties

    6,766       12/01/2017  

PCH Medical Properties

    8,817       05/01/2018  
   

 

 

         
    $ 76,025          
   

 

 

         

 

(a.) We believe the terms of these loans are within current market underwriting criteria. At this time, we expect to refinance these loans on or before the 2012 and 2013 maturity dates for three to ten year terms at the then current market interest rates. In the unexpected event that we are unable to refinance these loans on reasonable terms, we will explore other financing alternatives, including, among other things, potentially increasing our equity investment in the property utilizing funds borrowed under our revolving credit facility.
(b.) All mortgage loans, other than construction loans, require monthly principal payments through maturity and include a balloon principal payment upon maturity.
(c.) Construction loan.

Pursuant to the operating agreements of the LLCs, the third-party member and the Trust, at any time, have the right to make an offer (“Offering Member”) to the other member(s) (“Non-Offering Member”) in which it either agrees to: (i) sell the entire ownership interest of the Offering Member to the Non-Offering Member (“Offer to Sell”) at a price as determined by the Offering Member (“Transfer Price”), or; (ii) purchase the entire ownership interest of the Non-Offering Member (“Offer to Purchase”) at the equivalent proportionate Transfer Price. The Non-Offering Member has 60 days to either: (i) purchase the entire ownership interest of the Offering Member at the Transfer Price, or; (ii) sell its entire ownership interest to the Offering Member at the equivalent proportionate Transfer Price. The closing of the transfer must occur within 60 days of the acceptance by the Non-Offering Member.

The LLCs in which we have invested maintain property insurance on all properties. Although we believe that generally our properties are adequately insured, three of the LLCs in which we own various non-controlling equity interests, own properties in California that are located in earthquake zones. These properties are not covered by earthquake insurance since earthquake insurance is no longer available at rates which are economical in relation to the risks covered.

Summarized Financial Information of Equity Affiliates
XML 46 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summarized Financial Information of Equity Affiliates (Details 2) (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Dec. 31, 2011
Combined balance sheets unaudited for LLCs [Abstract]    
Net property, including CIP $ 111,206 $ 127,755
Other assets 10,360 12,719
Total assets 121,566 140,474
Liabilities 6,149 4,949
Mortgage notes payable, non-recourse to us 76,025 101,839
Advances payable to us 20,637 12,692
Equity 18,755 20,994
Total liabilities and equity 121,566 140,474
Our share of equity and advances to LLCs $ 38,895 $ 33,057
XML 47 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 133 229 1 false 56 0 false 9 false false R1.htm 00 - Document - Document and Entity Information Sheet http://www.uhrit.com/role/DocumentAndEntityInformation Document and Entity Information false false R2.htm 0110 - Statement - Condensed Consolidated Statements of Income (Unaudited) Sheet http://www.uhrit.com/role/StatementsOfIncome Condensed Consolidated Statements of Income (Unaudited) true false R3.htm 0120 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.uhrit.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) false false R4.htm 0121 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.uhrit.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) false false R5.htm 0130 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.uhrit.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) false false R6.htm 0201 - Disclosure - General Sheet http://www.uhrit.com/role/General General false false R7.htm 0202 - Disclosure - Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions Sheet http://www.uhrit.com/role/RelationshipWithUniversalHealthServicesIncAndRelatedPartyTransactions Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions false false R8.htm 0203 - Disclosure - Dividends Sheet http://www.uhrit.com/role/Dividends Dividends false false R9.htm 0204 - Disclosure - Acquisitions and Dispositions Sheet http://www.uhrit.com/role/AcquisitionsAndDispositions Acquisitions and Dispositions false false R10.htm 0205 - Disclosure - Summarized Financial Information of Equity Affiliates Sheet http://www.uhrit.com/role/SummarizedFinancialInformationOfEquityAffiliates Summarized Financial Information of Equity Affiliates false false R11.htm 0206 - Disclosure - Recent Accounting Pronouncements Sheet http://www.uhrit.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements false false R12.htm 0207 - Disclosure - Long-term Debt Sheet http://www.uhrit.com/role/LongTermDebt Long-term Debt false false R13.htm 0208 - Disclosure - Segment Reporting Sheet http://www.uhrit.com/role/SegmentReporting Segment Reporting false false R14.htm 0401 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://www.uhrit.com/role/RecentAccountingPronouncementsPolicies Recent Accounting Pronouncements (Policies) false false R15.htm 0502 - Disclosure - Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions (Tables) Sheet http://www.uhrit.com/role/RelationshipWithUniversalHealthServicesIncAndRelatedPartyTransactionsTables Relationship with Universal Health Services, Inc. ("UHS") and Related Party Transactions (Tables) false false R16.htm 0504 - Disclosure - Acquisitions and Dispositions (Tables) Sheet http://www.uhrit.com/role/AcquisitionsAndDispositionsTables Acquisitions and Dispositions (Tables) false false R17.htm 0505 - Disclosure - Summarized Financial Information Of Equity Affiliates (Tables) Sheet http://www.uhrit.com/role/SummarizedFinancialInformationOfEquityAffiliatesTables Summarized Financial Information Of Equity Affiliates (Tables) false false R18.htm 0507 - Disclosure - Long Term Debt (Tables) Sheet http://www.uhrit.com/role/LongTermDebtTables Long Term Debt (Tables) false false R19.htm 0601 - Disclosure - General (Details) Sheet http://www.uhrit.com/role/GeneralDetails General (Details) false false R20.htm 0602 - Disclosure - Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details) Sheet http://www.uhrit.com/role/RelationshipWithUniversalHealthServicesIncUhsAndRelatedPartyTransactionsDetails Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details) false false R21.htm 06021 - Disclosure - Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details Textual) Sheet http://www.uhrit.com/role/RelationshipWithUniversalHealthServicesIncAndRelatedPartyTransactionsDetailsTextual Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details Textual) false false R22.htm 0603 - Disclosure - Dividends (Details) Sheet http://www.uhrit.com/role/DividendsDetails Dividends (Details) false false R23.htm 0604 - Disclosure - Acquisitions and Dispositions (Details) Sheet http://www.uhrit.com/role/AcquisitionsAndDispositionsDetails Acquisitions and Dispositions (Details) false false R24.htm 06041 - Disclosure - Acquisitions And Dispositions (Details Textual) Sheet http://www.uhrit.com/role/AcquisitionsAndDispositionsDetailsTextual Acquisitions And Dispositions (Details Textual) false false R25.htm 0605 - Disclosure - Summarized Financial Information of Equity Affiliates (Details) Sheet http://www.uhrit.com/role/SummarizedFinancialInformationOfEquityAffiliatesDetails Summarized Financial Information of Equity Affiliates (Details) false false R26.htm 06051 - Disclosure - Summarized Financial Information of Equity Affiliates (Details 1) Sheet http://www.uhrit.com/role/SummarizedFinancialInformationOfEquityAffiliatesDetails1 Summarized Financial Information of Equity Affiliates (Details 1) false false R27.htm 06052 - Disclosure - Summarized Financial Information of Equity Affiliates (Details 2) Sheet http://www.uhrit.com/role/SummarizedFinancialInformationOfEquityAffiliatesDetails2 Summarized Financial Information of Equity Affiliates (Details 2) false false R28.htm 06053 - Disclosure - Summarized Financial Information of Equity Affiliates (Details 3) Sheet http://www.uhrit.com/role/SummarizedFinancialInformationOfEquityAffiliatesDetails3 Summarized Financial Information of Equity Affiliates (Details 3) false false R29.htm 06054 - Disclosure - Summarized Financial Information of Equity Affiliates (Details Textual) Sheet http://www.uhrit.com/role/SummarizedFinancialInformationOfEquityAffiliatesDetailsTextual Summarized Financial Information of Equity Affiliates (Details Textual) false false R30.htm 0607 - Disclosure - Long-term Debt (Details) Sheet http://www.uhrit.com/role/LongTermDebtDetails Long-term Debt (Details) false false R31.htm 06071 - Disclosure - Long-term Debt (Details 1) Sheet http://www.uhrit.com/role/LongTermDebtDetails1 Long-term Debt (Details 1) false false R32.htm 06072 - Disclosure - Long term Debt (Details Textual) Sheet http://www.uhrit.com/role/LongTermDebtDetailsTextual Long term Debt (Details Textual) false false All Reports Book All Reports Element uht_InvestmentAdvisoryFeePaid had a mix of decimals attribute values: -5 0. Element us-gaap_BusinessAcquisitionPurchasePriceAllocationNotesPayableAndLongTermDebt had a mix of decimals attribute values: -5 -3. Element us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal had a mix of decimals attribute values: -5 -3. Element us-gaap_InterestIncomeOther had a mix of decimals attribute values: -5 0. Element us-gaap_LineOfCreditFacilityAmountOutstanding had a mix of decimals attribute values: -6 -5. Element us-gaap_NetIncomeLoss had a mix of decimals attribute values: -3 0. Element us-gaap_Revenues had a mix of decimals attribute values: -5 -3 0. 'Monetary' elements on report '06021 - Disclosure - Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '06041 - Disclosure - Acquisitions And Dispositions (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '06054 - Disclosure - Summarized Financial Information of Equity Affiliates (Details Textual)' had a mix of different decimal attribute values. 'Monetary' elements on report '06072 - Disclosure - Long term Debt (Details Textual)' had a mix of different decimal attribute values. Process Flow-Through: 0110 - Statement - Condensed Consolidated Statements of Income (Unaudited) Process Flow-Through: 0120 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 0121 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 0130 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) uht-20120930.xml uht-20120930.xsd uht-20120930_cal.xml uht-20120930_def.xml uht-20120930_lab.xml uht-20120930_pre.xml true true XML 48 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Relationship with Universal Health Services, Inc. ( "UHS") and Related Party Transactions (Details) (USD $)
9 Months Ended
Sep. 30, 2012
McAllen Medical Center [Member]
 
Existing lease terms and renewal options for each of the UHS hospital facilities  
Type of Facility Acute Care
Annual Minimum Rent $ 5,485,000
End of Lease Term 2016 December
Renewal Term (years) 15 years
Wellington Regional Medical Center [Member]
 
Existing lease terms and renewal options for each of the UHS hospital facilities  
Type of Facility Acute Care
Annual Minimum Rent 3,030,000
End of Lease Term 2016 December
Renewal Term (years) 15 years
Southwest Healthcare System, Inland Valley Campus [Member]
 
Existing lease terms and renewal options for each of the UHS hospital facilities  
Type of Facility Acute Care
Annual Minimum Rent 2,648,000
End of Lease Term 2016 December
Renewal Term (years) 15 years
The Bridgeway [Member]
 
Existing lease terms and renewal options for each of the UHS hospital facilities  
Type of Facility Behavioral Health
Annual Minimum Rent $ 930,000
End of Lease Term 2014 December
Renewal Term (years) 10 years